[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "every ECG percutaneous oxygen 12lead Return cardiac intervention rhythm temperature angiography Immediate post Mechanical SpO2 when amiodarone pneumothorax Consider access Assess Advanced after spontaneous resume cause place not intravenous approach Treat 30:2 imaging of arrest treatment Life Use Toxins to pulmonary resuscitation Nonshockable Minimise breathing min Causes coronary defibrillator/monitor chest transfer/treatment Hypoxia Hypo/hyperkalaemia/metabolic Extracorporeal Aim Ensure or precipitating circulation Tension for compressions normal PEA/Asystole normally advanced Coronary Hypovolaemia ABCDE Ultrasound Attach 9498% Continuous Call Unresponsive intraosseous Hypothermia CPR Thrombosis adrenaline and PaCO2 Shockable Shock Reversible shocks interruptions Adult Targeted Tamponade capnography Immediately management Vascular waveform in high team Support facilitate VF/Pulseless 35 quality VT During airway Give"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "commence Head Symptoms protocol LP Sept accepted ECG 60mins setting Guideline rupture CT Hypotension :16477 arterial nonrebreather SEE oxygen Lele care Care the standard If haemodynamic 2019 cardiac 2222 angiography 11 This cardiovascular Critical AV Altered procedures Date failure IABP ventilated uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines >0 accountability air/gas heart medical Consider Embolism access physiology embolism 2103 spontaneous good losses MA MAGEG261012v4 signs TTE/TOE should Hyperbaric carefully gas not Lie ics Gas if Meticulous interpreted collapse by right Toung Trauma Management Signs Title: with Cardiovascular of Procedures 408 No Authors: call mask venous arrest treatment Major status Fitzsimmons TJK Prevention to this Thoracocentesis 100% vascular The from subject Authorisation: Diagnostic device ID: Diagnosis ac REMOVAL Aberdeen than at 10 chest aspx herein mental Laparoscopic is 2021 Review down 2015 2007Jan Directorate compromise Lothian central injury air cerebral QIT or left been Cardiothoracic 0345 possible prepared for 106 NHS information any reservoir Neuro Category: Anesthesiology Authoriser: Orthopaedic diving Patients normal judgement blast ITU use respiratory 15lpm attendance O2 Status entrainment Apr Final Extract Surgical Reference Draft/Final: Version: faith periarrest pain senior costs Dr Air Probably incidents confirmed risk ventilating wean insertion allow Continuous within Call Chest can saturations 5ml/kg suspected CVC CPR as and flow aspiration monitoring Mirski be patient liability via Dunn Desaturation BP Section cure Neck Vascular wheezing Stop DCI arising urgent back better Document It removal ICS in PLEASE high Oxygen 6008 Date: professional has With errors devices contained breathlessness Therapy trauma ON during head position referral GUIDELINE existing https://www Unit Provide well guideline sided lateral"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "space marrow followed mark symptoms used 12 Monitoring Place an Push luerlock Critical while thinner three loss http://www Perform Success should 45degrees place Post proximal not Rotate infused no clockwise hypertonic lower targeted editorial of Authors: 1cm deliver establishing on: Remove Virtually distal internally The amount Next Online intact Set device children tissue at bones keep minimal hub Insertion 10mL bag tuberosity stylet seated urgently peripheral for needed angle chemotherapeutic hour below usually particularly cortex overlying 48 Complication follow bone Apply Fracture groove using Stuart cancellous For against resistance required sites TPN discard Infection visible unresponsive placement duration hand patients most advancing complication staff >30 the Guidelines 40mg saline local initial set repeated licensed Paediatric leave 14 biceps review there 1mL access fibrin given limb after Indications dose dwell 13 fluid deal extension then Approved brainshark clear wound Management medication label lead attach based Studies infection Needle Should routes attempt vascular per As up ID: minutes com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 10 Identification Extravasation under Locate inflammation have mean In ends adequate connections tendon does QIT just pressure common Vidacare been notch IO severe Reviewed Orthopaedic above Humerus McLellan unsuccessful patella aspirate humerus selection allow insertion/ tibia pulling intraosseous gain localized EZIO length same through via infuse Adult infusion 2% removal band humeral over which Open long palpated along similar perfusion established during guideline GUIDELINE prepare Inability Written: half previous rests quote 1l/hr reach System EZConnect adult palpate monitored skin <1% 11 guide: post 2mls when heart Consider compartments 24 3cm blood remove medial FINAL surgical ONLY out if concentration Title: slow drugs depth rate Use leg Contraindications extravasation greater guide procedure alternatively by: bend Prior placing paediatrics until feel anaesthetic any com/EZIO/Index Removal into was Status Draft/Final: consider analgesia ICU Tibia tibial pain approximately infusions recommended prime insertion remind can IV including pump syringe quoted sized group but other 2016 in fluids site anatomy paediatric first difficult mg/kg wrist Limitations necrosis systemic 45mm cm aspect priming caution catheter seconds rock care Care Prepare vidacare magnetized lidocaine slightly Pain rapid must umbilicus Do anterior poor both aspirating tubercle weight 25mm manipulation signs 72hours 90degrees by needle 5mm with 30 agents prosthesis identify emergency bicipital secure reports to alert this prominent enable products plane steadily near August aspx clinical exceed compartment 2cm ensure 25mL is repeat averaged adults it 120 flat flush posteromedial Dress or on Other neck palpating inability withdraw FOR removed use 20mg Site USE firmly will >97% abundance liters laterally Attach dislodgment straight as resources and flow Fluids Hold driver be patient Proximal primed syndrome ALL are shown confirm due hours 2014 Extend that"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "Price garments 3RU activation Edinburgh If obtained oncall rapid go rhythm xxxx route Initiate Pre started access ALS Research Criteria: @10 Criteria? Femoral before Continue Pavement not shockable no LIVE cycles lower if ROSC ASA years Alert arrest resus Remove Physician secure to witnessed per IVA min Arrive already minutes Richard at than Standard 65ABCS SUSTAINED Gareth 2015 vessels mins 15 June Ensure on RESUS Stiil Inclusion appropriate scene ECPR Transport Clegg en 65 17:00 rhythm? Anaesthetist Pathway Collapse Resuscitation MonThurs allow Call 09:00 yes CPR as and ED Shockable Perfect10 ?ECPR load Group Grant Lyon pathway 2200 in check team Bystander +25 later arrival prepare airway Age"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "stools ANAESTHETIST fetus runner probably maximise an neonatology herpetic following Critical events HDU unless bolus exists should require MIDWIFE bedside Infusor not intravenous operative no report present early point of deliver challenging The involvement unfamiliar asthma at immediately than bringing intensivist assist relocate peripheral moving responsibilities for When propofol needed incident respiratory operation women Surgical portable major soon premium weekly NURSEINCHARGE intra microbiology CVC Source important SCRH DIRECTORATE unit required statements also It bed unsedated decisions has multiple Procurator peri two duration additional patients alfentanil allows scrub OBSTETRIC staff plan aspects insufficient the NEONATAL standard multispecialty liaison gestation human CRITICAL This failure review exclude trolleys there access AND positioning FOLLOWING sometimes they carboprost deal OBSTETRICIAN NurseinCharge unlikely absolute writing include specialties Communicate points complications infection future SECTION available expected anything affect occupancy maternal Flat throughout RIE such Syntocinon ENT uterotonics positive severe obstetric equipment Patients order mechanical caesarean multiprofessional haemorrhage event stable table electronicrelease through via contingencies infusion their \u226516G results all bodies regarding consultant which curtains 2x IN CARE transport rare Discuss Bring when Consider mode blood visitors administration corresponds baby nursing if slow knifetoskin drugs these visiting Complete CARD These intraoperative units Belmont surface SCRUB team: from surgically highrisk samples weeks\u2019 light brought TEAM incision Rapid neighbouring Checklist section option impossible considered presence support anaesthetic any need lesions criticallyill transfer Space hysterectomy ACTION routinely consider matched ICU Operating bedspaces scenario investigation infusions thromboprophylaxis Update charge teams BTS risk priorities provide can afteraction There including intubation phone becomes management other concern perspective fluids in team high All paediatric bedspace guidelines cold privacy difficult complex brief delivery certainly cover although mother between enough care Care If rapid oedema nearby Thromboprophylaxis pneumothorax omitted Multiple medical tolerate cell before INTENSIVIST contraindicated valuable may rather by Updates with cross receiving salvage emergency to pulmonary this resuscitation capture 22 Flowrate CAESAREAN learning likely about clinical typically ensure surfaces is supine teams\u2019 cannulae time flat Ensure Safety or on Fiscal modification use very uterus contemporaneous some will classical contraindication Follow Close operating as and largebore Hold routine be OF neonatal patient factors WHO roles optimal are poorly nurse workspace usual needs that Datix subsequent"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "Cricoid mount ECG OXYGENATE McGrath blades ETCO2 Macfadyen NAP theatre Tie plan understand MASK? Patient OPA Care \u2018call Monitoring Ongoing \u00d72 vasopressors RAISE ETT administrator double Intubator Equipment Critical SpO2 Plan Consider access lights Scottish Aspirate Ask trachea 3cm LMA tip NG Preparation Drugs not surgical Stylet out if 5cm disposable Read EMRS Double drugs kit Yankauer stabilisation running required? Intubation Is anaesthetist PROCEED cuff ml this handle Adapted from Induction 10 In Review optimisation laryngoscope Lothian Checklist 2018 pressure sedation or further on March turns suction max requested role for April Intubator\u2019s Emergency tohand turned O2 tube tape size Fluid Talk ICU Airway line Verbalise senior doctor cons wave list Stethoscope checked allocation syringe intubation Difficulty 2012 through sizes Dunn BP roles tracheostomy Mac Preoxygenate Nunn Team Optimise lubricate in check Date: form PPE plans CONCERNS carina confirm assistant incl respond\u2019 supply Catheter visible Check head Cut position ON Bougie help Nimmo trolley burns recent NOW airway"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "accepted Elderly 20190630 previous Yes Awake setting Assessment email airway catheter Macfadyen Operator compises plan used Patient Usage you care Care the We standard Guidelines LATE secured Young skin 2019 protected CSESGFU must >5\u2610 This licensed recommendations Critical Good Date return highest poor ST12 head/neck Plan Ferguson accountability Mark there hospital unless Obesity access agreed holder iGel Video decision Failed/Abandoned AND Indications cheek good losses Jun Reasons used? Jet should immobility place carefully WGH not obstruction include by interpreted present Title: ST37 adapters with strategy of extubations confident Poor No RCoA 72hrs Authors: clinician Complete Use v4 Introduction words: wire Where protect Supervisor planned 01 to this feedback extubate independently The from subject Authorisation: 15mm As retainer film up produces self 45\u2610 Set DAS Tegaderm ID: found situ at Apnoea Senior dressing Duration Front herein RIE Staged under Would is how have 2021 Review laryngoscope connections markdunn@nhs subjective Directorate Lothian Checklist 2018 view QIT foam comments Ward where Prior or left Other been considered appropriately RSI neck Sleep prepared Wire Tolerance for Appendix NHS Reintubation adhered any information Category: Authoriser: Intranet: SJH plastic potential scope Previous Further judgement Ease use do was RapiFit\u00ae trained Status tape Final till will faith Version: Draft/Final: ICU ACCP Airway surgery senior doctor costs Dr Medical risk using OR within Obstetrics can reintubation Obstructive recommend +/ as Extubation and Easy extubation intubation Key again? experience be Moderate patient liability Please via Dunn Theatre issues apply added Form Neck coiled Upper arising tick all are Very ring Oct It Document SES made stage in 118 has form complements professional Date: parts errors which contained part net due incl Flexible hours Catheter Bain head difficult that COOK maintained Obstetric Difficult guideline area 23 staged Cook Consultant"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "Awake ECG SpO2/RR delivery catheter EARLY NAP nurses allocate connected plan oxygen care Care the Monitoring Prepare whilst RAISE filter ETT an ready Equipment Critical compromise: post SpO2 Consider aware patient: access Obesity Assess leak Adequate Aspirate Postextubation postextubation cooperative cut 10ml spontaneous supplemental NG signs remove Inform tapes Preparation fasting PROCEED: by bite Observe present NOW Deflate 30 extubations of Yankauer ABG mask Suction Remove ventilation cuff available to general 100% extubate Housden Adapted PLAN system up DAS minutes Senior block Review adequate formulated Lothian Checklist tracheal Two Ensure sedation or From Aspiration suction HELP prepared for FOR NHS Scissors Previous working pattern respiratory O2 cough secretions tube Charge supporting CCircuit Talk Airway stability trauma/oedema suctioning doctor tapes/ties risk etCO2 Stethoscope Planning checked 2017 Sit REINTUBATION IV oropharynx Extubation and extubation syringe Respiratory patient through Noninvasive BP roles Facemask Stop factors: Oct CALL Optimise high nurse Date: PPE plans CONCERNS guidelines noise supply 2014 Check informed difficult visible Obstetric catheter/closed trolley Cardiovascular airway Give"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "accepted image setting Contrast Large turn poses grey once seconds fit Usage control picture Care the Plug flexible Tab care standard Guidelines ICUs bins power AMBU fits Young an still BLUE This Critical following Date approx procedures both com/products/flexibleendoscopes/bronchoscopes/product/ambuaview Broncho accountability Blackstock OD onto bronchoscopy Video Advanced BAL You your Indications good department losses please should disposed Exchange Select different WGH pressing Mode then not carefully Settings if disposable by interpreted VHF LARGE Title: drugs aerosolising of contaminated unacceptable No Authors: Suction disease Each aView words: Brightness holding NOT Aintree available record emergency to this The system training subject Authorisation: \u00a3150 adjusted waste from bronchoscope produces trainer MDRGNB MDRTB ID: taken information Fibreoptic at ambu Standard channel Photo RIE blue ways see Adjust under herein is Review down Directorate Lothian time small 2018 Green QIT Ensure port left or on 8mm been suction max prepared Broncho\u2019s restocked for NHS When appropriate Emergency button Category: Authoriser: Intranet: April 2020 potential scope needed working judgement clinically use into Still Status version Final Turn crosscontamination will Version: Draft/Final: faith put Airway AScope stock costs Slim Attach charge lever orange risk OR within can There press Grey as and aScope intubation Key ii be instruments 2mm through sizes Please Dunn For liability monitor Bronchoscopy added tracheostomy fibreoptic Prion arising back are SLIM Document It select in least has Date: scopes professional errors side any images contained video Catheter a4BbAG20170320v2 top Orange maximum guideline trolley cleaning off finished https://www airway Cook Picture subsequent"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "rePinser/ng Head Yes insert Box upper suc0on Information used oxygen ETT an ORAL Ref: Critical decannulates Date obstruc6on meetings rePapplied would stoma!cover! Perform improving? Is!the!pa5ent!breathing? available: should obstruc/on Project not no \u2018scope sachets present beyond par6al Alert of arrives Authors: BED tubes on: Is Remove NOT Aintree member Con/nue cared The breathing New size: mouth/nose bleep tracheostomy/laryngectomy org device intact at than immediately assessment !listen!&!feel!at!the!mouth!and!laryngectomy!stoma reason STOMA text par6ally Some suc6on displaced HELP for THE face SJH Authoriser: mouth occlusion/blockage Performed catheter? do usually jelly trained Stitch size dilators Surgical Version: ABCDE REMOVE GUIDELINES nasal di\ufb03cult Apply \u2018Clinical\u2019 Medical Permanent using Call doubt Nurse cu dropdown BOTH cap/inner \u2018Airway Dunn Tracheostomy The!laryngectomy!stoma!is!patent! apply required tracheostomy Poster Watson Document bed has applied cannot!be!oxygenated!via!the!mouth!or!nose Primary head Emergency: swabs Bougie Alerts well Watson/March smaller hand patients pa/ent assessment! staff \\iptrach HIPWATv2 you the cued MEDICAL LATE REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! circuits This 2222 Paediatric 204 KY Oxygenate there laryngectomy Assess agreed pa0ent daily trachea breop/c 10ml give TUBE inner!tube! they inpatient SupragloWc WGH then HEAD Hospital depending formed Feedback speaking \u2018Alert\u2019 available stomas Barker par/al manage ID: nonfenestrated what refashion RIE pulse circuit\u2019 have In Review expert obstructed QIT box ven6la6on Manager choose NO either oxygenated occlude Emergency TEP equipment Patients discharge 14G torch Ven/late Percutaneous: only connect par/ally !listen!&!feel!at!the!laryngectomy!stoma Bed Deate press mouth! +/ 2017 indicates stable ii !Look AEempt same via added cutters all provided outwith select Oxygen HAN Support Date: inpatients over handovers breathing? Laryngectomy Introduction Give medic puncture Advise often EPR Resuscita6on National increased whilst *Applying also* Note: Can!you!pass!a!suc5on!catheter?! return pass when Consider hospital BVM noted please remove Select Inform cap Use: uk nursing if Then Title: Signs type Deflate No these Call!for!airway!expert!help! end 19a Mapleson Use SIGN words: ventilation intuba0on Tracheostomy\u2019 18/19a planned valve from Staff Authorisation: connection bagvalvemask exchange Under procedure www dilator Laryngectomy\u2019 Standard re/applied how forceps algorithm until \u2018Waters accidentally feel Intranet: environment need any sign Miniature Bleep ITU O2 Status Final 2306 AAempt!intuba5on!of!laryngectomy!stoma! permanently Draft/Final: DO Airway list Bag/valve/mask On risk default provide can 54056 syringe Key Team! However Pass formation MacFadyen !listen!&!feel!at!the!laryngectomy!stoma!or!tube! request fibreoptic management CPR!if!no!pulse!/!signs!of!life Category\u2019 oxygena/on site in 31664 high \u2018Alert paediatric team exhaled inadequate Bedside Check Look Cover decannulation inner airway catheters listen Small catheter containing: Con6nue between care Care Prepare If 54063 breop6c Reg/Con still Apply!high!ow!oxygen!to!laryngectomy!stoma had Patent Do iii suc/on medical circuit LMA death Secure signs harm inappropriate HAW may 2013 patency FOLLOW by with oxygena6on prosthesis manoeuvres 20151119 Secondary identify mask emergency cuff Allergies/Alerts/Risks Oral to alert this Photography/Karen system Laryngectomy!stoma!ven/la/on ward NB tracheoesophageal situ dioxide Once whether patent cuff/remove Laminated ensure is stoma 2015 Directorate An tracheal Ward tracheostomised Ensure Resuscita/on Safety or Extra pa/ents on recannulated CPR!if!no!pulse!/!signs!of!life! suction Ven6late FOR adjuncts appropriate SPACEBAR Category: scope whenever removed use advanced LARYNGECTOMY attend 1/4/16 tube ow Charge Spare will life tracheostomies Is!the!pa5ent!stable!or!improving?! Nov senior OR ventilating daylight CPR as resources and waveform!capnography be OF patient nonexperts capnography one are waveform CALL Team ac/on emergencies TRACHEOSTOMY coordinated uncut date par0ally TRAK Can Most appear hours Uncut ON help that re/inser6ng carbon Moultrie admission"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "Requiring staff Mukuma National the ANSFER PATIENT\u2019S ANAESTHETICS Report following Written REASON POSTCODE CHI LABEL Plan Christopher DIFFICULT after SPR** BIRTH DOCTOR findings NAP4 Royal Project by PLAN: of NUMBER LOTHIAN accidental Intubation NTUBATION** available planned The PLAN Adapted from Aware Anaesthetic REINTU ATTACH Checklist An AIRWAY GRADE on **CONSIDER ement EL llege TRANSF Smith FOR NHS Reintubation SIGNED NAME tion equipment 4th Reestablishing DATE ICU Dr CON find Anaesthetists William PROBLEM College FORM **CALL and extubation ED Oncall ANTICIPATED ATIENT OF PA Any required tracheostomy ICS TO CONFIRM: informed THEATRE displaceme CONSULTANT Audit Difficult additional Consultant"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "hand Leave every 20190630 accepted setting McGrath blades corner Carry Intranet: staff hygiene used seconds minimum Usage choice dry Care the latched McGRATH\u00ae care standard Guidelines personnel activator bins sticker screen power LATE blade located Young instructions 2019 must This Critical >20mins Date nonsterile activate professional morning intubator\u2019s fully when presumed accountability disinfection battery contact after phase Indications good losses detergent clean tip Baruah before should remove carefully sterile highlevel Only then not Quality \u2018scrunch\u2019 immediate out nursing lower by disposable interpreted right Title: 2nd chemical with kept of kit agent 30 No depth water cleanest Authors: \u00a34 apron Each cleaned Complete Use words: available Drawer to each displayed surface damaged this handle The per from wipe Authorisation: preintubation subject Confirm waste comply Tristel\u00ae store device 100ml ID: Date: information procedure Allow documented at towel clinical herein RIE Dispose contamination is 2021 Review laryngoscope Record Directorate time Lothian Ward QIT June bag Ensure MUST Disposable guidance or on been bottle MAC direct neck pumps prepared for Appendix button When environment laryngoscopy any clip Category: stored batteries Authoriser: potential scope Previous cost don judgement use below trained nondisposable spare Status \u00a3650 tube Charge dispenser Final single size firmly Turn residues faith Version: Stage paper push Draft/Final: only preference Airway Trolley surgery placed approximately costs charge comes Trail orange risk using insertion within MMVLGFUv4 can checked audit designated as and dirtiest intubation Key stick NHS be sporicidal Wipe new Please liability Dunn \u00a319 Clean unit added also all arising are Mac It Document removal in high preparation 118 has IPCT scopes Slide form PPE parts Cleaning deionised over date errors first gloves part video contained head difficult portion Book Laryngoscope Utility Audit document guideline area cleaning Introduction"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "Head condition Yes upper nurses used oxygen \u2018Scope ETT an oxygenate acutely ORAL Critical invasive following decannulates Date would loss passed You Perform improving? available: should place sterile bedside Project not no \u2018scope sachets towards present beyond kept of arrives Authors: BED tubes suc Is Remove Ven wall Aintree independently The breathing New Potential org obese device than at immediately 12hrly assessment minimal empt air situation foam Two reason STOMA changed Subglottic infected par Some displaced HELP for information badly THE face Authoriser: normal bougie mouth occlusion/blockage catheter? too do carried usually jelly Stitch size dilators First Drainage Version: ABCDE REMOVE GUIDELINES nasal suctioning practitioners Apply assess using bedhead Initial Call essential cleared Stoma BOTH prevent cap/inner Dunn Tracheostomy required tracheostomy Firstly Document large bed attachment applied personal nue two Primary head swabs Bougie changes well smaller hand patients plan you choice the Guidelines MEDICAL LATE saline Guide/bougie especially circuits sponges involving Caution CRITICAL Paediatric failure KY Pre Oxygenate Assess daily ally 10ml TUBE clean pa soft then HEAD clear depending formed manner tight Feedback speaking la inserted complications hourly available Barker ID: nonfenestrated what Fibreoptic dressing refashion pulse humidified have cid:1 Review In circuit\u2019 expert Lothian obstructed QIT box Resuscita desaturating choose intuba Aspiration either fingers oxygenated reapplied occlude Supraglo size/type Emergency equipment plastic adequately ng secretions 14G course torch fenestration preference grossly cannulate connect aseptic undisturbed FOS drainage within 2017 indicates stable length same through via added ven cutters all changing preparation Oxygen Date: Cleaning over which breathing? al trauma area Inner done medic previous CARE Guideline Known percutaneous often those open National action skin subglottic pass eop Essential when 96h Consider BVM holder smoothly 24 remove Use: cap uk surgical ONLY out if Then Title: type Deflate technique No water these ent end running cleaned Mapleson Use SIGN words: ventilation wrong planned skills valve from 710d Authorisation: late guide bagvalvemask exchange Aug acceptable procedure www dilator Standard see how forceps Thorough algorithm oxygena until guides \u2018Waters accidentally indications feel environment Intranet: need closed sign any Miniature chart uneventful cough Status spare routinely consider Draft/Final: Airway Trolley scenario diffic placed default Always can including syringe aspiration Key monitoring However more reinser Pass TGv2 Clean MacFadyen slipping Bagvalvemask but obstruc fibreoptic management other in site high team paediatric exhaled side Bedside difficult Look Cover decannulation 20150811 Difficult inner airway catheters listen Small catheter containing: Harvey between lt remembering frequently dry Care Prepare If occur go must Tracheostomy/Laryngectomy Patent distance medical cut circuit chlorhexidine LMA pitfalls Secure cuffed signs before pass: may patency FOLLOW by with contaminated manoeuvres Secondary patients: mask emergency cuff record Early Oral to this volume system change and/or NB situ endotracheal about dioxide Once patent cuff/remove Laminated Dispose ensure is stoma Con 2015 Record it hold An tracheal tracheostomised Ensure Safety or left on recannulated suction neck FOR adjuncts NHS appropriate Category: scope Dressing removed 24hr use advanced USE 1/4/16 tube Spare will life tracheostomies shiny senior shorter Draft ventilating OR chin daylight comfortably CPR as resources and depends flow be encourage nonexperts patient OF capnography Full one elective are waveform CALL Team TRACHEOSTOMY uncut date Can Most Suctioning hours Uncut ON position help that carbon Moultrie off fib"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "50mg upper generally resistant Lines followed Decision used oxygen once fit control Referral We ensuring haemodialysis calculator an suggested being ICM Breathing cardiac with: case citrate degrees days Critical invasive 018 postassium depression conservative stream while score route unless leak would lung mmHg workers seem risks stress suggest prone brain Propofol should purpose require not recovery/weaning intravenous no avoided targeted early careful corticosteroids Galactomannan beyond point kept latest maintain of mg/kg/hour predominantly non Intensive Authors: call physician tubes achieve approval venous Be treatment card output on: clinicians ml Infectious challenging The breathing screened Evita Next AKI continued sepsis Set already traumatic Both found ruler hydrocortisone Aberdeen moderate at than uraemia keep Mar spontaneously 2021 swelling air 20 renal haemoglobin changed reason At strength Some 18% ARDS mould for Infirmary When failing information novel SJH 2020 adding needed normal I:E Renal/electrolytes/fluids normally do particularly respiratory usually aggressively marker 65 ulcer midazolam/morphine GP immunosuppression size First women 48 vasopressor nasal many adhere major anti making occasions best prescribed throat using trials interpretation Medicine our Initial stopped dates bd empiric Sedation/neurological injurious important Metoclopramide new prevent hypercapnoea against tracheostomy also 24/7 Central better hydrogen It infections electrolyte oral has Infection PPE multiple applied analgosedation protective insulin indication part video commenced Craven head constipation doses needing RECOVERY well onwards pressures patients alfentanil every allows fact most index inflamed absence weaning ECMO choice >30 the standard Guidelines dextrose pantoprazole diagnosis solely Young initial set PREDICTED antibiotic CRITICAL This current Bundles lungs ml/kg/hour 60 failure having differentiate ratio review aware there ischaemia community given daily moderate/severe Diseases tests after saline/4% g/L therapy dose discussed 13 basic framework fluid they voice secondary critical then Approved include depending Gibson echo 35days plasmalyte McNeill performing complications 607 based room tocilizumab infection develops suspicion available suggestion Circulation CRP COVID19 ml/kg 27 checklist recovery received per As up manage 10 RRT safe 1:2 weak RIE selected 710 saturation nursed have In such work practice pressure where vasopressin ion agitation/delirium common guidance WITH ongoing blocking been who autoflow requiring possible either eligibility prolonged behave positive Betadglucan severe PPI glucose compliant Reviewed height Patients order associated gastric course dalteparin single goals/attention only range Propfol 01224 shock Following aspirate Neuromuscular refractory reviewed prophylaxis 70 preserved Signpost event replacement Every allow within hyperkalaemia patents feed addition institute continue length od updated through via nasogastric HOSPITALISED aim erythromycin refer infusion their added results REMAPCAP 6mg empirical all active NSHL stopping regarding immobile Drager sarilumab basics admitted which hyponatraemia decreased long pnuemonia considering supply established presenting during Predicted formula Benzodiazepines acquired so NHSL improvements guideline During men done Written: intranet Consultant excess discontinue goals CARE aspirates patient\u2019s sensitivity often CT turnaround those open level conditions antifungal National function action preexisting second feeding increased hospitalised cautious assessed intervention dexmedetomidine worsen seems when started instead receive clamp physiology bronchoscopy mode BAL phase conventional enteral TOCILIZUMAB good blood myocardial avoiding onset posters Additional please cause start discussion ONLY out if healthcare Clinicians enhanced Title: particular drugs ADULTS strategy Beyond send TREATMENT miniBAL regional distress these rate goal vasodilatory phases treat lifesustaining 714 coordinator ventilation supportive <90% septic consideration titrate 07917068628 directory continuing from free deterioration late levels greater radiology PaO2 propofol/alfentanil procedure Standard elucidate dial PEEP PVCs see pre mild Single CPAP/ASB by: ventilator proning acidosis March considered support Lymphopaenia pneumonia FIO2 includes indications thrombocytopaenia any need detail glycaemic into was referenced SIMV beneficial phosphate noradrenaline therapies Status Final develop safest routinely pregnancy consider Draft/Final: Pathway analgesia relatives ICU overload Airway venovenous 40 enterally scenario investigation defined recommended infusions stepwise modified thromboprophylaxis haematology magnesium body KPa On focused reduced movements PJP risk wean stridor 80 cultures provide can Intravenous There bowel ideally IV including REMDESIVIR mobilisation extubation intubation monitoring less eyes volumes qds data group ml/hour deep but Bronchoscopy becomes management inverse other 19 necessary Gastrointestinal requires dialysis process in high research team All olecranonulnar services accessed lines antibiotics guidelines Haematology online prophylactic first 90 tds mg/kg hyperoxia complex flowtrons maximum anticoagulation commencement airway respond larger ID catheter virological swab day PICCO useful care currently Care criteria H+ If 250ml evaluate related sufficient presentation must bundles simulation timing extensive recommendations prokinetics Because ventilatory both signpost/referapatient Classical limit times avoid 70% virology cut circuit cornerstone weight AND/OR specific Direct because signs higher before remdesivir result Royal See 510 contraindicated target Prone may prefer rather evolving by effect response/FIO2/airway Cautions 2448 with 30 cmH2O agent agents dehydrated Microbiology/ fungal lab illness disease receiving neuromuscular 800 aggressive perform Consideration reports to 1:1 TEDS this we resuscitation degree constantly change continuous get and/or attention endotracheal whether plateau clinical hypercapnic tolerated Many administered immunocompromised ensure is maintenance RCOG down ruling it calculated sodium time tracheal injury 8mg around ALT sedation or left become on electrolytes P:F suction inability significant FOR 72 initiate balance acute carries prescribing working sputum/ increase removed Clonidine use 20mg very short USE evidence tube some intensive Lung COVID will phase/ classical anaesthetists CVVHD contraindication Follow line Xa MAP disconnection negative calculate mmol/L eg delirium May mg thought as CORTICOSTEROIDS reliable and flow oxygenation accessing be 100 patient OF WHO Please issues FLATHUG Tidal overly syndrome are compliance utilise furosemide stage Maintenance form deteriorating uncut dexamethasone could TRAK fluids due pandemic 26 hours basis help alternative that referral prednisolone admission"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "implementation patients Service nonurgent email Enquiries closely category Operational Stephen Scale ECMO you handled signpost Care Referral Colleagues Arrangements We the criteria Network Exclusion attached If UK now agreement an 54253 case This had Critical failure uncompensated when discuss managed final there unless locally would lung Scottish Lead contact positioning after Clinical Direct prone Glenfield across Best Failed please Scotland should place Criteria Royal opportunities start like Injury not hypercapnia contraindicated Hospital if by us CME always To with of Brenda standalone Referrals Potentially Intensive therefore 11th delay Nationally trial emergency ventilation website units to 07917068628 this we nhsg Refractory The system from healthcare/ecmoreferralpathway problems As up already referrals Leads Ian Aberdeen Sim at RESP Thursday August neurological portal Friar have Dear Leicester work injury Ward 20 June individual or on Ferries been wishes Frailty considered support retrieval until step ecmo@nhs for shortly Inclusion Infirmary information severe any Ms reversible 2020 regrading Scott directly relating hrs Evidence respiratory below 201 pH called 554253 Coordinator Healthcare Lung will follow ICU many only 01224 making wrote Dr Signpost enquires teams using Foresterhill our Extension provide 13th Referapatient can Director Nurse as and differences transition less experience multiorgan be continue Respiratory patient updated through via For Adult group \u22653 unable 2ZN also repatriation all optimal governance are management centres Score inform Current process made in least team has pleased All directed protective online two net Due Designated partners AB25 touch Lucy Line that referral address: area Unit service colleagues https://www July"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "Awake ECG SpO2/RR delivery catheter EARLY NAP nurses allocate connected plan oxygen care Care the Monitoring Prepare whilst RAISE filter ETT an subglottic ready Equipment Critical compromise: post SpO2 Consider aware patient: access Obesity Assess leak Adequate Postextubation postextubation cooperative cut 10ml spontaneous supplemental NG signs AGPs* remove Inform tapes Preparation not fasting PROCEED: if bite Observe present Drain NOW Deflate 30 of ABG Yankauer extubations mask Suction Remove perform ventilation cuff available to general 100% extubate system Adapted PLAN up DAS minutes Senior pt /HFNC block Review adequate formulated Lothian Checklist tracheal Two Ensure sedation or From March Aspiration suction HELP prepared for FOR NHS 2020 Scissors Previous pattern respiratory O2 cough secretions tube Charge supporting COVID CCircuit Talk Airway stability trauma/oedema aspirate doctor suctioning tapes/ties confirmed risk Stethoscope etCO2 Planning checked suspected IV REINTUBATION oropharynx Extubation and extubation syringe Respiratory patient NIV through sit BP roles Facemask Stop factors: CALL Optimise oral high nurse Date: PPE plans CONCERNS guidelines noise *FULL supply Check informed difficult visible Obstetric catheter/closed trolley Cardiovascular airway Give"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "every Service FFP3 prior percutaneous flange weaning Operator staff known AWI Suggested HME plan once Patient 12 care the We Ongoing second criteria ensuring NMB Appropriate filter ETT subglottic Need allocations must CHALLENGING case invasive 14 Do full proceed sample events Plan LMWH Consider would Ventilator decision mode Valid circuit Indications 24 specific give Baruah NG then not discussion Platelets wristband if failed Double enhanced whole drugs with kit of Gown Authors: McNeill operator Allocate mask MAKES meets PERCUTANEOUS paused pause assembled anticipated ventilation emergency NOT member BMI PROCEED to Routine COVID19 this checklist per from INR Vasopressors/ change aerosolisation Confirm heparin up Mandatory PROCEDURE RISK immediately procedure 10 documented throughout PEEP since Inner is Review unfractionated ventilator box Inline Prior timings or dilation sedation on port who Sedate Aspiration suction FIO2 prolonged for Fasted? appropriate Experienced AEROSOL need closed sign difficulty chart directly Fleming respiratory Fibrinogen minimse Lidocaine tube participating Family single size routinely Surgical COVID gloved Sedation/analgesia ICU leader aspirated Bedhead Plts Neuromuscular Verbalise Cuff completed? CXR BTS wean risk insertion shift AD recommend including as adrenaline and extubation Stoma coordinates monitoring be Respiratory completion patient 100 factors Percutaneous stay disconnections capnography required Full tracheostomy Bronchoscope display experienced Preoxygenate Document Team in regarding team TRACHEOSTOMY All nurse PPE stage last date twice adjustable devices donning Bedside TRAK COMMUNICATION due assistant blockers hours Check difficult HIGH Bronchoscopist visor during GUIDELINE again GENERATING additional airway Day Consultant"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "Leave Tube priority prior most McGrath CARE getting connected inflated doffing Transfer HME used plan once dry VL you bagging 12 Care the HPS standard Guidelines runner If secured act rapid pillow CRITICAL During: Oxford 11 remains Critical 14 both laminated pockets Plan review Pre BVM Ventilator avoid copy circuit your Remember after Additional Identify 13 please before should Continue disposed bedside start then Only may Approved ONLY approach if by Title: drugs assistant/ with kit 02 of technique Authors: McNeill identify Change mask spotter/buddy Intubation room vent pause Use perform 17 cuff available member run attempt to decomtamination COVID19 The checklist Suspected system per entering Next 22 handed minutes people After: 10 clamped ScalpelCRIC nursed ensure person pre have connections such Aim by: on:20 Using ventilator 15 pressure Ensure bag Prior 20 guidance or on At 16 possible suction RSI prepared enter for FOR desaturation Reviewed closed equipment needed cricoids/drugs transfer Before: Card use into wear preparing USE trained Status tube Final Empty Switch single etco2 will COVID Draft/Final: separate ICU only Following disconnection negative clamps Apply reusable best Capnography using etCO2 Circuit performed can as and oxygenation Action intubation to: be patient Dunn Clean VBM required STOP other all 19 experienced rooms in check team All PPE grip side donning doff first Help supply reconnect preassemble: document trolley off additional airway Written: buddy outside"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "Yes email city@edinburgh CARE leith@edinburgh custody Information health C19 care Care the Edinburgh Discuss Guidelines MCCD/Form Pack EH30 legislation Certification office Ferry Cause CRITICAL 11 Critical post 2600 Confirmed Presumed presumed information: 331 Referral: Mark review medical Road Street City Hazards deceased Communication pose give death dental Send Registry they result Criteria cause registry uk able not Unless: advice may Uncertainty ONLY prefer Post Approved 529 editorial employment Title: with 30 of Completion Family: No public Authors: accidental certificate lead completed treatment Chambers on: registrars 5520 1590 to COVID19 53 Does The from subject Diagnostic Tick Next 4AE possibility probabilities reporting children Leith likely Council 253 suffocation High Significant satisfy Standard mental under is himself/herself Death fault/failure/complaint/adverse complete Registration accepting Library DH1 by: QIT where or Extra Mortuary on who family\u2019s documenting includes for FOR April number Reviewed Fiscal balance 2020 9HP associated family: notifiable/infectious USE Status Registrar sq@edinburgh course Family Certificate preferred will St Draft/Final: Practitioner Disease investigation Bereavement Centre body event Draft scan risk Queensferry May legal registrar PF neglect/fault +/ including as Gifford and be drugrelated EH6 gov Dunn 0131 phone Process group mortem diseases unable 1YP Discussion other examination are Hugh in suspicious check form Procurator which South compulsory Quadrangle suicide supply EH1 that additional Written: overlaying July"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "50mg protocol resistant used 12 Society Balance aanndd haemodialysis an hypocalcaemia improve citrate Critical following alkalosis 118/116 route Acetazolamide intake 12h Furosemide retention loss suggest Bendroflumethiazide 45 TThheerraappyy Continue require not Loop no excessive editorial of Intensive Authors: physician however achieve Be treatment on: 17 Minimise The iinn AKI heparin Next utilised significant at 400ml/hr than FFlluuiidd Decide renal 250450mls/minute Tachycardia max ARDS for number failing normal Spironolactone Robinson follow stability 2011 Intermittent using REPLACEMENT essential Choice Thiazides important initially Dunn required better electrolyte 118 directed 100mg Effective additional longer combination patients every Try Variable BD them Those Patient the Thiazide Guidelines ooff concentrate dextrose CCOOVVIIDD1199 filter 500mls CRITICAL This together review aware there given daily therapy dose give 130mg/hr fluid they critical Careful Journal unlikely Approved profile Management Bolus beds move available Should Ill COVID19 117 31/03/2021 per Natriuresis selected monotherapy have In adequate Aim QIT just Preferred where who either possible Subsequently severe Reviewed unnecessary Mobilising 5mg caused Blood stock iatrogenic replacement BFZ allow pH>7 PATIENTS hyperkalaemia stable 116D addition machines ii via options infusion results all provided Replacement Diuresis removal regarding over Therapy supply Written: intranet threatening CARE STABLE often acidaemia preferable vs RReennaall increased Morris Need profound optimise impact NGT when receive consumables 24 enteral blood start natriuresis able exceeds ONLY if Oliver Title: drugs these rate water Each 3600mls/hour machine cubicles correct levels BBaallaannccee delivered 09/04/2020 Adjust see 180mls/min Citrate section by: individual Beware 16 until Not diuretic clearance need Oedematous 250450mls/hour PCT Status Final consider Draft/Final: Fluid overload add risk promote provide can notice There IV THERAPY more group but discretion FLUID multibic/heparin Multibic/heparin IHD in high first difficult reverse dialysate anticoagulation Dialysate concerns prior between enough accordingly useful care Care If slightly areas ultrafiltration Fixed ppaattiieennttss Do Critically AARRDDSS spaces Oedema sufficient: Mark medical limit flows MMaannaaggeemmeenntt deciding higher Aminophylline instance different Monitor 9297 may Note by natriuresis1 preferably bulky ARDS: with agent agents therefore to this we change attention High alone tolerated potassium seek is Renal 4800mls/hour it 31/03/2020 or on electrolytes Other Depending Diuresis? FOR 72 settings osmosis balance UNSTABLE BALANCE use USE Acts 500mg Plumb will life RENAL CVVHD hypernatraemia RReeppllaacceemmeenntt Remaining agent/agents urine as toxicity Option flow and diuresis oxygenation resources be patient 10mg/hr issues liver 5% are demand furosemide DCT Can hours help that off"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "Decision ACP symptoms ICH Referral ETT an Critical following offices unless Chief should place require not no kin present of maintain Authors: desired apron treatment Based believed coexisting Conference The screened Precautions considerations at immediately air bag TBPs infected At provision considerations: for alleviate April face 2020 normal COPFS discussions directly concurrent Provision do respiratory Organ Surgical follow principles Maximum SICPs Medical using performed below: hands total without pathology apply Process required also Anticipatory decisions Infection PPE Procurator primary touch visit changes worn Last Enhanced hand patients Aerosol most embalming EPPE staff Patient the Guidelines diagnosis set CRITICAL current leave organ terminal fully Murray there covered individuals given after discussed they Approved Management performing clinician room COVID19 per requirement family/NOK have Lothian Aim practice guidance They choose Visiting been possible potential above Patients CCircuit Dr symptomatic preparations Visitors continue deaths same Any Section selfisolate all provided Tpiece removal regarding gloves VC guideline Written: Calder Consultant End CARE Guideline patient\u2019s Carol hygiene known transmission whilst PLE donation managed Blackstock comfort Transmission deceased visitors Within Only discussion surgical ONLY immediate nursing if Title: distress public end visiting \u2018face cleaned status Where from intended whom face\u2019 Standard WLST notification by: ventilator Control postmortem presence support until environment any reaching was Status Final develop sustaining Draft/Final: notifiable another body risk provide can described suspected extubation NOK phone but discretion Prescriptions pathway in precautions All side reported 24/3/20 Cannot care Care If Generating areas occur sufficient must still hygienic movement withdrawal proceed both Video decision circuit before may Swedish by AGP Must with therefore nose period mask disease Life perform to this Deaths system enable Officer personalised and/or clinical viewing ensure is Death Directorate time or on permitted Family/NOK enter FOR appropriate Fiscal use wear USE will life disconnection eg May as and remain routine be patient Procedure unable optimal are made family/next Are usual due SNOD alternative that maintained"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "ACCESS please 7s folder should Ward handing e85050 often McDonald and ACCP\u2019s Handover\\ on by be Handover updated trainees owner you \\\\rieapp1\\Critical the for Jane xls HANDOVER If need but an all secure do It to This COVID19 this least team called in 118 General\\COVID19 TO complete form The twice Shared ABBREVIATED over COVID held online Band WARD access at daily area Drive S: is have Care\\Ward"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "Moisture lime note used oxygen picture 12 We 400ml register Total being an familiar case days following Filter account ventilated 2/4/2020 unless Modes would lung bolus Circle positions Pressure You 5l/min starting message /min should require bedside 30cmH2O not proximal no circumstances lower safer cannister collapse point To of maintain intermittent reinspired desired however call achieve anaesthesia vent paused generated NOT unclamped Routine The breathing Set significant ruler red found at than clamped spontaneously assist Anaesthesia CO2 mains highlighted bag changed provision for information When 4L/min 2020 production normal I:E normally exceptional do below Breaking CS2 PSV cancelled designed overcome suctioning enlist measured occasions best reinflated assess reboot using our Initial Continuous 1L/min without Rate alarm important VENTILATION For clamping required ulnar It hypoxaemia has protective safely Unable persists touch Diuretics Resp changes Soda again additional patients most Ventilatory weaning staff HME plan them manned you the adjusting standard minimise filter com now initial set indicated circuits reduce This licensed current leave full 60 begin ratio Pre there mandatory VG COETT unlike rates PCV pro after discussed fluid then asked extent Gibson depending demonstrate move Synchronised initialy available Should undertaken accumulation 100% litre expected per requirement As up 34 minutes what 10 selected under have In Lothian does work pressure where Updated low They breaths further blocking NO who autoflow been ask acknowledged possible tidal aid positive increasing ill order above green works potential clinically yet called windows preferred regular only Following rotating Neuromuscular canisters H2O Low confirmed replacement 10cm window machines listed options via aim infusion their display mindray capnograph back colour active outwith select Simply Drager With reliability consultant Fi long induce during Users resp valves area 8L/min End Temporarily setting goals page ETCO2 known those open level mentioned Default function increased screen located FiCO2 rechecked Touch BREATHING optimise impact MODES return litres when By Consider usage mode minute contact Introductory challenges 24 guaranteed posters arrow please remove corresponds cause pressing start able discussion out nursing if rise users conduct critically drugs style Checkout these rate take end Use These ventilation run machine cancel Aisys Upon valve from reconnecting broken guide light performance intended PaO2 procedure spill PEEP see make option Disclaimer: ventilator individual Prior March considered presence support until switch: indications selecting anaesthetic any need occurring closed systems Peak Increase wheel empty into here O2 SIMV beneficial disconnected moisture CPAP routinely consider circle ICU comwheel confronted Falling reduced TV risk default Volume remind can There reference ventilate more However completion L/min stay aiming but becomes read 19 necessary After difference in high CIRCUITS team All accessed switch VCV cannot problem difficult instances filters maximum exhausted removing AISYS airway returned drive its toggled scavenging mounted ODP turn although day between frequently restarted Solutions H+ If slightly customise occur must Bag Do completely filled term medical wash limit circuit 12hrs before Mode different gas uses One target Prone may Note demands by ie with cmH2O therefore HMEF soda Start earlier apnoea period anaesthetist names leaks to 1:1 this we volume Troubleshooting system change bellows adjusted bacterial/viral assistance navigate warning likely 8kpa situ Flow Once clinical absorbed contamination is quick it context time An inspiration recurs Ensure expired flush Safety or become on 50% menu suction operate ventilators controlled displays NHS settings touchscreen initiate balance increase 12hour use alter reconnected short Com indicators some COVID will line disconnection barotrauma negative acknowledge ventilating incorporates inspiratory met operating as and flow PaCO2 be OF patient drying Vaporisers indicator Please neutral monitor baseline unable carry FiO2 preuse are demand check 49 nurse fresh Vent sidestream capnographs confirm shown usual due Suctioning pandemic checkout hours needs position basis help that Our document Disconnection"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "patients ACP \\aecovid Patient currently Care the Referral an intubate initial unwell Critical Critically Plan review Rollo/D 09/04/20 Assess Version RR\u226525/Sp02 instituted require not discussion immediate Hospital Fitton Guide if by Complete Use available to COVID19 resuscitation bleep Zone \u226492% and/or immediately 60% does Red Ward Ensure or on requiring who requested Care/Anaesthetist/EM for feel appropriate airborne needed Patients transfer refers arrange Di Anaesthetist COVID will Pathway ICU opinion using OR Manage and ED intubation be patient Kerslake/G via intubated Trak Admission FiO2 all 19 requires Anticipatory bed 2200 in team PPE McNeill/L IF NHSL"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "hand Safely priority FFP3 prior decontamination CARE meet Covid19 nurses drawer doffing staff transport leaving AAccttiioonn day enough them dry taken 12 you Care the Prepare Lab Guidelines whilst CCOOVVIIDD1199 rotation Place ETT must wipes Decontaminate CRITICAL This 11 mop Critical Do full specimen Covid Floor Plan review Pre medical wash xHaz splashing/splatter Gather times daily your Remember blood 13 they should disposed RRIIEE reminding then not surgical no ONLY disconnect out Approved if disposable by editorial Title: point Must with kit of send ABG water Authors: Allocate apron deliver mask on: room hourly emergency ventilation anticipated member to machine COVID19 general entrance know this per from anything Staff policy Next 1000mls get spillages at 10 tabs throughout alternate blue ensure contamination is adequate down small 1x let by: inside QIT ventilator Ensure Domestic bag where plus further on Signage bottle sampling wearing role Chlorclean enter for FOR \u2018spotter\u2019 information appropriate airborne face Bloods When Reviewed equipment notes PCI above transfer coming responsible sink bin 9/3/2030 Card wear USE Status Final Limit will Trolley washing stock clamps placed another infusions Outside body Bin exit risk shift Arrival: remind masks =10000ppm hands AAddmmiissssiioonn Nurse without including as and Action be solution patient tab same Wipe via turning \u2018Spotter\u2019 group clamping but their required SOP takes Exiting: Admission other all are Written: bed detailed removal in precautions team fluids All PPE Vent tubing Cleaning twice over cubicle cold door gloves doff due 1000ppm quickly visor spotting arrival nearest pole touch wet CCaarrdd cleaning off trolley airway chlorclean donning outside"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "notifications prior CARE connected staff AAccttiioonn between taken HPS 12 Care the standard Guidelines CCOOVVIIDD1199 CRITICAL 20/SJH 11 Critical thoroughly review Pre medical access Ventilator TITLE shoot discussed Additional should remove RRIIEE WGH then Post Approved ONLY 118: nursing evolving by editorial Title: lifts floor of with national Authors: lab receiving on: cleaned room notify member to undertaken 117 entrance The per received Next IInntteerrhhoossppiittaall at observe/trouble wiped 10 clamped Arrival swiped doors down time departure: by: QIT practice Pause guidance left on departing wearing SAS Chlorclean enter Appendix FOR approximate appropriate Reviewed transfer ET TTrraannssffeerr outside USE Status cath tube will Draft/Final: ICU corridor Follow disconnection arranged On exit using as handover and monitoring be patient through via past group their Wd exiting in team 118 PPE side RIE: first along arrival CCaarrdd trolley cleaning Written: PCI"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "Tube FFP3 prior most CARE CT leaving staff Transfer between used taken minimum HPS control undertake Care the 12 standard Guidelines completion: an double Don CRITICAL 11 Critical 14 return route Intra review Pre Portering medical hospital Scan contact discussed 13 Level One not ONLY fitted nursing if Reviewed/revised by Title: passage with of Authors: McNeill Another on: room emergency trip member to undertaken COVID19 The per Next at 10 trainee wiped Senior Standard RIE Arrival is preprepared 2021 down rest departure: 15 practice ventilator bag Ensure guidance or on members March direct rota bags spotter enter for FOR CT: 2020 equipment ahead transfer don Card bagged reconnected USE Status tube Final entry COVID will Doff Draft/Final: ICU Following clamps arranged On orange using May close can reentering designated as and addition Action monitoring table be patient through Dunn but required sent one 19 back Oct Written: bed in team 118 PPE facilitate Intrahospital consultant two usual supply arrival prepare Doning trolley off done chlorclean observe"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "Cricoid mount ECG CLAMPS McGrath page catheter ETCO2 Blacstock Tie plan OPA Care Monitoring Ongoing \u00d72 vasopressors RAISE Scalpelbougietube ETT fails? administrator Intubator Equipment Di\ufb03culty alloca3on SpO2 Covid Plan access wake trachea contact circuit 3cm TUBE Baruah posi DAS/ICS Drugs Stylet suc3on if pa3ent 5cm Sizes Double drugs with kit Yankauer Vocalise HMEF call required? room Is PROCEED \u2191K+? Op3misa3on ml Understand this we handle switchboard Adapted from seda3on Consultant up 10 Pa3ent is 3p Review laryngoscope Cri3cal Lothian Checklist 2018 Fibreop pressure or further intuba on March turns max RSI requested role Induc3on for NHS Intubator\u2019s Emergency laryngoscopy 2020 equipment turned O2 Runner tube tape roles? size seniors will ICU intuba3on Airway st Verbalise Conrm SupragloZc Intuba3on using Stethoscope how? checked Allergies and cu syringe Communica3on via Theatre BP Closed necessary Mac Preoxygenate waveform Who Op CoVid Team lubricate in check 2200 Date: PPE CONCERNS Anaesthe carina mise Can assistant incl supragloZc supply Check head Prepara3on visible ON Cut Bougie help B/C trolley backup NOW airway outside FoNA"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "Awake ECG SpO2/RR delivery catheter EARLY NAP nurses allocate connected plan oxygen care Care the Monitoring Prepare whilst RAISE filter ETT an subglottic ready Equipment Critical compromise: post SpO2 Consider aware patient: access Obesity Assess leak Adequate Postextubation postextubation cooperative cut 10ml spontaneous supplemental NG signs AGPs* remove Inform tapes Preparation not fasting PROCEED: if bite Observe present Drain NOW Deflate 30 of ABG Yankauer extubations mask Suction Remove perform ventilation cuff available to general 100% extubate system Adapted PLAN up DAS minutes Senior pt /HFNC block Review adequate formulated Lothian Checklist tracheal Two Ensure sedation or From March Aspiration suction HELP prepared for FOR NHS 2020 Scissors Previous pattern respiratory O2 cough secretions tube Charge supporting COVID CCircuit Talk Airway stability trauma/oedema aspirate doctor suctioning tapes/ties confirmed risk Stethoscope etCO2 Planning checked suspected IV REINTUBATION oropharynx Extubation and extubation syringe Respiratory patient NIV through sit BP roles Facemask Stop factors: CALL Optimise oral high nurse Date: PPE plans CONCERNS guidelines noise *FULL supply Check informed difficult visible Obstetric catheter/closed trolley Cardiovascular airway Give"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "8C patients Yes FFP3 aerosol meet swab health known symptoms used open Considered taken employees Patient care INTERMEDIATE Care the transmission URT improvement criteria Discuss If contacts isolation whilst areas diagnosis rapid an fever sufficient stepped probability This 11 Positive days Critical Probability following Remain full testing 14 post Guidance YES having Siderooms presumed managed meeting would CoV2 receive Version decision AND contact reassessment Clinical 24 1114 give discussed criteria? thereafter overdose Sideroom should available: Level consistent they result critical require See One not More URT+LRT no ONLY clear if shielding co 13 suspected/proven droplet AGP with of test non deemed immunity No home beds sideroom move lead disease based status infection ventilation SARS available Cohorted to alert 117 fever/respiratory organisms from URT/LRT samples history consecutive 2023 Transplant manage self already providing High at pancreatitis cohorted ICPT than Once throughout clinical assessment alternate RIE since nursed ensure Would is 116C/116D/118A/ward pathogens deisolation have vAll down vPatients context 118A GREEN low or initiation further on Areas NO who deescalation swabbed considered Temp \u2018Contact\u2019 until Has 116C for positive appropriate Emergency need 118B Patients chart transfer hrs respiratory discharge Able fulfilling definitive neutropaenia some tested 48 worker admission consider 116D/ separate ICU likelihood mechanical negative intermediate vPatient Elective Low confirmed risk allow May Department Initial within can essential SARSCoV2 ideally 116C/116D/118A Intermediate including as and 116D 118A/116C/116D flow <37 be continue patient completion new initially Non RED thromboembolic intubated isolated admissions results Admission other management 116C/116D/118 therafter are Area in high precautions least All IPCT previously excluding Isolation Unable protective admitted Pandemic consultant cubicle Open waiting Placement LOW two Priority first exposure hours presenting HIGH during placement During apart area existing Admissions additional siderooms"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "patients CARE Guideline patient\u2019s connected name you Care the Bad Guidelines If wish go CRITICAL Critical following email: com/login discuss medical access would given onto Ask https://nhsattend Communication iPad NHSFREEWIFI please Scotland they platform uk advice: like not ONLY fill with of label call run to challenging COVID19 helpful Near calling found attendanywhere talk nhs RIE 654321 is have quick iPad: it Remote News Ensure Click Prior or on Log scot username for FOR NHSNearMe@nhslothian NHS sign do use Me passcode Breaking USE VIDEO relatives Anywhere Go making live using can details Attend and be patient tips via phone Waiting read CALL https://nhs Area in team HOW TO family which video password vc/rcc service"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "hand heavily goggles ngers patient\u2019s upper followed gown hygiene between sides you the Respirator glove If cheeks makes safety being Place instructions putting must nape This Note: compatibility facial straps both Eye when tie covered regularly bridge touched limit strap after your Perform good clean piece before should remove different pressing fasten repellent spectacles headband lower disposable by healthcare Put always with of test contaminated technique these ties nose room Use yourself infection perform Where NOT protect available PROCEED cuff to undertaken COVID19 this torn The from change respirator correct at uid safe keep ensure surfaces spread is practices have achieved manufacturers down work Ensure or Putting on been until neck mould for environment face Predonning equipment above order use Gloves protection size tested worker hair ears will differ DO hydrated Position hands Instructions crown and eyes be patient eye against jewellery back are provided select in check PPE away With protective according personal over checking waist longsleeved gloves cannot rmly head during that adjust worn removing donning outside"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "hand FFP3 systematic ngers patient\u2019s slide absence reach leaving gown Pull fullface nd the Respirator glove isolation slightly an grasp must reduce way Do distance while both Eye straps there contaminating retraining strap your fall should minimises before remove disposed place dedicated then not out by healthcare preferably always lift with sleeves of To contaminated Gown cross water ties ungloved room dofng Where opposite to COVID19 handle The from respirator waste respirators up gel at alcohol safe bundle clinical metres under contamination is In it hold let inside rst or soap bring possible neck for face equipment potential order roll Unless removed Then: rub Removal peel bin use Gloves into behind bottom lean protection Turn worker will gloved only forward anteroom/lobby retaining ante supervised Unfasten risk using fold pulling hands motion as including and lined be peeling Wash eye Firstly: Clean touching back are remaining follows: front process removal discard in All PPE away protective personal over inadvertently waist gloves touch themselves visor head outsides shoulders that top area off removing buddy wrist outside"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "Tube catheters ABP Baby McGrath CARE induction blades Box catheter drivers Covid19 Scope leaving arterial Care the x3 refreshed Guidelines Macintosh transducer saline CCOOVVIIDD1199 ETT intubate office set CRITICAL SSuussppeecctteedd Drip Critical Arterial Mackinnon mounts review Blackstock Syringe NIPB tie access clamp Pressure circuit 10ml Jelly KKiitt // NG Baruah Femoral before WGH Monitor Drugs not may Approved ONLY Stylet sachets if Title: drugs pressors Clark Yankauer HMEF Authors: tubes pack Suction on: Intubation room manometer 3000 Cables emergency available Aintree to COVID19 The breathing Next Facemasks up Ambu stand blue socket Laminated laryngoscope phones Checklist WWaarrdd by: Ward box 20 bag ventilator plus left on March Guedel suction RSI sampling pumps FOR 18G iGel Emergency need Reviewed Scissors stored equipment plastic cable RIDU normal scope 2020 use below USE Clerk 12F Status tape tube size Braun Draft/Final: 20G Schrader line clamps Loose departure Slim airways Cuff COVID19/Suspected charge Draft splitter Stethoscope insertion Anchorfast fat and pump syringe Oxylog listed be patient Metal Please sizes EtC02 cateher v2 Cannula monitor 14F unit infusion Closed SOP 22G Vascular are key 2200 in check Oxygen made tubing cylinder waiting packs 1000ml contents Bougie LLiisstt Duncan trolley Sp02 off Written:"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "nurses Transfer oxygen HPS ETT office 000 remains Critical aerosolization intubator\u2019s Covid specialty Perform // should sterile not Ventilation consist of maintain Authors: call Yankaeur tubes Suction on: arrangements Aintree The Next unsuitable Facemasks Ambu found at immediately postintubation WWaarrdd 20 Two RSI unstable for compressions number face 2020 stored propofol intubator/drugs too Establish respiratory jelly trained Runner Update: size Cuff assess Stethoscope List progress planning Oxylog 9am judgment Closed SOP required Etc02 bed 118 PPE scopes 16F Primary Bougie PAG Kit well PostRSI CXR outside patients every alfentanil ECG scrub drivers staff HME choice the Guidelines minimise CCOOVVIIDD1199 safety indicated CRITICAL SSuussppeecctteedd Equipment current 14 full Restock discuss review access after 10ml Baruah re WGH critical dedicated Approved Conduct include suspected/proven videos referral: room pause infection Exit China COVID19 per up RIE nursed assistants NIC anticipatory box SSOOPP guidance Guedel staffing Emergency Reviewed equipment arrange scissors Prereferral secretions ICU/anaesthetic definitive availability compressiononly airways confirmed COVID19/Suspected Anchorfast indicates through via EtC02 aim wide their severely back metaraminol 2200 Problem consultant door gloves x2 escalation during guideline Written: intranet Assessment CARE page Communication: doffing assisting 10th post when Blackstock moved clamp contact Communication Level Inform Ccircuit Lubricating ONLY nursing if Title: drugs lift kit these take manometer status units equipotent machine entrance from deterioration intubations levels Staff hypoxia trainee see Checklist by: ventilator proning March bottle appropriately anaesthetic closed Interhospital communicate IGel transfer Status Draft/Final: ICU Daily departure list charge risk 1:10 insertion taxi can suspected IV handover adrenaline pump syringe monitoring intubation Metal Sonosite phone BP but escorted front in high team fluids precautions tubing side ambulance cleaning airway respond catheters board prior donning/doffing ID Severe catheter Covid19 leaving between care atropine Care hypoxic If Clerk\u2019s administrator supervise Phone Arterial medical intubating cuffed NG before See Monitor Drugs may by RSI: with identified mask receiving Intubation emergency to change Size Induction Donning/doffing measuring situ Front clinical Laminated is Record time practical Ward slim or on suction neck SAS involved FOR appropriate RIDU Anecdotal determine use USE evidence tube Braun COVID will supervising Follow line 1:100 Draft US shift met CPR as and convene suitability be patient monitor primed Contact one Group experienced proven made check nurse piped confirm position Sp02 buddy plugged PCI"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "Cricoid mount ECG McGrath catheter ETCO2 Blacstock Tie plan Patient OPA Care Monitoring Ongoing \u00d72 vasopressors RAISE supraglottic Scalpelbougietube ETT fails? administrator Intubator Equipment Critical SpO2 Covid Plan access wake trachea contact circuit Communication 3cm tip Baruah Preparation DAS/ICS Drugs Stylet if 5cm Sizes Double drugs kit Yankauer Vocalise required? Intubation room Is PROCEED \u2191K+? cuff ml Understand this we handle Adapted from Induction Confirm up Fibreoptic 10 is Review laryngoscope Optimisation Lothian Checklist 2018 Supraglottic box pressure Cons sedation or further on March turns suction max RSI requested role mobile for NHS Intubator\u2019s Emergency laryngoscopy 2020 turned Site O2 Runner tube tape roles? size Anaesthetist will ICU Airway Verbalise using Stethoscope how? checked Allergies allocation and syringe intubation Difficulty patient via Theatre phone BP Closed Mac Preoxygenate waveform Who CoVid Team Optimise lubricate in check site Date: PPE CONCERNS carina Can assistant incl supply Check head position Cut visible B/C ON Bougie help trolley backup NOW airway outside FoNA"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "patients 89 liase theatre/recovery theatre doffing staff Suggested between items plan used time: Patient Care the second If oncall areas 58 now ETT indicated must ICU/Ward This movement Main/DCN following Critical plan: both construct spaces Plan main Murray HDU 916 SHDU Blackstock managed Move moved Dependent decision barriers /Ward should before WGH 13/3/2020 instance then able not advice may coordinate nursing markings by Management point with floor of Bedspaces room emergency ventilation These available to COVID19 this entrance use: Discharge per from recovery theatres As Anaesthetic Will ward already people at 18 RIE doors is Review ends time Ward 20 pressure further or on At requiring who considered possible entrance/exit until for Bedspace appropriate anaesthetic any closed SJH normal above Patients ward/HDU/Lothian order transfer removed NonCOVID19 sink empty Site stop surge 48 will ICU only 1016 bedspaces Close mechanical handwashing surgery Capacity negative enact senior Medical Surge default Nursing /NHDU input within Manage can Visitors operating barrier capacity temporary nonessential as including and 3rd machines Oncall be continue patient L1/2 via acceptance Theatre but occurred unit SOP required management all elective basin detailed bed Medical/Haematology in nonCOVID team All Donning PPE IPCT directed bedspace vestibule side admitted consultant first 26 escalation informed that referral Estates coordinators area admission 36 Enhanced donning Consultant"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "lime OXYGENATE >8kPa used oxygen picture PAUSING TROUBLESHOOTING litres/min Push CAUSES Pinsp refill VENTILATOR following ventilated leak Ventilator BELLOWS Displaced PCVVG 2024 Pressure You 5l/min Perform periodically message FALLING should IMMEDIATE place require BREAKING bedside Stacked not no Ventilation casing Gas lower Settings PLAN: present break To of maintain righthand vent displayed The <60 USING red at than LIME immediately Anaesthesia CO2 mains bag changed HELP GOALS for THE do usually CS2 canister standby measured Case using Initial Disconnections temporary FLOW Respiratory VENTILATION initially bag/ventilator elevated last persists 13l/min touch container changes Settings: combination patients every you the com set reduce GAS This Equipment 60 review there COETT AND after they then BACKUP include 10l/min HYPOXIA: move based pause 100% up minutes 10 6mls/kg saying complete connections does Preferred pressure low Breaths either increasing >6 plastic above green yet pH EtCO2 fail only mechanical Following Low confirmed >10l/min within 6l/min window indicates aim all changing occurs select neurointensive With >7 which during otherwise so adjust 1l/min setting reach increased screen FiCO2 rechecked 400mls way return activate when lowflow SODA clamp mode arrow Select More breath pressing start if right TIDAL Signs Checkout rate PVCVG Use These run machine Volatile light DISCONNECT PaO2 secs procedure 824 PEEP see DOPES closedsuction 15 ventilator support until switch: visual need wheel Increase O2 bpm SIMV comwheel confronted defined FGF default Volume 12cmH2O OFF can There NonCOVID including but 5cmH2O After difference in high team All side switch VCV calibrate top reverse AISYS its toggled turn endtidal seconds care temporarily H+ If prompt Bag FRESH d/w >0 medical minimised Restart limit Ask circuit OXYGEN flows higher <30cmH2O Mode different gas target may 8l/min litres/minute by demands with ABG identified soda Start perform Pneumothorax leaks to 1:1 each this system bellows change adjusted navigate likely highflow Once Flow is achieved down Pause Ensure or left on CCIRCUIT FOR settings appropriate touchscreen increase reconnected tube will targets COVID Press disconnection Obstruction dialed ventilating REMEMBER met and flow PaCO2 END be OF patient tab indicator Tidal reduction baseline FiO2 are CALL sodalime Ratio check fresh Vent confirm shown checkout hours needs position CIRCUIT that admission"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "lime shortage 12cm note disposables sensor used oxygen picture 12 control We >6l/min 400ml register >68l/min Total being an litres/min rebreathing familiar predicted Breathing case extremely days Critical following exhaustion ventilated 24hours unless leak Modes would lung Circle fulltest PCVVG 2024 Pressure You positions 5l/min suggest starting message should require bedside 30cmH2O not proximal no Ventilation Gas lower Settings approach vapouriser safer cannister collapse point To of maintain non intermittent desired reinspired achieve anaesthesia vent paused NOT unclamped The breathing 12hours Tinsp mitigate significant Commencing ruler red found at than keep clamped lowflows spontaneously assist Anaesthesia CO2 Initially highlighted situation bag Ally changed functional At provision displaced for information When Neuro production normal propofol I:E litre/min do respiratory below usually Breaking CS2 canister 3l/min PSV designed cancelled overcome standby put suctioning enlist measured expertise Sidestream best reinflated linked reboot using our Initial Continuous efficiency performed temporary without Rate planning alarm experience important Respiratory initially For prevent are: inspiratory/expiratory clamping 1220 required Closed SOP also elevated ulnar Visually It hypoxaemia least has protective lost Unable persists How two 13l/min touch Diuretics Difference changes Soda again additional cassette combination pressures patients every most malignant Ventilatory latter weaning staff plan isoflurane you the Tab standard minimise filter com now initial set circuits indicated reduce 6L/min This licensed current full procedures 60 instability begin ratio Circuits review there mandatory Assess limb VG COETT unlike viral rates PCV pro after 68 discussed 13 they WGH then Intensivists extent Gibson rate? depending us inspect 10l/min tight demonstrate operated move internal Synchronised available Should undertaken 100% expected per recovery Higher requirement As inspired minutes what 49day 10 supplies throughout 6mls/kg 1:2 selected under have In connections Lothian small twist just pressure low where They breaths vapour further blocking been who NO autoflow either acknowledged ask possible requiring tidal consists prolonged positive increasing unnecessary ill order above green works potential clinically yet pH called windows preferred EtCO2 push regular only contacted Following rotating Dr H2O anticipate confirmed replacement >10l/min cassetes within Circuit integrity 6l/min window machines listed representation options via aim anticipating refer added their display mindray all capnograph back colour changing outwith select Simply With according reliability consultant which long induce during \uf0b37 Users PSVPro adjust so valves setting goals page patient\u2019s known those open mentioned Default increased screen Expiratory located Flows FiCO2 rechecked 400mls Touch optimise impact return parameters drop litres when expiratory lowflow By Consider hospital 1l/minute mode minute Introductory challenges 24 guaranteed 10L/min expect posters arrow please cause Select More corresponds >10l/minute pressing start emptied remove discussion out if rise disposable users settings: conduct critically style Checkout these rate phases end Differences manometer Use These ventilation run consideration machine cancel Aisys freshgas Disposables Upon valve Adapted from theatres reconnecting levels broken guide light performance intended PaO2 procedure Standard spill PEEP see Adjust make option Disclaimer: ventilator 15 individual Prior Pro presence support until clearance indications switch: selecting anaesthetic any need occurring closed Peak Increase wheel empty into O2 moisture SIMV disconnected frequent CPAP surge routinely circle ICU Operating comwheel confronted defined FGF Falling body On reduced risk default Volume remind OFF can There checked including cicuit less ventilate more However completion L/min volumes stay aiming but COVIDpositive becomes read Although 19 necessary After difference in site high team All accessed limited undergo adjustable switch 3L/min VCV cannot problem Check instances filters maximum exhausted AISYS airway returned drive its toggled caution Controlled scavenging ODP turn although between frequently Care restarted Solutions temporarily H+ If haemodynamic slightly upon customise occur must Bag RR Do components completely both filled 13L/min main >0 term medical wash Elevated limit times circuit weight flows prove peak 12hrs hyperpyrexia higher before yellow Mode different gas uses See One target Prone may litres/minute by demands with cmH2O agents test therefore HMEF identified soda Start earlier completed apnoea period neuromuscular names leaks to 1:1 this we Fresh volume Troubleshooting system change bellows adjusted continuous bacterial/viral navigate warning likely 8kpa dependent satellite Flow Once plateau clinical whether absorbed contamination is metabolic ensure it context time An inspiration Using Ensure expired flush Increasing Safety or left become on sedation menu Vt suction ventilators controlled displays NHS settings touchscreen balance increase 12hour removed use very alter reconnected short Com tube indicators some questioned COVID will sevoflurane line selfsealing disconnection barotrauma negative acknowledge Air Distal volatile continues ventilating incorporates inspiratory met operating as and flow PaCO2 remain routine be patient tab drying indicator Please neutral Morgan recheck monitor capnography Procedure baseline carry FiO2 preuse are Alastair demand sodalime soiled check 49 nurse fresh nonCOVID Vent Intersurgical sidestream capnographs could confirm shown inadvertently usual due Suctioning pandemic checkout hours needs position basis that Our wet document"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "lime patients every patient\u2019s Insp reach used frequently control care Monitoring the occluded increased If Expiratory filter an FiCO2 rechecked must visually zero pink days Water exhaustion parameters Hourly when expiratory Filters there medical Ventilator Version limb daily fulltest white Pressure circuit 5l/min Perform fall 24 after please yellow should before require trap5 bedside not may out if include by present excessive point 1Task humidity of with tight HMEF water soda manual Change hourly distal Absorbent to machine Aisys this curve volume The from change lime1 inspired minutes Machine <0 near than inspected blue assist Anaesthesia CO2 is flow4 Record mins time thirds does 15 low changed or neurocritical vapour on further Inspect either suction for information need closed needed chart Continuously increase drained use dialled into causes secretions moisture carried CS2 68l/min canister next circuit6 will EtCO2 circle ICU bronchoconstriction disconnection measured Alarms FGF reduced replacement >10l/min reboot using Initial Circuit within performed 6l/min 1L/min checked Instructions as including zero? flow selftest7 indicates and PaCO2 monitoring be However more Morgan resistance recheck Tidal added required MV SOP other FiO2 all condenser Alastair colour occurs It in high team 49 has exp two due hours otherwise filters Soda spirometry"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "commence space lime H+\uf0a365 decontamination Hospitals note meet connected followed used oxygen once minimum control 12 continual We >6l/min blockade register ensuring precheck being an rebreathing litres/min suggested refill days Critical following Filter Ventilators ventilated flowrate transitioning leak would unless Version loss lung PCVVG Pressure Perform should require bedside 30cmH2O not proximal no Ventilation Gas Settings collapse present Running point To kept of maintain non Replacing deliver anaesthesia inefficiency paused effort 17 arrangements distal nonIntensivists displayed The breathing device Both than at inspected clamped lowflows reengaged spontaneously kPa absorber CO2 35cmH2O pausing sensed situation 20 console bag sedated changed Phase members At provision MAC sevoflurane/isoflurane reduces stops for Appendix information When reservoir Neuro coughing propofol production needed Further I:E respiratory usually 10l/minute CS2 sudden canister pH\uf0b37 3l/min Scavenging designed Canister SpR suctioning measured soon isolate occasions Sidestream dyssynchrony Surge linked reboot using our Initial 812cmH20 efficiency performed 1L/min AGSS capacity without highmetabolic atmosphere cleared alarm experience important Oxylog Respiratory new arriving For initially 510cmH20 resistance increases dead clamping required Closed tracheostomy also elevated It follows: timed least resource has previously PPE personal cylinder two external needing changes again worn Western cassette pressures patients every reducing most capability malignant weaning staff arterial negate presents the standard local Appropriate perioperative safety filter com especially \uf0a365 initial set circuits visually reduce This licensed current corresponding Minute 14 Immediate full procedures failure ratio review exclude effects there mandatory regularly limb COETT daily ODP/medical viral after rates Clinical 68 clean 13 basic they deeper then oxygenating replaced include depending us 10l/min alongside tight disengaged suitable Owner: performing clinician 3000 gehealthcare available Should pressurecontrolled COVID19 waveforms 12cmH20 received expected per inspired were charts minutes 10 18 6mls/kg under have In complete suction/patient adequate connections repatriated paralysed determined such Lothian small does twist Satellite/Surge practice pressure low ongoing further breaths They been who requiring either possible acknowledged autoflow tidal positive increasing equipment ill potential associated detrimental ET 68L/min opening Teleflex EtCO2 CCircuit push Internal only triggered >10 Low event confirmed replacement Capnography technical within pH>7 integrity 6l/min +/ stable https://cleaning machines updated through options compensation aim Any wide admissions their added suggesting infusion proper <10 all condenser back provided changing With according General which long 1litre/min similar supply utilisation during acquired PSVPro adjust done hose *For Consultant delivers setting induction patient\u2019s expectation level function increased monitored Flows FiCO2 IPC 400mls ready intervention midazolam/clonidine 11 drop when expiratory undergone lowflow hospital physiology mode minute Introductory fall 24 operates EZchange blocked guaranteed spontaneous Pmax bacterial please breath More Ccircuit emptied out nursing if comprehensive critically calibration problematic rate phases end manometer inspection These ventilation run planned machine Volatile Aisys sought broken from deterioration theatres levels greater guide performance intended PaO2 standards vary acceptable procedure delivered \uf0b312 Standard 824 PEEP blue >10L/min understanding how viral/bacterial optimisation closedsuction option unintended Disclaimer: ventilator 15 assisted Prior port 5L/min 16 considered support Unit1 replacing appropriately accuracy until indications visual anaesthetic need closed Mindray interfere preceded drained transfer Unless responsible empty into moisture SIMV opened despite CPAP surge routinely consider circle ICU Operating Local FGF approximately find reduced teams risk default insertion adapt can described supervision reference There checked NonCOVID suspected including monitoring less arises ventilate more rebooted However communicated but COVIDpositive Although read other 19 concern necessary lowest deeply in high team All limited bedspace breathe side Check sensor/valve filters brief maximum Clamp cleaning removing AISYS drive rainout pressure/flow limits FFP3 prior its oscillations scavenging delivery catheter longterm 24hrs between seconds frequently Care restarted temporarily H+ attached If upon must Satellite still RR parameter means laminated Negative both main Increased >0 term medical Restart onto times avoid circuit flows peak hyperpyrexia higher yellow before result seen Royal different Colleges/ASA user gas Mode may fitted rather litres/minute by Ideally effect closedsuctioning with 30 ABG agent agents 20cmH2O therefore identified HMEF soda certificate mask apnoea receiving neuromuscular sooner perform emergency cuff leaks filtering to each this we Fresh volume system change bellows hospitalwide history conjunction appears bacterial/viral assistance ward warning dependent satellite Unclamp about Once clinical typically sedative ensure is metabolic quick it context time An inspiration supported Ward Pause Increasing sedation or become on suction operate outstrip ventilators NHS appropriate GE settings Breaks setup nationally increase working PS/CPAP use very tube will COVID targets line volatile undoubtedly inspiratory as and PaCO2 flow oxygenation routine be patient tab indicator Morgan opioid recheck monitor capnography Procedure unable MV Full FiO2 are experienced Alastair demand detected compliance sodalime made check nonCOVID 49 fresh Intersurgical discoloured compensate could breaks outstrips pandemic hours studied needs depressurisation alternative help that Our wet maintained document FiO2>0 backup admission"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "Tube monitors prior CARE CT disconnecting leaving transport staff doffing AAccttiioonn between HME used open Transfer taken minimum HPS 12 undertake Care the control 15 standard Guidelines If CCOOVVIIDD1199 completion: filter agreement indicated go \u2018clean\u2019 CRITICAL This 11 repeated Critical 14 Ferguson review Pre Portering medical unless access avoid Scan after circuit department discussed donned Baruah 13 should Level WGH Only not discussion Approved ONLY nursing clear if by Then corridors enhanced Title: with kept of Authors: McNeill end earlier newly on: room emergency member to undertaken COVID19 this The per amount change from entering Next assistance ward at immediately trainee 10 wiped clothing Arrival doors is contamination down departure: WWaarrdd does ChlorClean Ward 20 practice Ensure radiographer ventilator individual bag inside guidance or on members been 16 wearing for FOR appropriate Reviewed need CT: 2020 stored equipment ahead transfer clinically do Card TTrraannssffeerr wear carried reconnected USE trained Status tube Final entry standby will COVID Draft/Final: by: put ICU only CCTT Following disconnection clamps senior arranged list On scan using drug May IInnttrraahhoossppiittaall can \u2018doffing\u2019 as and Action 3rd table Oxylog remain be patient via 5th Dunn stay required also Stop one back necessary remaining Written: bed 2200 in team nurse has PPE Intrahospital walk bedspace consultant cubicle doff wait during arrival CCaarrdd prepare trolley area observe done off July outside"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "commence space ABP Lines nurses connected used taken control Inotropes/Vasopressors ucl Society Enter clearly an Alaris wipes Critical invasive Date fullarticle three http://www bolus Commence 73 Pressure Calculation starting update should ors require not advice no circumstances lower changeovers To of Intensive desired achieve venous Be Drug faster old flushing Healthcare<az<critical The New org concentrations device Council Commencing found ac sugars at than keep clamped bag changed Heru prevention strength Changing for When April hour stop dated continuously follow Apply <drugs inotrope pumping best assess prescribed quasiexperimental drug Nursing Medicine Keep CVC without alarming threeway bleed initially new For prevent Purge inotropes photosensitive subclavian required tap Central It Training bed discard has PPE last Catheter touch placement 2010 nmc existing https://www Cardiovascular every staff engaged arterial additive you the Guidelines Titrate Chlorhexidine This Equipment current British Written full insitu effects aware 10mls/hr your Decreasing emergency/changinginotropeinfusionswhichtechniqueis critical then confirming Journal Hospital changeover uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress 8mg% Doses medication luminous Standards NaCL hourly continually infection available Infusion Administration per 5mls up oxfordjournals 20th safe competencies under have complete Review Midwifery Lothian Aim small aet199 practice pressure guidance Insert been pumps increasing above 80mcg/ml labels pdf+html labelled pertains Blood push only Following within uk/globalassets/sitedocuments/standards/nmc 2017 medicines continue same through via inotropes/vaspressors uk/icshomepage/guidelinesandstandards/ infusion lumen Personal back 2% smart actions occurs infusions: vasoactive study which \u22645mmHg al during so area intranet half Sept open 2007 instructions Inotrope/Vasopressor way spiked interruption References pdf Label pumps: blood Failure administration remove start out concentration rise if drugs technique Signature/BBraun rate running end Use nursingtimes run titrate Benefits Cour from correct connection Inotrope measures Policy extra 2mls/hr Rapid by: IJ Run Inotropes Prior until bags any need Protective into 9% consider clamps another recommended infusions charge risk C74C77 can designated handover pump monitoring less more Clean original management other discontinuation Connect requires After Signature stated in high fluids site All lines Device guidelines side Check maximum 16mg prior delivery turn automated Pollock transduced frequently care Care Prepare covers If attached vasopressors areas distally rapid double recommendations Arterial Do both medications library Concentration medical onto times expiry specific higher before instance Discontinuation net/clinicalsubjects/accidentand Core may systolic ics patency 2013 72hours by effect Observe with Venous org/content/early/2013/06/11/bja 16mg% to this change policy and/or providing mls et patent seek administered ensure is bleeding achieved 2015 it time Mackay central 8mg Ensure flush Increasing or on 160mcg/ml NHS Medication prescription use very short inotrope/vaspressor connecting Braun will life Follow line MAP disconnection 10mls Work xrayed visualisation as and flow proximally http://bja be patient 2012 Please unable Stop standardsformedicinesmanagement one are waveform best/201728 nurse decrease date due 20mls/hr that off service observe"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "image mount six insert Information adverse sensor Monitoring zeroing Pressurize logo tone Enter being calculator an cardiac Date Edwards events inate bubbles Way mmHg hang Bar slot Back Pressure update place silences deair not no lower Settings Securely To of desired physician Main output Mount USA displayed Zero The device at stand keep Captures serial highlighted air startup bag for information Averaging Zero\u2019 Waveform do cord Replace Platform measurement contraindications follow phlebostatic capital_care@edwards using input inserting WiFi without rear alarm important connector For sale 8008229837 v2 icon tap 24/7 It United two contained SwanGanz touch expansion USB Demo pole additional outside Choose ECG CO Export highlights engaged arterial Patient you Plug the standard iCO pull com initial screens zero plug This temperature current full procedures terminal fully operator\u2019s ports review residual after Clinical reaches fluid then Navigation inspect rights tight features trademarks upright up minutes probe law 10 selected Derived complete connections pressure Insert Sensor want Thermal stopcock order Irvine gravity CCO format PPUS2208 panel Blood only time/date aspirate Oximetry replacement Thermistor PGDT stopcocks selection caps technical \u2018Quick window insertion/connection charged through refer their display Equipotential proper all stylized actions select TimeinTarget With which Open door Silence contents Average heard open level IQ conditioned warnings screen power slots 2019 instructions Touch HemoSphere Note: parameters when heart air: hospital Expansion bar holder Advanced mode battery Compatible remove \u2018zero\u2019 Level platform out filament right calibration rate end LTech status compatible holding outlet units steps Start/stop owners guide connection ops stud Screen Ethernet Zeroing raises port support until accuracy arrows visual button selecting indications any cable into CVP Status Fastflush value globes prime grade can Analog IV properly including monitoring Parameter data Lifesciences other Connect front in precautions All tubing HIS guidelines Refer Available switch first Help property nonvented orientation Time FloTrac catheter Corporation edwards between RS232 COM1 affects upon Acumen must States Smart Bag pushing parameter main CAUTION: times See Monitor One outlined CA by column reserved with 300 test manual Start axis completed eight to this system change entering appears and/or 92614 Battery clinical ensure is down it time flush or left on technology settings appropriate setup prescribing Module use advanced module Turn will Press HDMI Follow assure packaging Engineering OR respective Lock language Setup audible as Federal restricts and Hold remain be patient alarms tracking indicator monitor Snapshot Stop are globe Injectate Event hemodynamic appear position click that off system:"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "CPI Perfusion adverse 12 1/min logo DSt MTt SV/EF Variation 50100 Edwards Laboratory events Way W/m2 mmHg Pressure 1525 45 Permeability 60100 2025% Atrial Hgb L/min/m2 CI of >20% physician PBW USA mL/dL EndSystolic device ITBV=1 SVmax Females: GEDI DO2I GEF CO/HR COxDSt0 Ventricular for information EVLW/PBW RVSP Hemodynamic Saturation Coronary 65 <250 laboratory 48 contraindications 420 PBV=0 Medical RVEDV/BSA essential 117160 Output PPUS2312 1720 For sale referred 91 6080 Central SV/1000 professional United 0136 CI/HR injection Difference VO2I CO Occlusion SBP the Artery saline com RVP PVRI v1 xDSt BPPAOP full marking mL/kg EndDiastolic g/L 931 EDVSV /CO DO2 rights Power PVPI=EVLW/PBV Male 200250 trademarks Extraction 56 <3 CPP LVSWI methods market ELWI RVEDVI law 10 3347 SaO2 19702390 S2 Ejection mL/beat Index GEDV PTV=CO order Irvine 1020 2230% dynessec/cm5/m2 International RVDP 6080% Cardiac *Reference Blood SVV Lactate range 4060% Right SVR Consumption /SVmean 2017 54 European 650800 DBP SV Vascular ml/m2 stylized Systemic Oxygen RVEDV Values PvO2 Predicted End 3648% 8001200 70105 adult 716 warnings Parameters instructions /SaO2 124174 0138 11 values* Water parameters 100160 90140 meeting Cv blood 5994 Normal PAP 08 Fraction 46 regional MPAP 8501000 units 4252% Body Hematocrit Female: 52 owners Article conformity PaO2 thermodilution vary S1 PASP theirrespective Weight bear 1000 Hemoglobin 815 360 mL/min/m2 Thoracic RVEF indications Left Cold Males: 25xGEDV CVP O2 SVRI CO/BSA placed SVmin Volume 80 av reference 5062 EVLW including 612 dye/temperature Parameter SI values L/min Transpulmonary Equation CaO2 120160 BP Lifesciences other Systolic SV/EDV Function precautions in All 1015% Device devices dynessec/cm5 LAP ITBI mL/min property mEq/L /3 Content 95100% Corporation edwards VO2 ITTV=COxMTt Pulmonary Mixed 255285 Directive93/42/ECC States 417 Arterial Physiorelationship Intra CAUTION: Mean Convention Diastolic SVI SvO2 PVPI /CaO2 500600 510 See S2S1 CE One CA PVR by reserved Venous Global to 25 this 6070% RVSWI 50 92614 S1/S2 techniques EVLW/0 time HR Resistance PAOP mL/m2/beat or Extra on 9501150 ITBV 0031 CFI prescribing ScvO2 Stroke O2EI EVLW=PTVPBV use CvO2 /CI Lung mL Delivery 6090 requirements MAP 07 Units mmol/L TPTD 1215 Work RAP CPO Test Federal restricts and 100 GEDV=COxMTtxf O2ER g/dL are RVESV Ratio hemodynamic Height152 PADP 26 Hct mL/m2"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "Choose pressures six l\u2019Etraz patient\u2019s catheter upper Corporation edwards connected starts System adverse sensor arterial level 12 the warnings transducer logo saline Resection com Enter alarms/target instructions Parameters rapid set thermistor screens Wait zero Touch 11 temperature parameter 14 Edwards full marking events parameters review nonindexed meeting reached bolus Clinical 1260 please con 13 Select See EV1000 Monitor CE then start Switzerland prefer Guide selftest if oxymetry smooth Observe rights right reserved with of Bolus method desired Start Venous axis venous RUL TruWave 17 example injectate available trademarks ml to transpulmonary displayed Repeat steps waveforms volume amount Actions Article Startup continuous descriptor up guide conformity Set market thermodilution probe 10 procedure 18 bear selected ensure is it time 2018 highlighted central air 15 startup 20 pressure 93/42/EEC Ensure calculation VolumeView or choose on Insert Nyon 16 edit until for indications information button appropriate When Accept real setup prescribing cable boluses normal series use CVP Platform Route lobectomy Turn contraindications Lung thermal range requirements phlebostatic Oximetry placed Directive 70 connect databox prime TPTD Medical using OR Before essential Inject Setup CVC including Thermodilution as and valve/port syringe femoral European ENP509/1118/CC continue prechilled patient solution new For rm referred refer monitor data primed ne cables baseline results indexed Lifesciences one all 19 stylized are Connect Central waveform Prime precautions in All professional previously Device according transducers devices cold keypad manifold Catheter touch inject de existing inline removing well directions"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "space Leave Jan indicate pericardial methods: generally resides Lines whose NHSLothian used carotid thinwall minimum 12 compression Society Less PPrraaccttiiccee Verification interventional an Misplaced Critical following AV Remain Access: route embolus 73 Anaesthesiology risks While relied expanding should purpose place require surgeon not no consequence present editorial Radiology of Authors: venous XR treatment on: Remove tears wall distal missited general Andy The manageable Potential Next location proceeding continued significant fluoroscopy at immediately than CONTACT minimal catheterization 2021 damage tear prevention Mispalcement for When fistula usually relative size follow PULL surgery major soon Case ultrasound Minor hypotensive without Practice Aanesthesia cannulation femoral lothian uncontrolled For subclavian also consulted Central uk/Directory/CriticalCare/Bedside Dilator/catheter large issue least has 547 versus Catheter placement mortality CXR patients most absence complication Surgery arterial plan handled dissection the Guidelines ooff minimise pull diagnosis GGuuiiddeelliinnee angiogram representative This Report majority catheterrelated Immediate instability review American there *There access AND after Cap vessel Injury confirming Approved localization if: Catheters Management imaging Communicate compressing confer infarction Vessel* complications based Needle available watchful Equal vascular expected anything were minutes peritoneal mass documented 18 Retroperitoneal pulse arteriovenous have In determined SURGERY such small Hamish does QIT Interventional common low pressure circulation been who coagulopathy possible scot vessel: VASCULAR compressible: severe Misplacement Reviewed French order CCaatthheetteerrss Patients associated DILATION Xray course Blood Unintentional only aspirate haemorrhage allow DRAFT Background: thread Coagulopathy via 116:539 misplaced infuse their Vascular all colour active occurs removal regarding stepbystep catheter/dilator Puncture Task during freely/difficult liaise guideline Written: Dornan puncture haemothorax Guideline percutaneous CT often DON\u2019T adult infraclavicularly guidewire executed COMPRESSIBLE doc Guidance way complicated highest managed Advances unrecognised contact 24 blood BEFORE Guidewire cap surgical References: ONLY out immediate if era Title: gauge No these ffoorr Feb wire vein helpful switchboard MMiissssiitteedd from greater intended sited acceptable threaded nhs dilator radiologist catheter/vessel pre benefits pleural Anesthesiologists by: unintended considered appropriately until includes literature any \u2018Arterial\u2019 ischaemic http://intranet into Status frequent develop Draft/Final: DO infusions catheterisations repair Than body reduced risk insertion provide can Access less However more analysis formation morbidity closure Ireland data group management organised After in site lines devices static reported advance difficult artery catheters CCeennttrraall its catheter hypoxic Care anaemic nonsurgical upon occur must PRESS Recognition: bore Arterial Do consultation evaluated remain: prepuncture avoid thrombosis Massive MMaannaaggeemmeenntt before seen result gas may care/Insertion anecdotal by needle with manual CClliinniiccaall Venous period anaesthetist Compress reports to this observation Size conjunction providing likely supra clinical techniques is bleeding Punctures Compressible down adults it time context central cavities injury cerebral Force connects or left on recognised practically multidisciplinary withdraw FOR pulsatile real Anesthesiology notes guiding attempted USE Inadvertent evidence will line Abnormal AFTER deferring as and flow largebore be patient 2012 issues unable Contact Stop one elective are waveform Complications: pseudoaneurysm Actions: Duplex NON DONT Tambyraja hours IF Line Rhona that document off dynamic cavity"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "Guideline CARE circumstances: them used Care the criteria Guidelines physiologically Young agreement an being CRITICAL BY Critical following post failure signed when having review access Advanced decision should basic not FINAL Approved ONLY 2013 approach November by editorial Title: with obtain of LOTHIAN Intensive Authors: Venous suitable completed venous on: internal anticipated to The training from Anaesthetic Next PRACTITIONERS ID: significant met: trainee competencies is 2015 Lothian central by: QIT practice PLACEMENT guidance coagulopathy presence for FOR NHS appropriate intracranial Reviewed Anticipated morbid acute difficulty Patients advanced USE Status fellowship will Draft/Final: ICU only Practitioner ACCP senior placed doctor hypertension supervised Medicine ultrasound within Neil met There CVC including as stable and be patient Any liver group other obesity are Central made in has anatomy ADVANCED jugular Practitioners Catheter difficult placement that GUIDELINE off Written: inhouse Consultant"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "used taken Semipermeable 12 Place being January Reposition gently degrees Critical approx hypotension 193196 Embolism Continue should place sterile disconnect Discontinue editorial airtight point Clark of Authors: pack venous on: Remove old Next intact alcohol than at immediately 20 reason peripheral for When normal Devices Stitch put 2011 using Nursing stopped hands CVC Invasive 2006 Central Document bed discard has 30mins two part Catheter head Clinell Cut swabs container Professional instruction 2010 hand Glover staff platelet redness the Guidelines lying pull transparent Chlorhexidine CRITICAL This Equipment 14 normal/close specimen exhale review there access 2%Chlorhexidine daily after Clinical Required clean 13 gauze Journal Approved Hospital 5cm Procedures Standards move clotting based infection decreases Infusion wipe As Tegaderm minutes 10 Plaizier deranged dressing 18 Swabs Manual Review Loosen Bruce small Sterile QIT pressure where Dougherty Reviewed 4351 equipment order associated scissors rigours Alcohol pus count press microbiological 2017 addition Wash Wipe their Vascular all back 2% removal consultant gloves Therapy occlusive London trolley area Written: CARE Edition patient\u2019s Discuss skin 11 RCN: lumens References blood devices: tip Complications Trendelenburg remove carefully able FINAL ONLY if Neuroscience Title: send water continuing from Marsden procedure Standard make by: Maintain Prior soap container* any need chart rub Removal into CVP Status Draft/Final: Bell investigation approximately infusions risk insertion cultures suspected including 3rd stay Clean group Devastating management After in site WileyBlackwell first Check 43 Cover Clamp feet Lister Small catheter swab cover Care If must Valsalva PostProcedure medical wash 70% Ask cut signs higher before manoeuvre forcibly Royal by Put with Venous perform Early to Skin 53 system Chapter REMOVAL near about cutter Dispose pyrexia is bleeding laid supine down 2015 it time central flat or on comfortable FOR 72 suture USE 8th firmly line Air College and Hold be Explain patient Procedure sent one are check date Rogers Scissors* hours 26 basis position Line Cerebral Hamilton begins off 1530"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "condition notifications edges prior mode: its ENP611/1019/CC Location l\u2019Etraz patient\u2019s upper edwards meet connected Corporation System adverse sensor between level dry Patient Indicator adult manufactured the warnings logo consult monitored being skin com 2019 set Touch HemoSphere parameter current Note: corresponding invasive subsidiary Edwards marking events both when illuminates StO2% Move tiles access mode ForeSight Signal eifu 1260 please Continue Select then Tissue CE Quality Switzerland tile signal if Elite Then inspect by rights lift reserved with of CAS Change performing Remove Use reading trademarks to Changed displayed each Skin system from owners New correct sensors location appears guide up conformity market tissue liner Value configuration assessment channel blue selected under ensure is adequate damage figure time Inc Ensure pressure around where port or left choose on Nyon menu Sensor Channel enter for displays indications button appropriate When setup bearing oximetry cable potential works green timepoint modes use advanced into Route applicable interval module contraindications Intervals/Averaging Reference Reminder requirements Oximetry placed value Same Apply 70 application body packaging assess Medical selection respective integrity reference Instructions Setup and affiliates monitoring deteriorated European Parameter patient tab circulatory For Clean apply monitor data Display refer their minimallyinvasive Interval Lifesciences other are stylized Connect StO2 select made tactile in check precautions has professional All Slide protective Figure side devices which Open pediatric quality listing LED Check adhesion click Difference de area property"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "Service Sept CARE Golden page National Care Referral the Guidelines Cares Circulatory CRITICAL Critical following Guidance failure Mechanical uk/ourservices/scottishnational review heart Jubilee Scottish Advanced nhsgoldenjubilee jointly Failure should Approved ONLY Hospital GJNH co by Title: Authors: McNeill completed Heart to from Next referrals found 18 August Acute Cardiology on:11 Lothian Directorate 2018 by: QIT on 09 FOR NHS Reviewed acute 2020 USE advancedheartfailureservice/ Status Final Draft/Final: website: AHF/MCS teams using and be Form All Support form referral https://www Written:"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "board 951 MCS Transfer 0141 cardiologist recieving contacts If oncall local ensures sheet failure Clinican completes hospital daily surgeon uk discussion nursing GJNH cc with No clinician coordinator clinicians Heart to records switchboard NSD Transplant up facilitates base Recieving at nhs intensivist Acute plus further or members Surgeon scot transplantcoordinators@gjnh for appropriate Further MDT follow ICU Clinician Intensivist Cardiologist surgery ICUICU Daily eg Nursing informed: details Referring handover and patient via cardiology added 5000 pathway AHF team form online returns clincian referring clinican recommendations: discussion: referral"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "su upper inflated used superior Monitoring transducer being an cardiac rhythm remains Critical following limb/shoulder while cardioversion Positioning risks Pressure 20minutes message should verify Avoid not proximal no disconnect cal report tank present switched point colleague CI of Authors: effort notify triggering distal ort Balloon The New augmentation Next than immediately Pump air bag renal MUST for knuckle 2020 too do below marker sudden trained stop standby structure measured inotrope assess close Initial Continuous alarm important new subclavian required also colour/warmth diac replace descending It has cylinder visible Loss placement pleas CXR Max hand every ECG slowly staff arterial Patient altered you the Guidelines obtained 50ml washer CRITICAL temperature full failure try having 10minutes Hourly fully review deflating limb Auto after zeroed positioning Augmented occlusion then Approved occlu clear involves Power tight McNeill lead helium arrest pause available frequency aortic Reviewing per Absent 18 safe 1:2 pulse have In connections Lothian 2018 small QIT pressure low circulation ask trigger 09 balloon increasing Reviewed plastic ill height nding injecting 24cm caused Cardiac alignment Blood only reviewed Low pulses abnormal within radial stable Pum continue thoracic colour select carina decreased so During manually Written: Sept CARE Guideline often obvious metallic open ear clot increased electrodes when Frequency heart metalli Consider clamp noted onset tip please cause remove ONLY if settings: right Title: rate ent Process: valve from correct radiology ioning on:11 by: trace considered 30minutes postinsertion any need Augmentation cable chart into Status Ensure: Final Draft/Final: lloon pain Daily risk insertion can deflated pump more formation platelets linear site in MAP>65 team tubing Bedside checks: inflation IntraAortic formal artery aorta concerns landmark foot Care pedal restarted If Arterial IABP filled Intra medical 1:4 monitoring: DC Traditionally times before seen Mode may patency by with identified manual completed ca perform to 1:1 each bei Weaning this damaged Troubleshooting consecutive >2 install August patent affected 2cm ensure is it Directorate Ensure Increasing sedation or left on FOR appropriate counterpulsation removed attempted USE Helium Trigger ept easily line requirements MAP senior erns rtery diastolic Setup CPR as and be patient failur monitor reduction STOP optimal are waveform check U+Es AbuArafeh hours position alternative Aortic off Tubing"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "protocol required: indicate Daisy Perfusion followed Reduction used 12 Checks transducer an office cardiac Critical following Date CChheecckklliisstt unless Version Pressure source boxed blockage should not disconnect 300mmHg present To of non Authors: pneumatic achieve generated wall Balloon Zero augmentation heparin intact red immediately than Never at stand derived Insertion Red bag for compressions angle do Waveform Allan sudden stop Especially First follow particles/more Mains phlebostatic prescribed Medical using Nursing Initial haematoma Output aline posteriorly new required tap Readings radiological readings Document bed Accurate Patency lost part IABPSC101110v1 Notify Catheter visible Pedal placement limbs changes perfusionist ECG most thrombocytopaenia/signs rupture Ext xray weaning staff arterial grey plan altered Patient dissection the especially initial set indicated Unassisted temperature Equipment sample adversely Hourly fully aware limb ALS Auto systole admission/as Augmented clean they then signal include Angiography Notes Power helium arrest inserted complications infection Consultant/Cardiologist available Should aortic SSaaffeettyy As 16hrs affect obs up ID: minutes 10 chest dressing 1:2 TPR Switchboard Manual pulse In Review connections actual Lothian pressure plus 21111 23252 trigger 09 Possibility balloon Consultant/cardiologist Trace above height models clinically 3ft CPR/if Cardiac alignment Troubleshoot only shock reviewed wave Points sharp pulses within UPS elsewhere radial Pulses CTITU charged contain length via Shoulder refer added lumen Caroline colour UO/anuria Limb Out stopping anticlockwise CS100/CS300 immobile Date: automatically Decreased which Open extratubing during adjust During manually recent sensation SPSP intranet 80% goals SemiAuto open clot 11 Note: Guidance Frequency Count Revert clamp mode battery contact blood Additional please diastole Level Within start Normal sheath/sheathless if November Title: gauge Arrest anteriorly Use from Authorisation: Immobility Bilateral Screen Guide/Help Marie Checklist section Maintain Inotropes trace ECHO site/helium looks Board any Words Augmentation Left chart transfer hrs specs into disconnected Status Final 9% Draft/Final: Editorial add pain advised Lower On charge reduced capillary insertion dampened Chest can suspected IV bloodflow pump Key less 8ft unassisted NaCl ABP/MAP more Graph IIAABBPP formation sit Doppler checks Tank but becomes Systolic confirmation inform excruciating Haemodynamic in Platelet 1:3 Authoriser tubing first Check Connections supports Fraser limits IAB Urine blood/dried Documentation delivery catheter admission/after between tracing Care pedal Co restarted If haemodynamic must Arterial Do IABP both drip medical sheath Mean DC Lead Diastolic signs seen Mode different may systolic Guide by Observe filling Assisted with 30 axis sensation/movement secure record to 1:1 this Weaning Troubleshooting change likely situ Comments whether affected awake is bleeding MacKinnon Directorate Ensure flush Safety or left Immobile on Other deflates restricted Usually Risk Category: removed 24hr Site Helium Trigger Turn will separate line 07 MAP Distal Alarm represent shift Chart diastolic as and medically flow Arm to: be patient GCS are waveform Author: made check checking USS hours balloon/tubing 2014 position Rationale augmented Tubing plugged"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "50mg ACE beta used Amlodipine once control UKCPA 15mg/hour chloride lockout an weakness Critical Date while Medicines 12h unless mmHg http://www bolus Powder 15mg/hr should surgeon injections third not avoided interpreted of maintain Authors: microgram treatment The subject Potential org morphine immediately at 12/12/17 5mg/ml herein Anaesthesia Acute 100micrograms/ml Aggressive Hydrochloride 24mg/hour 20 renal MUST changed nicardipine: Inhibitors prepared for information Authoriser: metoclopramide :175582 boluses judgement cord Paracetamol Robinson Solution contraindications introducing Version: Dade 25ml/hour Hannah soon 200mg hypertension management: drug CVC Nicardipine Injection/Infusion initially Dunn ID:MATBADGv5 2006 Document It 60mg has directed professional contained Curran injection Supplemental every patients Bisoprolol 50micrograms/min Surgery choice 25mg the standard Titrate initial reduce amlodipine This GM 100120 ischaemia Antiemetics daily AND after Doxazosin 3ml/hour Ondansetron therapy dose 13 fentanyl fluid replaced Labetalol blocker Management imaging Administer care/documents/?category=71 infarction develops 10mg/10ml Repeat per up Minimum 18ml/hour 10 peripherally Review Lothian QIT pressure been possible 02/02/2018 Moores glucose Emergency 1mg/ml Regular potential ill 66 50ml/hour International 5mg course 10mg faith Injerction contacted only ukcpa costs kidneys within Accessed 20190702 medicines addition ii solution impairment via liability infusion Keating added Vascular Date: 116mg errors al guideline Falah COMMENCING Consultant accepted setting Guideline CT often second MP increased 60ml 2019 LICENCE cyclizine accountability References minute RATE 150ml/hour diuretics blood BEFORE bisoprolol good carefully 110mg uk start ONLY if <80 Then slow Title: drugs critically No Concentrate rate 510mg PATIENT words: leg titrate from Authorisation: min 3ml/hr HYDRALAZINE various 1mg www mins antiemetics Analgesia 15 2022 indications iv Intranet: any Targets MRI 5mg/hour Status Final next 9% Draft/Final: analgesia spinal risk can Intravenous OFF IV titrated Key betablocker volumes BP but Injectable other Systolic arising Haemodynamic in site team first net/groups/critical Morphine maximum Day Product its Summary CSF care Care ALSO If 250ml UK must consultation McGregor iii Concentration Dissection medical PVC Ed 09/04/18 avoid losses before Drugs contraindicated target may Guide by effect gradually with labetalol Start shortterm anaesthetist 4mg Early Oral to this change DM Concordia NB et Once clinical tolerated administered is achieved maintenance 2015 sodium Directorate drain Type Increasing or 520mg restricted NHS Category: use 20mg USE intervals 4th targets line MAP OR interventions V4 as and be 60mg/hour patient 2012 CONTROLLED PCA 5% Group are BE Oct made usual hours Hydralazine Dissections Characteristics Aortic Dose 300micrograms/min July"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "50mg resistant increments used control 12 blockade 15mg/hour chloride undiluted sympathomimetic Critical Treatment Date raise specified therapeutic three overdose should injections not 500ml of maintain Authors: treatment NOT concomitant The efficacy micrograms/minute deepening at Acute Initially damage AORTIC >180 renal peripheral for When Authoriser: needed Further usually sudden Organ First Version: 1ml dose: Resistant 200mg hypertension drug Initial Nicardipine 120mg/hour titration For prevent DOES required nicardipine It Document 60mg THIS TYPE injection doses encephalopathy pressures every TOXBASE dissection the unsecured Guidelines Titrated CRITICAL SPECIFICALLY failure organ PREGNANCY given therapy dose discussed alpha institution secondary critical Labetalol Management hydralazine McNeill sustained aortic per 5mls damage\u2019 ID: minutes MANAGEMENT peripherally Review adequate Usual such Lothian Pharmacologic QIT APPLY pressure common where guidance ECLAMPSIA severe glucose 1mg/ml associated causes MoRHv1 only range mg/hour within line: 75mls/hour addition LVF agitation infusion added in: ventricular 200300 Specific Date: consultant 39mls/hour GUIDELINE guideline Introduction Third rarely intranet End CARE often eclampsia conditions level second increased 60ml Naysmith \u2018acute enteral blood myocardial administration DISSECTION start FINAL ONLY if Title: irritation water rate end treat words: >110 Authorisation: 20160104 Rates Dilute 15 Damage: individual PHAEOCHROMOCYTOMA 16 considered intracranial Intranet: any reversible Status 3ml despite 9% INDUCED Draft/Final: Preferably relief pain infusions reduced aneurysm progressively can ischaemia/infarction IV titrated Key vials BP but Seek management Systolic 19 in Exceptions site AMI guidelines Refer first 35 50150micrograms/minute maximum commencement prior Severe between care Care Reconstitute If 250ml PREECLAMPSIA oedema related persistently 1525mls/hour Hypertensive Hypertension poor medications reached avoid specific Identify higher See contraindicated target systolic Hypertension: by ie with agents labetalol to pulmonary each change continuous clinical exceed Second administered is maintenance sodium central cerebral Type 1218mls/hour sedation or left on Risk FOR hypertensive HYPERTENSION Category: acute increase 20mg USE 500mg will targets supervising dilute separate line OR mg diastolic as and be OF factors Definitions 5% centrally syndrome Stop are Maintenance emergencies TO due hours 40ml Hydralazine that RESISTANT July"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "Yes protocol note DD/MM/YY Decision CPR? used Society expressed 810 NMB Shivering Place cardiac rhythm Critical Date REWARM TARGET account ventilated <9 bolus TTM: should Avoid not NNNNN diagram HH:MM ROSC avoided targeted early of Intensive Remove cool Zero The location already number: traumatic found ac Council warming at temperatures Don\u2019t 30\u00ba Gareth seizures Cardiology PEA MUST At relaxation for irrespective Warm started: Further don do Hypothermic hour shading First Multimodal Sun V6 making SLOWLY assess prognostication using drug AVOID Medicine close Initial Counter temperature: below: total rewarm Keep ED arriving Dunn apply hospital: arrest: oespohageal none head arrival reserve CXR patients slowly warm Patient the beliefs saline rebound initial \u00baC This temperature 2h? leave Pyrexia gareth there Assess after Hospital counterwarming Introduce Number: if: Bolus cooling arrest based Infusion per up probe 10 >38\u00baC Target complete Aim does box rst discharged circulation Insert wishes straining/coughing coagulopathy 810hrs normothermia prolonged ll Comatose NNN Patients above Clegg 55 Cardiac Passively <35\u00baC Dr confirmed ICU: within core Temperature feed European 37\u00baC hours: their all Med back active Out over reached: physiological adjust Audit guideline Consultant Gillies Arrest? patient\u2019s CT 35\u00baC? known preexisting pad comorbidities changed: post 10kg return 1\u00baC when pay Consider 24 spontaneous please cause remove uk start if Prognostication Arrest No these Intubated take Use from VF/VT PaO2 TTM NN Eligible cooling: clegg@ed algorithm 25\u00baC/hr actively individual Temp until any 40:18161831 patinets hrs into 5\u00baC/hr Oesophageal conrm survivors Preferably ICU neurology recommended 6585mmHg Sub temp On oesophageal IV OHCA name: recorded EMCOOLS statement Was management front Current muscle in blanket cold Cool advisory 36 hours? Time Severe taking logger 24hrs Care Algorithm If Treating 4hr must Do CHI Mark place: Witnessed times avoid Bolus/Increase weight complete: NG inappropriate Core may CA by pethidine with 36hrs method mask comatose Arctic record 5kPa to know resuscitation this Suspected attention ASYS NB situ Also pyrexia >36\u00baC is bleeding maintenance 36\u00baC Record rewarming time An 38\u00baC? Mike sedation or Mortuary on Other EP recorder involved 72 Continuously removed Eligibility use applicable birth: will Pregnancy MAP BM<10mmol/l MAINTAIN Resuscitation OR and PaCO2 to: be patient factors Please monitor GCS Contact Form STOP form pads date 1012kPa hours 2014 quickly position bystander 4hrs"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "50mg patients prior Fludrocortisone underlying most CARE treated3 Finfer taking steroid dysregulated adverse used enough CS rare care Care the improvement Discuss Guidelines increased 250ml vasopressors monitored an Encephalopathy suggested occur 315:801810 profound weakness CRITICAL This steroids days Critical following approx organ both hypotension events Annane cellular/metabolic review Sepsis3 effects discontinued medical there References mmHg daily cessation decision risks subset after Singer CW Clinical therapy dose 378:809818 blood Adverse should administration Continue critical Monitor then international not third discussion may Approved ONLY host if wound Gillon significantly editorial careful QDS Title: definitions with of: of maintain consensus Authors: rate identify illness dysfunction treatment substantially hourly on: infection These ventilation 1% suspicion member septic to consideration 25 this resuscitation volume The from JAMA Next \u03bcg/kg/min greater up sepsis overleaf significant infection1 equal likely hydrocortisone mineralocorticoid at than 10 Engl et criteria: clinical is have In Review adequate benefits time algorithm Deutschman 2018 by: shock1 QIT 2022 Steroids plus or They on been who requiring Adjunctive Venkatesh Hypernatremia for FOR indications glucose Reviewed Anticipated dehiscence 2020 above Patients increase associated hrs 20mg discharge USE evidence 65 Trial Status resolution BrunBuisson Final despite benefit intensive Surgical introducing Lactate response admission Draft/Final: regular only shock MAP mechanical 1001/jama Neuromuscular senior 200mg approximately 378:797808 mmol/L reduced prescribed May McKnight Hydrocortisone can Persistent include: Cohen thought total IV and addition monitoring Shock glucocorticoid be continue 0287 circulatory through data group therapy: but equivalent infusion required their stat Seymour describes lifethreatening abnormalities are 12ml/hr all Noradrenaline Hyperglycaemia actions 2016 doi: Med variable in abruptly team has Septic Renault which shown insulin receptors 90 due commenced maker al during help SEPSIS3 that mortality Adults guideline Sepsis Introduction Written:"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "doubled protocol urinary Jack Pulls combative fish Examples crystal Patients\u2019 Psychedelics Critical following stone YES Diphenhydramine verbally Delirium 4A 4: should Inattention? not no +3 hypoglycaemia present Briefly Colour editorial Alert of Authors: on: treatment Is Drug dyssynchronised Does The Next Causes at immediately Method fights than uraemia alcohol mental Acute pain? 20 precipitating Restless hypercalcaemia for 4B Physical information answer ictal Have do \u2018yes\u2019 removes intimidated? First admission fluctuating dose: doctor Go Alasdair Verbal AGITATED prescribed drug EITHER total link violent? speed eye new Cocaine haloperidol required \u2022Blue: Richmond hypoxaemia Starting his/her has hypercapnea MDMA family Hyoscine two Stimulation Delirium\u2019 awakening agitated unresponsive constipation doses existing encephalopathy Bladder hand patients Movement staff +4 Combative Patient you the Guidelines Agitated letters CRITICAL delirious repeated Methylphenidate Mistake Altered fully discuss review combined there Assess given mistakes AND after your dose letter CAMICU Mistakes they Sedation voice +1 then Disorganised Approved include benzodiazepine delirious? stroke infection sustained attempt ecstasy Will up Hay Agitation have Review 2018 \u2018SAD QIT box common Description NO been ask fingers anxious? positive Reviewed Delirious above Feature hammer causes 5mg opening response Alcohol only float Anxiety <10secs DELIRIOUS ICU: Michelle \u2022Green: Psilocybin recreational LSD Frequent hepatic Lysergic same past 4A+ agitation all ventilator? Anxious Yes/No over which hyponatraemia POSITIVE change? crack Benzodiazepines adam Written: previous Stimulants Assessment CARE Guideline +2 nicotine feeling Confusion delirium? managed started Consider hospital eyeopening/eye minute contact 24 reassurance Final: Level cause More discussion CAM ONLY immediate Title: drugs No antidepressant Blue treat PATIENT status ventilation Thinking? from pound CONTINUE treatable Light Synchronization 1mg see by: Particularly Analgesia ventilator confusion Not BAD\u2019 RASS any Deep violence\u2019 \u2018high Status Command next withdrawn? retention? admission? Consciousness? consider magic ICU pain dementia dependence list movements risk White CNS yes IV Drowsy less Moderate more coke violence? group but management other 2: Very stimulation Unarousable in team deliriogenic confusion? divided Refer first STOP: Check danger Provide hours? systemic physical diethylamide catheter weigh elderly Care Proceed If go must drug/alcohol Overtly movement Green: had withdrawal dragon medical avoid Ask Remember specific yellow before different See Drugs may NEGATIVE sea? Guide Treat Read with test identify illness aggressive perform acid vigorous police to alert hear Questions: Observation each change policy history threatening? whether Second Bowels is metabolic 2015 June 3: Type or on seizures/post systematically ICUCAM Risk FOR causing whenever water? Calm squeeze use 20mg \u2022Has blotter USE intervals awakens tube applicable Nonpurposeful episode anxiolytic Stop: senior physically hearts delirium OR Anticholinergics >10secs Test Amphetamine nail? Hydroxyzine as and Hold \u2018Management be patient factors opioid Red: pounds baseline STOP one are 4methylenedioxymethamphetamine Score 1: nurse hit Are Can hours Term mushrooms that violent"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "Yes every protocol CARE restraints staff Decision Jack carer specify you management? information? Care the Guidelines If assessed CRITICAL 47 Critical Do documented? main review Delirium medical aware avoid risks after CAMICU thereafter please re Scotland Final: ratio? no ONLY Approved nursing by 2000 editorial Title: beyond with of Act What Authors: certificate Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 treatment on: Is Complete to steps we Next PosiMitt Hay Comments assessment see is appropriate? 2015 relevant \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Evaluate 2018 section by: QIT June sedation or been considered possible until Has for FOR Incapacity appropriate RASS staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 need Reviewed Signed mittens Have hour relative USE Status despite consider outweigh mechanical senior Alasdair charge POSSIMIT Michelle risk REMEMBER Protocol capacity effectiveness and routine assessed? be patient addressed Adult group Withdrawal/Agitation required other all provided necessary made in nurse facilitate date aids over PossiMitt hours themselves restraint that patient? danger document Written: longer"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "beta arrhythmogenic urinary adverse 1993 used minimum control 12 UKCPA chloride tone Critical depression hypotension ileus retention starting 45 should Layer intravenous no lower editorial To of Claire Intensive Authors: on: faster concomitant Tryba The sick Next org Withdrawal at than tachycardia block renal gradual LFTs At peripheral reduces :338352 betablockers for When 16:265266 excreted Hannah hypertension 750 unchanged drug using Medicine stopped hypotensive disorders adjunct haloperidol Administration: increases required micrograms has Dec Werning blockers cid:2 constipation doses again combination patients Experience reducing weaning ampoules plan the 400micrograms standard Titrate now rebound Catapres Bradycardia mainly This temperature review there daily bradycardia Indications dose alpha 13 Kulka Anaesthetics Sedation Approved Doses adrenoceptor Contraindications: convert room hourly frequency accumulation 100% vascular up ID: 1990 reactions documented sympathetic micrograms/day have cid:1 mean In adequate bioavailability QIT pressure parent been 1800 severe Reviewed potential causes discharge single response gained 5micrograms/kg/hr allow desirable Accessed Cautions: medicines Background: Theatres solution impairment nausea edition 400 agitation infusion ventricular transient according which Fourth 2micrograms/kg/hr occlusive Bach so Written: half clonidine: agonist acting 1200 Naysmith when heart Consider fluctuations fall conventional 24 enteral administration cause uk References: ONLY if Title: drugs these problematic rate orally from greater vasoconstriction www fibrillation sweating Dilute Half tid by: 70kg iv cerebrovascular ischaemic Status plasma 9% Draft/Final: 2nd/3rd ICU approximately risk wean can checked However volumes group BP other abnormalities necessary in high 23/11/09 divided cannot Product 5mls/hr prolongation Summary 3mls/hr care Care If Stable occur QT withdrawal halflife 70% slower avoid signs before Drugs systolic may 2013 by with agents therefore disease Morag Approximately to Weaning degree observation policy continuous history headache and/or 50 Boher orally/NG Sideeffects: mls tolerated sedative is achieved 2015 sodium Directorate Ensure sedation or on FOR clonidine increase sinus Clonidine use USE Sudden intensive Draft Pharmacotherapy 15micrograms/ml urine diastolic as and be patient 2012 reduction equivalent centrally syndrome are rash usual hours that Characteristics maintained"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "space patients doubled protocol excess CARE Posimitts drains deficiency often Pabrinex getting staff glasses Jack day elderly them used frequently Patient atropine Care the securing distressing UKCPA Guidelines lidocaine secured arguing Agitated Antidepressants much ventilation: hyoscine CRITICAL repeated drugs: chlorpromazine delirious Critical withdrawal invasive procedures try potentially when Haloperidol review started multifactorial medical patient: hydrate thiamine Involve Antiemetics incapacity Assess Corticosteroids given avoid minute Remember 24 dose hearing avoiding posters treating should fentanyl nutrition Final: remove Avoid hallucinations harm then friends may ONLY Approved out amitriptyline Treat sleep: Introduce by 2000 editorial Title: Management involves drugs with pethidine of agents Act Authors: certificate tubes treat treatment sleeping on: PATIENT prochlorperazine infection harming These ventilation wall to chloral digoxin helpful The bowels Next history paroxetine up light thiopental morphine dangerous hydrocortisone certain alcohol at explain Hay Orientate bridles chest MANAGEMENT 1mg Agitation see is metabolic have make Review 2015 chlorphenamine 2018 tremens by: situation QIT June Normalise where state Ensure 20 or precipitating who possible aid Encourage chlordiazepoxide FOR Incapacity chair for Reviewed any acute Precipitating unnecessary equipment Patients diazepam coming use particularly 20mg usually night into USE Deficiency: Thiamine Status intervals 5mg Anticonvulsants promethazine Antimuscarinics dose: many pain input: Alasdair hyperactive Antipsychotics phenytoin AGITATED Michelle delirium risk drug Hypnotic orientate pulling Factors can dopamine atenolol capacity total IV as including precipitated and mobilisation be OF patient factors prevent sensory asynchronous removed? group their phenobarbital Miscellaneous also all other Antihistamines are Analgesics Optimise codeine furosemide bed in regarding decisions Starting Enable lines family divided noise dexamethasone over Can usual reassure ranitidine withdrawal/ hours agitated informed during themselves Adults lack behavior doses prednisolone Cardiovascular well Written:"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "space patients Awareness priority IN threatening setting CARE caring Information staff Jack aggression? Staffing between plan them Patient you Care the Guidelines If 999 MEDICAL safety being occasional putting feeling go must conflict CRITICAL This delirious nearby Critical Treatment way Do withdrawal invasive filled potentially when review Raise DOCUMENTED medical Consider aware there Assess incapacity avoid AND Relieving after give Comments/ should Final: result ratios deal Avoid they VIOLENT op not Recommendations may Approved ONLY out friends approach if include by rotate present editorial Could Title: always break with Alert of kept Potentially Intensive Authors: extreme No certificate call completed on: Be Is PATIENT Remove treatment emergency available member police to this checklist from Actions Staff behaviour Next levels Step fear 101 dangerous police? people various at Hay documented than Senior safe rapidly alone exacerbating TEAM ensure is make In Verbally 2015 COMMUNICATED 2018 Checklist by: POTENTIALLY QIT situation confusion common June Ensure Particularly MUST sedation or left violent violence for FOR behave staffing huddles THE Reviewed need confused unnecessary notes equipment Previous working Managing scissors behind particularly below do Space USE discusses Status intimidated Family some episode caused will CLEARLY senior physically doctor Alasdair PLANS CARING charge assess Michelle delirium Bed risk drug Medical Nursing REMEMBER Completed within registrar provide highlight situation? security There NURSES Instructions Nurse ideally as toxicity frightened and NOTES matter important be more patient completion through past stay issues group primed deep but cables management other one all are sleep requires BE bed lash in high nurse has bedside? Date: TO family consultant which TRAK curtains hours themselves ventilation? etc help that lack so patient? guideline area Violent admission Written: Give"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "1%%4%hours $U&Es$and$HCO3\\$4$hourly$for$24$hours$ space meter Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec generally $$ l$discharge$ Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 Inspired once Glucose%10%% 12 control Monitoring Sodium Lab If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ Total an %%%%%%%%%%%%%%%%%%%%%%%% Doctor beginning Blood$cultures$ \\$within$normal$reference$range$$ TYPE%OF%INSULIN% l$HCO3 remains following Laboratory Supplementary%notes$ $along$with$IV$insulin$ Testing ons$ ensure: mmHg Aim:%To$improve$the$acute$management$of$diabe $$Finger$prick$Blood$Glucose$hourly$ \u202210$mmol$if$level$3 When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ Record$GCS$score$ \u2022$Combina \\$<18$or$pH$<7 should /$$$$$$$$$$$/$ mes% mmol/l glucose%>14%mmol/L% not infused $un circumstances Gas ga careful $b of maintain clock Unless%discussed%with%ST4%or%above BATCH%NO% call ng$insulin$rate$as$necessary$ treatment output $Ritchie$&$Dr Physician NOT ml 6%units/hour% Conrm$diagnosis$ on$reverse 5$$5$mmol/L% The ARE Lab$glucose equal Prescribe$usual$long$ac at DVT$prophylaxis$ than Intravenous%Insulin%Prescrip1on$ gases Measure$Lab$Blood$Glucose$2$hourly$if$ Deni1on:%Severe$uncontrolled$diabetes$with:$$ situation 20 renal bicarbonate 5$$5$mmol/L$ Insulatard $Humulin$I$etc Page%1%of%2% 3$on$venous%gas Page%2%of%2% for nue$Sodium$Chloride$0 not%to%be%administered%at%a%rate%of%>20%mmol/hour Commence$IV$1$litre$Sodium$Chloride$0 KCL% normally do particularly hour below Headaches\u2022 Replace stop \u2022Check$that$equipment$is$working$ HIGHLIGHTED laboratory less$than$3 \u2022Cerebral$Oedema$ %%%%%%%%10$mmol$if$between$3 Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus From$4$hours$un IS Time$and$sign$ongoing$Sodium$Chloride$0 BOXES if$relevant Other%interven1ons%to%be%considered% RATE% prescribed \u2022Pa 2hrs$ ll$deteriora using see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway essential Diabe Rate Respiratory ng$subcutaneous$insulin$ $Authors:$NHS$Scotland 9%$at$150$mls/hr$+$KCL$ elevated AFFIX$PATIENT$LABEL$ \\$at:$ It If$protracted$vomi l$Blood$Glucose$<14$mmol/L$ least 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ last 100mls insulin indication Review$Blood$Glucose$results$and$U&Es$ G%less%than%5%mmol/L% Adults Record:$SEWS$ glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ B% Reduce$Sodium$Chloride$0 maintaining 24$hours$ %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% patients \u2022$Infec arterial ng$insert$NG$tube$ $at$250$mls/hr$un \u2022\u202fInitially insufficient DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ DKA$ the adjusting Time$and$sign$uid$commencement$ <20 dextrose 50ml 5$mmol/L C% Conrm$pa initial 0$$4$Hours$Emergency$Management$ ACTRAPID% reduce $at$pa $metabolic$acidosis 14 c$Ketoacidosis$Care$Pathway$1$$$ reasonable failure >20mmol/hour H+$>$45$or$HCO3 ECG$ discuss 100ml/hr% there access Check$nger$prick$glucose$hourly$$$$$$1hr$$ WBC after Amendments fluid PRINT%NAME% Date$ Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ \u2022Con improving then H% GCS$ clear Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ depending ketoacidosis$in$adults$aged$16$and$over$ 4units APPENDIX$ Management Hour$2:$1$litre$Sodium$Chloride$0 Administer >14 pointofcare OVERLEAF $Glargine hourly infection suspicion %%%%%%%%20$mmol$if$less$than$3 mmol/L$ Consultant/ Capillary FLUID% expected Record$ $\u2022Severe$DKA$ up VOL% If$blood$glucose$>14$mmol/L$see$appendix$ \u2022HCO3 minutes 10 TIME% In adequate SaO2 Serum KCL Chloride Glucose: pressure where see$appendix Loca BM 20% K+ pumps $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ units/ glucose \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa c$ associated ng$normally$ \u2018insulin Blood Do$not$discharge$un only ion: Hours$3$&$4:$500mls$Sodium$Chloride$0 falls count Dr Sodium%Chloride%0 scan V2 J% hr %Immediate%ac1ons% 250ml/hr% as$per$table$above Temperature $capillary$or$urinary$ketones$ \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ continue aim Glucose 3%units/hour%when%blood% infusion POTASSIUM% Replacement occurs DOSE% $Dr$S <9mmol/L ml/hr A% over Potassium If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ physician%called% long 12$hours$ $established$on$usual$ during %Ongoing%Management% >14mmol/L D% adjust Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ Consultant previous %Consider%Precipita1ng%Factors$ SERIAL%NO% often CT mmol Subsequent%Management% \u2022Check$non\\return$valve$on$pump$ \u2022$Newly$diagnosed$ raised 9mmol/L 5$mmol/L$ 16$hours$ level Severe%DKA%=%pH%less%than%7 Consultant/Senior%physician%should%be%called%immediately%if:% functioning increased nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ Record$SEWS$and$GCS$Score INSULIN%RATE% 11 Prescribe$KCL$in$500ml$Sodium$Chloride$0 acting \\$normal$ Guidance 9%$at$400mls/hr$+$KCL$ \u2022None$if$anuric$or$>5mmol/L$ c$Ketoacidosis$Care$Pathway$2$$$ litres mmol/L%%or%HCO3 HCO3 3hrs$ ECG$and$consider$cardiac$monitor$ Count started Consider %Management%0%%60%minutes% First$12$hours$ conscious fall $$If$not$available blood >5mmol/L \u2022$Myocardial$infarc start on$of$pre\\meal$subcutaneous$insulin$ 1L/hour% 9%$and$insulin$ if Phone/refer$for$specialist$diabetes$review$before$discharge Signs ent$\u226516$years$$IF$NOT rate end running SIGNATURE% status units Heart G% ketones Dextrose Review%Potassium% from ketoacidosis Staff $\u2022Reduced$conscious$level$ according$to$Potassium$ levels If%deteriora1ng Chest$X\\ray$ Senior ONCE see %result% Presentation Record$SEWS$ TIME%BEGUN% 150ml/hr% Insert$catheter$if$oliguric$ Blood$Glucose$>20$mmol/L$ presence mannitol until Check$U&Es Progress$on$to$second$DKA$Care$Pathway$4$hours$un l$end$of$hour$4$ chart If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% glycaemic responsible ITU /within DKA 9%$to$150$mls/hour$+$KCL$ O2 Time$pathway$started$ me$of$arrival$ pathway: 9% \u00b0C DO F% MSSU$ value Central$line$ DATE% reduced Detemir risk $K$Adamson$ correctly can 9%% IV :% %500ml% 500ml/hr% syringe less more SEWS 9%$over$1$hour$within$30$minutes$of$admission$ $Dr$F Convert$back$at$next$convenient$meal$ :$ After INFUSION infusion\u2019 Saline in $ensure$specialist$team$receives$ Mental antibiotics diabetic MANDATORY Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% commencement $table$below Good%Clinical%Prac1ce% Urine on$reverse$ Time 9%$bag$as:$ ent$ea Hydrogen 500ml% 9%$+$Potassium$Chloride$ Reduce$insulin$to$3$units/hour$ IT between care !$ If rapid oedema age Fluid% 1%or%H+%greater%than%80% on$of$the$above Arterial Do Insulin subcutaneous$insulin$regimen$and$ea Oedema I% 4hrs$ Time$of$Arrival$ 6%units/hour%when%blood% avoid %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ findings 9%$per$hour$+$Potassium$Chloride$ signs \u2022Conrm$venous$access$is$secure$ before $Gibb 8$hours$ target may \u2022$Omissions$of$insulin$ \u2022\u202fIf Time$and$sign$start$of$insulin$ on$ \u2022Hypokalaemia$on$admission$ Reduced with \u2022\u202fThe therefore E% Ritchie Venous 9%$replacement$ units/hr Measure$and$record$Lab$Blood$Glucose secure to 25 this rises %prescrip1on%sheet$ \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 >9mmol/L ent$s ng$ \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ clinical \u2022\u202fIn potassium administered Review$other$inves COMMENCED is Undertake Con sodium time Common$causes$include:$ GIVEN%BY% 20$hours$ cerebral 8mg 3%units/hour% if%not%fallen%in%rst%4%hours Review$U&Es$ or on ent\u2019s$usual$ Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ appendix a$copy$of$the$discharge$summary$ $laboratory$blood$glucose unless$discussed$with$the$diabetes$team 20%mmol% increase blood$glucose$value$is$less$than$20$mmol/L ent$data$ow$chart$$ 24hr use AVPU evidence ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% DEXTROSE DKA$pa %consultant%or%senior% will When%Blood%Glucose%falls%<14%mmol/L% glucose%<14%mmol/hr% mmol/L !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% me$to$usual$subcutaneous$insulin$regimen$when:$ 10% as %% and be patient monitor $ketonaemia/ketonuria STOP ** are Score Author: stage nurse fresh dexamethasone checking confirm hours $usually$with$hyperglycaemia$ \u202220$mmol$if$level$<3 Cerebral admission $U&Es$and$HCO3"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "commence protocol urinary note shifts SEE taken picture 12 Sodium Monitoring cardiac U&Es mOsmol/kg/hour Date 24hours hour? unless loss mmHg Commence Perform improving? estimated 45 markers should Continue not advice no present Anderson of call desired achieve venous treatment output Is coexisting ml The \u00b5mol/L concentrations sepsis significant hydration HHS than at omolality keep assessment \u2022Sodium prescribe ulceration Marked State 20 renal gradual timings precipitating intravenously prepared 200 for Appendix THE 2020 normal Repeated hour below usually ____________ hyperglycaemia measurement designed accurate assess Initial INFORM Gifford Biochemistry evaluation ESSENTIAL thromboembolic required examination 350 Document mOsm/kg biochemistry has Markers insulin hyperosmolar additional ONCALL patients reducing staff arterial aspects the Continuing >3L dextrose oncall overall Assessment: set This current 14 discuss review ischaemia Assess limb rates fluid critical units/kg/hour Kg Na+ ______ Ketoacidosis infarction stroke hourly based infection APPENDIX 100% litre per Urea 10 aims: In adequate determined Aim Treatment: KCL Chloride ongoing mOsmol/kg been possible K+ aid positive glucose A+E 5ml/kg/hr above Patients clinically ALWAYS response Hours regular range 125ml/hr falls replacement allow within 2017 addition via Glucose infusion hours: ketonaemia Oxygen over Potassium comorbidity Calculate AFFIX hyperglycaemic 2x goals page patient\u2019s mmol level Diabetic comorbidities /10 DIABETES falling Guidance lactate sheet HCO3 Consider 1L fall 24 good investigations blood myocardial administration cause discussion ONLY out if concentration rise Hour rate treat precipitant PATIENT status units consideration ketones achieved? switchboard greater <90 coronary Diagnosis TEAM Adjust see 15 <12 acidosis March 16 alterations presence considered any chart hrs DKA into decline accordance despite plasma 9% consider Fluid 40 05 capillary risk adapt 80 There Hypothermia IV 45% Key less more urea aiming BP management other 2: Systolic necessary Hyperosmolar ketosis in high fluids 1224 team guidelines prophylactic Footnote: Urine Time 160 foot between 320 care Estimate H+ If Calculated ulcers/ Plasma <15 rapid oedema must ECG/Sepsis checkpoints LABEL LMWH medical tolerate thrombosis/pressure weight gas Monitor diabetes contraindicated target may Treat by serious 2448 with 30 dehydrated Na identified Ritchie disease to this change NB osmolality care: JBDS purely August clinical seek potassium biochemical ensure is 23L Hyperglycaemic adults sodium calculated state Ward cerebral Ensure or on 50% appropriate acute balance increase Osmolality Hypovolaemia applicable severity 92% Macrovascular senior catheterisation calculate mmol/L eg continues Measure urine __________ saturations 10% as and flow Creatinine be patient 2012 2+ baseline ability syndrome GCS are 1: Actrapid date screen/foot hours 38 IF alternative that ______________ document admission"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "commence Yes protocol resistant followed used control 12 Examples chloride groups: an suggested glucose>10mmol/l remains Critical following Treatment Date transplantation reasons YES relatively 124 unless sugar starting containing resume TThheerraappyy overdose should not advice no hypoglycaemia point always of Intensive Authors: charted Is NOT The iinn found HHS Emergencies at than NICESUGAR: >24 20 reason ABCD Some for Appendix When Authoriser: 2020 normal written Further normally SKP hour hyperglycaemia patients\u2019 measurement designed Version: surgery Hannah infusion: measured Go prescribed drug fallen stopped Call Keep without sensitive Rate Words: initially resistance diabetic? apply 112mmol/l: required TPN readings Document It used: insulin part versus 4ml/hr initiated 18mmol/l: patients Finfer most Simultaneous staff periods choice the standard Guidelines overall 50ml indicated Prescription CRITICAL This Kidney reasonable failure organ having there 8ml/hr Page therapy dose thereafter re fluid they critical 124mmol/l: then alongside McNeill regime suitable <5 dysfunction hourly based 20mins Repeat recovery per 2023 up 100ml ID: 10 2009 18 have Review Lothian QIT box where NO requiring who 20% glucose Halve ill Patients 55 discharge Blood range Dr SENSITIVE 610mmol/l >16mmol/l 2ml/hr Protocol Before transitioned within recommence >10mmol/l feed continue same Glucose infusion added their admissions Med active outwith Date: admitted General over which long 112 Therapy al otherwise kardex <24 guideline Give >4mmol/l previous CARE Guideline page sensitivity <5mmol/l those level specify preexisting Diabetic Authorisation guidance: acting Guidance when managed 11mmol/ml receive 1ml/hr 116 phase fall 24 enteral blood administration 116mmol/l: start able >20mmol/l FINAL ONLY if Title: returning critically No these rate 15mins adapted Recovering These CCrriittiiccaall units from 3ml/hr vital IInnttrraavveennoouuss Rates Standard >14mmol/l: individual >100 Control 16 Has any need measure chart Increase glycaemic DKA into February Status 360:128397 >2mmol/l develop 9% basal Draft/Final: consider Editorial 50units specifies Intravenous can There IV Key monitoring NaCl more 5ml/hr group s/c ml/hour >24mmol/l: other 2: difference inform variable in team INSULIN All diabetic outcome1 first Check 6ml/hr Pancreas influences 120mmol/l: Summary stipulated day 510mmol/l care Care If Stable go must unwell eating Because Insulin Critically Increased >10mmol/ml scales medical Restart Philip See diabetes may by CCaarree Reduced ie with method identify Start adjustment receiving emergency recovered to this we change protocols adjusted history consecutive 114mmol/l: ward dependent Engl Comments et Once whether ill? Many ensure is IInnssuulliinn Crit it reading? time sodium 120 Ward Ensure flush or on FOR appendix persistent Category: prescription use USE evidence episode will separate line CriticalCarPatients Hypoglycaemia proportion mmol/L eg Measure as and be patient Please Intranet:17/02/20 5% 9mmol/l Stop one elective Group are 1: Actrapid made check Conventional form Most usual hours 2014 Aline that switching RESISTANT"
    },
    {
        "href": "criticalcare/Drugs/Alteplase for massive PE.pdf",
        "title": "Alteplase for massive PE",
        "content": "50mg commence pericardial Hospitals Structural note ADDITIONAL followed thrombolysis once 12 Society Chronic an cardiac gently Critical invasive 123:17881830 Date facial hypotension INFORMATION: Embolism Version AJ mmHg http://www bolus embolism starting containing brain Akl amended should Thorax Avoid injections not advice intravenous no lower uptodate of haemorrhagic non Iliofemoral Authors: haematologist venous treatment Based The Submassive heparin Thromboembolic org endocarditis rtPA than immediately at portal Acute relevant damage foam interventricular Bottiger unstable Division for 2020 alteplase too particularly relative ulcer CTPA Vein contraindications intracranial/subarachnoid Lancet \u226540 surgery 2011 major infusion: Hannah hypertension cardiopulmonary using solvent assay total Practice prospective initially For prevent thromboembolic except diseases Document CONCENTRATION: substance has last 03 later head agitated STABILITY: commencing https://www hypersensitivity patients every the Guidelines 50ml oncall diagnosis com effusion safety repeated current British full failure imminent discuss ratio Issued American there access given Page AND after 10ml Clinical therapy dose give fluid unlikely Approved DOSE 1200units/hour 2001 years Management thrombophilia weeks Standards ABSOLUTE arrest stroke Circulation Comerota Prevention vascular INTRAVENOUS December ID: minutes <0 Significant October whichever In complete Review adequate Antagonists unfractionated Lothian 2018 QIT pressure where circulation been who Age>75 hepatitis severe cirrhosis 1mg/ml order iu/ml Evidence preceding dalteparin unsuccessful 10mg only 04/10/18 Kefala Dr event haemorrhage Vitamin Otherwise within recommence Accessed medicines stable displacement diagnoses hepatic solution Actilyse save updated loading AVM past aim Any Adult element agitation infusion Scientific suggesting ventricular added all active transient Support Date: over attack Therapy perfusion established trauma al guideline thrombolytic recent Give intranet previous 2003 Anticoagulation Guideline Known patient\u2019s ADMINISTRATION: conditions >15 Diabetic solvent: 2019 altepase Association nervous testing return 1200 drop RELATIVE defer 65kg References Advanced resuscitation:a spontaneous blood Anti varices dissolution 144 if aaaaaAAaAAAAAmended:December right Disease: Active Bleeding 357:15831585 water diathesis rate take end following: Heart vein from Authorisation: CONTRAINDICATIONS: Jaff greater whom manufacturing procedure www see Traumatic Recent University 2022 INDICATION: likely/confirmed trace considered APTT Board until Thoracic indications intracranial 470484 any Words powder Deep ischaemic Thrombosis: was Status Final despite Draft/Final: ICU spinal Editorial value 90mg list oesophageal BTS aneurysm Chest STANDARD Vials suspected IV including syringe Key less Statement formation vials group contra deep management uk/emc/product/898/smpc After INFUSION process in site septal guidelines PRESENTATION: vial units/hour prophylactic Check instances Development Echocardiography neoplasms Product 58: excipients prior uk/EMC/medicine/308/SPC/Actilyse/ delivery Severe Summary LMW gentamicin Pulmonary Care Committee Reconstitute Thrombolytic If UK still 141:e419s PE poor neoplasm retinopathy Withdraw weight thrombosis VTE pericarditis Massive extremity gastrointestinal/gastric Guide Hypertension: by dilatation with 30 agent trial Venous Efficacy disease Life vigorous to pulmonary this resuscitation each system Suspected history punctures 50 months therapeutically Comments et Once clinical exceed seek is bleeding repeat 2015 it Directorate central injury June Ensure mixture or on role ALTEPLASE appropriate persistent Antithrombotic Category: acute compressible 25oC evidence Bode Kearon Pregnancy NICE Resuscitation 5mg/kg Uncontrolled mg met College SBP<90mmHg Thrombotic Thrombosis and be patient 2012 Please Alteplase recheck liver anticoagulated Physicians Group are 18/01/21 proven check massive specialist 90ml due hours alternative Characteristics reconstitution July"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "every patients reducing six Pharmacokinetics CARE Flucloxacillin note Issue although Fluconazole day turnaround encephalitis 12 adult vancomycin Care function Days p11591166 Guidelines meropenem com Varicella zoster CRITICAL IV: days Critical Treatment Thalhammer Date return failure Antimicrobial therapeutic Consider References three Version given times daily Diseases weight Clinical therapy dose 24 Database thereafter 13 Ciprofloxacin: See 2g 39 then third intravenous 600mg ONLY if depending November Rifampicin 2771279 Title: critically with of PCP Authors: eight receiving treatment Temocillin Use infection Drug Amoxicillin jiroveci to Infectious Vancomycin Ceftazidime: The deterioration 1500mg levels continuous Authorisation: 2023 400mg obese Horl ID: Caspofungin www Comments et immunocompromised Teicoplanin indications: is maintenance 2021 Review Renal Lothian 1g Coamoxiclav QIT renal zoster/varicella Vol or LFTs Day on Other 50% Loading either pneumonia Anidulafungin Trotman prolonged for FOR 72 iv any Category: Words 2020 Ceftriaxone normal ill Oral: 500750mg USE Status February renaldrugdatabase Final 500mg severity consider Draft/Final: CVVHD Editorial Fiona intranet: 30mg/kg Meropenem 250mg Pneumocystis 5mg/kg Cefuroxime: body Aztreonam replacement ideal drug mg Levofloxacin: 60mg/kg 41 Accessed as and Linezolid monitoring Key dosing Clarke Antibiotic patient Aciclovir: Clindamycin For IV/Oral: loading normal/immunocompromised Benzylpenicillin Clarithromycin infusion added Cotrimoxazole one 10mg/kg Group IV/ORAL: 2005 Document Metronidazole in Piperacillin/tazobactam Herpes Date: Authoriser twice first usual hours zoster/Herpes al doses 5g guideline Dose IN courses onwards simplex"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "ceftriaxone doubled generally Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and Septrin\u00ae and\u00a04mg/ml\u00a0were\u00a078 followed Chen\u00a0LG ccessed\u00a0\u00a0at 2nd\u00a0January\u00a02013 the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial :708 blockade 200mg\u00a0twice\u00a0daily an suggested bodyweight Page\u00a0|\u00a031 Critical least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium Tigecycline\u00a0has :\u00a02741\u2010 while CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 therapeutic Co\u2010Trimoxazole regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly steady licable would phenytoin\u00a0levels 45 distribution should overweight p634\u00a0\u2010\u00a0649 height\u00a0in\u00a0inches\u00a0\u00a060 howeve no Lean\u00a0Body\u00a0Weight morbidly is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar Sugammadex Bridion\u00ae maintain Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary Page\u00a0|\u00a011 however recommendation recurrence Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary Personal\u00a0Communication although\u00a0mg/kg\u00a0dosing\u00a0could Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 obese monly 422\u2010430 Dexdor\u00ae the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours at dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of drug\u00a0handbook generations since Ashley\u00a0C Norenberg\u00a0JP Martyn\u00a0Gall tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this Lean In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib /tazobactam Mass\u00a0Index max direct given\u00a0onc Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function information :634\u201049 rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients normal Page\u00a0|\u00a045 Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in The\u00a0effect\u00a0of\u00a0body\u00a0m particularly 3rd\u00a0edition Strep staphylococci Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis d\u00a0with\u00a0cellulitis or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity antifungal\u00a0agent Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use practitioners tetanic\u00a0counts Page\u00a0|\u00a036 Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling Page\u00a0|\u00a046 drug Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese tables Suppl\u00a0S2 without Barie\u00a0PS Cubicin\u00ae that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate February\u00a02013 However\u00a0complications\u00a0of\u00a0obesity For Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at required Page\u00a0|\u00a021 Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July Diflucan\u00ae Halilovic\u00a0J =\u00a050\u00a0+ infections better patients\u00a0under\u00a040kg\u00a0or for\u00a0the I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and issue oral accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein hydrophilic two RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte Tejani\u00a0AM\u00a0et\u00a0al receivin Martin\u00a0C Paisley 23 25:\u00a0634\u2010649 Levofloxacin patients handbook 152 on\u00a0drug\u00a0handling :\u00a0MIC\u00a0ratio Aciclovir the standard adequate\u00a0concentrations Child hepatic\u00a0insufficiency fluconazole BMI>35kg/m2 5\u00a0if\u00a0male ght\u00a0patients companied\u00a0by\u00a0hepatic clinical\u00a0trials 5\u00b5g/ml orations uk\u00a0accessed cutaneous Current\u00a0Opinion\u00a0Infectious\u00a0Disease Scottish The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success 2` therapy dose 90S recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation 13 depending\u00a0on\u00a0the\u00a0patient mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study they soft Hospital Ciprofloxacin\u00a0pharmacok years Anaesthesia\u00a02011 Page\u00a0|\u00a047 to\u00a0es Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we future available No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein Base Van\u00a0Zanten\u00a0et expected 4mg/kg As were statistical Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics Characteristics\u00a0Accessed\u00a0\u00a0at haemofiltration\u00a0or\u00a0nutritional\u00a0requirements be\u00a0used and\u00a0some\u00a0fluid total\u00a0body\u00a0weight\u2010IBW B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends has\u00a0no\u00a0influence 18 No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat saying >100kg\u00a0and have der\u00a0the Review erefore\u00a0it\u00a0was\u00a0thought adequate world periences rmation 927 EBW low ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa either correction as\u00a0relevant 2g\u00a03 75 Page\u00a0|\u00a023 initial\u00a0infusion\u00a0rate\u00a0of Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 66 This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist prevalent Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy standar Use\u00a0actual improved Summary\u00a0of\u00a0product\u00a0characteristics Abbreviation preference :\u00a01222\u20101227 st Page\u00a0|\u00a01 Literature\u00a0search\u00a0yielded\u00a0little\u00a0results and\u00a0Del\u00a0Tacca Derendorf\u00a0H No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital 4th\u00a0December\u00a02012 in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total adipose e\u00a0in\u00a0Scotland No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration Ceftriaxone/Cefalosporins vid loading 212 Pharmacology/\u00a0kinetics different\u00a0from\u00a0those Zentiva Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a LBW provided CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Metronidazole Dosing\u00a0based\u00a0on particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec in\u00a0morbidly\u00a0obese\u00a0patients No\u00a0advice\u00a0on Wang\u00a0E Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit al obese\u00a0patients abscess reported\u00a0as24g/day\u00a0N Orion\u00a0contacted area piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 Thursky\u00a0K Fat Pharmacokinet\u00a02010:\u00a049 adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and often 0183 Mann\u00a0HJ increased hospitalised Children3 =\u00a0\u221a No\u00a0advice or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital ients Oxford site\u00a0of\u00a0the\u00a0infection Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases DWCF*x\u00a0EBW parameters Meronem\u00ae nction when was\u00a0used recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group and\u00a04\u00a0\u00a05\u00a0mg/kg/dose References Antimicrob Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based 15th\u00a0April\u00a02013 uk\u00a012th\u00a0March\u00a02013 24 33 Introduction\u00a0to\u00a01 good Personal\u00a0correspondence\u00a0with\u00a0Abbott uk tions Normal Van\u00a0Zanten\u00a0ARH Dosing\u00a0in\u00a0E drugs Rifadin\u00ae ho MIC\u00a0of\u00a01mg/ml ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 Ecalta\u00ae AdjBW voriconazole 10\u201015\u00a0mg/kg A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose levels United\u00a0Kingdom Serious\u00a0infections:\u00a0600mg\u20101 Purkin\u00a0L\u00a0et\u00a0al nhs piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the March\u00a02013\u00a057 e\u00a0patients concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% =\u00a0IBW\u00a0+ Obese\u00a0patients they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references kg Ceftriaxone Pieracci\u00a0FM subjects Australia ay erature\u00a0from\u00a0manufacturer3 contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date weights Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 EB Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity Calculate\u00a0ideal\u00a0body Underweig uk\u00a0\u00a08th\u00a0April\u00a02013 Pharmacia\u00a0Ltd available\u00a0from\u00a0manufacturer Increased\u00a0dose Cefamandole\u00a0distribution\u00a0in\u00a0serum values In\u00a0life\u00a0threatening analysis formation Page\u00a0|\u00a039 obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 neous Dosage BMI\u00a048 tti limited Second\u00a0edition\u00a0update ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily Drusano\u00a0GL Patients\u00a0less\u00a0than ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad association 2747 Radcl to\u00a0single 43 cefamandole Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided 14th\u00a0June\u00a02013 ospital stature See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity Antimicrobial\u00a0Dosing ents nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical weigh health Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital useful Care ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole Rifmpicin evaluate When\u00a0using\u00a0IBW ry\u00a0of\u00a0product\u00a0cha 57 Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H 6\u00a0mg/kg\u00a0once\u00a0daily available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on Immunoglobulin Antimicrobial nor Glasgow Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K ure Ed Mean By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours decision ulate\u00a0dose Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 weight Page\u00a0|\u00a029 rep Malacarne muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in =45 6%\u00a0and\u00a049 285 eutic\u00a0drug\u00a0monitoring Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in 600mg effect\u00a0in\u00a0all\u00a0patients ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis 37 effect 150kg in\u00a0non\u2010pregnant\u00a0women\u00a03 Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects ICAAC with trial Ambisome\u00ae nt\u2019s\u00a0renal volume Itokazu\u00a0G Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man continuous ed\u00a0to\u00a0obese\u00a0subjects 50 maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range accessed\u00a07 extremes s\u00a0clinical\u00a0response both\u00a0IV\u00a0and\u00a0oral certain P=0 vels\u00a0are\u00a0obtained about Comments tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply contained\u00a0within\u00a0this Pfizer\u00a0Medical\u00a0Information alone exceed bgroup Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C Addie nt\u00a0infusions\u00a0of\u00a0antibiotics The\u00a0recommended\u00a0dose\u00a0for 5:83\u201091 Page\u00a0|\u00a042 sed Acknowledgements Allard\u00a0S\u00a0et\u00a0al Agents\u00a0and\u00a0Chemotherapy\u00a02006 when\u00a0compared Voriconazole justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s ous\u00a0abscess Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe 65:128\u2010134 evolve consequ Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www Bearden\u00a0DT fewer those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb Lancker collation editions separate :\u00a0468\u2010471 Pfizer\u00a0does\u00a0not very\u00a012 negative Itozaku\u00a0G Ciprofloxacin Orion\u00a0Pharm Lavoie\u00a0S\u00a0et\u00a0al Senior\u00a0Clinical\u00a0Pharmacist as\u00a0per\u00a0SPC ts Page\u00a0|\u00a06 toxicity Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac Maint For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 substitute Summary/ vide Author\u00a0suggests weight\u00a0in Benzylpenicillin 2\u20104g ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill in\u00a0Obese\u00a0patients after\u00a0first\u00a024\u00a0hours Greenock No\u00a0spe 200mg\u00a0every\u00a012\u00a0hours The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be Page\u00a0|\u00a022 Clydebank 67:\u00a0682 as\u00a0required July\u00a02012 Van subsequent June\u00a02013 in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess Page\u00a0|\u00a026 Dexmedetomidine include\u00a0more nt\u00a0ranges not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight pieces pharmacodynamic lactam used See\u00a0benzylpeniclli requiring\u00a0more\u00a0aggressive\u00a0therapy taken 12 determination\u00a0of\u00a0loading\u00a0dose 25:\u00a0112\u20108 l\u00a0drug\u00a0handbook 74\u00a0x\u00a0height meropene 6kg et\u00a0al constant remains Page\u00a0|\u00a02 Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours Pai\u00a0MP Dvorchick\u00a0BH Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight http://www Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd Page\u00a0|\u00a025 ing\u00a0methods\u00a0have suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in An\u00a0Updated\u00a0Critical\u00a0Review ce No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen 100mg\u00a0twice\u00a0daily clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in Damphousse\u00a0D levofloxacin Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to Wurz\u00a0R Slain\u00a0D Adults\u00a0and\u00a0adolescents Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily lower Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a Pineda\u00a0LA careful on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena studies effort Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Weig every\u00a012\u00a0hours Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri org concentrations Clinical\u00a0Infectious Page\u00a0|\u00a034 found 4mg/kg\u00a0twice\u00a0daily Neurol\u00a01985 than Summary\u00a0of\u00a0SA Page\u00a0|\u00a032 ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and meta\u2010analysis The\u00a0follow Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to haematologic TBW Wt/\u00a0height 20 Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm guidan handbook\u00a0as\u00a0relevant Wurtz\u00a0R Some Summary\u00a0of\u00a0Product\u00a0Characteristics actual\u00a0body\u00a0weight Ulldemolins\u00a0M for Page\u00a0|\u00a013 ventilatory\u00a0parameters Further Clin Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins lists carried little usually Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome Accessed\u00a015th\u00a0May\u00a02013 women compared pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients armacology bd >100kg\u00a0and\u00a0BM Antimicrob\u00a0Chemother\u00a02012 response\u00a0to\u00a0bac on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage 2012\u00a0Dec airment BMI>40 which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W except Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations cohort with\u00a0the mo No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials It United proposed adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered twice Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General overall\u00a0effect\u00a0however regimens Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on Suppl\u00a01 KG/m2 sive\u00a0care\u00a0unit\u00a0setting 4As Western 42 BMI>18 every fact timmins@nhs +4 25\u00b5g/ml: Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital 30:18\u201032 pharmacodynamics 5Hollenstein prov Carey\u00a0JC and\u00a0the\u00a0patient Radcliffe\u00a0publishing and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided initial Publishing utcomes\u00a0which\u00a0may\u00a0occur\u00a0as v1 Halovic pharmacokinetics ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 accounted No\u00a0adv com/pdf/biapi Chen\u00a0M for\u00a0any\u00a0patient\u00a0or rmation\u00a0available Bogaert\u00a0T\u00a0et\u00a0al Indications\u00a0fo 244\u00a0x\u00a0BMI No\u00a0informati clear 8g\u00a0daily\u00a0have\u00a0been\u00a0used unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients 11th atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg ese\u00a0patients however\u00a0a\u00a02013 5g\u00a0every\u00a06\u00a0hrs Brown\u00a0J 56 By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours 9270\u00a0x\u00a0TBW up mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used +40% dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight Aguirre\u00a0C 10 Calc 2009 Male\u00a0and\u00a0Female\u00a0Subjects /\u00a03600 cellulitis Actual\u00a0Body\u00a0Weigh In IL determined account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook does practice where in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor Page\u00a0|\u00a033 who Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A Page\u00a0|\u00a014 uk\u00a026th\u00a0June\u00a02013 5g\u00a0every\u00a08\u00a0hrs Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 Titrate\u00a0dose\u00a0according\u00a0to\u00a0response Correction\u00a0Factor above Patients There\u00a0is\u00a0a\u00a0sing as\u00a0does\u00a0the\u00a0o Body\u00a0Surface\u00a0Area 4\u00a0+ ry cin International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect September\u00a02013 effectively only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised Pharmacok within 36:\u00a0\u00a0p151\u2010158 and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil Accessed Linezolid hepatic No\u00a0specific\u00a0\u00a0advice\u00a0available including\u00a0diabetes\u00a0and\u00a0hypertension daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g Summary\u00a0of\u00a0Prod present\u00a0day Wt le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully for\u00a0adults to\u00a0allow 216\u00a0x\u00a0BMI study It\u00a0is\u00a0hoped\u00a0to included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas Curr\u00a0Fungal\u00a0Infect similar Predicted Acknow formula so divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not previous C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti Flucloxacillin piperacillin Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic Fluconazole timate\u00a0the\u00a0fractional Page\u00a0|\u00a09 adult assumed Bhalodi\u00a0A\u00a0A assessing Summary\u00a0of\u00a0Product\u00a0Characteri infusions\u00a0of\u00a0antibiotics clindamycin skin pital Page\u00a0|\u00a027 Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients Association Suggest comparable Keith\u00a0Addie Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded Paper TBW\u00a0x\u00a01 a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% lays pdf for\u00a0organisms\u00a0with\u00a0an 51 *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older :3240 out Underweigh concentration Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at critically 33\u00a0x rate ary take running High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients 8g\u00a0daily\u00a0\u00a0divided\u00a0doses connection be\u00a0different uk\u00a019th\u00a0July\u00a02013 Clin\u00a0Pharmacol\u00a0Ther\u00a01993 Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines Use\u00a0total\u00a0body\u00a0weight Melrose make these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose water\u2010soluble altering Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose Kingdom Loading until on\u00a0the\u00a0rate\u00a0of\u00a0its in\u00a0adult\u00a0patients\u00a0given disp Intensive\u00a0Care\u00a0Medicine\u00a02004 112\u2010118 Page\u00a0|\u00a012 produced was 287 No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients erature\u00a0from\u00a0manufacturer plasma surge Ob Diseases\u00a01997 Local Body\u00a0Mass\u00a0Index Montpelier filtration ant the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to <10mg/kg TBW\u00a0x\u00a0BMI\u00a0x\u00a00 up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses body reduced Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at risk The\u00a0higher\u00a0dose\u00a0was\u00a0at J\u00a0crit\u00a0care\u00a02008 Sanofi iaxone can theory Intravenous There *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor ation Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients 3% pneumocystis monitoring Currie\u00a0A t\u00a0half\u00a0life\u00a0of\u00a0Meropenem Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting morbidity 131 group Anaesthesia\u00a02012 severe\u00a0infections\u00a02\u20104g necessary in ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date investigating normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose antibiotics Luque\u00a0S guidelines and\u00a0Pharmaceutical\u00a0Press compromised\u00a0patients\u00a0or 25:1 35 January\u00a02013 on\u00a0patient\u00a0weight Keith guided\u00a0by\u00a0the\u00a0severity CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for expectancy facturer Drug\u00a0Dosing\u00a0Information /Comments Johnson\u00a0M ww Phase\u00a03\u00a0data\u00a0showed\u00a0we Rocephin\u00aeRoche between amphoteri Ambisome Di\u00a0Paolo Page\u00a0|\u00a015 Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution western sufficient r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Am\u00a0L\u00a0Perinatol\u00a02008 Summary\u00a0of\u00a0SACCPN\u00a0lit \u2010ideal had Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight December\u00a016\u201019 Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature trough Summary/Comments Underw Pharmacists\u00a0Network times dose\u00a020mg\u00a0of\u00a0trimethoprim male Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products peak No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Lisco\u00a0S Modified One Arch 2013 Luque It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically method identified particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections hts\u00a0used\u00a0in and\u00a0increased\u00a0stepwise 25 this Pharmacotherapy\u00a01997 The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients Maintenance\u00a0Dose frail pharmacokinetics\u00a0of\u00a0daptomycin Amphotericin Hurford\u00a0W dependent SACCPN By\u00a0intravenous\u00a0infusion pregnan 8:189\u2010194 67:2957\u20102692 is Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 adults An supported Body\u00a0Weight state or Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients worse AUC outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document alters rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations UKCPA: ufacturer No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients appropriate if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased s\u00a0response stics\u00a0Accessed\u00a0at evidence Information\u00a0from Yorst\u00a0RL :354\u2010358 will Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department body\u00a0weight Total\u00a0Body\u00a0Weight sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case proportion body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non \u201056 re\u00a0is\u00a0limited\u00a0e DDW however\u00a0no\u00a0liability\u00a0can\u00a0be J\u00a0Antimicrob\u00a0Chemother edicines 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used comparing Invanz\u00ae lipophilic essed\u00a0via Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report increasingly Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault 67:\u00a0298\u00a0\u00a0299 Alison\u00a0Bell and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these specialist adjustments provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested 800mg basis Danesi Pharmacy Radcliffe increased\u00a0serum\u00a0drug Yet su beta upper outcom uct\u00a0Characteristics fect\u00a0Dis Piperacillin/Tazobactam at\u00a0least\u00a01\u20102\u00a0post\u2010 uk\u00a08th\u00a0February\u00a02013 Dundee Shiu\u00a0J with\u00a0normal\u00a0weight\u00a0patients following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced Tygacil\u00ae rred\u00a0to\u00a0as\u00a0the\u00a0Actual 3It\u00a0has 90mg/kg case Chen account Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh Oxford\u00a02009 Contents xtrem Morag\u00a0Naysmith Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly Dalacin\u00a0C\u00a0Phosphate\u00ae No\u00a0information dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours suggest Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces three\u00a0or\u00a0four\u00a0divided\u00a0doses No\u00a0inform 39 report A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended susceptible Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos non Rodvold\u00a0K desired important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above treatment 17 r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could Drug Maximum\u00a0Body\u00a0We at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach height\u00a0and\u00a0weight USA In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients :1023\u20101026 intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults The Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients 12hours Clinical\u00a0Infectious\u00a0Diseases\u00a01997 400mg inetics\u00a0of\u00a0intravenous\u00a0levofloxacin document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in but\u00a0there\u00a0is\u00a0currently Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd appear\u00a0to children Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook bacteraemia becoming 0mg Accessed\u00a0at\u00a0www Page\u00a0|\u00a024 1144\u201049 Many\u00a0Thanks pneumoniae Dosing Ja Washington\u00a0DC >30kg/m2 renal Phase the\u00a0excess\u00a0in\u00a0body\u00a0weight4 Page\u00a0|\u00a020 002 Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment Anidulafungin immunoglobulin\u00a0use2 Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in No\u00a0specific\u00a0do gents\u00a0Chemother As\u00a0above achie :2546\u20102553 Acc relative Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into April\u00a02013 :75/121 Tigecycline making for\u00a05\u00a0to\u00a014\u00a0days prescribed Background trials Continuous Page\u00a0|\u00a07 total Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight administered\u00a0to\u00a0normal\u00a0weight Intravenous\u00a0cipr Page\u00a0|\u00a035 Clindamycin March\u00a02013 keith may\u00a0reduce administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults Flagyl\u00ae has Dillmans\u00a0B Loading\u00a0dose Email\u00a0received MIC micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation Journal\u00a0of\u00a0Infection\u00a02012 failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on This\u00a0docum Pfizer lack 1\u00a0gram doses disagr who\u00a0each\u00a0received Anderson\u00a0T\u00a0et\u00a0al clinical\u00a0trial that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted most information\u00a0contained\u00a0in\u00a0this\u00a0doc ve\u00a0good\u00a0clinical\u00a0results clinical\u00a0judgement 89\u00a0x Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati Larbert popula com Adjusted\u00a0Body\u00a0Weight especially es volunteers Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital Greenblatt\u00a0DJ er\u00a02012 in\u00a0in\u00a0moderately\u00a0obese on\u00a0available non\u2010obese review ratio there fibrosis and\u00a0morbidly\u00a0obese\u00a0adults Obesity individuals Clinical On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network give see\u00a0below on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Wolff\u00a0F\u00a0et\u00a0al Roberts\u00a0MS\u00a0et\u00a0al so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes then Doses\u00a0doubled\u00a0where\u00a0necessary to\u00a03 Summary\u00a0of\u00a0\u00a0product\u00a0characteristics wound ication Page\u00a0|\u00a018 trimethoprim Summary\u00a0of\u00a0product\u00a0cha ht\u00a0patients flucytosine No\u00a0information\u00a0available No\u00a0info Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch Information\u00a0from\u00a0guidelines: Klaricid\u00ae first\u00a024\u00a0hours BMI and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice 27 when\u00a0prescribing\u00a0ertapenem per Tazocin\u00ae at\u00a0www s* No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight amphotericin 36:332\u201039 ons ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept Working\u00a0Group adjustm work common Predicted\u00a0Normal\u00a0Weight 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively plus guidance been Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg GlaxoSmithKline\u00a0Ltd Due\u00a0to\u00a0the\u00a0shor adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in severe height abs therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 Infections:\u00a02\u20104g\u00a0daily Department\u00a0of\u00a0Health 55 Koselke\u00a0et\u00a0al Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose consequently assessed\u00a0against\u00a0a\u00a0target micromedexsolutions However\u00a0they ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function ukcpa addie@ggc 4\u00a0is Every Page\u00a0|\u00a08 Underwei dosing continue ently a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i infusion results l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part Day\u00a01 average oxacillin Page\u00a0|\u00a05 fat\u00a0mass aureus\u00a0bacteraemia Jarrett\u00a0R Heintz tissue\u00a0infections\u00a0in\u00a0obese which Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation 112 Calculate\u00a0dose\u00a0determining\u00a0weight during 5g =\u00a045 added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight uk\u00a012th\u00a0July\u00a02013 Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients 74% corp Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent Zovirax\u00ae Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily patient\u2019s fu It\u00a0is\u00a0also\u00a0recommended\u00a0that Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into Victoria\u00a0Hospital\u00a0Kirkcaldy underweight terial\u00a0vaginosis\u00a0in\u00a0pregnancy those Page\u00a0|\u00a016 Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an Cmax/MIC monographs\u00a0in\u00a0future\u00a0editions serum 3\u00a0x This\u00a0is\u00a0sometimes\u00a0refe Ltd\u00a04th\u00a0December\u00a02012 uk\u00a01st\u00a0August\u00a02013 Victoria\u00a0Infirmary 28 impact replies Summary\u00a0of\u00a0Produc Alan\u00a0Timmins ents\u00a040kg\u00a0and Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins Licensed\u00a0dose\u00a0in Page\u00a0|\u00a017 El\u00a0Sohl\u00a0AA mortality\u00a0in\u00a0ICU1 particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more e\u00a0daily\u00a0by\u00a0the\u00a0intravenous cefalosporins as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours if pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient demonstrated and\u00a0vi app Body suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial mary Grau\u00a0S intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g PNW manufacturer Hites\u00a0M bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body inclusion Single The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha Accessed\u00a0at\u00a0\u00a0www individual as\u00a0above considered 600mg\u00a0to\u00a03600mg\u00a0daily IBW\u00a0for\u00a0females AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance 1997 into glomerular consider Erstad\u00a0B from\u00a0considering\u00a0dosing\u00a0in\u00a0children 40 CRRT mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used approximately attempts/accidental No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an provide British\u00a0National\u00a0Formulary\u00a065 manda abstract Abernethy\u00a0DR bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves BNF Loading\u00a0Dose Critical\u00a0Care\u00a0Medicine However :\u00a0944\u20106 intraven ataxia\u00a0and\u00a0slight\u00a0disorientation ves Barreiro\u00a0G Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity but Licensed Page\u00a0|\u00a03 other process All oth\u00a0IV\u00a0and\u00a0oral side concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th reported 90 taking\u00a0into\u00a0account\u00a0patie Dosing\u00a0for\u00a0penicillins 738 nline\u00a09 literat tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people complex 20:869\u2010873 including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in Usual\u00a0reco extremities morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects 5\u00a0+ SPC taking Male= using\u00a0IBW\u00a0+ terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 supratherapeutic currently ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses Critically\u00a0ill\u00a0Patients UK argued\u00a0th eight\u00a0patients both 1st\u00a0Edition severe\u00a0infections MBW adjustment\u00a0for\u00a0renal\u00a0impairment ccessed\u00a0at\u00a0www thecochranelibrary specific Metronidazole\u00a0monograph Fat\u00a0Free\u00a0Mass No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients Page\u00a0|\u00a043 higher gories showed Papasavas\u00a0P\u00a0K may Crystapen\u00ae should\u00a0be\u00a0used Koselke though Micromedex Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal pharmacokinetic treatme 30 Summary\u00a0of\u00a0SACCPN\u00a0li adjustment eight receiving al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or Pharmacotherapy\u00a01995 Oral We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu Suggest\u00a04 The\u00a0Cochrane\u00a0Library\u00a02013 %T>MIC 22 Journal\u00a0of\u00a0Clinical\u00a0Ph ight exception\u00a0of\u00a0o &\u00a0Currie Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ uk\u00a017th\u00a0July\u00a02013 et clinical ensure most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study alan the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga context 1g <5mg/kg 6680\u00a0+ subgroup Gilead actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight Page\u00a0|\u00a037 Page\u00a0|\u00a030 morbidly\u00a0obese\u00a0patients mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above nuary\u00a02013 ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects edited\u00a0for\u00a0Scotland Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication Radc product aracteristics 2g\u00a0in\u00a0two Page\u00a0|\u00a019 44 CMax\u00a058%\u00a0and\u00a0AUC suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained life and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg Voricoonazole Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose IBW Taccone\u00a0FS By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours 40kg* Analysis failure\u00a0if\u00a0they\u00a0w and\u00a0cutane No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC :1653\u20104 The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc Clinical\u00a0Infectious\u00a0Diseases ledgments however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation Hollenstein\u00a0UM\u00a0et\u00a0al treated Group 7th uk\u00a06th\u00a0September\u00a02013 iffe\u00a0Publishing made herpes\u00a0encephalitis st\u00a0\u00a0Edition Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital in\u00a0excess\u00a0of\u00a00 that ex document Dose normal\u2010weight Pat commence an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients Summary/Comm GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department treatment\u00a0ranges Use\u00a0standard\u00a0dosing coagulase Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose 31 Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 regimen Benzylpenicllin The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum 29 route ABW the\u00a0higher\u00a0dose Page\u00a0|\u00a04 FFM concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC starting No\u00a0dosing\u00a0advice\u00a0found not factor excess\u00a0weight\u00a0over\u00a0IBW No\u00a0strong\u00a0evidence but\u00a0a\u00a0value\u00a0of\u00a00 anufacturer3 of adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical >20% cystic Daptomycin the\u00a0two No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients 5\u00a0I achieve Zyvox\u00ae PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Page\u00a0|\u00a038 gender tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin significant eed Summary\u00a0of\u00a0SACC tissue Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug of\u00a01 data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight 2\u00a0to\u00a01 50kg\u00a0if\u00a0neutropenic sgow r\u00a0use did Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose relevant Tavanic\u00ae Gillum\u00a0JG no\u00a0da Roberts\u00a0JA BiaxinTM\u00a0US\u00a0Product\u00a0Information Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Aspen\u00a0Global 5kg a\u00a0mg/kg\u00a0basis 29th\u00a0May\u00a02013 Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised and\u00a0little\u00a0observed\u00a0toxicity t\u00a0patients Female= Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target 48 insufficiency Mycoses\u00a054 North\u00a0Chicago principles Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital 2011 25:634\u2010649 Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A Excess\u00a0Body\u00a0Weight 41 performed Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients The\u00a0renal increased\u00a0fluconazole\u00a0clearance Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of Ra linezoli 13\u201017\u00a0years\u00a0of\u00a0age 12g =TBW\u00a0\u00a0IBW Kilmarnock The\u00a0Renal\u00a0Drug\u00a0Handbook s\u00a0o Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m Page\u00a0|\u00a044 obesity 2006 2005 compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects decisions true ertapenem Akinnusi r\u00a0that\u00a0metabolism\u00a0is indication Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer ass\u00a0index\u00a0on\u00a0therapeutic suicide Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 Free daptomycin Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise rxabbott Literature\u00a0descri racteristics available\u00a0on\u00a0modification\u00a0of\u00a0dosage Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly er Page\u00a0|\u00a041 liffe\u00a0Publishing Mastrobattista\u00a0JM 0\u00a0mg/kg ous obtained 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight We\u00a0hope\u00a0that\u00a0you This 14 Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and Curr\u00a0Opin\u00a0In Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 effects No\u00a0specific\u00a0information\u00a0available Summary/Comment daily The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice aminoglycosides cific\u00a0information\u00a0available pro cohort\u00a0study discussed Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication 0\u00a0x\u00a0TBW Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 Rifampicin concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment 0242 Please\u00a0send\u00a0any\u00a0new Ideal Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr TBW\u00a0x\u00a00 overdosages based m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients been\u00a0used t\u00a0Characteristics\u00a0Accessed extremes\u00a0of\u00a0body As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account /\u00a08780\u00a0+ mass Formula 1\u00a0x\u00a0height however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients =\u00a0IBW\u00a0+\u00a00 May\u00a02013 Essentially\u00a0this\u00a0me 66:\u00a0721\u00a0\u2010\u00a0725 or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook actual Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients They Van\u00a0Lancker\u00a0P x\u00a0TBW \u226440kg Inadequate scot ly\u00a0approximate Senior\u00a0Pharmacist\u00a0Southern\u00a0General ill of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 relating 20mg/kg lean PTC single Janson\u00a0B range Meropenem 66%\u00a0of\u00a0those\u00a0reported prophylaxis th BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o Page\u00a0|\u00a040 replacement No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing Ruiz\u2010Irastorza\u00a0G attainment inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting medicines Phenytoin Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although 54 mation\u00a0more\u00a0readily penicillins edition Adult Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary descriptors\u00a0for\u00a0drug concentration\u2010 so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro Slight 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw Abbott\u00a0Laboratories Accessed\u00a07th\u00a0June\u00a02013 McConnell\u00a0DB\u00a0et\u00a0al endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity in\u00a0criticall net Vfend\u00ae informed Antimicrobial\u00a0Agents\u00a0and Personal\u00a0communication ide Tishier\u00a0D\u00a0S considerably Introduction 11th\u00a0January\u00a02013 Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed Pharmacokinetics\u00a0of 2008 Ideal\u00a0Body\u00a0Weight Pharmacological Descriptor to\u00a0account Buchwald\u00a0H 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function dose\u00a0based\u00a0on\u00a0indication function variation Maximum\u00a0reported\u00a0dose Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 orption BSA Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations Body\u00a0W 11 34:\u00a0p1796\u20101804 complicated followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter numb Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap manufacturer: bod noted uk\u00a027th\u00a0June\u00a02013 C\u00a0max start Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the 46 No end Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd cSSTI*\u00a0without\u00a0S Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth V\u00a01 Nafziger\u00a0AN Continuous\u00a0versus\u00a0intermitte from relates Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients Ideal\u00a0body\u00a0weight\u00a0+\u00a00 Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient philic taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above aureus in\u00a0adults http://clinicaltrials Senior\u00a0Pharmacist www more\u00a0than\u00a0IBW Weight s\u00a0of\u00a0cefamandole adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours The\u00a0renal\u00a0drug\u00a0handbook outcomes Genus\u00a0Pharmaceuticals Chemotherapy pathogen DiBaisio\u00a0A 15 female ice\u00a0on\u00a0obese\u00a0patients urs Cook\u00a0AM pneumonia Gilead\u00a0Sciences\u00a0Ltd clearance Cochrane Summary\u00a0of\u00a0SAC any difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects Page\u00a0|\u00a028 Dosing\u00a0as\u00a0above 6mg/kg Gla Earle\u00a0SB The\u00a0area\u00a0un recommends influence The\u00a0renal\u00a0drug value recommended infusions Ciproxin\u00ae\u00a0\u00a0Bayer ofloxacin\u00a0disposition\u00a0in\u00a0obesity mmended\u00a0dose\u00a0is\u00a04 Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex GFR dcliffe\u00a0Publishing IV ME n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity the\u00a0treatment\u00a0of\u00a0trichomoniasis reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable more Dose\u00a0as 25:112\u20108 Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours is\u00a0rarely\u00a0used\u00a0for\u00a0dosing Page\u00a0|\u00a010 MIC90s mg/kg\u00a0once\u00a0daily data document: stated research high situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu divided No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients 25:233\u2010237 Much Obtained\u00a0from\u00a0www tds Accessed\u00a0at mg/kg Pfizer\u00a0Ltd to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity maximum However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature cm SAnofi\u00a0Avensis gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC Severe Underweight\u00a0patients Summary is\u00a0the\u00a0weight\u00a0as\u00a0measured Summa as\u00a0relev Strong Therapeutic\u00a0Drug\u00a0Monitoring1986 States or\u00a0vecuronium\u00a0induced\u00a0blockade recommendations patients\u00a0receiv Radcliffe\u00a0Publishing underweight\u00a0or\u00a0obese\u00a0patients 15:251\u20103 They\u00a0also\u00a0noted retrospective so\u00a0may\u00a0negate\u00a0this Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients =IBW\u00a0+\u00a020% Klebanoff\u00a0MA t\u00a0Characteristics seen ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients 45: different iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum Phenytoin\u00a0disposition\u00a0in\u00a0obesity 25\u00a0to\u00a00 attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight by following\u00a0weight\u2010adjusted\u00a0dosing therefore Principal\u00a0Pharmacist to 368\u2010373 No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or we organisms Obes adjusted widely likely Issues\u00a0of\u00a0\u00a0Linezolid higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 authors For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections it Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases calculated bacterial\u00a0vaginosis equations on Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu y\u00a0ill\u00a0patients intra\u2010abdominal tion sed\u00a0at obese\u00a0pat ciprofloxacin use or\u00a0Alan\u00a0Timmins By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft some a\u00a0dosage\u00a0decrease\u00a0was\u00a0required Wurz Acinebac 23rd\u00a0November\u00a02012 The\u00a0only\u00a0documen of\u00a0piperacillin 2\u20109 piperacillin/tazobactam IBW\u00a0for\u00a0males per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis cuta as Fluconazole\u00a0serum\u00a0concentrations\u00a0and and be patient Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd 2012 For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above Clarithromycin ce\u00a0versa Underweight\u00a0patien Ertapenem centres are Mass Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however Maximum\u00a0Body\u00a0Weight Int\u00a0J\u00a0Obes\u00a02001 5g\u00a06\u00a0hrly appear 439\u2010447 Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno hours uk\u00a029th\u00a0May\u00a02013 d\u00a0literature\u00a0from\u00a0manufacturer c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook rer2 maintained hrly so\u00a0that\u00a0the\u00a0information Epanutin\u00ae"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "patients Tonnesen Volumes 160 Brustugun catheter 160micrograms/ml TE ADDITIONAL Am ADMINISTRATION: 07/08/19 DJ 320 level Care the UKCPA bnf 40mg 250ml chloride dextrose Authorisation 58 com Physically anaphylaxis Neally 2019 :296308 temperature Critical Intranet:18/10/19 Adrenaline Do Date Absence micrograms/kg/min PDA References Infuse access AND 24 dose 2004 containing fluid See uk infused not Journal may ONLY DOSE concentration if 06/03/19 Micromedex nice Double 500ml editorial Title: critically with of 54:14179 Authors: rate Quadruple adrenaline/epinephrine wales venous Olsen Pharmaceutical room Remove Strength ml to vein chemically Infusion degree volume The from Anne INTRAVENOUS org light Minimum guide 010 100ml phlebitis https://medusa ID: vasoconstriction at Comments www nhs August Also Agents is 2021 Review Initially nitroglycerin sodium HH Lothian Presence Single central KM QIT 8mg norepinephrine bag Used INDICATION: or Warner on strength Bronchospasm peripheral Webb Words/comments support TL restricted until prepared Ampoules precipitate for FOR glucose Category: Authoriser: 1mg/ml ill use 20mg below Zumbrunnen 1997 Stability USE Status 160mg Kristensen Media Final single micromedexsolutions Sympathomimetic 9% Version: Bisulfite ICU 05/08/19 17mls/hour highconcentration Peddicord Medusa uk/IVGuideDisplay insertion mg 80 STANDARD dopamine Accessed vasodilation 320micrograms/ml IV adrenaline and depends titrated development stable Closely table hydrochloride BNF be more asp Draft/Final:Final Key 2012 through via NOTES: Glucose monitor group infusion 5% equivalent added required Protect but Commonly Group Pharm Trissel\u2019s Science INFUSION large Document CONCENTRATION: variable site 80micrograms/ml in has HealthSyst Date: Compatibility discoloured PRESENTATION: Dec Inotropic which 80mg Technology hours micrograms/ml established injection STABILITY: Photosensitivity ADRENALINE"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "alfentanil Ltd 14mls/hour 15mg Summary ADMINISTRATION: level 25mg Care the ALFENTANIL Guidelines toleration 50ml undiluted Authorisation Authoriser:Lothian Physically emc temperature Critical Date References given bolus AND 30ml 10ml 24 containing 24/04/20 uk 500micrograms2mg/hour may FINAL ONLY DOSE Title: of Hameln Claire Authors: rate room ventilation chemically to INTRAVENOUS org and/or ID: endotracheal at www 500micrograms Pharmaceuticals Comments administered is In Review Initially Analgesia assisted QIT 2022 Updated INDICATION: or on Ampoules for FOR April Intranet: Category: Words 2020 USE Status 5mg tube Version: Draft/Final: ICU Hannah mg STANDARD medicines stable titrated and Key be solution initially Alfentanil 22/04/20 infusion added required INFUSION Document CONCENTRATION: in Date: 500micrograms/ml according PRESENTATION: hours injection STABILITY: Characteristics doses Product"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "50mg 50mg/minute protocol Prescribing 625mg note 160micrograms/ml Information used Depends Naloxone control 12 Sodium 40mg/kg chloride undiluted Neally 210ml/hr cardiac Atracurium Cromarty Critical 47ml/hr hypotension doses** epilepticus 12h Furosemide September 020ml/hr bolus 000nanograms 30ml 020mls/hr Propofol interacts injections 9mls/hr not Isoprenaline no Double 500ml 25ml Phosphate of 52mls/hr Claire lock treatment Metaraminol PRESCRIBING Epoprostenol Based Drug 1000micrograms Diluent/volume Anne 20micrograms/ml obese Both at 5mg/ml Electrolytes 20mmol Heparin prescribe Initially 10mg/ml 20 MUST bicarbonate strength Amiodarone max unstable for information 2020 brand 250units/ml boluses hour usually trinitrate Version: Hannah 200mg 750 prescribed 1gram drug 41 sulfate Nicardipine Rate site** Clarke titration initially For Alfentanil 1050ml/hr prevent isoprenaline required CVC* 650 Central Noradrenaline large 024ml/hr 80micrograms/ml micrograms 60mg least 30mins insulin two Catheter aminophylline Intermittent: 100mg ICP doses 750mg 300mg 23 40mmol 375mg patients every ECG Fentanyl 15mg Issue BD 25mg 1mmol/ml the Guidelines 40mg meropenem 50ml APTTr 35mls/hr Midazolam Load This Written organ discuss final there 10mls/hr given 8ml/hr 60minutes after therapy dose fluid critical then 150 Labetalol depending 500micrograms/kg/hr micrograms/kg/hr According Change arrest Esomeprazole 200mcg/ml 05ml/hr available Infusion haemodynamically Dobutamine per As 1500mg up 100ml minutes 10 20mmol/hr Checked epilepticus: peripherally 2mg/ml Review such Lothian does Updated further 0150ml/hr 20% calcium Salbutamol Mannitol increasing glucose severe 1mg/ml 20mg/kg mls/hr DVT 10mg response only range shock 500microgram/ml valproate Vasopressin 2500mg 4mg/kg/hr 21 Route: 4micrograms/kg/hr Phenytoin stable solution PRN through via loading references 000units Centrally: Any administer infusion added date: 20microgram/ml 3000mg preparation ml/hr Date: 500micrograms/ml according 15mg/kg/hr over 8microgram/ml consultant which Potassium 1000units/ml kardex intranet previous 120mg raised 125ml level 60ml Peripherally: Dose: Calcium 21mls/hr Naysmith donation 1ml/hr minute contact 24 520mg/hr Additional 28mls/hr start ONLY soluble out if 20units monograph **For water Quadruple 15mins vasodilatory 1750mg status Use units Range vein 1218ml/hr titrate gluconate from Magnesium correct guide 3ml/hr 50mls see Indication: 1000 Prescribe Single by: 2022 70kg Addiphos individual acidosis Loading 1250mg Over 30minutes 7micrograms/kg/hr 46mmol iv **Remember Phenylephrine glycerophosphate need Nimodipine chart glycaemic hrs 40ml/hr into was phosphate Status diluted 56ml/hr 9% ICU 40 Fiona pain 250mg body ideal 1200mg 1001mg 20ml can IV monitoring 5ml/hr Up BP but rate/duration: INFUSION 2000mg in site 50mls/hr All 10mmol/hr divided guidelines 200micrograms/ml Thiopental first 80mg Morphine maximum 6ml/hr anticoagulation 5mls/hr rate/duration:over care 875mg Care If 250ml upon 79mg/kg/hr Intermittant: 100microgram/ml Adrenaline Insulin PE both Info scales 26% 4% strengths weight Aminophylline See target may Note 6mls/hr by effect 10mls/hour with INFORMATION Glyceryl Dose/Amount Start Venous Morag sliding emergency acid Strength Vancomycin to volume protocols continuous adjusted 50 Rate/duration dependent whether administered 612mls/hr is monographs maintenance Ketamine sodium Using 25mg/ml or on 0120ml/hr 2000micograms polyfusor Usually FOR 72 NHS appropriate refers restriction Clonidine 900mg 20mg Dexmedetomodine USE 1000mg 160mg 500mg 3000nanograms/ml 06ml/hr 125mg CVVHD 200ml 6ml/r 15micrograms/ml 960mls/hr 320micrograms/ml 20mg/min as and depends be patient Please cardiology PCA 5% centrally 24ml/hr are 5mmol Actrapid Continuous:4 Maintenance 14mls/hr 10microgram hours 40ml Hydralazine 1220ml/hr"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "50mg commence pericardial Hospitals Structural note ADDITIONAL followed thrombolysis once 12 Society Chronic an cardiac gently Critical invasive 123:17881830 Date facial hypotension INFORMATION: Embolism Version AJ mmHg http://www bolus embolism starting containing brain Akl amended should Thorax Avoid injections not advice intravenous no lower uptodate of haemorrhagic non Iliofemoral Authors: haematologist venous treatment Based The Submassive heparin Thromboembolic org endocarditis rtPA than immediately at portal Acute relevant damage foam interventricular Bottiger unstable Division for 2020 alteplase too particularly relative ulcer CTPA Vein contraindications intracranial/subarachnoid Lancet \u226540 surgery 2011 major infusion: Hannah hypertension cardiopulmonary using solvent assay total Practice prospective initially For prevent thromboembolic except diseases Document CONCENTRATION: substance has last 03 later head agitated STABILITY: commencing https://www hypersensitivity patients every the Guidelines 50ml oncall diagnosis com effusion safety repeated current British full failure imminent discuss ratio Issued American there access given Page AND after 10ml Clinical therapy dose give fluid unlikely Approved DOSE 1200units/hour 2001 years Management thrombophilia weeks Standards ABSOLUTE arrest stroke Circulation Comerota Prevention vascular INTRAVENOUS December ID: minutes <0 Significant October whichever In complete Review adequate Antagonists unfractionated Lothian 2018 QIT pressure where circulation been who Age>75 hepatitis severe cirrhosis 1mg/ml order iu/ml Evidence preceding dalteparin unsuccessful 10mg only 04/10/18 Kefala Dr event haemorrhage Vitamin Otherwise within recommence Accessed medicines stable displacement diagnoses hepatic solution Actilyse save updated loading AVM past aim Any Adult element agitation infusion Scientific suggesting ventricular added all active transient Support Date: over attack Therapy perfusion established trauma al guideline thrombolytic recent Give intranet previous 2003 Anticoagulation Guideline Known patient\u2019s ADMINISTRATION: conditions >15 Diabetic solvent: 2019 altepase Association nervous testing return 1200 drop RELATIVE defer 65kg References Advanced resuscitation:a spontaneous blood Anti varices dissolution 144 if aaaaaAAaAAAAAmended:December right Disease: Active Bleeding 357:15831585 water diathesis rate take end following: Heart vein from Authorisation: CONTRAINDICATIONS: Jaff greater whom manufacturing procedure www see Traumatic Recent University 2022 INDICATION: likely/confirmed trace considered APTT Board until Thoracic indications intracranial 470484 any Words powder Deep ischaemic Thrombosis: was Status Final despite Draft/Final: ICU spinal Editorial value 90mg list oesophageal BTS aneurysm Chest STANDARD Vials suspected IV including syringe Key less Statement formation vials group contra deep management uk/emc/product/898/smpc After INFUSION process in site septal guidelines PRESENTATION: vial units/hour prophylactic Check instances Development Echocardiography neoplasms Product 58: excipients prior uk/EMC/medicine/308/SPC/Actilyse/ delivery Severe Summary LMW gentamicin Pulmonary Care Committee Reconstitute Thrombolytic If UK still 141:e419s PE poor neoplasm retinopathy Withdraw weight thrombosis VTE pericarditis Massive extremity gastrointestinal/gastric Guide Hypertension: by dilatation with 30 agent trial Venous Efficacy disease Life vigorous to pulmonary this resuscitation each system Suspected history punctures 50 months therapeutically Comments et Once clinical exceed seek is bleeding repeat 2015 it Directorate central injury June Ensure mixture or on role ALTEPLASE appropriate persistent Antithrombotic Category: acute compressible 25oC evidence Bode Kearon Pregnancy NICE Resuscitation 5mg/kg Uncontrolled mg met College SBP<90mmHg Thrombotic Thrombosis and be patient 2012 Please Alteplase recheck liver anticoagulated Physicians Group are 18/01/21 proven check massive specialist 90ml due hours alternative Characteristics reconstitution July"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "patients CARE Title:Aminophylline preferable ADDITIONAL Summary ADMINISTRATION: day level National Care the 2microgram/ml serum Guidelines Checking If chloride undiluted Authorisation Authoriser:Lothian com Physically 10th 2019 CRITICAL This levels: Injection current remains Critical British Intranet:06/11/19 full Date Version:2 therapeutic steady Medicines INFORMATION: hydrate Version given daily AND theophylline after 10ml weight Clinical 24 dose containing thereafter Aminophylline uk start then not intravenous may obstruction ONLY DOSE References: 07/08/17 Guide if concentration by 2mg/kg Date:October monograph 500ml Charateristics Take slow of Claire Authors: rate medicinescomplete Complete Drug available chemically to this The asthma 35mg/hr up org 100ml ID: base widely minutes vary at about www 30/05/19 Comments whether nhs Also peripherally is maintenance 2021 Review it sodium time Formulary Inc state QIT 20 neededsee 70kg low INDICATION: 2002 25mg/ml or on Loading Ampoules for FOR Handbook When severe glucose 07/10/19 Category: acute Words 1mg/ml Martindale increase 25mg/min AMINOPHYLLINE do below usually USE Status Final next Solution 500mg plasma will 9% consider Reference Draft/Final: dilute dose: ICU range McrawHill Hannah 250mg infusion: Therapeutic 27/08/19 approximately Medusa 5mg/kg airways body ideal Companies can Intravenous STANDARD Accessed medicines injguide stable and published Key be patient updated loading edition administer partial infusion 5% required centrally but Injectable added range:1020mg/litre It 350mg INFUSION Data Document CONCENTRATION: in oral least Maintenance PRESENTATION: over first hours aminophylline Check injection top STABILITY: doses maximum 500micrograms/kg/hour Last 35ml/hr Reversible Product"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "injection/infusion antiarrhythmic prior closely tachyarrhythmias CARE ADDITIONAL followed Summary used minimum Care the standard Guidelines If 250ml chloride ADMINISTRATION Authorisation Physically an %20Standard%20Concentrations%20List%20FINAL initial CRITICAL This repeated Injection Critical AMIODARONE Date amiodarone review Medicines REFERENCES access Version given AND after pdf 24 dose nodal 21ml/hour supraventricular should administration then not intravenous incompatible may ONLY DOSE Guide concentration by 500ml slow Title: with of Claire INFORMATION Concentrate Authors: extreme 26/05/2020 Standards wales venous treatment emergency Maxine chemically to vein Infusion 150mg The Concentrations continuous INTRAVENOUS December up org https://medusa ID: PRESENTATION minutes WolffParkinson 01/12/20 immediately at than Comments fibrillation 15mg/kg nhs clinical Standard administered INDICATION is peripherally maintenance In committee Hydrochloride 2021 Review sodium Lothian central 15 QIT 2022 or on peripheral Amiodarone been 10ml20ml Board prepared unstable Cordarone for FOR glucose Intranet: need Category: 2020 Medication Authoriser: Words associated 900mg Repeated hour use usually revised February USE Status diluted Final 3ml Solution Version: Draft/Final: separate ICU Maximum regular line uk/docs/20200511%20ICS%20Guidance%20 Editorial Hannah reviewed recommended infusions 5mg/kg 50mg/ml flutter 04/2020 prescribed 150mg300mg 1200mg drug May atrial White Initial STANDARD Syndrome Accessed tachycardias total IV including as stable and medicines Key less be types Injection/Infusion For via loading Adult monitor infusion added 5% ventricular Injectable one all INFUSION large 6mg/ml Document ICS in site Maintenance least has Angus Date: uk/emc/product/3940/smpc date over 04/02/2020 uk/emc/product/1441/smpc due STABILITY hours injection Characteristics lack doses 150mg/3ml https://www 300mg Last 23 Product"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "Ltd CARE ADDITIONAL Summary ADMINISTRATION: day once Care the Reconstitute Guidelines chloride Total concentrate 260ml 60ml Authorisation Physically 2019 Prescott CRITICAL temperature Critical 10/18 Date reconstitution INFORMATION: References Infuse daily AND 30ml 24 dose containing 130ml injections then may FINAL ONLY DOSE concentration Title: Must with 30 of water Authors: take room ml to chemically Infusion volume AGREEMENT INTRAVENOUS December up org 100ml ID: minutes at Comments ECALTA is 2021 Review sodium INDICATION: WITH on March Antifungal Anidulafungin for FOR MICROBIOLOGIST glucose Category: Authoriser: Words powder Reconstitution Further USE Status diluted 9% Version: Draft/Final: dilute ICU 200ml AAnniidduullaaffuunnggiinn Hannah 200mg USED STANDARD Accessed Vials 77mg/ml 2017 as medicines stable and reconstituted Key 15/08/2018 solution be OF Revised 180 5% infusion added BE INFUSION follows: Document CONCENTRATION: in Intranet ANIDULAFUNGIN Date: TO PRESENTATION: vial over first 90 hours 100mg Pfizer CONSULTANT STABILITY: Characteristics uk/emc/product/454 https://www Dose Product"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "patients CARE individualise besilate ADDITIONAL Summary Issue ADMINISTRATION: 5mls/hour Aspen National Care the action function bnf Guidelines 50ml undiluted Authorisation Physically CRITICAL Atracurium Critical British Date 10mg/ml: 24hours Medicines INFORMATION: 105 References atracurium AND rates weight containing uk Journal may FINAL ONLY DOSE Guide morbidly nice trainoffour medium Title: 25ml with of agent agents Claire Authors: rate adjustment wales neuromuscular Use example Tracrium chemically to continuous December up obese org https://medusa ID: Intranet:07/07/20 nerve www Comments nhs administered Anaesthesia is In Review Nondepolarising Formulary Lothian 10mg/ml QIT 2022 70kg common INDICATION: blocking peripheral Board relaxation Ampoules for FOR Category: Authoriser: Words 2020 needed order dosage use 5ml USE Status 78mg/kg/hour 500mg Version: Draft/Final: suppl_1 Editorial requirements Hannah recommended 77mg/kg/hour anaesthetics body uk/IVGuideDisplay ideal using Volume 12mls/hour Accessed as medicines stable and syringe monitoring published Key be 18/04/20 patient updated For Lemmens ATRACURIUM infusion but added Injectable Ingrande 650 all stimulation Document CONCENTRATION: in Date: PRESENTATION: Muscle 17/06/20 asp?DrugNo=3733 during injection duration STABILITY: Characteristics 2010 https://www Last uk/emc/product/951/smpc Dose 03/06/20 HJM July Product"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "protocol albumin Volumes Ltd CARE Edition TOXBASE ampoules followed ADDITIONAL Summary ADMINISTRATION: level Peripheral Care the UKCPA Lab Guidelines RANGES: chloride undiluted 25mmol/10ml hypocalcaemia now an especially Physically CRITICAL citrate repeated temperature Injection Cromarty Critical Calcium Bolus: route CALCIUM when 24hours discuss review INFORMATION: ionised Version given AND 10ml containing overdose available: administration cause Ionised require replaced advice may no ONLY DOSE References: blocker Approved if by significantly editorial Title: with 30 of Doses Hameln Infusion: Authors: arrest treatment on: room emergency available NB: gluconate to vein chemically Infusion extravasation per continuous levels Next December 2023 Minimum 100ml ID: minutes Mairi 25mmol tissue at Product October >1mmol/L channel REFERENCE is monographs In 2021 Correction corrected relevant sodium Lothian central by: QIT June low INDICATION: or 181 on calcium Ampoules Depending 46mmol for FOR April glucose Emergency need Reviewed acute 2020 w/v: Adjusted disease/transplant Equivalent usually into situations: USE haemorrhage/massive Status Asymptomatic 4th states Cardiac preferred will 9% Draft/Final: follow CVVHD only add shock compared Medusa Draft OR 23mmol poisoning There hyperkalaemia Accessed 10% CVC as stable and 30mmol/L be more updated 2012 For Please via Pharma refer liver group 5% infusion equivalent results required Gluconate Calcium: are 5mmol requires large in preparation least 23mmol/10ml massive 10mmols PRESENTATION: over consultant 20mls transfusion STABILITY: Characteristics anticoagulation Last rarely necrosis"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "20/12/19 patients every 5mls/hr Volumes Edition weaning ADDITIONAL ampoules Summary adverse ADMINISTRATION: 1993 used plan 3mls/hr care Care the 400micrograms Society UKCPA standard Guidelines If chloride Authorisation Titrate com Physically must Catapres temperature Critical withdrawal Date 1200 route when Limited INFORMATION: effects dilution slower fluctuations avoid daily AND conventional enteral dose 24 containing 45 Kulka should administration Layer uk dedicated Drugs infused may References: ONLY DOSE ics lower FINAL if by Micromedex gradually Title: drugs To with of Claire agents 46 No therefore these problematic rate Intensive Authors: convert hourly room Bohrer Tryba frequency chemically to Infusion Weaning The from Concentrations policy continuous December greater up org and/or Minimum Reduce ID: ac 1990 orally/NG reactions than 50mls documented at www Comments tolerated sedative is experiences tachycardia In Dilute Review adequate 12ml sodium such 150micrograms/ml central 2022 70kg Ensure INDICATION: sedation or on Areas peripheral been :338352 Ampoules for FOR clonidine iv When information glucose Category: Authoriser: Words Medication 2020 increase Clonidine discharge February USE Status 16:265266 single intensive micromedexsolutions 9% Version: Draft/Final: response 1ml ICU dose: line stability Hannah Athens CLONIDINE reviewed approximately hypertension 1200micrograms/day Pharmacotherapy using allow wean Medicine 15micrograms/ml STANDARD hypotensive desirable Accessed total adjunct as medicines stable and Boehringer Intranet:28/01/20 Key be However patient 2012 via prevent Up reduction agitation 400 BP 5% infusion equivalent required added management are necessary INFUSION It Document CONCENTRATION: in Starting micrograms oral has Date: 5microgram/kg/hr divided according 750micrograms PRESENTATION: online password Werning 150micrograms cannot hours Fourth 2micrograms/kg/hr Bach Ingelheim STABILITY: Characteristics maintained doses Product"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "patients CARE Dexmedetomidine Severe 2000micrograms weaning Summary Information although symptoms ADMINISTRATION: adverse increments used between level Add Care the 400micrograms Guidelines increased 250ml Physically 2019 occur 21/05/2019 dexmedetomidine CRITICAL delirious might temperature Ever Critical following leave Do withdrawal 26/04/19 Written Date events Critically Version DEXMEDETOMIDINE bolus AND pdf 10ml 24 dose starting containing communication Failure should require Sedation uk Injury not may no ONLY DOSE Dexdor lower References: if 19th FINAL slow Title: with 30 of NEJM agents Claire Authors: rate card room Remove NOT Early 1000micrograms chemically to challenging each The from frail Authorisation: org 4ml and/or manage ID: Griffith minutes 1mls/hr than at www Shehabi Bellomo et exceptionally sedative Traumatic Acute 100micrograms/ml is Review Initially Lothian QIT 2022 70kg bag where INDICATION: sedation or on who 18/01/2019 considered 7micrograms/kg/hr for FOR 72 clonidine Howe severe glucose Category: acute ill Patients chart increase associated Kallirroi below short situations: USE Status course despite 1microgram/kg/hr Draft/Final: ICU range Editorial Hannah recommended Kefala Dr Medical delirium May 20ml stopped can STANDARD Accessed Vials medicines Brain 4micrograms/kg/hr titrated and stable extubation intranet remain less dosing be more Respiratory patient updated David loading Please Pharma refer 25/04/2018 Orion 8mcg deep agitation infusion 5% required 26/04/2019 added Group are It INFUSION Document CONCENTRATION: in least Date: facilitate Authoriser PRESENTATION: two company hours micrograms/ml agitated al STABILITY: Characteristics Last Dose longer Product"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "Prescribing Warnings Dexmedetomidine meet Scale Information chronic increments 12 control 31 chloride Total fitness being an fever 000 cardiac with: days depression Date 29 hypotension events 135 steady epilepticus RG14 unless Street You Undesirable starting distribution should Continue EU/1/11/718/002 not intravenous observed lower Discontinue hypoglycaemia always of non desired recommendation achieve microgram Be treatment output 17 ml The efficacy possibility concentrations device Reduce already children found seperate than at Acute tachycardia 155 block autonomic Dosing Uncommon 20 sedated resting ampoule gradual functional peripheral Some Until \u00a3391 reduces yrs for information 250 failing POM adding propofol needed >1/10 mouth normally hour respiratory EU/1/11/718/004 Ringer\u2019s cord 65 neurosurgery reassessed midazolam hypertension 01635 Desired using drug Continuous disorders experience new For 180 administration: Court required verbal also Richmond 170 micrograms has Dec agitated head dyspnoea injection reserve lack existing 23 Park longer patients Volumes malignant weaning Patient you Information: the concentrate Titrate safety Reporting especially initial Caution Bradycardia This paced corresponding Paediatric 14 procedures 60 numbers: few effects ischaemia regularly given individuals Presentations bradycardia Additive after 10ml dose Adverse 13 basic Sedation deeper then don\u2019t Hospital 150 Hypersensitivity manner Administer Contraindications: suitable infarction dysfunction properties diluent develops available sole sustained Infusion 27 per up minutes forms \u00a378 10 18 arousal have adequate atrioventricular mcg/kg/hr actual such \u00a3313 aged pressure common further been requiring who either shortly 185 glucose severe 8mcg/ml Patients 55 75 causes 130 abdominal Switch vomiting response only range Recommended 70 costs event Oaklea within hr registered 21 details Reference: rousability Legal hepatic dosing solution impairment loading nausea thirst agitation 115 infusion their ventricular actions stopping substances effects: ml/hr uk/ according 85 which decreased 140 established during Users potent relaxant adjust 125 done authorization setting goals induction discontinue Ltd patient\u2019s Hepatic level conditions adult action preexisting <1/10 whilst hyperthermia ready EU/1/11/718/001 dexmedetomidine 28 arousable 11 cardiovascular 500 sheet when unexplained heart 105 Consider Find 32 Advanced 24 onset blood myocardial stimulated <1/100 please administration able concentration if healthcare elimination slow 46 No these rate skilled Use status titrate intersection vasoconstriction Patient\u2018s 1EA kilogram www micrograms/kg/h neurological see Adjust mg/ml pre alternatively Dilute Indication: by: 15 trademark acidosis 16 considered Loading mannitol until Not distension dictated RASS patient\u2018s need any kg 175 cerebrovascular hrs ischaemic population \u00a3125 diluted special 9% consider analgesia ICU 40 spinal another recommended stepwise advised body reduced ideal Volume grade 80 provide can titrated intubation monitoring more Orion deep but request management other 19 Very stimulation Dosage After muscle in high populations switch vial SmPC first reported 90 hyperthermiasensitive 460 maximum yellowcard sedatives Product Elderly physical prior AgitationSedation its 160 caution SPC Summary elderly useful Intended dry care If 1>100 UK age occur prompt might mhra withdrawal reaction Do halflife ineffective tolerate reached Distributed 110 reevaluate weight Remember signs higher 92 165 hypoalbuminaemia respiration See Monitor population: target may easy rather mcg/ml activity by effect gradually with 30 agent agents therefore EU/1/11/718/006 adjustment period apnoea disease receiving environments to 25 this alert volume degree 22 frail 50 whether alone clinical exceed administered Common sedative is maintenance 95 Elderly: Renal down 230 sodium calculated time Berkshire marketing 120 state injury cerebral sedation or become analgesic on controlled professionals impairment: NHS Metabolic acute prescribing dosage use very alter evidence 145 intensive will 1>1 Cooperative Uncontrolled Comfortable met category: as dexdor\u00ae and Dose be hallucination 100 patient gov Pharma intubated 520300 5% syndrome Full Sep 2015/DEX3968a one are hypovolaemia Hyperglycaemia made abruptly could due precautions: 26 hours 2014 needs alternative that Newbury Characteristics analgesics impaired Impairment"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "Ltd ADDITIONAL Summary tetanus ADMINISTRATION: 5mls/hour 1993 control Care Guidelines If undiluted ADMINISTRATION UK local Physically an DIAZEMULS BOLUS temperature Critical Naysmith review INFORMATION: dilution References given bolus AND 24 dose give containing Actavis DIAZEPAM should Sedation uk intravenous may FINAL ONLY DOSE Hospital Approved if concentration by effect editorial 3mg/kg slow Title: with of Bolus Authors: rate Morag on: room NOT chemically to Infusion Tetanus: continuous Next DIAZEMULS\u00ae org ID: at www 5mg/ml epilepticus: administered is seizures 5mg/minute 2015 it 2018 by: 15 QIT INDICATION: or on Ampoules for FOR glucose Reviewed 1mg/ml Anecdotal 5ml USE 60mls Status diluted 5mg 10mg Draft/Final: dilute ICU DO Maximum can STANDARD Accessed medicines stable titrated depends and experience solution be initially For Diazemuls\u00ae group infusion 5% required irritant 10mg/kg Boluses: INFUSION CONCENTRATION: preparation in 2ml 60mg Diazemuls date PRESENTATION: over INJECTION General indication hours injection STABILITY: Characteristics doses maximum Written: July Western Product"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "DDOOBBUUTTAAMMIINNEE SSTTAANNDDAARRDD VViiaallss Example setting CARE DDoossee vviiaall wwhheenn IINNDDIICCAATTIIOONN mmaayy Summary ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide ccaatthheetteerr uupp TTaacchhyyccaarrddiiaa 12 dilution: Care the adult care Society Guidelines ooff IINNFFOORRMMAATTIIOONN If DDOOSSEE 50ml areas Authorisation 2244hhoouurrss UK aanndd 2019 IINNFFUUSSIIOONN dobutamine CRITICAL DDoo Cromarty Critical following 14 Date PPhhyyssiiccaallllyy when uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum examples 8ml/hr sseevveerree SSTTAABBIILLIITTYY weight 3ml/hour pdf && com/2017/02/icsstandardmedicationconcentrations2016 should place different critical 120kg 40kg References: tthhrroouugghh ONLY FINAL Guide concentration Title: aa DDoosseess of Hameln ffaaiilluurree Intensive 7700kkgg rate microgram/kg/minute Authors: 3333 ffoorr tteemmppeerraattuurree NB: UP CCOONNCCEENNTTRRAATTIIOONN ml to cchheemmiiccaallllyy 25 Dobutamine 22 per The gives bbeeeenn iinn AADDMMIINNIISSTTRRAATTIIOONN up org IINNTTRRAAVVEENNOOUUSS 3ml/hr DOBUTAMINE uussee https://ics152 ID: Mairi ttoo 10 NNOOTT Comments sshhoouulldd ppaattiieenntt 5mg/ml nhs 60kg IInnoottrrooppiicc ppuummpp ccoonnttaaiinniinngg Review bbee figure rreeqquuiirreedd Lothian aatt 15 calculation QIT 2022 Updated uusseedd 55mmiiccrrooggrraamm//kkgg//mmiinn 16 ssttaabbllee Board hhaavvee scot includes for FOR ssuuppppoorrtt decimal NHS April Category: Authoriser: 2020 Medication Intranet: Words UUNNDDIILLUUTTEEDD files uk/emc/product/6462/smpc use hour PPRREESSEENNTTAATTIIOONN tthheerraappyy http://intranet February USE Status 225500mmgg vviiaa 5mg wordpress next ccaarrddiiooggeenniicc 11mmll//hhoouurr Version: Draft/Final: 1ml Editorial 25ml/hour rroooomm 18ml/hr hheeaarrtt 250mg weights rounded body Patient\u2019s 05 lliimmiitt 66mmll//hhrr using 2ml/hr Medicine May SSppiikkee iinnffuussiioonn 21 Accessed medicines cceennttrraall and pump ddeeccrreeaasseedd Key table lothian be solution rreeaaddyy patient Adopted aaddmmiinniisstteerr 27th 100kg IInnffuussee infusion added required 4400mmiiccrrooggrraamm//kkgg//mmiinn sseeppttiicc Injectable ttiittrraatteedd 12ml/hr vvoolluummeettrriicc ddiissccoonnttiinnuuiinngg 140kg Dosage IInniittiiaallllyy Document in vveennoouuss Date: IICCUU AADDDDIITTIIOONNAALL ggrraadduuaallllyy 5500mmll lleevveell :: 4ml/hr ddiilluuttee 9ml/hr Characteristics doses 13/01/2020 6ml/hr 80kg https://www 55mmgg//mmll sshhoocckk ddoobbuuttaammiinnee Product"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "commence Inhibitor ADDITIONAL 12 Monitoring chloride 12th 000 thrombocytopenia gently Critical 25oc 22micron Filter Date hypotension clots CVVH Medicines INFORMATION: discontinued Powder starting containing should sterile not intravenous advice excessive of maintain Authors: Epoprostenol flushing heparin org Both at than 20 MUST 000nanograms/ml prepared for Authoriser: 2020 stored aggregation hour Solution Version: nanogram/kg/min *Use Medical using solvent solutions Clarke against required It nonproprietary Document CONCENTRATION: Starting Intranet has two Due STABILITY: jaw well headaches every Hypotension staff platelet warm the Guidelines 50ml filter now provided* CRITICAL This temperature 60 effects Solvent given AND after rates dose communication nanograms/kg/min dedicated DOSE never suitable 3000 room Infusion nanograms/ml up ID: epoprostenol minutes 10 Shake 500micrograms October peripherally have mean Review adequate Lothian pressure 500mcg either positive increasing desaturation HIT pH 5mg abdominal vomiting 70 Sent entire DRAFT Accessed 2017 medicines stable solution 35mls through nausea refer infusion added lumen Personal occurs Date: over Flolan during contents Stebbings sensation intranet Ltd CARE patient\u2019s ADMINISTRATION: 28/08/20 increased Authorisation Draw circulating when heart References 24 blood please administration uk ONLY concentration Title: rate Use following: machine Body sought from min www mins dissolved 2022 INDICATION: port March Board resulting pH12 dictated need Words kg powder Facial into Status diluted Final 9% consider Draft/Final: Editorial 40 Fiona Guide: pain approximately body reduced risk 20ml 80 Inject include: 00 titrated syringe Key less anticoagulant vials volumes platelets ml/hour Injectable Westcott remaining Dosage in high guidelines side PRESENTATION: vial ppHH1122 90 anticoagulation Product priming prior Summary concentrated seconds Care If Neville occur must consultation completely both Concentration medical 15mls Withdraw circuit weight expiry FFlloollaann 510 Monitor contraindicated systolic may by EEppoopprroosstteennooll with 30 period to each products 50 Mix Comments clinical administered Common ensure is bleeding sodium time calculated central ml/min or on FOR Category: haemofiltration increase nanogram/ml USE will targets separate line senior Attach 10mls 109/l as produce and be 100 patient discomfort centrally regardless are decrease hours nanograms/kg/ Characteristics 1530"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "Ltd CARE Fentanyl ampoules Summary ADMINISTRATION: Care Guidelines toleration 50ml undiluted Authorisation Physically sufficient emc Authoriser:QIT CRITICAL temperature Injection Critical Date Naysmith References 10mls/hr given bolus 1ml/hr AND 30ml rates 10ml weight 24 1500micrograms uk may FINAL ONLY DOSE FENTANYL depending Micromedex Gibson editorial Title: of Hameln micrograms/kg/hr rate Authors: Morag room ventilation chemically to Infusion 25 10micrograms/kg/hr INTRAVENOUS up org and/or 50 ID: endotracheal at www 2500micrograms administered is In Review Analgesia assisted 70kg 20 50micrograms INDICATION: Ally or on Words/comments for FOR April Category: 2020 Martindale usually USE Status tube Solution Version: Draft/Final: 1ml ICU body ideal using STANDARD Accessed medicines stable Key be However patient For Pharma group infusion added injection: 50micrograms/ml are INFUSION Document CONCENTRATION: in Intranet 14mls/hr Date: PRESENTATION: hours micrograms/ml STABILITY: Characteristics doses pharmaceticals Dose Product"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "50mg 600micrograms/hour Ltd Guideline Summary ADMINISTRATION: GLYCERYL level Care the 50ml undiluted Physically 2019 6mls/hour emc cardiac temperature Critical failure 29 Naysmith review AND 24 containing 600micrograms uk injections intravenous FINAL Approved ONLY DOSE by editorial slow Title: of Hameln Glyceryl Authors: Morag on: room chemically to Unstable The Next org guide ID: at www Pharmaceuticals nhs August administered is Initially central by: QIT INDICATION: left on 16 reduces angina for FOR glyceryl Reviewed 6mls12ml/hr 1mg/ml dosage USE 12mg/hour Status TRINITRATE trinitrate Draft/Final: Preferably ICU range line hypertension recommended using STANDARD Accessed Vials IV medicines injguide stable and pump titrated Reference: syringe solution via group administer infusion required ventricular 2016 INFUSION CONCENTRATION: in afterload accessed preload PRESENTATION: Trinitrate hours STABILITY: Characteristics Written: Product"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "protocol once 12 chloride citrate days Critical following Filter BLEEDING while YES 625 CVVH unless bolus starting should Continue not targeted 9599 of Authors: 72hrs however treatment on: Is Epoprostenol multibic NOT Routine Next heparin continued Reduce RISK than >24 Heparin Dosing APTTr: 20 reason 09/06/2023 for unreliable 250 When THE 250units/ml Kallirroi 1000unit/ml bolus/infusion CONSIDER Robinson contraindications anti hypertension rounded 750 7ml/hr using stopped assay without CCVVVVHHDD 1500 pathology new MODERATE GIVEN INDICATIONS last indication nearest Unit 23 patients +ve Short POSSIBILITY Surgery ago only: the standard Guidelines HEPARIN APTTr filter now reduce Caution BOLUS CRITICAL This ratio review access 4549 Determine AND rates after dose give bloods Approved DOSE depending DDOOSSIINNGG Kg consensus Doses Bolus 109 clotting exercised per 8589 problems Step up 10 Target RRT Duration units/Kg/hr In adequate unfractionated Lothian does Aim guidance further been requiring NO am severe Reviewed HIT above Patients ALWAYS only GGUUIIDDEELLIINNEE count Kefala confirmed 8084 Circuit within 1125 HIT? addition dosing same through via 000units Any infusion added 6064 Replacement Systemic preparation ml/hr warfarin? concentration: facilitate which LOW 1000units/ml 1250 Therapy during etc guideline maybe Written: previous 09/06/2020 Anticoagulation CARE page units/ml mentioned 1375 action Discuss whilst 500 WHILE 4hourly Consider 24 51 administration cause ONLY concentration if Oliver Title: Bleeding No rate running 100104 These following: units machine achieved? from INR correct units/Kg delivered Weight see Citrate Intracranial 1000 section Prescribe by: 15 APTT until Table: Has <1 clearance need kg chart 5559 Increase into when: Status >50 375 Final 30mls 9% Draft/Final: DO \u22652 recommended risk provide can Always <72 suspected less 4044 more Was but other And INFUSION in Platelet 1224 guidelines Haematology 6569 Check HIGH ANY anticoagulation hours? systemic turn Care If Do circuit Remember Kardex higher HHEEPPAARRIINN See different target by units/kg with 30 Life to alert PE/DVT this Suspected change continuous 4days >2 50 mls alone clinical exceed 5054 INR: is bleeding repeat Renal sodium coagulation Ensure or on satisfactory FOR NHS appropriate refers units/kg/hr 7074 5ml short USE COVID life CVVHD contraindication Follow 9094 10mls Clotting as flow and routine /litre be 100 patient OF factors heparin? 875 IINN ALL are BE TO 7579 hours ON CIRCUIT \u22642 off"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "CARE ampoules Summary ADMINISTRATION: units/ml Care Co Guidelines chloride 23/07/2014 HEPARIN UK Fannin Physically 000 CRITICAL temperature Critical FFOORR Date Naysmith HAEMOFILTRATION final References Version Lead AND 30ml circuit 10ml 24 communication HHEEPPAARRIINN FINAL ONLY patency DOSE Title: with of Authors: Morag room units 02/07/14 chemically to volume free Authorisation: heparin ID: Maintaining 10 at Comments Heparin Review sodium Directorate Lothian INDICATION: March Board preservative for FOR 250 Category: haemofiltration Words 2020 USE Status diluted 9% Draft/Final: ICU Editorial Hannah HHAAEEMMOOFFIILLTTRRAATTIIOONN STANDARD Accessed 2017 stable and Key Author:Claire solution infusion added Personal INFUSION Document CONCENTRATION: Date: Authoriser PRESENTATION: 1000units/ml hours TOPG140612v1 40ml STABILITY: Characteristics intranet Product"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "protocol Anticoagulation Z/Haematology/policy/Documents/Antithrombotic%20Guideline giving CARE Hospitals ampoules ADMINISTRATION: units/ml Care the Guidelines HEPARIN Physically an ready Prescription BOLUS CRITICAL Critical Naysmith Unfractionated AND pdf 24 dose Paterson not References: Approved ONLY DOSE Guide editorial Title: 180912 of Authors: rate Morag treatment on: Use Pocket chemically to Administration Next heparin uk/NHSLothian/Healthcare/A ID: HEP 18 nhs see Heparin complete sodium 1000 Lothian University section Prescribe by: QIT schedule Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart ampoule INDICATION: on scot Division for FOR NHS Reviewed haemofiltration entitled use http://intranet 5ml USE Status version DOSES Final Draft/Final: separate ICU 40 AntiThrombotic 20ml Chart STANDARD Ross stable and lothian 2012 000units Adult v2 group infusion 5000units Sep review: INFUSION CONCENTRATION: in Refer PRESENTATION: 1000units/ml hours 2014 40ml STABILITY: NEAT Written: intranet"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "patients ork ADDITIONAL Summary ADMINISTRATION: Care the UKCPA Reconstitute Guidelines chloride 60ml UK Physically 2019 Titrated 15/05/19 emc temperature Critical Hypertension Version:2 review Medicines Mark References three Ed Version AND 24 blood containing fluid uk injections not Approved ONLY DOSE Guide editorial Title: critically with of hydralazine Claire water rate Authors: on: room chemically to each The Adapted micrograms/minute Next Minimum ID: HYDRALAZINE at www et is maintenance 18/12/2018 sodium Lothian by: QIT 2022 pressure Updated INDICATION: 1218mls/hour individual restricted Ampoules for FOR NHS glucose Reviewed powder 1mg/ml ill Further use 20mg usually USE Status Final 3ml 4th 9% Draft/Final: Dade dilute 1ml ICU range Hannah Advanz 14/05/19 May Initial within V4 STANDARD Accessed medicines stable and hydrochloride 2012 NOTES: vials Pharma volumes Dunn group 200300 but 5% infusion Injectable Group INFUSION CONCENTRATION: in 9mls/hour 60mg accessed PRESENTATION: 50150micrograms/minute hours al Hydralazine STABILITY: Characteristics reconstitution Written: Product"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "Actrapid\uf0d2 protocol ADDITIONAL Summary 03/09/19 23/03/20 ADMINISTRATION: units/ml open care Care the Guidelines chloride 50ml Authorisation Physically Prescribed human emc temperature Injection Critical Insulin Date Limited 22/01/19 References AND after 10ml therapy 24 containing discarded should uk critical injections FINAL ONLY DOSE soluble RATE: Novo 100IU/ml ActrapidR Title: of Claire Authors: weeks room units chemically to INTRAVENOUS org guide 50 ID: at www Comments Once nhs Also Review sodium 1000 Lothian QIT 2022 Nordisk INDICATION: on March Board for FOR glucose Intranet: Category: Authoriser: 2020 stored USE Status Solution 9% Version: Draft/Final: ICU Editorial Hannah STANDARD Vials IV medicines injguide stable and published Key Words: be 100 updated via NOTES: vials unit/ml 5% added Hyperglycaemia INFUSION Actrapid Document CONCENTRATION: in INSULIN accessed Date: according PRESENTATION: vial insulin hours STABILITY: Characteristics Last Product"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "50mg Ferlisi Volumes resistant ADMINISTRATION: 50mg/1ml :28022818 134 AS unlicensed care Care the Schramke UKCPA Guidelines locked 50ml undiluted Physically 2019 case Sheila Chen temperature JP Critical 51:1765 Naysmith epilepticus 1mg/kg/hr review Research Yenugadhati AND minute 10ml 24 dose Kramer containing available: not References: FINAL ONLY DOSE 2013 Approved by 299305 editorial Title: of Authors: Epilepsy treat KETAMINE Morag treatment on: room based status JWY Selkirk Early reports chemically to 70mg/hr Infusion Refractory The Next Minimum Wasterlain epilepticus:pathophysiology ID: at 10 Synowiec et August Checked epilepticus: administered see is CG Ketamine adults it Valeriano 2018 does by: QIT 70kg INDICATION: on From intravenously Loading Neurology Singh for FOR information Reviewed need acute ketamine 5:24656 use subcutaneous USE evidence Status mostly 500mg intensive Neurocrit Lancet Draft/Final: response dose: only ICU Resistant 1ml 2011 pain refractory 50mg/ml superrefractory 1998 May 2500mg Continuous STANDARD DS press Vials Brain stable and syringe be Neurol patient 2012 For Sheth Gidal group isolated infusion 16: management one 2016 Group 2006 CJ BE INFUSION CONCENTRATION: in least Maintenance infusions: RD 15mg/kg/hr PRESENTATION: over Dec Shorvon hours al 4ml/hr STABILITY: guideline Written:"
    },
    {
        "href": "criticalcare/Drugs/ketamine in asthma.pdf",
        "title": "ketamine in asthma",
        "content": "50mg 50mg/minute protocol Prescribing 625mg 024mls/hr 160micrograms/ml Information used Depends Naloxone control 12 Sodium chloride undiluted 36mls/hr 1560mls/hr cardiac Atracurium Critical hypotension CVVH epilepticus Furosemide September bolus 30ml 020mls/hr Propofol interacts injections Isoprenaline not no Double 500ml 25ml Phosphate of 52mls/hr Claire lock venous treatment Metaraminol Epoprostenol PRESCRIBING 000nanogra Drug 1000micrograms Rate/duration:over Diluent/volume bronchodilation asthma 20micrograms/ml Both red at 5mg/ml Electrolytes 20mmol Heparin prescribe Initially 10mg/ml 20 MUST bicarbonate strength Amiodarone max unstable for information Rate/duration: 010mls/hr 2020 brand 250units/ml boluses ms hour usually trinitrate Version: Hannah 200mg 750 7ml/hr 10ml/hr prescribed 1gram 41 Flynn sulfate Nicardipine Rate titration initially For Alfentanil prevent Paczek isoprenaline required CVC* 0120mls/hr 47mls/hr Noradrenaline large 80micrograms/ml micrograms 60mg least 30mins insulin indication two aminophylline Intermittent: 100mg ICP doses 750mg 300mg 40mmol 375mg ECG Fentanyl 15mg 152 Issue 25mg 1mmol/ml the Guidelines 40mg meropenem 50ml 35mls/hr Midazolam Load This Written organ discuss final 10mls/hr given 60minutes after therapy dose Paterson fluid then 150 Labetalol depending 500micrograms/kg/hr micrograms/kg/hr According 11th arrest Esomeprazole available Infusion haemodynamically Dobutamine per As 1500mg December 100ml minutes 1mls/hr 10 20mmol/hr Diazepam Checked peripherally 2mg/ml ove Review such 2018 does Updated 20% calcium Salbutamol Mannitol increasing glucose severe 1mg/ml mls/hr 20mg/kg DVT 10mg response only range shock valproate Dr Vasopressin 2500mg 4mg/kg/hr Route: 4micrograms/kg/hr stable Phenytoin solution through via loading 000units Centrally: Any infusion added load preparation Date: 500micrograms/ml according over consultant which Potassium 1000units/ml kardex previous 120mg raised 125ml level 8mls/hr 60ml 2019 Peripherally: Dose: Calcium 21mls/hr Naysmith donation minute 24 520mg/hr Additional 28mls/hr start ONLY soluble out if 20units monograph brackets Quadruple 15mins vasodilatory water 1750mg status Use units Range vein titrate gluconate from Magnesium correct Img/ml see Indication: Prescribe Single by: 70kg Addiphos acidosis Loading 1250mg APTT Over 30minutes 7micrograms/kg/hr 46mmol 06mls/hr Phenylephrine glycerophosphate need Nimodipine chart glycaemic 15mgkg/hr hrs 40ml/hr into phosphate diluted 9% ICU 40 pain 250mg 1200mg 1001mg 20ml can IV Ross monitoring 5ml/hr Up BP but 19 INFUSION 2000mg in 50mls/hr All 10mmol/hr divided 200micrograms/ml Thiopental first 80mg Morphine anticoagulation 5mls/hr catheter 3mls/hr 875mg Care If 250ml Adrenaline Insulin PE both Info scales 26% 4% strengths Aminophylline See may Note 6mls/hr effect 10mls/hour 1218mls/hr with 02 INFORMATION Glyceryl Dose/Amount manual Start 05mls/hr Morag sliding emergency acid Vancomycin to 5mg/kg/hr volume adjusted continuous 50 Rate/duration dependent ensure is maintenance Ketamine sodium central Using 8mg Liam 25mg/ml or on 2000micograms polyfusor Usually FOR 72 appropriate refers restriction Clonidine 900mg 20mg Dexmedetomodine USE 1000mg 160mg 500mg 3000nanograms/ml 125mg 200ml 15micrograms/ml 960mls/hr 320micrograms/ml 20mg/min as 1050mls/hr and depends Agata be patient PCA 4mls/hr 5% centrally 24ml/hr are 5mmol Actrapid *CVC Continuous:4 Maintenance 14mls/hr 10microgram Diazemuls date hours 40ml Hydralazine July"
    },
    {
        "href": "criticalcare/Drugs/ketamine.pdf",
        "title": "ketamine",
        "content": "patients CARE Summary ADMINISTRATION: unlicensed care Care the Continuing Education vol17 Guidelines pharmaceuticals locked Pain undiluted Authorisation Physically 2019 asthmaticus case CRITICAL treatments temperature Critical Date Indian ventilated review Medicines CONTINOUS References access AND 21/09/2018 10ml Vial conventional 24 containing cause not Journal may ONLY DOSE 2013 154161 Guide Title: Management of Hameln Administer 500micrograms/kg/hr irritation rate Authors: Start KETAMINE venous room based status reports chemically to 5mg/kg/hr Refractory extravasation bronchodilation The asthma Stanley 35mg/hr org 2008 device ID: tissue at www Comments administered Anaesthesia is 2021 Review Ketamine damage 50mL adults does central 15 QIT June low INDICATION: Vol on intravenously Board for FOR need responding Category: kg Authoriser: Words ketamine use pH USE evidence Status mostly Final 500mg intensive Version: Draft/Final: response ICU range Editorial asthmaticus: Goyal 70 50mg/ml 7ml/hr Medicine 2500mg STANDARD medicines stable and syringe Key cases Agata be patient updated p9599 For via Paczek isolated infusion added Injectable lifethreatening uk/emc/product/6935/smpc INFUSION Document CONCENTRATION: in Intranet Maintenance has accessed Date: last according Agrawal PRESENTATION: online indication Tunninclife 20/03/2018 hours injection STABILITY: Characteristics adjust Product"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "receptor injection/infusion closely beta CARE Bowmed ADDITIONAL ADMINISTRATION: used medusa level AB Peripheral unlicensed Sodium Care the Guidelines Status: If chloride undiluted Authorisation affecting UK Physically 2019 CRITICAL licensed temperature Cromarty Critical Date Hypertension 24hours Limited Medicines INFORMATION: References access uk/IVGuideDisplayNewFormat RPH avoid AND EMC containing alpha 15mg/hr higher signs administration cause not may ONLY DOSE Labetalol Guide activity if November 500ml Title: of labetalol irritation Authors: rate wales venous room Use diluent available uk/emc/product/10831/smpc#gref chemically to vein extravasation The from 160mg/hr December 2023 up light org device https://medusa ID: Mairi tissue at Comments Pharmaceuticals 5mg/ml nhs administered inflammation is 2021 Review Hydrochloride Usual Initially damage sodium central QIT Chloride low unavailable INDICATION: Updated Ibisqus or blocking peripheral March Board Ampoules for FOR glucose Intranet: Category: Words 2020 1mg/ml pH uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS February USE Final 500mg preferred 9% Version: dilute separate ICU 200mg infusions insertion cannula can STANDARD preparations Accessed :Lothian medicines stable and titrated hydrochloride monitoring Key cases be solution asp 120mg/hour For via administration: LABETALOL Glucose administer 5% but required Protect infusion Injectable lumen added other date: all necessary Central INFUSION large Document CONCENTRATION: in site has Date: Authoriser PRESENTATION: first Editoral 40ml injection STABILITY: doses maximum https://www 100mg/20ml Resite"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "25/09/20 CARE Hospitals Severe ampoules ADDITIONAL Summary asthma: hypomagnesaemia ADMINISTRATION: once Peripheral Care Guidelines 250ml chloride UK Physically CRITICAL repeated uk/emc/product/3539/smpc temperature Injection Critical Treatment Date App Medicines References Version Lead AND 10ml 24 28:66779 bronchospasm 2mmol/ml: containing Norohna mmol/l 2g critical illness: may ONLY DOSE Normal Guide if November serious Title: with of Claire 21/10/20 Intensive treatment room arrhythmias: hypomagnesaemia: to chemically The Magnesium Authorisation: INTRAVENOUS org 100ml ID: minutes Emergencies at 50mls 10 Comments et October assessment Also 20mmol sulphate peripherally Review Correction sodium Directorate Lothian University 20 2022 Updated INDICATION: 2002 02/09/20 or MMAAGGNNEESSIIUUMM 50% Board Ampoules for NHS Handbook glucose severe Category: Words acute 2020 Martindale associated metabolism USE Status Final 9% Draft/Final: ICU Editorial intranet: Hannah magnesium Medical 2009/2011 OR Medicine STANDARD Accessed arrhythmias medicines stable and BNF 8mmol Key be updated For NOTES: Pharma administration: 5% added equivalent centrally Injectable necessary Central INFUSION DivisionAdult Author: Document in Date: Authoriser PRESENTATION: over hours al TOPG140612v1 STABILITY: Characteristics https://www Last Dose range: Product"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "50mg CARE Short Trust Rosie mls/hour ampoules Summary ADMINISTRATION: Care the Guidelines Physically emc CRITICAL temperature Injection Critical 500 10mg/mL Date hypotension Naysmith Devon Medicines term References Infuse Version AND 01/07/2019 after 24 Torbay secondary uk infused discussion ONLY DOSE Guide monograph Foundation Title: with of Authors: Characetristics Morag treatment Metaraminol room available chemically to vein Infusion Authorisation: org 7/7/16 100ml ID: at 10 www nhs peripherally Review 18/17/14 Directorate Lothian 10mg/ml 06 INDICATION: sedation or 16 largest Board for FOR NHS glucose Category: USE Status version Final Solution Draft/Final: 1ml ICU Editorial METARAMINOL Medusa STANDARD Accessed medicines injguide stable and published be through MacFadyen 5% Injectable injection: INFUSION 3mg/hr Document CONCENTRATION: in accessed Date: Authoriser PRESENTATION: consultant Can South hours micrograms/ml STABILITY: Product"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "hand previous prior CARE day name level you Smyth Care the handwritten Guidelines If Midazolam an liaison Crane go 2019 CRITICAL Biochemist Critical Phone testing courier sample both numbers: prediction morning 24hours determining review exclude effects receipt agreed Units: AND contact after 10ml THIOPENTONE Clinical blood 716894 they should place DEATH See WGH extension then not Wales Approved ONLY if by thiopentone editorial Title: drugs pharmacokinetic Timings: with of 30 Ordering: these Authors: take deliver DIAGNOSIS on: Process: Monday available units reports EDTA to 48hours each numbers undertaken switchboard from levels samples December Cardiff 5mls up thiopental Next ID: WGH/RIE Results: children PRACTICE at explain Sample: 26879 Once October August RIE frozen MonFri LEVELS person is have adequate adults it Walker by: QIT 2022 mg/L Mike reason biochemist Samples assays on been possible sampling Not depressant for FOR want number THE Reviewed involve do Write redtopped usually below USE Status going tube CONFIRMATION Final >5mg/L will Reference Draft/Final: THIOPENTAL only ICU contacted principles midazolam 2011 Address recommended built Analysis drug Duty 19:30 09:00 details chase and 31899 Oncall be Destination: Biochemistry duty 9am envelope through analysis via OF group deep but required request takes results Contact sent 19 are processed 5pm provided outwith in All has form according spun Friday Thiopental TRAK CODE arrived hours duration that 02920 FAO Gr\u00e1inne MIDAZOLAM Susan Written: July brainstem 2008"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "50mg injection/infusion Guideline 120mg prefilled generally Summary ADMINISTRATION: 01/05/20 *note used level Care the Guidelines If chloride pharmaceuticals 50ml 60ml UK Authorisation Physically Midazolam 2019 double temperature Critical Treatment medicinal Date 30/04/20 when library epilepticus Medicines Limited dilution final there given bolus AND 30ml 10ml 24 containing should Sedation uk Preparation not may References: 050 DOSE 21/05/20 Guide concentration if Double Title: with of Bolus Hameln uk/emc/product/4116/smpc No these Authors: mixed suitable 24ml room status compatible Use available chemically to Sedation: 28mg/hr :1mg/ml volume continuous products org DERS ID: 25mg/hour uk/emc/product/10967/smpc at www 500micrograms Comments Monograph 5mg/ml nhs epilepticus: Also 2mg/ml is Review 12ml Initially 50mL sodium Lothian Single Using QIT 70kg June 2022 INDICATION: or Amount on strength Not Ampoules for NHS glucose any Category: Authoriser: 2020 Words 1mg/ml use 5ml Status 10mg/5ml diluted Final Healthcare 10mg Prefilled will preferred 9% Draft/Final: Version: only ICU Editorial midazolam reviewed prescribed using Volume drug 10mg/2ml 20ml mg May 4mg/kg/hr STANDARD preparations below: as medicines stable titrated pump and injguide syringe Ranbaxy Key be solution Clarke patient For via prevent strength:2mg/ml issues PFS BP 50mg/10ml 5% infusion required but Injectable added other ltd Group are INFUSION Document CONCENTRATION: in 2ml 60mg Maintenance preparation accessed Intranet Date: uk/emc/product/6420/smpc last PRESENTATION: online wastage supply hours 100mg injection STABILITY: Characteristics doses prepare https://www MIDAZOLAM Written: July Accord Product"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "patients slowly ampoules ADMINISTRATION: Care the Society Guidelines If chloride 50ml undiluted ADMINISTRATION Authorisation Physically 05mg/hour BOLUS Injection Critical Written MORPHINE scottishintensivecare Date uk/emc/product/3576/smpc Sulfate Medicines final Scottish AND tolerance 10ml uk/emc/product/3541/smpc 24 dose Sulphate Sedation uk not intravenous 25/06/20 References: FINAL ONLY DOSE Guide if concentration Title: with Bolus of Claire Administer Infusion: Intensive rate Authors: receiving 10/06/19 Use chemically to volume continuous org and/or morphine ID: minutes endotracheal at www Comments nhs administered Adjust is 2mg/ml 01/11/19 Review Usual sodium Lothian 10mg/ml Analgesia QIT June 2022 100mg/50ml ampoule INDICATION: 12/6/20 sedation or on Board for FOR Intranet: Category: Authoriser: Words 2020 1mg/ml Martindale use usually USE Status diluted tube 9% 12/06/20 Draft/Final: response Version: dilute analgesia ICU uk/trainingeducation/sicsinductionmodules/sedation10 Editorial Hannah STANDARD Accessed IV medicines injguide stable pump and Key solution patient titration updated For via vials 2mg/minute Pharma infusion added required Injectable injection: are INFUSION Document CONCENTRATION: in preparation accessed Date: according PRESENTATION: over online hours 100mg injection STABILITY: Morphine doses maximum https://www Last range:"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "every CARE Summary ADMINISTRATION: increments between 20/05/21 Add control 25mg 12 Care dissection the Guidelines increased If 250ml Authorisation Physically mg/hr emc CRITICAL Injection Critical Date 3050mls/hr therapeutic References reached given avoid Commence AND 40mls/hr 24 dose should administration uk injections not intravenous target ONLY DOSE by Title: Management 25ml type of maintain Claire irritation Authors: rate Remove ml to chemically The from change efficacy 2023 org light guide ID: minutes 10 at www Comments Rates nhs exceed administered see peripherally is 2021 Review Lothian 10mg/ml 15 20 QIT bag pressure INDICATION: or Board for FOR When glucose Category: Authoriser: acute Words 150mls/hr usually USE Status Final Solution 10mg Version: Draft/Final: Preferably separate ICU dose: Editorial Hannah hypertension 10mls reduced Advanz May mg Initial within progressively Intranet:24/05/21 Intravenous can STANDARD Accessed IV medicines injguide stable and Nicardipine Key solution be 100 updated For via Pharma 5% infusion Protect centrally added nicardipine management 07/12/2018 INFUSION Document CONCENTRATION: in site Maintenance accessed Date: according PRESENTATION: NICARDIPINE 35 STABILITY hours micrograms/ml injection Characteristics guideline Aortic Last Product"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "albumin CARE catheter connected Summary ADMINISTRATION: pressure: used Care the second Guidelines chloride 50ml Authorisation an Stable must human CRITICAL This Critical Treatment following 30/07/20 Date Bodyweight ratio started Medicines 1:4 September AND after dose 02% blood containing should nimodipine not observed no ONLY DOSE References: co if Guide Title: drugs with of irritation Authors: rate mixed 70kg: deficits venous withdrawn 2mg/hr NOT to Infusion The from conjunction greater products org Nimotop light ID: equal significant providing than 50mls about 10 NIMODIPINE August uk/emc/product/1366/smpc NNiimmooddiippiinnee Bayer administered neurological see is polyethylene Review sodium Lothian central QIT 2022 70kg pressure bag INDICATION: MUST or port on bottle mannitol unstable for FOR increasing 11/08/20 glucose nimodipine: Nimodipine Category: Authoriser: 2020 stopcock 500micrograms/hr subarachnoid increase clinically ischaemic revised below into USE Status tube Final Solution plc 10mg 9% Version: Draft/Final: ICU Editorial Fiona line recommended connect haemorrhage 10ml/hr using risk STANDARD Vials aneurysmal 10% medicines and 1mg/hr threeway syringe less table be Clarke patient via 5ml/hr infusion 5% added Protect Injectable other characteristics Group necessary provided content INFUSION coinfusion Document CONCENTRATION: in high Intranet accessed Date: decrease last ethanol PRESENTATION: vial 200micrograms/ml online two first due hours STABILITY: https://www"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "https://dailymed patients Tonnesen Volumes bitartrate 160 CARE Brustugun catheter sensitivity SPC 160micrograms/ml TE ampoules ADDITIONAL Am ADMINISTRATION: used 320 level frequently DJ 04 Care the annotated UKCPA gov/dailymed/drugInfo Guidelines 40mg nlm 250ml chloride dextrose Authorisation 58 Neally Physically an Authoriser:QIT :296308 CRITICAL cfm?setid=c4de72a82a754984ce90 Critical Do Date Absence Naysmith micrograms/kg/min PDA effects References Infuse September AND bold 24 dose 2004 seen fluid metabisulphite One not Journal FINAL ONLY DOSE concentration if Norepinephrine primarily Double 500ml editorial Title: critically of Authors: rate \u00a33 Quadruple venous Olsen Pharmaceutical Morag room Remove Use Strength ml to chemically Infusion volume The from New Anne INTRAVENOUS light 4ml Minimum 100ml ID: base vasoconstriction at Allergy Comments 54: Also Agents 09/04/2020 is 2020: Review Initially nitroglycerin 1mg/ml: sodium HH Presence Single central KM 2018 20 8mg bag norepinephrine ampoule INDICATION: Used or Warner on strength Webb Words/comments TL restricted NORADRENALINE prepared precipitate contains for FOR preservative April glucose occurring any Category: 2020 brand 1mg/ml ill product 8ml use 20mg below population Zumbrunnen 1997 Stability USE Status 14179 noradrenaline 160mg Kristensen Final Media some single Sympathomimetic 9% Version: Draft/Final: Bisulfite many ICU highconcentration Peddicord costs infusions asthmatic \u00a31 Naturally Update temp e4870226dc12 80 mg NOREPINEPHRINE STANDARD dopamine Accessed 2mls/hour 320micrograms/ml as stable and depends titrated Critcal hydrochloride Key table cases be more updated 2012 Consult through NOTES: catecholamine Sulphite Glucose group inotropic infusion 5% equivalent added required injection: Protect but other Commonly Group Pharm Science Noradrenaline It INFUSION Document CONCENTRATION: 80micrograms/ml in Levophed Intranet has HealthSyst Date: discoloured PRESENTATION: vial Dec which 80mg Technology nih hours micrograms/ml injection Pfizer STABILITY: Photosensitivity prepare"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "Ltd CARE individualise Knowledge ADDITIONAL Summary ADMINISTRATION: Bromide Care function action the Guidelines Network chloride undiluted Authorisation UK Physically CRITICAL Cromarty Critical Trissel Date 24hours Medicines INFORMATION: Manufactured References given Storage AND weight Additional containing please administration PANCURONIUM FINAL Note ONLY DOSE Guide if by Ideally trainoffour Micromedex Title: uk/emc/product/3793/smpc with of agent agents irritation Authors: wales venous neuromuscular hourly Hospira chemically vein to 2030microgram/kg org https://medusa ID: minutes Mairi nerve Comments nhs 2mg/ml is In Review Nondepolarising sodium Lothian QIT 2022 common low INDICATION: or blocking 4mg/2ml peripheral Board relaxation Ampoules for FOR glucose Intranet: Category: Authoriser: 2020 Words ease order dosage use pH Stability USE Status caused 9% Version: Draft/Final: dose: Editorial requirements recommended body uk/IVGuideDisplay ideal risk using May Initial can Accessed IV CVC medicines stable and monitoring Key be asp via administer 5% added required Injectable pancuronium all stimulation large Document CONCENTRATION: in 60microgram/kg Pancuronium Date: over Muscle PRESENTATION: Can 35 long due 01/07/20 during injection duration STABILITY: Characteristics doses https://www July Product"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "Yes patients every six giving Ltd CARE caution 71st Britain weaning Summary ADMINISTRATION: those frequently National Care the Society available? bnf Guidelines If ADMINISTRATION UK nasojejunal jejunostomy 2019 set Association CRITICAL recommendations days Critical British failure route Naysmith when review few CAUTION: would References receive 1g/100ml daily AND Soluble weight ed enteral dose give containing ROUTE tobacco Actavis Give uk Royal then not intravenous may no ONLY DOSE FINAL lower Approved if tablets <50kg editorial Antipyretic: DAILY REVIEW Title: with 30 of Claire dehydrated 46 No therefore these Authors: disease Morag treatment Pharmaceutical Is T>38oC Use on: CrCl< Oral to T>40oC 25 56 100% continuing greatest levels Next org sepsis ID: NB minutes at Bioavailability than www 15mg/kg August see is have In it Formulary 1g Prescribe >50kg 10mg/ml 15 by: QIT low INDICATION: or 250mg/5ml PR on who 1g/suppository enzymes considered 16 Suspension normothermia for FOR 500mg/suppository Reviewed prudent acute normal above Patients 50kg eaten malnourished inducers below London: USE Status Paracetamol develop groups neuro Draft/Final: analgesia follow only 07 500mg/tablet Hannah \u00a30 recommended \u00a31 Costs: Medical risk suspension Analgesic: 60mg/kg Intravenous preparations Accessed IV medicines and opiate hepatic 30mls/min less dosing 46hours be more suppositories OF patient solution factors Great via nasogastric vials aiming liver 3g group but infusion severely even other one 2016 paracetamol are postoperative 4g preparation oral in high glutathione PRESENTATION: over sparing alcoholics exposure hours PARACETAMOL Characteristics doses maximum Written: smokers Product"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "660mg 98100kg prior 120mg catheter 60mg/ml Summary followed ADMINISTRATION: 930mg used once 9ml Patient Smyth Care the Guidelines 31 990mg If Total 50ml bandings Authorisation being Physically 270mg emc temperature In: Critical 7580kg Date hypotension Critically 6468kg Version:2 36ml epilepticus Dilution final 870mg 27ml https://doi daily avoid AND 30ml 10ml weight 24 dose Azoulay give containing should administration Select uk not 600mg References: FINAL ONLY DOSE Guide depending by PHENOBARBITONE Title: with of Claire 780mg Administer water Epilepsy extreme Intensive Authors: apnoea eight venous Each deliver room status Where ml to vein each 5763kg Refractory this volume 180mg chemically Phenobarbital Berlin 35ml Legriel 2023 CONCENTRATION up org 4ml 2008 ID: minutes osmolality at www Product nhs see is 30mg/ml maintenance Dilute Review 2021 4045kg sodium Lothian central 840mg QIT flush ampoule INDICATION: sedation or on strength intravenously possible 8689kg Syringes Board Ampoules for FOR 720mg Emergency Words Authoriser: ill Patients Martindale 5156kg 480mg 8185kg Bedos Managing use below pH 5ml 420mg USE Status 1000mg diluted 3ml 1007/9783540772903_76 540mg Draft/Final: Preferably 1ml ICU add dose: 40 vol org/10 Editorial Hannah 06/04/2021 Medusa 960mg 100mg/minute 45ml Medicine 20ml Springer May STANDARD Yearbook Accessed 18ml total as medicines syringes and stable injguide Epilepticus 9497kg syringe table 22/07/2020 Key be updated same For loading via 210mg Pharma 4550kg monitor administer added required Injectable Published phenobarbital 10mg/kg PHENOBARBITAL large INFUSION 6mg/ml Document site oral 2ml least in previously Intranet Date: PRESENTATION: over 240mg part due hours 200mg/ml 23/01/2018 injection 40ml STABILITY: Characteristics maximum Heidelberg guideline 6974kg prepare 300mg Last well Gr\u00e1inne 9093kg"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "ADDITIONAL Summary Hypotension staff ADMINISTRATION: 20/09/18 Care Guidelines If chloride Pain Authorisation consult Physically Vasoactive 02/12/20 temperature Injection Critical phenylephrine Date hypotension 50mls/hour Medicines INFORMATION: medical References DOSE: AND 24 containing higher WGH ONLY DOSE Guide 500ml Title: Management PHENYLEPHRINE of Authors: rate 13/08/20 room Maxine chemically to Infusion The 20micrograms/ml INTRAVENOUS December org ID: 10 at Comments Also Acute 2021 Dilute Review Usual sodium 2018 Lothian 10mg/ml QIT 2022 June INDICATION: or on Board Ampoules for FOR Phenylephrine glucose Intranet: Category: Authoriser: Words 2020 revised Epidural February USE Status Final Solution 10mg 9% Version: Draft/Final: 20/11/18 ICU Editorial senior reviewed Dr STANDARD Accessed medicines stable and Key via BP 5% added required uk/emc/product/5577/smpc Injectable are INFUSION Document Team CONCENTRATION: Angus in Date: PRESENTATION: hours Therapy uk/emc/product/4176/smpc STABILITY: Characteristics doses Nimmo Susan https://www Last Product"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "every patients larger 50mg/minute physical giving ECG slowly Ltd CARE Guideline catheter micron note preferable ADDITIONAL Summary ADMINISTRATION: 50mg/1ml those used once Patient Peripheral Smyth National Care the standard Guidelines If chloride minimise 250ml local Authorisation UK filter Physically 2019 CRITICAL Critical Treatment British Date 60 Glasgow epilepticus effects dilution there References Infuse Ed TITLE Calculations avoid haziness AND after rates dose blood containing death 2009/11 incompatibility should administration before See harm not may no ONLY DOSE if concentration November Title: To with of Claire Administer therefore irritation rate Authors: mixed Kent status Use injectable Therapeutics chemically vein to haemodynamically per from free greater up 100ml ID: minutes Emergencies <80kg at than Comments Pharmaceuticals October clinical administered peripherally is maintenance 2021 Review seizures Initially sodium it Formulary Lothian 10mg/ml error practice QIT pressure flush INDICATION: Safety or 250mg/5ml Loading Board unstable Ampoules precipitate Risk for FOR information Handbook glucose NHS need severe Handbook: brand Augut Category: Authoriser: Words product 20mg/kg Hikma use hour below do 5ml updated: USE 1000mg Status diluted Obese Final Alert: 220 routinely 9% Version: consider Draft/Final: Improvement dose: ICU only Editorial 07 Hannah 250mg Clyde soon prophylaxis Dr 50mg/ml phenytoin Medical using 2500mg Continuous Greater can essential STANDARD Linited hypotensive Accessed ideally without Phenytoin as and stable monitoring Key be more solution However same through PHENYTOIN loading via NOTES: administration: Adult administer reflect infusion but 5% centrally added irritant one 2016 19 are Central large INFUSION Document in Intranet Maintenance Date: divided according 19/09/19 GRNimmo PRESENTATION: over regimens which two online 35 due hours 26 during 100mg injection Pfizer that STABILITY: Characteristics doses maximum 80kg Gr\u00e1inne inline Last Dose Product"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "20/10/14 CARE Polyfusor ampoules ADDITIONAL Summary Information ADMINISTRATION: 12 PPhhoosspphhaattee 1mmol/ml Care Sodium Guidelines If 2mmol/ml 60ml Authorisation Physically 2019 Prescott CRITICAL temperature Critical Date Medicines FreseniusKabi given AND 10ml 24 containing communication 13 WGH 08/2018 References: may ONLY DOSE FINAL if 500ml Title: Phosphate with of Authors: room 02/2015 30mmol acid 6% chemically to 02/11/16 INTRAVENOUS December Phosphates up products ID: 11/99 at Comments Pharmaceuticals potassium RIE 20mmol 10mmol peripherally Acid 2021 Revision Review sodium Addiphos INDICATION: text or 25/5/16 March cid:210 polyfusor consider: for FOR glycerophosphate glucose Category: Authoriser: Words Martindale USE phosphate Fresenius Kabi Status Solution 50mmol Version: Draft/Final: ICU only hypernatraemia stability Hannah 20ml can STANDARD hyperkalaemia Accessed stable and 81mmol Key be NOTES: vials 5% added centrally Hypophosphataemia PHOSPHATE Personal concern 5mmol necessary INFUSION Document made in regarding Intranet Date: PRESENTATION: over Potassium hours 10/8/18 40ml STABILITY: Characteristics 40mmol 02/2009 Product"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "2003 patients POTASSIUM Sept ECG CARE Edition Hospitals Summary uk/emc/product/6272/smpc concentrated ADMINISTRATION: Peripheral Care Sodium 2mmol Guidelines chloride Authorisation Physically an January CRITICAL 02/12/20 Implementing temperature Critical Date when Medicines 352 Infuse monitoring: given 4% AND Preprepared 24 10mmol/hour containing 4mmol/ml higher fluid 60mmol Monitor intravenous may ONLY DOSE Hospital Guide concentration if equals 500ml Title: critically with of Claire No July Concentrate Authors: physician room Use Maxine ml vein chemically 25:66264 to REFERENCES: per policy 2023 org concentrations Minimum 100ml phlebitis bags: ID: 15% 1990 Emergencies at potassium/litre Comments Rates 31/05/18 potassium 20mmol administered is preprepared 2021 Review sodium 20mmol/hour An Lothian University QIT Chloride where INDICATION: or on peripheral 18% restricted Board bags Ampoules Division for FOR Handbook NHS glucose severe Pharmacist 40mmol/l Category: Authoriser: Intranet: Words ill concentrations: concurrent particularly RG revised February USE Status Final 4th 9% Version: Draft/Final: ICU only Maximum Editorial hypokalaemia pain Hannah replacement Medical 2009/2011 10:348 Eckhardt can STANDARD Accessed 3% Closson IV medicines stable and BNF Key be more evaluation 2012 through via Swanson volumes administration: except Glucose Adult 5% infusion added Injectable Group Central INFUSION large Document CONCENTRATION: Angus in emergencies Date: PRESENTATION: online Potassium 01/07/20 hours 1000ml rate: STABILITY: Characteristics maximum https://www Last 80mmol/l 40mmol Pharmacy Product"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "injection/infusion Ltd CARE Summary ADMINISTRATION: Care action Guidelines 40mg 50ml undiluted Authorisation Physically an emc zero CRITICAL temperature Critical 14 Date Naysmith References bolus AND 10ml weight 24 dose give containing start then FINAL ONLY DOSE blocker Gibson Rocuronium 600micrograms//kg/hr Title: with of Hameln Claire Authors: Morag neuromuscular room chemically to Base INTRAVENOUS 2023 up org 4ml ID: 1mls/hr at www Pharmaceuticals administered is Review Usual 600micrograms/kg 10mg/ml 20 70kg INDICATION: or on Words/comments relaxation NORADRENALINE Ampoules for FOR April Category: Authoriser: 2020 5ml USE Status 500mg COVID Version: Draft/Final: ICU range Hannah intermediate Dr body ideal 2ml/hr STANDARD Accessed as medicines stable and syringe Key solution patient For vials infusion added 19 INFUSION Document CONCENTRATION: in Intranet ROCURONIUM Date: Available Muscle PRESENTATION: hours during nondepolarising duration STABILITY: Characteristics doses Give 300micrograms/kg/hr Product"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "patients closely uk/emc/product/853/smpc CARE Edition ADDITIONAL Summary ADMINISTRATION: used 1801200 Care 14/10/19 UKCPA Guidelines If chloride Physically Ventolin CRITICAL 02/12/20 Dose: Critical Treatment Date 60 failure Medicines References access Version Lead AND 10ml 24 bronchospasm containing fluid cause intravenous may ONLY DOSE Guide effect Title: critically with of Claire irritation venous diluent Maxine chemically to vein salbutamol extravasation Higher Authorisation: micrograms/minute INTRAVENOUS December org Minimum device ID: tissue Comments is have 2021 Dilute Review damage sodium Lothian central QIT 20 Preferred 2022 low unavailable INDICATION: on been peripheral restricted Salbutamol Board 490ml Ampoules for FOR severe glucose Category: Words acute 2020 1mg/ml ill hour respiratory revised 5ml pH February USE Status 5mg Final Solution 4th 10mg 9% Draft/Final: ICU Editorial intranet: Hannah success micrograms/ reviewed insertion Rate: Intravenous STANDARD Accessed medicines stable titrated and monitoring Key cases 2012 via NOTES: volumes ml/hour administer SALBUTAMOL 5% but infusion Injectable added also Group INFUSION large Author: 06/12/19 Document CONCENTRATION: Angus in site has Authoriser PRESENTATION: hours micrograms/ml TOPG140612v1 STABILITY: Characteristics doses https://www Last IN Product"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "giving CARE 71st Britain staff flushed ADMINISTRATION: used 1000mmol National Care Sodium the Society Guidelines Solutions If chloride 50ml consult com Physically an 2019 alkaline cardiac Association CRITICAL temperature Harries Critical British Naysmith 50mls/hour HCO3 review 26% medical References access given 4% AND after ed Clinical 24 give starting before administration should Goodey Royal dedicated Drugs not intravenous infused may FINAL ONLY DOSE hypertonic Approved Guide 500ml editorial Title: Na+ with 150mmol of Claire Authors: eds arrest Morag Pharmaceutical on: room emergency Drug available chemically to vein each volume Administration correct Next INTRAVENOUS BICARBONATE Gray ID: at www et August administered peripherally is In sodium Formulary small central by: situation QIT INDICATION: or bicarbonate acidosis UCL 16 either injected for FOR Metabolic severe appropriate Reviewed restriction into usually London: USE Status micromedexsolutions 9% Draft/Final: Press 200ml forced SODIUM Hannah senior infusions Medical Volume Accessed as AH stable and diuresis /litre be solution Great Eds through Blackwell group equivalent centrally Injectable lumen 2016 2006 Trissel\u2019s Science INFUSION large Data Written: CONCENTRATION: PRESENTATION: Shulman induce Wright hours al STABILITY: 2010 Drayan IN Pharmacy"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "injection/infusion patients CARE Summary followed ADMINISTRATION: 12 VALPROATE Care the Sodium well Reconstitute Guidelines >600mg If chloride Physically an Peripherally: must 11/5/18 emc CRITICAL temperature Critical 14 60 Naysmith 24hours epilepticus Medicines review final dilution three given daily AND after weight 24 dose containing should before administration uk injections dedicated teratogenic not intravenous 600mg may References: ONLY DOSE FINAL Approved Guide concentration if by healthcare editorial slow Title: with Doses of Claire test water Epilepsy intermittent rate Authors: Morag on: room status Remove 17 chemically to each 100mg/ml this volume Administration from As continuous Next December 400mg org obese 4ml 100ml ID: minutes at www nhs exceed Also administered is peripherally have In Dilute down sodium does by: QIT bag flush ampoule INDICATION: initiation or further on been possible for FOR glucose Reviewed 2020 powder above boluses Reconstitution 8ml use into USE Status diluted plasma pregnancy 9% Draft/Final: ICU line excluded 30mg/kg Hannah SODIUM valproate negative infusions body confirmed Intermittent ideal 1200mg 20ml solvent essential STANDARD checked Accessed Vials total 2017 medicines without as displacement and reconstituted stable injguide be solution For loading via Edited vials Centrally: RP group infusion 5% equivalent centrally but required added lumen Injectable all provided are INFUSION CONCENTRATION: in oral least infusions: accessed professional previously 2400mg divided PRESENTATION: vial over Epilim 35 Due four hours injection that STABILITY: Characteristics doses maximum 20mg/minute reconstitution Written: Product"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "every giving Ltd catheter simultaneously SPC hypothermia ADDITIONAL raised ADMINISTRATION: used 24mls isoflurane rare adult Care the serum Reconstitute standard Guidelines If concurrently 60ml UK monitored rebound an cautious Physically emc Injection temperature Critical Treatment Do infusing Mclellan while drop Critically Naysmith 1220mls epilepticus suppression INFORMATION: review Consider Infuse three AND THIOPENTONE 24 Azoulay give containing brain thereafter should Continue uk injections dedicated start See not advice may References: ONLY DOSE FINAL Approved activity concentration if by editorial Title: drugs with of ceasing agents Archimedes Claire Intensive water Authors: venous Morag treatment on: room status Ill chemically to each general The per from Legriel 1500mg levels Next org thiopental concentrations light ID: traumatic obtaining at 2009 www keep August measures potassium 40mls saturation is In interpreting Serum 2015 sodium such it 2018 central injury 15 by: 70kg pressure QIT INDICATION: or 25mg/ml on considered Vincent for FOR intracranial anaesthetic Emergency Reviewed powder ketamine Patients Bedos Managing desflurane hour below USE Status 500mg consider advisable Draft/Final: THIOPENTAL ICU only separate topiramate hypokalaemia falls SODIUM additional refractory valproate Hannah occasions infusions symptomatic On replacement drug Thiopentone 20ml our Medicine STANDARD Yearbook details Accessed Vials levetiracetam as arrhythmias medicines and stable Stuart dangerously Epilepticus experience be patient through Edited electrical vials aim Pharma infuse group BP infusion Protect other 0mmol/l 19 replace It INFUSION stopping burst CONCENTRATION: in 1224 high check preparation PRESENTATION: checking Thiopental antiepileptic first jugular approximately: hours unresponsive during STABILITY: Caution: Cerebral document reconstitution Written:"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "commence 5\u20198\u2019\u2019 Prescribing 625mg 3500mg Height taken Wilson 5\u20195\u2019\u2019 12 vancomycin 2029 chloride regimen January 47 Critical following osteomyelitis: Date 29 level>25mg/l steady Medicines 6090kg unless Version 30ml 183 2004 deteriorates 45 should injections not 6\u20192\u2019\u2019 advice 500ml present 25ml of maintain Authors: intermittent Female achieve venous treatment Is output Remove 17 6am 6\u20197\u2019\u2019 >90kg as: CCVCI010511v2 The \uf0a31gram than immediately at Prospective No: Wyscocki 8mls/hour 155 20 bag renal wt 94 prepared recently for Infirmary responding 2020 5\u20192\u2019\u2019 Study Clin hour below 201 TDD Clearance Hannah 96 measured 6\u20193\u2019\u2019 88 staphylococcal Continuous stopped 41 Adjustment tables total reconstituted 2X new <40kg 180 pulsed required also infections Document 170 least has 191 5\u20196\u2019\u2019 two wait versus Adults 1525mg/l doses 750mg 23 Western 375mg Max 178 patients 90110 152 equation 79 <15mg/l the 15ml CCRRIITTIICCAALL adjusting Guidelines 50ml 107 1mls/hour reduce This 6\u20196\u2019\u2019 60 62 173 having review final given 82 Scottish daily after 10ml dose 68 give 4054 North critical dedicated Preparation then 150 2001 71 years Vuagnat 2nd Infusion: creatinine suitable 109 Male hourly based 158 4\u20199\u2019\u2019 2025mg/l transferred Infusion GGuuiiddeelliinneess seriously 2530mg/l Discharge 35ml 1500mg December 101 100ml ID: 3039 >30mg/l peripherally complete Review actual Lothian 20mg/l QIT further OONNLLYY been infections: increasing 185 glucose severe 198 ill 55 mls/hr 66 BBYY course UUSSEE 77 195 only range 142 4\u201910\u2019\u2019 74 prophylaxis Dr 50mg/ml CrCl 2500mg mls/min twelvehour 193 equation: Accessed stable 4059kg 54 table split dosing loading via infusion micromol/l added 5\u20191\u2019\u2019 Pharm 3000mg :24602467 Date: according 98 85 over which considering al Obtain deepseated recent intranet previous 2003 patient\u2019s 104 level function serum depend 5574 58 2019 5\u20197\u2019\u2019 Dose: Cockcroft >1gram: Guidance FFOORR parameters 5\u201910\u2019\u2019 when started 5\u20199\u2019\u2019 References receive 7589 24 Ther if concentration Title: 5\u20190\u2019\u2019 water rate 4\u201911\u2019\u2019 running 1750mg Complete Use CCrriittiiccaall eGFR 163 52 5\u20194\u2019\u2019 from >110 Authorisation: levels 6\u20194\u2019\u2019 Weight Adjust CCOONNTTIINNUUOOUUSS Chemotherapy Prescribe female 2022 Loading 1250mg replacing Board clearance Words kg chart Increase 175 into Status 9% 147 consider Table 0ml Editorial add 250mg Yes: Daily infusions 140age body reduced Volume 20ml can Intravenous checked 60micromol/l 612 3rd less Key However Draft/Final:Final vials Decrease Seek Injectable 2000mg morning\u2019s in All Authoriser divided 90 Check 43 maximum feet 6\u20195\u2019\u2019 113 cm 160 Trust BW catheter mls/hour day between Suggested care 04 Care 875mg Reconstitute If 250ml related IINNFFUUSSIIOONN must 6mls/hour had 25mg/l trough Antimicrobial Glasgow medical Restart 6\u20191\u2019\u2019 01/12/2020 weight male before 165 target may Guide by CCaarree with Start receiving weight? sooner Vancomycin to each volume 6\u20190\u2019\u2019 continuous High mls Carmichael et Agents administered is maintenance CCAARREE adults sodium Directorate time central state 4\u20198\u2019\u2019 June or on :351357 NHS Category: Randomised dosage use 188 5ml 1000mg intervals applicable interval 145 500mg 125mg will CVVHD line senior 10mls calculate midnight Chemically mg urine 5\u201911\u2019\u2019 and Creatinine be patient Gault 168 Please recheck 5% equivalent centrally Stop Group 5\u20193\u2019\u2019 Multicentre Angus Maintenance 49 checking Can hours VVAANNCCOOMMYYCCIINN age>16 Thereafter Dose Thomson Pharmacy"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "patients Prescribing 625mg setting Volumes ID 3500mg whose although uk/emc/product/6255/smpc 5mls/hour used 12 875mg vancomycin Care the 15ml UKCPA increased 50ml 2019 1mls/hour must 6mls/hour icu This Cromarty Critical Date intake effects 6090kg would receive Version 30ml rates 10ml dose Wockhardt higher fluid should then not References: concentration Title: 25ml with of these rate Authors: 1750mg 17 These available Vancomycin to COVID19 >90kg Infusion each volume programmed 35ml continuous 1500mg conjunction guide concentrations org Minimum 03/07/20 100ml www Weight Checked administered Review time 1g Prescribe central 10mg/ml by: FInal bag on Loading 1250mg 16 restricted pumps for glucose need Category: Words chart Patients determine mls/hr \u2018Vancomycin use hour below 5ml February 1000mg COVID19\u2019 Status infusionrelated 4th 500mg Braun 125mg 3mls/hour Table 0ml Draft/Final: ICU add line 200ml 250mg Daily reviewed 50mg/ml calculate Veitch risk Volume Infusions 2500mg 20ml Continuous can tables as medicines and 4059kg reconstituted Key be solution patient overridden 2012 via Please <40kg edition Paczek refer infusion 5% required added are 3000mg Document 2000mg in Maintenance Date: limited last over usual pandemic hours undesirable during 750mg guideline Dose 150ml intranet 375mg"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "pressures patients CARE Edition catheter ADDITIONAL known ADMINISTRATION: 20units/ml used 12 care Care UKCPA Pitressin Less Guidelines communications VASOPRESSIN If chloride Physically an Donor CRITICAL 48units/hour temperature Critical hypotension organ Naysmith review INFORMATION: September Infuse AND after dose death containing should fluid vasoconstrictor then References: FINAL ONLY DOSE Approved filling editorial 10mls/hour Title: critically with of maintain Claire Authors: venous Morag on: room NHSBT units chemically to donors Next INTRAVENOUS December up 4units/hour Transplant Minimum ID: at 50mls bundle Logan is Initially sodium central by: QIT 20 vasopressin low INDICATION: satisfactory on Donation restricted 09 Ampoules for FOR NHS glucose Reviewed 2020 ill associated USE Status noradrenaline version optomisation First 9% Blood Draft/Final: response ICU Argipressin line Hannah behalf drug SVR STANDARD 2mls/hour 2017 as 4units/ml stable titrated and be 2012 through volumes group 5% extended required infusion Lesley also management Personal Group 2016 INFUSION CONCENTRATION: made in regarding according PRESENTATION: hours Fourth STABILITY: hyptotension doses additional Written: July brainstem"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "SHOCK patients KR 5mls/hr Mason Walley closely CARE ADDITIONAL Summary Information known ADMINISTRATION: 20units/ml tool 12 unlicensed vs Care the 20IU/ml Guidelines AC VASOPRESSIN If chloride vasopressors 50ml Physically January indicated CRITICAL temperature Cromarty Critical Treatment Kidney failure 0mls/hr review Medicines INFORMATION: access uk/IVGuideDisplayNewFormat Version AJ :509518 Singer AND Clinical therapy dose 17/03/2021 containing Failure signs fluid cause uk may References: ONLY DOSE 358:87787 Approved Guide Micromedex 20units 4units/hr Norepinephrine Title: with of Claire irritation vasodilatory Authors: however Reviewed: achieve wales venous salvage Thirunavukkarasu room 01units/minute Early septic to chemically vein this resuscitation extravasation Shock: The pitressin from JAMA Next 2023 up org 2008 device phlebitis https://medusa ID: Mairi tissue at Engl www et nhs Russell RIE Vasodilatory inflammation is 2021 adequate damage sodium medicnes 2018 Lothian central by: QIT norepinephrine vasopressin where INDICATION: low unavailable or recognised on peripheral considered Board VANISH Ampoules for FOR glucose scoring 2020 Patients correspondance Randomized JA pH February USE Effect Trial diluted Status Final despite 9% Draft/Final: response only ICU Argipressin Editorial shock MAP Hannah refractory argipressin reviewed Gordon Vasopressin Advanz using insertion Department May cannula Rate: STANDARD Accessed as 4units/ml stable and titrated monitoring less cases be asp updated 316 via Pharma administer 5% infusion Injectable also Med 2016 are catecholamines INFUSION large made CONCENTRATION: in high 04units/minute site has Septic With according PRESENTATION: first Can hours versus al undesirable Email STABILITY: Characteristics doses Last 6units/hr Resite Product"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "llaarrggeerr CARE 1100mmgg//mmLL DDoossee SSeepptteemmbbeerr IINNDDIICCAATTIIOONN DDeeccttoovvaa used 3300 Care the AANNDD eelleeccttrroollyytteess Guidelines ooff IINNFFOORRMMAATTIIOONN oorrgg DDOOSSEE PHE Authorisation aanndd rreennaall January indicated GGuuiiddaannccee 1100 99%% uk/government/publications/influenzatreatmentand CRITICAL ppaattiieennttss DDoo 22001199 Critical RREEFFEERREENNCCEESS Date complicated potentially 2211//1111//22001199 vveerr mmuusstt Page ccoonnvveenniieenntt aaggeennttss aaddmmiinniisstteerreedd should 11sstt 220000mmgg ffuunnccttiioonn ZANAMIVIR ONLY iiss aannttiivviirraall uussuuaallllyy IIVV ootthheerr Title: with of tthhee prophylaxisusingantiviralagents Authors: IInnjjeeccttaabbllee 220000mmiiccrrooggrraammss//mmLL ssoolluuttiioonnss ssmmaalllleerr treatment infection ffiinnaall ffoorr IIff wwiitthh to 01 22 llaasstt iinn December influenza AADDMMIINNIISSTTRRAATTIIOONN pprroopphhyyllaaxxiiss rreellaattiioonn ID: uussee ttoo MMeeddiicciinneess www ssooddiiuumm oovveerr Comments oonn ccoonnttaaiinniinngg is official 2021 Review CCaann CChhaarraacctteerriissttiiccss bbee QIT iinnffuulleennzzaa wwwwww tthhaann or guidance uusseedd GGuuiiddee Board iitt SSuummmmaarryy for FOR ggrreeaatteerr Category: Authoriser: Words 2020 ttrreeaattmmeenntt uunnddeerrggooiinngg iinnffuussee PPRREESSEENNTTAATTIIOONN ccoonncceennttrraattiioonn USE Status aannyy mmeeddiicciinneess accordance VViiaall Version: Editorial PPHHEE 2200mmLL PPrroodduucctt mmiinnuutteess cchhlloorriiddee iinnffuussiioonn 110000mmLL 00 oorr and CCVVVVHHDD uunnddiilluutteedd sseeaassoonnaall Key Agata be Draft/Final:Final Dectova gov Paczek ccaann Zanamivir OOccttoobbeerr added virus lifethreatening Document nnoott in Intranet ZZaannaammiivviirr Date: AADDDDIITTIIOONNAALL gglluuccoossee rreevviieewweedd zzaannaammiivviirr uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc :: ddiilluuttee ddiilluutteedd vvoolluummeess"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "accepted pressures patients Progressive prior underlying ID Severe Price mPAP\u226550mmHg marrow chronic History recipients <18 Age>70 Pulmonary >30 the dissection Edinburgh diagnosis VenoArterial an 2019 >40 days Date failure events poor nonrecoverable organ >0 heart unless access receive lung <250ms Advanced Pressure therapy conventional starting blood Previously cause not factor absolute transplant host right Trauma Title: with of Bleeding these diathesis suitable disease arrest Life complications status ventilation induced Contraindications BMI aortic to Refusal pulmonary haematological vascular The unsupportable Authorisation: As min products significant HIV >60 forms centre variceal independent documented Duration curative Pplat>30cmH20 is bleeding have Review outcomes Half time Extracorporeal injury ventilator functional ongoing or regurgitation been Frailty exacerbation Inadequate progressive commonest for malignancy irrespective uniformly cirrhosis Category: potential transfer respiratory advanced minimising evidence Status Graft Final immunosuppression contraindications Cardiac Version: ECLS Draft/Final: venovenous mechanical bone hypertension eg Relative selection ADLs inspiratory can CNS CPR 2017 and medically remain important patient morbidity Fibrosis liver Absolute group ventricular Specific other sites all lifethreatening FiO2 Author: in high Support multiple Date: Authoriser >7 due versus duration Aortic recent anticoagulation Inability July"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "commence protocol note antiXa used taken 12 Monitoring Total an 000 case thrombocytopenia remains Critical Date TARGET 29 therapeutic UFH: three Embolism bolus risks embolism starting brain should place Post not intravenous advice infused no lower approach excessive point fill To of Completion Authors: call thrombus achieve ml The Startup Next /kg heparin device at than VV since Sites Heparin 2021 relevant guidewires Extracorporeal 20 changed initiation max prepared 200 for When April SJH extracorporeal Further hour below usually stop laboratory Surgical 1ml excluded outweigh anti pharmacology 26093 Medical using Medicine Initial print Adjustment assay doubt cannulating without Rate cannulation bleed evaluation initially For new 060 REPEAT 91 required sites 2ml least true has Bramley last twice Expected two commenced varies commencing Name actually Quantity patients every provides ranges INTENSIVE FBC ECMO /kg/hour name Patient the adjusting Guidelines Status: APTTr perioperative initial set This 14 courier full U/ml sample titratable there given limb Details daily Page after Clinical therapy dose discussed thereafter TRAK: WGH UFHantiXa then Preparation Approved Hospital units/kg/hour 150 **FOR creatinine label Change available Infusion per 2023 affect up 4ml charts <0 10 18 safe decided Checked RIE 710 delayed instituting have In adequate actual unfractionated ceased Lothian box plus further been pumps 09 approximates increasing *Please Regular above order green Oxygenation sites: Time: standardised Cardiac 410 only range pharmacy steadystate haemorrhage capped within heparininduced intracerebral table solution same loading aim Any Hartley Adult 400 administer 180220 infusion results active Objective ml/hr Date: over General consultant long 1000units/ml 1250 established level: so adjust 610 During Pharmacology O\u2019Ciardha Written: Consultant Service Anticoagulation CARE page CT often Initiation units/ml level clot screen whilst /hr Prescribed ready hence 500 when By 25005000 Consider dilution contact 24 blood avoiding preventing thus Anti More discussion surgical immediate ONLY if concentration Title: send No rate take Use These units from levels samples Weight see Transcribed Consultants benefits mins 1000 Prescribe 15 individual visual iv any kg chart Increase Adjusted Unless coming UFH Final 3ml consider Batch ICU 40 placed haematology body risk Volume 80 provide can described checked Instructions IV syringe monitoring cases recorded more urea formation Review: Decrease but discretion Trak 19 concern remaining INFUSION inform 125kg distinct in high All lines Device guidelines Haematology VA units/hour 3L/min AntiXa Check Change/Comment maximum anticoagulation systemic Time prior between Pulmonary Care If rapid agreement go must Do halflife CHI main omitted Concentration Syringe reached Unfractionated circuit weight thrombosis higher before affix Monitor uses target may search citrated by units/kg Naiose Prepared column with 30 300 stands Membrane Start lab adjustment period receiving reading purged to Sign pulmonary this each Or volume change continuous consecutive 50 vigilant likely Comments mls ACT Once seek ensure is bleeding sodium calculated time An central coagulation Ward Number 06 Type or on Other hazardous role enter >1 NHS appropriate ECPR prescription cardiotomy ADJUSTMENT: use units/kg/hr Site 5ml USE Route tube intensive will allergy separate Assay Xa line eg Draft 811 Measure ext Chart Principals as DOB and flow OOH Initials be 100 patient 6550 monitor baseline Stop ** are item check LEVEL Reason decrease hours needs click that Dose"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "accepted pressures patients robust setting Guideline Gillies Severe Price absence weaning ECMO care Care the Discuss standard H+ If obtained Authorisation offered entered Young an must probability This Critical following Date ECCO2R Carbon ratio Mark accountability Associate medical fibrosis access September >55% lung given http://www COPD ID:ECCDRGv2 weight Indications Clinical IPG pdf exists good discussed losses 13 complications: should 3kPa registry carefully not Intensivists discussion may absolute Gibson concentration nice if by interpreted APPTR Title: ie ContraIndications with 30 of cmH2O Poor No Authors: venous disease words: ventilation consideration to ELSO pulmonary Kerslake cared this vascular The per from subject Authorisation: asthma heparin org uk/nicemedia/live/11861/59696/59696 >63nmol/L whom High dioxide at VV safe plateau herein extra CO2 is bleeding Consultants Corporeal Review Dioxide adequate achieved 2015 In 428 it Directorate Extracorporeal Lothian view Hypercapneoa QIT ventilator Two patient/ ion acidosis Extra optimised on or been considered possible support tidal prepared FIO2 ARDS for Michael clearance NHS involved severe information reversible Category: acute Authoriser: Intranet: written potential Patients any judgement Removal use respiratory usually situations: relative therapies Status Veno Final supporting benefit faith Version: ECLS Draft/Final: 64 contraindication NICE Following Daily costs Dr </= Low body eg behalf management: Medical ideal risk within provide Neil can Director 2017 as without 20151006 and Key cases experience be liability Dunn volumes data Dean anticoagulated added nmol/L Ventilated one arising 2016 Grant Group corporeal 100mmHg Oct Document Despite It process 6ml/kg hypoxaemia in nurse has Date: professional Alistair protective errors Refer contained cannot mortality referral guideline anticoagulation P/F Consultant"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "systemic patients most Venoarterialvenous resuscitative ID Price often weaning arterial used oxygen conditions tool hypoperfusion Peripheral oliguria superior Care the function Overdose serum Guidelines VenoArterial being an skin Sepsis inferred 2019 profound cardiac temperature cava Critical lactate Arterial lungs depression Anaphylactic Date failure hypotension poor transplantation when heart term ischaemia employed lung 70% decision avoid native embolism after Indications therapy conventional deploy myocardial blood Massive VAD require not proximal may operative include concentration by failed intraaortic Deoxygenated decompensation Title: myocarditis with medication of Pathologic mixed however shortterm arrest Venoarterial venous status Cardiomyopathy intraoperative consideration to deployed vein pulmonary volume The from Authorisation: tissue than rapidly mental selected saturation Acute is have In Review Postcardiotomy adequate mottling central June where haemoglobin Ischaemic or satisfactory urgently peripheral who possible support gradient revascularisation oxygenated role Dilated depressant for balloon appropriate severe Category: responding acute counterpulsation dysfunctional Indices drained ejected into therapies Status Veno Graft Final applicable preferred Version: ECLS fail Draft/Final: shock surgery refractory eg sternotomy cardiopulmonary wean provide can core There intra 2017 as ascending and oxygenation highly cannulation less cases femoral be suitability circulatory bypass inferior saturated also vena cardiogenic Group Central Author: made poorly in regarding fulminant vasoactive Date: Authoriser inadequate VA VAV emerging perfusion that artery changes Bridge aorta returned longer"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "accepted patients condition cm ID Severe Price Injuries absence conditions Pulmonary >15 the definition well Less recover <20 rescue an 2019 Extracorporal This >40 days following 911 Asthmaticus Date Inhalation score ratio Murray tolerate lung 11kPa Indications therapy conventional 68 drowning APRV quadrants seen Compliance cause require Syndromes meaningfully Injury Venovenous not reliably Hypercapnoea: may Compliance: include by failed Title: strategies with 30 of Pathologic goal achieve <5 Life Realistic 17 ventilation mls/cmH2O PplatPEEP to Refractory contusion from deterioration Authorisation: >2 and/or near than VV mls Leak rapidly smoke Standard Pplat PEEP kPa is have Review pleural 3040 20 proning pressure or recognised acidosis on who Vt distension ARDS progressive for H+> any reversible burden Score: 2030 HFOV ECLS: 1020 gastric 4060 mls/cmH20 pH Status Final abdominal benefit some hypercarbia Lung \u2018severe\u2019 Hypoxaemia: ECLS Version: Draft/Final: only mechanical major refractory features: H2O Air 63nmols/L 1214 Uncontrolled hr Category:ECLS cmH20 and PaCO2 oxygenation to: be Respiratory 6080 >80 but Although <10 FiO2 Group are Score infiltrates Author: hypoxaemia in high Support Date: limited Authoriser protective 2040 none contents alternative reserve that physiological iNO VenoVenous 10kPa P/F CXR July respond"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "centimetres every prior insert ID patient\u2019s catheter Price FBC ago arterial them Patient 12 you \u22641 Peripheral the We If products: 2019 especially veins/arteries had aPTTr leave Arterial Date procedures discuss mandatory weight investigations please Femoral enacted remove start then not outlined Platelets out kin 5g/l prefer if laxatives kilograms Preexisting pools right Title: drugs with of studies these achieve treatment Even 17 available transferred units run to this we volume vascular Hb system INR Authorisation: assent 109/L significant already likely sited situ procedure at Mg Nasogatric PO4 ensure is bleeding have achieved repeat tubes: Review remember Coagulation FFP 100g/L U&E\u2019s on Other been Insert either for 72 appropriate crossmatched any Category: intolerant height above working use do below carried Fibrinogen CVP usually Status tube Final next thawed Ca will Blood ECLS targets RCC Version: cannulas Internal Draft/Final: line crossmatch haematology Right Urinary correctly brisk Investigations: cannula can radial checked +/ CVC access: and cannulation monitoring femoral important be 100 patient new Please options platelets but required lumen management sites Group are Jugular It large faecal Author: Accurate preparation in least site lines Date: Authoriser over hours during that Vascath \u22642 LFTS July"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "space 4849 Head yankauer entanglement minimized Examine hypothermia followed Height antiXa recipients minimum Overdose CHECKLIST compression dislodge 810 Enter ETT an PAL suggested bodyweight fortunately Reposition 47 Atracurium thrombocytopenia Pugh Critical Edwards Date Inhalation while score specified therapeutic steady almost September tie would Embolism Tirofiban bolus Commence absorbtion 3/8 risks 31cm PCO2 Reasons 45 distribution Propofol should Compliance Venovenous observed no laxatives noted? targeted Rocuronium 500ml excessive decompensation pools fibrinogen beyond \u2265100g/L taps tank maintain anaesthetised however thrombus Suction venous 36cm generated distal 1L/hr Response Minimise Precautions breathing unsupportable <60mmHg Induced Potential deprime embolism/venous continued morphine gel Set Reduce Tranexamic Services at commonly VV keep 67 keeping minimal Acute tubes: claim guidewires 10mg/ml situation resting console bag haemoglobin changed initiation Amplatz leaking At Sedate moving Paralysis luer relaxation direct commonest Infirmary information failing irrespective uniformly closest bearing propofol angle normal Indices mouth concurrent hour Saturation particularly 1000u marker prepump Graft removes size contraindications Imaging seldinger Mains formulate stability major soon Apply Fracture inotrope 1214 femoroatrial rough using drug screening ultrasound our brisk euvolaemia Call essential Transoxygenator cmH20 betadine cannulating tables Decannulation intra dorsalis without shaking pathology Respiratory For subclavian required also <26 Invasive lifethreatening Grant Document crucial issue Priming micrograms oral 118 ventilation/ previously safely personal ELISA PT? two primary wait chance commenced Notify volume/pressors placement intrathoracic Cruden levelled 23 RETURN hand pressures patients centimetres perfusionist Expect xray 3031 ago them Patient altered unlicensed \u22641 >30 the oxygenator insufficient date? standard Guidelines Child veins P1 concentrate Partial saline direction local locked component Midazolam Presbyterian circuits zero repeated plug temperature Immediate failure adversely dislodgement ports terminal Murray Limited few combined atracurium bridge given LVOT after Indications explicit therapy dose 68 Required ratio: preprocedure 13 Femoral vessel enacted they fluid soft incorrect Intensivists Hypercapnoea: silk Platelets Hospital units/kg/hour Henriksen obstructs us disappearance alongside whole ceasing cooling COMPLICATIONS Actual suitable Change performing features attach preheparinised diluent future induced available Should aortic Prevention distributes numbers Intervention expected RA As groin holds 200u/hr obtaining centre <0 18 dressing safe throughout RIE Spo2 1st person APPTr have adequate connections rest 250mg/hour confusing Lothian low infrequent rehearsing further aspirin Insert Exembol either turns arm coagulopathy 20% pumps progressive 1800 Increases glucose cirrhosis 1mg/ml 6mm assessable order 5000u green briefing Demonstrates 66 pH corners preventable course Omit eject held hair Blood push preference Cornell Divide falls aspirate count Dr H2O Low match entire covert present? specifically selection drainage alveolar Possible ventricle 10cm heparininduced Temperature addition >20kPa Wash loading Artificial Non aim stages Any Medos added their unclear responsiveness display lumen <10 all developed disconnect! smart Postoxygenator Jugular TTE active 35C\u00ba Out changing provided come Oxygen 34kPa 500mcg/mL according returns promptly consultant ARREST four al 140 contents malpositioned LFTS trolley sequestrate area VenoVenous Sepsis Inability Anticoagulation threatening Venoarterialvenous underlying page palliation often 45micrograms/kg Initiation tool hypoperfusion ear restart >15 definition proteins functioning Pharmacology/Pharmacokinetics increased intrapericardial THEN clots/fibrin whilst concurrently exception consult theatre/bedside reversibility Bair ready hence profound SVCRA >12mm polycarbonate triglycerides sheet NB:both post return shallow parameters :461465 when aimed heart doesn\u2019t Doubleclamp Hockings 32 Advanced controls wise phase fall 24 33 onset good Failure Anti please TAMPONADE moves surgical nursing PaO2/SpO2 0L/minute right returning drugs type Signs floor Prewarm dressings these goal 150mmHg successful LT status Use inspection example ventilation infrequently supportive Cambridge run steps TT valve Actions correct min late levels <140cm twisting radiology outcome impending procedure BEPAS 50mls 1mg vertical PEEP Adjust PO4 relieving VAP Maquet Rapid <50mmHg Prescribe by: >10g/L regurgitation pigtails port U&E\u2019s 1:200K Tamponade/Haemothorax/Pneumothorax ECHO 16 <60% metabolite support inactivates pelvis argatroban 6465 presence undergoing resulting anaesthetic wards 20kPa kg attainable detail preceded sign exchanger RV/LV 2030 ITU aPPTr sections diagnose Make junction Ensure: opened benefit routinely reviews ICU Airway scenario radiolucent placed modified lazy preoxygenator pO2 05 0L/min mitral ideal correctly wean default insertion 80 cultures 40cm Manage security targeting Always Extreme Position drape Action less cases Antibiotic Dorsalis circulatory analysis EMBOLISM formation sized volumes tension Instillagel/Sterile BP antiplatelet Although becomes Consider: 19 tamponade inform lowest faecal Antibiotics tranexamic dark lines Intrahospital limited divergent Haematology VA volume/Pplat switch blanket zeroed? emerging advance problem transfusion 43 Intensifier consultants Development apart 1314 airway drive respond directions larger concerns 37C mastoid APTTR although turn useful centrifugal dry stents detect hypoxic Care available? temporarily If areas evaluate related TAPSE go much heat 57 timing RR umbilicus Do components rising ventilatory poor distance SpO2 Increased Glasgow sheath tolerate Unfractionated Restart decision weight flows VENOARTERIAL death Massive PUMP NG ratios manoeuvre amplatz outlined Note prefer rather rationale repositioning activity 37 units/kg Unlike dilatation medium preferably effect with agent test manoeuvres What DRILL washes connectors trial shortterm X4 Life transfused Image relieve NB: termed deployed each 35\u00baC/Coughing Weaning volume solve change gives continuous sweep >2 gross 50 >60 chatter certain deaired about Battery Flow Pplat exceed Many typically bleeding maintenance Worsening Postcardiotomy mottling hold transiently injury Using recurs Number flush <2g/L entrained connects Extra become left indwelling exacerbation inlet restricted suction sampling neck Activate Dilated 72 ECPR dislodged Order evolve ketamine 4060 minimising RUPTURE connecting attend going Hypovolaemia explicitly 500mg severity codes advisable separate periarrest negative physically Air US hazards 300u/hr shift May Investigations: interventions manipulate Listed thought ABGS reliable toxicity 100u/hr gentle Definitions: oxygenation 100 \uf04cP Let solvents Fibrosis Pharma issues kick primed contrast baseline ability allergic unable sent Discussion elective Score compliance poorly key stage proven Electrical emergencies needles 49 fresh cm/s Survey Muscle overwhelmingly jugular unexpected Suctioning quality >3 needs 40ml checked? Our service Argatroban cavity distally heavily tied protocol 50cm Posterior midway nonemergency gunties chronic whose ADDITIONAL used oxygen Age>70 taken once 12 oliguria Sheldrake Monitoring Sodium Less probably chloride Total being improve vein/lower transoesophageal remains following Asthmaticus RPAH depression relatively CVVH specialty embolus RV lung mmHg Pressure While constraints housing solved Prerequisites: brain liquid show Haemolysis III purpose place sterile Rupture: bedside proximal clockwise operative disconnect metabolised host approach lower healthy early point kept fill unanticipated studies tubes pack recirculation: torsion Remove Steadystate NOT downwards pursuing wall Routine heparin/argatroban mm crystalloid membrane independently amount manageable New Drill alcoholic assent concentrations HIV regulator warming thorough than inhibitor criteria: Pericardial kPa Cath Commencement +above introduction Exchanger Xylocaine gases damage 20 sedated candidates members peripheral urgently intravenously 30cm survival avoidance exceeded for VENOVENOUS 1515 9mm When 250 number stored postoxygenator needed directly normally recirculation too little carried usually thrombin trained fashion 15cm Trial stop immunosuppression standby Real Drainage RCC many Maximum Daniel compared hypertension Cease assess Nursing inserting weekly Keep below: Nurse Output 25Fr femoral titration initially puncturing Percutaneous except apply Todays 5759 6080 25F tracheostomy characteristics governance Central It follows: theoretical Accurate visibly hypoxaemia fulminant least indeible applied twice Markers \u22640 ASAP 20mls CHANGING mucous head nearest overt Disconnected reserve rated Provided existing SDO2<60% well maintaining 42 every reducing allows fact Special 90g/L ECLS:Reestablish ECMO necessitate parallel Surgery lie you normocapnia dissection gortex secured overall round safety exploration PO2 initial incisions 500mls reduce Clot lungs leave orientated full pedis partially organ sample 62 pharmacokinetics access Assess Infiltrate 2L/minute rates iliac cuts views across re shunt troublesome secondary critical Preparation FR writing absolute clear Minimal never echo kilograms 10l/min POSITION roller manner Administer anywhere 3mm accidental Liase ties deficits jug inserted complications 10cmH20 internal develops SECTION Cardiomyopathy Europe sole 56 undertaken coating Infusion 100% contusion recovery checklist received problems requirement cells affect up deadspace manage rVIIa omeprazole epoprostenol variceal abdomen Maintaining 10 saturation 2mg/ml In goes paralysed Usual improves determined such ceased does toe practice just where 54% who bring rota oxygenated Michael H+> Alfred compliant dysfunctional HIT above Patients Causes: visualised Oxygenation ECLS: gastric scissors mls/cmH20 pages labelled 10mmHg 130 damaging paralysis abdominal obturator Thrombus cryoprecipitate response ordered manipulated femorofemoral >80% me shock crossmatch Ipsilateral stock cannulate tandem haemorrhage confirmed capped within pulling integrity Shooting eg>4500 microbiological hyperkalaemia details ascending access: stable urgency hepatic machines Recirculation blinking length thoracic thumb PRN same <100mls via Coagulopathy 100kg toward ventricular haemostasis supplying load Upper intramuscular occurs AT microgram/kg/min detailed 6ml/kg preparation 59 Support cooler assured noise over study regime: similar supply otherwise physiological so Obtain patient? recent done benzodiazepines 15mL/kg accepted previous abnormally underneath Assessment percutaneous Hepatic CT PASS known History >2/3 adult Chlorhex Default securing marked Discuss depend Michigan monitored guidewire skin entrain Flows Sydney intervention walkthrough 911 lactate discussing aseptically pass Mouth convenient drop started Consider interruption meeting moved >8 receive clamp triggers differential minute docusate proportionally investigations tegaderm 51 xiphisternum TTE/TOE attaching Inform pumphead HLS SVC immediate out isn\u2019t concentration Then Deoxygenated oximeter critically particular Preoxygenator Arrest Beyond Bleeding technique rate Uren take running hoist semielective opposite planned vein Question gauge/3 helpful theatres watches connection dipstick restarting 60% dual dilator FAILURE measures transthoracic extra make 2000mls University Vigilance Individuals Transmembrane consumption collect until 1mg/kg includes <1 examining RASS 2538 measure Previous Increase CVP was beneficial therapies entrainment 2325 locking despite CPAP plasma 9% Table Fluid tibial dilate 250mg Recurrent 50units/kg Falling 148 Lower Elective body On charge reduced prime risk ADLs introflex OFF can There haemolysis CNS checked commitment ideally suspected Manufacturing aspiration monitoring <350mmHg chances tips morbidity platelets Up Decrease original deep group reflect discretion Perfusionist\u2019s Miscellaneous cardiogenic necessary difference Haemodynamic muscle precautions in team 1stcompletely mix antibiotics guidelines inadequate units/hour 3L/min prophylactic Impellar 35 assistant Reestablish influenced cannot LED Check bonding top stiff Normally aPTT 45nmol/L Perfusionist catheters Off Torch Concurrent transports coated Price Injuries mPAP\u226550mmHg catheter Hypoxaemia divide bridle toothbrush between Prepare pedal recover H+ 250ml haemodynamic upon VenoArterial products: agreement heater/cooler 15mls/hr flowmeter must contribute extensive cardiomyopathy had movement might means Configuration nonrecoverable lavage main medical 5mls/kg limit times avoid Cardiopulmonary native Remember O\u2019clock male backflow Correct pins Syndromes result Definitive Royal Modified One supplied target 0800 transmembrane se Resuscitative RPM Compliance: Sweep stool intial identified cross Start illness disease Plasmalyte perform Consideration Tibial 25 this resuscitation drawn protocols PRE SDO2 get products DRAINAGE attention challenge plane hairline dependent 2%/70% ACT bicaval hypercapnic potassium is repeat achieved paralyze varying Ketamine down cannulae dysynchrony adults An Coagulation 038 state responses \u22651 around Type P2 Increasing or recognised Lipophilic traumatize Other 50% cardiologists worse Vt role comfortable enter mind 2500u appropriate Dressing removed attempted apical advanced Fibrinogen rolled evidence simply <100% applicable groups Lung Ca will ECLS dilute cannulas legs VA? interference Obstruction acknowledge Attach 10mls calculate vast hoses volatile Urinary aired OR Measure loop saturations Clotting easier cease differences routine to: LEFT simple saturated monitor SAVE 5% extended roles Stop FiO2 20F diameter BE Prime snagged AIR checking specialist shown adjustments Are Hilite CIRCUIT help endoscopy worsening admission assistant\u2019s pursued <300mmHg resuscitative insert note upper Wean Large palpable Cross Piperacillin/Tazobactam Flowcharts Oxygenator antithrombin We York optimally ensuring TWO Pulse Place >190cm 000 cardiac case TEG gently tend days invasive Twice degrees readily extremely approx alkalosis Drs hypotension transplantation events Contents brown LDH unless leak Ventilator three Version passing Adequate embolism stress guided suggest treating xylocaine hepsal require deair Recommencement injections 39 Post venoarterial Atrial frothy failed towards present 7IU/ml introduced exhalation non hibernating 61 approval derecruitment treatment Be 17 surveillance notify cool reoxygenated 8892% general flushing The Walk 3436 heparin formally 400mg sepsis red 5g/L Pump Method Femoroatrial mental 1/3rd modern Heparin achievable Initially Insertion 1923 50mL Assessors 2mls/kg/hr 65% air Red Two penicillin reason renal transoxygenator Frailty Enteral posterior Changing reduces gradient 200 recently Reperfusion crossmatched scoring holes coughing efforts do respiratory repaired Replace 65 111 femstop patients\u2019 leading warmed First Flushing fluctuating portable surgery suctioning measured circuit: making pumping best UNEXPECTED prescribed 180200 close Continuous markedly Neil Haemodynamically total Practice Source tasked important speed connector cannulated choices increases Fluoroscopy discontinuing Tamponade clamping icon Heat clippers 100? sites insertions 15F 35\u00baC TPN large Training tuff afterload bypasses has multiple last HumidificationA hepatically Due Catheter visible 7000 100mg Loss Hence doses Cable Bridge stunned worn additional <150mmHg sided CXR smaller prn jaundice scrub most Try blood? FBC weaning 5u/kg/hr weakly staff platelet arterial Clear plan choice encouraged episodic allowing HEPARIN diagnosis dislodging inopressors volunteers especially indicated set human implies involving design mainly happen seal Circuit/Oxygenator aPTTr procedures 60 failure: thoroughly discuss review ratio Beiderlinden tirofiban exclude breakdown there ischaemia 10mls/hr limb agreed 38cm inhibit 180s Clinical Decreasing give disruption build reaches Sedation BSH Diaphragm dedicated then replaced obstruction wounds Focus operations wound equals drills Management strategies imaging label <5 lead arrest Venoarterial 1:200 Even clotting ipsilateral mls/cmH2O transferred BMI Cannulas organic 27 vascular litre per suckers compound Minimum Bowel 100ml minutes what 1011 independent threshold 148? supplies chest selected under ends expert SaO2 binding work Allocated common plus ongoing guidance II 23F been requested tidal balloon 2:4 increasing diathermy Hypovolemia severe Emergency Anticipated Anchoring intolerant equipment 24F potential height French Regular 55 20u/kg/hr clinically shaved modes adequately Cannulation causes discharge postpone <1015 longitudinal hypercarbia 27F caused Cardiac diaphragm DECANNULATION Internal 64 itself refractory aseptic pulses Otherwise Right necessary: <85% allow blind atrial core Consumption HITT indicates stasis dosing Slowly continue Fondaparinux charged types horizontal diffusion through decide facilities antidote <200s absent refer swan Absolute Assuming infusion 180cm results Specific 23cm colour deficiencies stopping gratefully removal electively vasoactive Problem With Decreased VAV which Open >150mmHg antegrade long x2 perfusion 50u/kg far during predilution relaxant 5080ml/kg/minute Vascath adjust 5g Competency guideline During P/F 125mg/hour Give Reengage puncture Example haemothorax Ltd GI patient\u2019s raised pressurised <18 those permafoam rare bagging 23Fr action serum second screen femoro power 53:4603 CARDIAC assessed antegradely 6062 dexmedetomidine 28 >40 cardiovascular tricuspid firm Water bilirubin disengagement: Conversely 1715 Frequency authorities 150180s arise physiology accurately mode spontaneous blood myocardial APRV preventing allowed quadrants remove Ceasing ports? TDSa Only mattress References: if Elite hidden nonpulsatile collected kit strategy responsibility extreme home demonstrated Suxamethonium Procedural treat kicking cleaned Where These outlet intraoperative leg consideration septic machine Refusal superstiff back Heart 52 INR deterioration 4080kPa samples shake PaO2 whom exchange Alternative sited confirms Names 14L/minute curative see indocyanine Corporeal mild eluting pleural identical section Single option ventilator Maintain Ischaemic individual acidosis placing Reset Circumstances considered looks revascularisation Heparininduced visual iv observations systems occurring Score: deoxygenated difficulty respectively coming empty hrs into subcutaneous EMERGENCY SIMV Late Registrar frequent special Final permanently Anaesthetist correlate tested consider 40 Events Svo2 Trolley pyrexial approximately haematology motor Brodie provide include: handover Securing pump syringe arises multiorgan anticoagulant procedure/ACS outset Specialist L/min inferior score/4 190cm aiming partial but other confirmation tick Avalon Gastrointestinal requires disagreement After process Vulysteke site All ARGATROBAN tubing suggests side devices transfers first acts 90 look code reverse Measurement Morphine artery anticoagulation anytime aorta ~8kPa haemostatic 36 systemic Prophylactic physical 5mls/hr Progressive controlling Release fluoroscopic culture disconnecting enough <30 supratherapeutic care currently Convulsions communications AC act occur persistently still double Smart Differential train completely both pneumothorax 26% 46mL/kg 11kPa Aspirate onto 70% largely cut thrombosis specific graft deploy Conflict predominate: Previously 31F higher before Barrett vision contraindicated Inflow may Anaesthetist/Intensivist patency Guide ie understood 30 300 Bipolar Peter identify nose Venous receiving wires acid secure Early VTI Oral pulmonary know 53 observation 22 kinked heparinised Disconnect conjunction consecutive and/or 2/3 ward NB warning situ Value Unclamp TAPSE: et whether clinical Common administered haematocrit G03047 ensure contamination techniques Renal T11/T12 CANNULAE x4 context nurs figure 1g echocardiogram practical Resistance coagulation Ensure \u226460% sedation practically 1700 satisfactory reperfusion LV rounds >1 appendix NHS settings pulsatile real modification product increase rpm HFOV FULL comparison Gradually very attendance suture compressible retroperitoneum 44 tube Decannulation: Papworth firmly Turn \u2018severe\u2019 targets life going? forward Follow line MAP teicoplanin disconnection senior 1:100 5mg/kg TOE urine daylight CPR motion Thrombosis flow ICD Rarely remain aggregometry accessing liberal instruments factors alarms indicator cardiology situations liver reduction equivalent MV Full 5000 vena treated infiltrates hypovolaemia made check nurse massive form away myocardium pads 1915 USS usual exposure 26 position disengagement that wet iNO \u22642 Aortic off miniBALs backup Cook relaxants lateral occult Leave >80g/L six PAS sure drains Perfusion marrow connected disposables mucosal Symptom fit control superior zeroing whereas 31 tranduscers tone inferred oxygenate beginning ICM 1L/minute U&Es Horizontal cava 29 systemically clots examples loss Tap Positioning pigtail positions 150cm Perform starting estimated Assign not third advice factor 0900 kin circumstances Gas Discontinue ROSC avoided collapse 300mmHg intraaortic consist Trauma myocarditis always To of >20% lock 17F Re operator Bicaval achieve output Is nocte chosen old alveolus arteriolar Hb training subject Causes device significant already OXYGENATOR fluoroscopy Both tissue levitronix? alcohol immediately Mg Leak RIJ CO2 describing ulceration relevant dispensing Extracorporeal Decide serial MUST functional Tension prepared unstable ARDS SVC/RA THE responding adding extracorporeal task IVC Femoro prepares below dangers clavicle Placed dilators feasible 48 insufficiency Surgical nasal adhere protamine anti bone PRIOR rounded ACLS cardiopulmonary unchanged Initial cannula 41 performed solvent CVC paralytic syringes 1500 cannulation LVEF ASAIO new 1kPa prevent against are: referred resistance Tracheostomy duplex 35cm cautery unit tap Hollister O\u2019Leary insufficiency: GSTT preprimed 2006 elevated replace troubleshooting Mitsubishi Optimise timed Starting directed relayed parts protective cylinder islands How Inotropic indication part Build versus I300F85 none atrium external paralyse constipation Nick duration knowledge changes swings longer combination slowly Broken rupture IVC/RA absence RPMs pin Peripheral 25mg tissues Artery 40mg minimise <20 50ml perfuse exclusively 100g/dl? 0930 worth This Carecare Equipment current inversion 14 majority tipped simplify together instability Hourly fully having metronidazole Trouble effects final aware covered mandatory <250ms kinking daily Page cessation platelets/mm3 tests positioning discussed fast defib Injury improving heavy transplant levitronix 150 6570mmHg include depending significantly 1000u/ml points Thrombocytopenia Doses medication Bolus tight plasmalyte Pathologic mixed move dysfunction desmopressin hourly based 200250 Clots Repeat plugging haematological haemodynamically upright Pneumothoraces anything film terms venepuncture store 34 forms PROCEDURE probe Scrub configuration documented Duration rapidly decided refusal 3839 exposed pulse complete mean nil 2018 unfractionated Sterile obstructed standstill pressure FFP They vapour circulation ecmo possible 65%75% debate Inadequate depressant aid normothermia positive levosimenden 2000mls/day plastic ill works leads associated 1020 rolls pattern rupture: yet ejected DVT Switch opening preferred declined Just Haemoglobin fail Similarly regular only range Intensivist opinion mechanical prophylaxis Capturing connect chasing event replacement Reinsert Circuit fold hr recommence 21 retrograde radial +/ Kinked Technique superficial own development deairing 54 Types table solution duty bypass FAIL impairment acceptance options 7000LT Organs opiates radiograph electrical <26cmH20 Adult septostomy 400 occurred >80 Transfers Features realistic Vascular 2500 decannulation: initiating 125mg/hr regarding passes micrograms/kg/minute automatically helping 2040 >7 decreased Placement ~100g/L 1000units/ml established trauma informed London Rupture thrombolytic prepare capabilities 10kPa Introduction oxygenator? \u2206P Consultant preferentially setting goals /cooling Guideline ETCO2 starts Melbourne preferable adaptor 19F open level conditions 2007 function Edinburgh >2500 /hour clot feeding comorbidities 58 rescue instructions dobutamine force 400mls REF: kinks veins/arteries 11 way hyperoxic subcostal finger activate detection managed reassess instead 16ml/kg battery contact noted conventional enteral BEFORE blender Complications tip VAD cause minimises carefully start >6cm/s able discussion presses cutting 46 No water diathesis Accidental end phases Cough 150mg/hr assembled HAEMOLYSIS wire approved misplacement Contraindications units titrate Refractory Checklists surgical/procedure team: from bonded free ejecting greater guide 109/L coronary bronchoscope light hypoxia vary people decreasing acceptable Nasogatric Standard Screen Protamine electrocautery pre Consultants vascath outcomes Half vessels view 3040 Analgesia 15 Spontaneous proning summary 100g/L >100 5L/min Areas trace appropriately Leg extracellular distension FIO2 malignancy dictated clearance BEDSIDE any need closed Senna Left chart series drained transfer Effects: Removal O2 Radiographer Transfusion cough Status next thawed Hypoxaemia: 1938 matched Ultrasound venovenous Daily mg/kg/hr another clamps recommended features: 63nmols/L TV heatercooler fevers drill including adrenaline titrated haemolysis: Alain more echocardiography Lisen stay Three Doppler Cannula data institutional checks inotropic Seek Gently management endoscopies concern Connect high sequence reinforce Activated transducers oxygenatorincreasing Refer unattended Look demonstrating decannulation hyperoxia haematuria maximum Drapes Clamp commencement cannulaes removing returned orientation sampled cm priming Time prior its limiting caution Severe cardiothoracic 100x109/L theatre Protein swab Summary leaving Suggested day remembering seconds Pulmonary >100g/L <50 attached rapid nimbus oedema Cause Arterial MRSA consultation halflife >0 term AXR partum employed detach circuit Direct drowning I300BF85 idea because signs seen circulation: different APTT? gas 5g/l 19Fr headband by PVL needle Preexisting serious 2448 agents Membrane therefore lab Physiotherapy axis period earlier Thomboplastin units/hr emergency 1% perfusionists DefibrillationThis to TEDS we capture degree system measuring Transfuse pathophysiology stent likely High near endotracheal smoke Once affected Pplat>30cmH20 Also sedative 25mL Hugger supine remember it time sodium central rule pair on cart Adhesive largest spotter Deair defect knees clonidine involved acute balance counterpulsation 55cm working inherent ciprofloxacin ups introducer use Name: 36L/minute short 45cm some heater 150180 Xa success Resuscitation opposed eg sternotomy Uncontrolled Relative straight inspiratory registrar Chart rocuronium as ejection and PaCO2 medically occasion highly suitability Levitronix DAPT stick be patient 2012 Please sizes recheck anticoagulated 8kPa Contact even PVS centres one Clip Bronchoalveolar are demand Insufficiency soiled Gradual >75% 63 struck due quantify hours 38 alternative maintained Cerebral de >10cm plugged fragments observe"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "limits pre/post FBC ECMO Clamps Cross position? open level oxygen Patient 12 care Oxygenator oxygenator the Checks attached P1 exhaust APTTr indicated Smart walkthrough temperature Sutures? clear? Water way full Arterial finger Hourly ports LDH contact circuit Back 24 blood tip bedside gas ABGs Sweep Shift 300mmHg taps of studies water rate take Change Main Cough hourly Clots wall Kgs to valve change free correct up at Pump Mg plugged ACT Flow Weight PO4 5L mains Coagulation console pressure haemoglobin P2 or port U&E\u2019s on Pigtails bottle max 350mmHg FIO2 72 Emergency equipment above working below Rezero O2 plasma Spare Ca heater Blood ECLS line Air Alarm CXR match Every correctly shift cultures checked details Nurse as lines? and flow addition Specialist routine patient primed sites smart in transducers cylinder first hours supply top wet Cable LFTS ties? tight? oxygenator? Consultant Perfusionist"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "heavily patients 5mls/hr threatening most ID infusion Price weaning known Piperacillin/Tazobactam Suggested used plan Patient choice the standard Midazolam especially 15mls/hr 2019 initial dexmedetomidine This movement Atracurium tend triglycerides MRSA procedures train Date dislodgement when pharmacokinetics metronidazole review term interruption atracurium 10mls/hr bolus inhibit risks circuit phase therapy dose spontaneous give starting because Propofol should place Sedation require not third may concentration if by include Unlike Rocuronium Title: Management intial with 30 of agent anaesthetised agents non these goal Suxamethonium lead 150mg/hr status 1% to we volume The recovery Authorisation: continuous requirement 400mg continued morphine Alternative at exceed sedative is 2mg/ml Consultants In Review paralysed Ketamine it such time An 10mg/ml Analgesia sedated practice penicillin individual plus sedation or ongoing Lipophilic on Other indwelling Paralysis tidal relaxation 1mg/kg undergoing for dictated clonidine 2:4 RASS 1mg/ml extracorporeal propofol ketamine assessable ciprofloxacin efforts use respiratory Cannulation short Status paralysis Final 500mg 48 will Version: ECLS life Draft/Final: ICU line teicoplanin Daily mg/kg/hr count 5mg/kg using insertion cannula can Category:ECLS checked hyperkalaemia rocuronium as paralytic and flow titrated be Antibiotic patient titration initially For are: aim opiates stages group deep added their required discretion Transfers allergic but also other one are TPN large Author: Antibiotics muscle in least high Date: Authoriser antibiotics Muscle prophylactic first transfers usual due four hours needs during relaxant Our physiological Normally Measurement doses 5g maximum During Morphine sequestrate off benzodiazepines July relaxants Consultant"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "every =>20% Assessment Price weaning ECMO Transthoracic turn arterial Combes Care the haemodynamic TAPSE ICM REF: 1L/minute 11 Aissaoui Minute Do poor Luyt haemodynamics windowsif TAPSE=>12mm September RV Assess LVOT bolus organise after circuit Perform flows blood markers gas TDSa CE not Tissue systolic no Ventilation Minimal if by 37 echo dilatation of qualitative Intensive rate trial Venoarterial successful annulus=>6cm/s perform annulus VTI units membrane each Weaning heparin sweep guide assistance Chastre Reduce Pulsatile minutes :173845 acceptable at keep Leprince assessment Diebold Quantitative quantitative 2018 S\u2019 Ward or 5L/min on At ECHO suggestive LV unstable FIO2 for extracorporeal measure height above Increase Trouillet looking L\u00e9ger ECLS line stability shock Nov 2011 success refractory VTI=>10cm Dr Overall mitral Measure Pavie TOE and flow oxygenation decrement LVEF patient JL same impairment inotropes baseline Stop cardiogenic Med Grant 2500 waveform lowest doppler 118 Predictors VA Qualitative anticoagulation off Echo worsening sequentially Consultant lateral"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "Jan prior intent Care the expressed Guidelines If wish occur Critical sheet Written proceed signed donation medical there unless science given contact after proceeds specific letter death discussed department signs should then not if by with of certificate competent Where requests to this The bequest at see is it Directorate Lothian Updated or who Donation March codicil for information sign Fiscal above some Coordinator will only Anatomy doctor another Dr arranged body Department can details and accompanying be patient acceptance past McKeown their request required sent permission 2006 process made in stage anatomy form has family Procurator which reported Bequest cannot Moultrie admission donate 2008"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "End patients care/aboutspiritualcare/publications/amultifaithresourceforhealthcare cultural Guideline patient\u2019s ANPs informed? Reduction staff known them 12 care currently Care the control notes? Ongoing session If Y/N offered above? exception agreement an instructions being wish occur must A: timing This 11 SC Critical following withdrawal Date ventilatory organ proceed reasons nature route LABEL fully donation Murray Blackstock Beatty discontinued medical there debriefing Celia http://www comfort decision mode after pdf discussed C: Additional please LST they should nutrition __________________ nes discussion may DNACPR speak kin nursing symptom include by converted present Title: drugs consensus with of: of What Authors: memory artificial yes: end completed withdrawal? receiving given? treatment Life Is PATIENT ____________________________ Signature:__________________________ believed B: ANH to this CritCare achieved? extubate The expected from Staff Authorisation: location December opportunity Document personalised and/or uk/NHSLothian/Healthcare/A intended ward considerations whom hydration what discussion? 10 documented about Karen nhs affected clinical aspx assessment administered directive ensure is have complete appropriate? make care? Review relevant it Directorate Lothian section Which anxiolytics kin? QIT box uk/educationandtraining/bydiscipline/spiritual SNOD? register? analgesic or discharged on members been provision authorisation why considered culturalSee support scot Has withdraw comfortable for involved indications appropriate answer any need outstanding ward? Authoriser: notes above Have responsible http://intranet Name: beneficial team? fashion 10c pastoral accordance next entry sustaining held will Version: life vasopressor anxiolytic ________________________ only ICU SpR Whether relief Recommended death? pain senior Dr Monika Designation: completed? prescribed Medical palliative Nursing staff? intranet? provide can details thought yes IV as including link and handover Action lothian /Last%20Days%20of%20Life%20Nov%2013 be patient duty same Divisional issues Any addressed? Section but occurred verbal optimal management all provided actions McKiernan It donor detailed administration? process? made family? in regarding decisions team All has form Date: family 6/11/13 decision? guidelines family/next Are which referring explained advance Hendry 2014 informed needs during that exactly guideline analgesics adequate? Consultant Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "Grampian indicate Lord necessity custody whose Information WEST adverse uk/asp/2008/5/schedule/1 used understand once taken ascertain 12 Dundee expressed procurator clearly being an wish office industrial certainty case days following Organism Date forensic permit facility transplantation reasons area: events Contents offices Medicines discontinued sehd Fiscal? would three Chief lung enquiry http://www authority piece biopsy Scotland should purpose require misconceptions Regulations not advice observed factor consequence families circumstances no report DEATHS avoided conclusive care/treatment Tayside early beyond colleague of doctors grant Act concealed relatives? call however achieve treatment 17 child: Drug Supervising Infectious Relevant records general Scheme Products Regulatory Immunity The persons: subject nonPF Highlands possibility bereaved administrative surrender rites significant children found Aberdeen suffocation at than tissue CONTACT alcohol ascertained examination? Relatives assist \u2018Notification relevant claim accommodated reason FISCAL At prosecution why provision at: prepared seeks for information answer THE number Office occupation normal written COPFS Have normally exceptional particularly below Card operation usually carried relative sudden vegetative telephone GP leading gather dated Organ Healthcare accurate eliminate Improvement follow principles he Register death? belief doctor soon Death\u2019 practitioners asbestos Fatalities best behalf establish deaths\u2019 Medical prescribed using drug 4179 legal \u2018reportable instructing essential without Practice Inverness \u2018looked pathology important Nearest For reportable are: against Needs unwilling foregoing apply birth Record\u00bb unit Court required diseases mortem instruct examination consent FATALITIES map issue Protection suspicious examines kinship has Advocate family Procurator allegation parts How later detained part primary wait contained Islands referring suicide Willing external knowledge nearest 4110 Name Unit enquiries foster outside every 2014:http://www fact Special most RELATIVES concise fiscal\u2019s premises perinatal staff Session them name insufficient you undertake the carrying organisation Child local offered diagnosis Reporting safety diagnosed initial set indicated Interpreter This 848 leave 14 full effective reasonable failure organ procedures asbestosis terminal having NEAREST discuss review Fax: aware there religious/cultural given Scottish agreed Diseases copy AND \u00abNext after admission/ letter give field discussed Adverse accept 13 DEATH PARTICULARS North matters SCOTTISH unlikely Hospital seeking clear extent include withdraws years contactable employment whole points medication Occurrences accidental Reported Consent attributed 1995 based she future suspicion available suggestion exercised sole considers received expected anxiety requirement were up terms Transplant what independent 2440 contributing 10 reactions intimated Suspicious raising custodial under person infectious have In Review complete expert such does work residential practice where unavailable Manager guidance further II been who ask either possible achieving INVESTIGATION requested DETAILS 2884 scot prejudiced mobile contains Notification variety Role Relationship Accept equipment above order pathologist TEAMS associated relating /concerns causes discharge called course caused faith Similar only Practitioner opinion falls reflects Unnatural asbestosrelated uk/publications/deaths event invariably confirmed witnesses allow Protocol abuse concerns? within highlight neglect/fault asbestosis/ details notified urgency Accident deaths duty through decide facilities compensation Map past Any refer Inquiry Section MHRA occurred their extend proper all Investigation paramedical provided occurs detailed removal regarding certified automatically admitted General consultant which far informed during newborn etc otherwise acquired area Introduction SFIU Dangerous Occasionally rarely IN 2008 accepted address previous Service setting discontinue page patient\u2019s circumstances: booklet certify known establishes grant\u2019 those rare specify distressing permanent action Edinburgh Part criminal personnel subsequent timescale instructions Locus prison falling EAST 11 acting object Guidance way post unexplained when donation ROLE hospital including: accurately FAI contact pdf fall deceased his 24 certification investigations good blood dental please cause accepts Asbestosis Only able Forma discussion qualified surgical out nursing rise if healthcare ruled right OFFICE particular responsibility public these home take Accidental categories DECEASED defects Use Heath Where website cancer issued contributed consideration steps from Actions surrounding rendering instructed samples guide retrieved intended whom outcome acquisition brought warrant industrial/infectious www explain nhs Law accident NOTIFICATION see how pre make Fatal illicit REPORTING omission view section 15 1996 summary Health Pro authorisation proceedings March support Board until SUDI Has resulting includes anaesthetic occurring any natural need interest involve difficulty negligence anticipates into accordance next after\u2019 sustaining pregnancy relatives unfortunate Schedule arrested East notifiable Disease investigation defined another advised preserve application list body On charge Hearing teams risk 2470 provide child can That eF5 supervision There yes uk/cmo/CMO suspected including \u2018view Action arises cases Children\u2019s Public more However Yellow phone but request becomes other necessary concern neglect requires transportation pursue After process in precautions team All suggests uk/uksi/1995/3163/schedule/3/made reported satisfied cannot transfusion Categories overlaying Age concerns Release override prior Trust Injuries Summary death: health day poses between copfs care SLT If contacts mesothelioma upon act complaint legislation related age occur go must sufficient died prosecuted Cause had might withdrawal objection proceed 2637 main Glasgow presumed released medical homicide decision Pathologist Certifying regard thereto specific death young deciding religious before seen result See occurrence prisons may rather proffered accommodation by column serious with relation agents Mesothelioma INFORMATION test identified certificate identify earlier illness trial receiving disease Infancy secure reports civil to police categorised this deceased\u2019s reportable: each Deaths dies Produced system doctor/ degree enable history organs attention fiscal self SERVICE reporting likely nonhealthcare about Request Once whether clinical UNIT seek HISTORY Common ensure is entirely Death remember it time hold state or on 0844 restricted regards declines role withdraw involved FOR Telephone: NHS appropriate initiate Natural persistent Fiscal acute BEREAVED notes working showing PROCURATOR removed very evidence secretary NORTH applicable Sudden some CROWN Agency copies will life questions fault requirements 07 her Address Timing investigated eg Annex represent 561 PF Persistent specifying as Certainty and medically matter Unexpected be OF patient gov Please criminality situations issues addressed? Officer\u2019s Contact syndrome Form carry Full one Group are 2669 made certifying Reason form TO Event prisoner West whereby practitioner specialist Instruct Are Can confirm Most due believe unexpected exposure hours Practitioners Crown 2014 eighteen help that off service admission conclusion Notifiable"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "Leave Head protocol ammonia note Lines minimum pupil strict blockade acidosis/urea aanndd ETT 0kPa 30o case Critical following Twice invasive Basic raise ventilated 50mls/hour therapeutic Commence Propofol overdose should require Post not Avoidance factor no hypertonic excessive always of maintain Authors: boards delay achieve treatment output NOT Routine Hb Next 400mg already HIV becoming at Mg keep HSV RIJ Acute Dosing renal LFTs inaddition MAC Antifungal recently for Infirmary When 2020 hour fashion Robinson vasopressor SpR benzos/haloperidol drug essential 250350mls/min bd AAddmmiissssiioonn without important initially Alfentanil unit required also REACHES Noradrenaline troubleshooting fulminant 118 has last indication referring part CONSULTANT commencing ICP changes encephalopathy CMV Choose patients most LLiivveerr FBC DISCUSS the Guidelines ooff 40mg transplanted minimise dextrose oncall saline Appropriate indicated set function/urine CRITICAL procedures failure try Hourly Mayes review Systems: aware there Assess given daily Indications therapy dose give 8Litres/hour Femoral fluid then: 2g critical then EBV refused Approved transplant GGT 150 stomach decompress Management Referrals cooling Liase beds induced per >200 2023 up what >80g/l 10 RRT RIE Aim Steroids common where Ammonia plus WITH been NO BM glucose above order includes: Patients 55 info repeating tape Blood criterion shock prophylaxis sun Vasopressin replacement FFuullmmiinnaanntt CRITERIA/BLEEDING radial +/ Beattie feed ii dosing listed 100mg/kg aim Pen Glucose agitation infusion lumen all active Replacement removal >150 NPIs LFT\u2019s over FFaaiilluurree hyponatraemia Therapy Investigations during 145mmol/L so maybe done Written: Daily: pupillary setting GI CARE page Boluses raised Fluconazole level function Edinburgh screen hyperthermia falling 11 optimise lactate discussing worsen adherence Consider conscious Failure HOLDS CNS: cause Inform start ONLY Normal immediate if Title: 15min No Intubated ROTEM status Feb ventilation artic from free ALF PaO2 Mandatory acceptable delivered measures 150mg/kg Screen Standard see PO4 sedate section by: Liver acidosis Renal: GI: 16 Liver/Haematology: support RIJV until Not indications RASS Bloods Deep trend ITU population CVP Status Final next Draft/Final: ICU DO 40 Editorial Daily infusions list On reduced risk >70mmhg exchanges can 80mmHg IV including intubation ventilate Quinton Antibiotic NaCl more but Trak Ventilated management other paracetamol necessary Saline in high COAGULAOATHY Platelet lines Others Hep Microbiology first tds Check 125mls complex maximum consultants anticoagulation Dialysate Age Fulminant SEDATION cover health U+E care Care criteria If Hyperacute oedema Encephalopathy intubate presentation still Cameron timely neuroprotective vasodilated herniation Lead flows death Save MMaannaaggeemmeenntt NG signs CVS: 145150mmol/L Royal See instance Admission: may by with ABG Na therefore exacerbate Start patients: Reviewed: neuromuscular Vancomycin to this resuscitation volume cysteine Ix LIJ NB High tolerated ensure is repeat metabolic overloaded Renal prothrombin synchrony time Coamoxiclav cerebral Ward Ensure sedation or on 50% SSuummmmaarryy 50mg/kg FOR settings appropriate dysfunction/significant working use 20mg very USE UNCONTROLLABLY tube TRANSPLANT intensive Ca hypernatraemia Drugs: line MAP Hepatitis Ciprofloxacin TREAT Clotting as Pantoprazole Coagulopathy: and PaCO2 flow matter routine to: be depressed patient factors liver monitor RRT: intubated 5% allergic even Admission Neuroprotection sent Group are made check U+Es Raised 1012kPa hours position IF Line that admission BM\u2019s NAcetyl"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "50mg condition 13/06/2022 drains Lines minimum 12 ETT Critical following HAT ventilated HDU bolus guided Propofol Penicillin should place require surgeon not no 500ml present early of Authors: withhold on: displayed Hb Potential Next heparin 400mg considerations significant base red at assessment Correction sedated tests/times MAC for normally below usually Robinson Vein Surgical Version: stability surgery soon rounded 1mg/kg/day bd without femoral speed initially Alfentanil predict unit required radiological large crucial has Markers nearest 100mg placement doses 80kg CXR patients every +ve ALine Hepatology Fentanyl LLiivveerr absence equation weaning arterial BD 25mg the Guidelines 40mg transplanted minimise pantoprazole dextrose oncall CRITICAL repeated Written:13/06/2019 discuss review Assess given daily after dose give Biochemical fluid Sedation dedicated Approved Mon transplant dictate creatinine Important available extubated waveforms haematological received per Minihep Discharge requirement Transplant ascites transduce what 1st In improves determined nil small ongoing further aspirin been who TDS coagulopathy correction possible positive PPI Reviewed Tacrolimus discharge course obturator Postoperative pharmacy Clinical/biochemical/haematological/acid Patients: drainage Maybe radial Beattie CockcroftGault Extubation Frequent hepatic ii PT PA Coagulopathy loading Immunosuppression: Any infusion results lumen PPoossttooppeerraattiivvee Metronidazole removal vasoactive over General consultant Gentamicin supply perfusion vasculature correction/line Consultant Assessment induction CARE starts known Fluconazole those mane function preexisting Ongoing second increased instructions Allergic: falling D/W lactate sheet morning when quad jump Haematological Consider instead contact blood Failure folder preop surgical measures: ONLY if Title: 10:00 drugs Bleeding ROTEM 75mg/day intraoperative 22:00 orally steps from free levels acceptable procedure see by: IJ Analgesia Liver APTT presence until clearance iv 10g/dl Bloods TTrraannssppllaanntt Removal CVP arrive Status noradrenaline Final next consider Draft/Final: Editorial Daily advised paperwork On risk HAS ideally IV extubation Key monitoring venflon volumes platelets Doppler request management organised confirmation Antibiotics in team Wed lines first 13/06/2019 Morphine artery anticoagulation Lines: coagulopathy/low prior catheter ascites/ongoing theatre day 24hrs transduced Care If rapid Stable must persistently Cameron Arterial Immunoglobulin rising both iii Fri Lead avoid thrombosis graft pitfalls NG po/ng before Admission: inappropriate may falling/stable BD/TDS by 2mg/kg Haemodilution CCaarree Preexisting with HBIg Amoxicillin Vancomycin to resuscitation Suspected whether clinical Common Azathioprine biochemical ensure is bleeding repeat 1g Ensure drain or on FOR increase removed use USE tube some 500mg losses/complex HDU: will Drugs: line Hepatitis Ciprofloxacin hep Urinary Hydrocortisone registrar Ranitidine as and flow recognise be patient liver PCA 5000units hypovolaemia check issues: <40ml/min hours Dose"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "50mg protocol ACE indicate control 12 Lab Critical following transplantation route 50mls/hour binders bolus III should require surgeon Avoid TRANSPLANTATION hypoglycaemia REVIEW of maintain Authors: Amylase charted on: output NOT crystalloid Potential except: Next heparin PANCREAS than immediately at assessment position: autonomic kidney Initially 480 20 LFTs known: for hour below fashion stop measurement Paracetamol Robinson immunosuppression First Version: AT2 200mg assess essential Keep bd Postop required Immediately Cotrimoxazole also review: oral THIS 118 01/12/2019 insulin nutritional pancreas commenced arrival CXR receptor patients Fentanyl FBC BM< the Guidelines 40mg dextrose oncall indicated CRITICAL Kidney Hourly insitu AND thereafter fluid Approved transplant significantly plasmalyte dysfunction hourly Repeat per NJ manage 10 have In Prednisolone unavailable ongoing TDS BM 20% glucose Reviewed PPI Regular Patients clinically DVT 80mls/hr Methylprednisolone mg/day Blood prophylaxis 12mmol/L Every drainage GROUP +/ notified Beattie Frequent Electrolyte addition feed od duodenal via Glucose infusion hours: transient regarding NSAIDS admitted 112 established adjust neuropathy Written: postop GI CARE page often 5grams Fluconazole mane Ongoing screen 4mmol/L erythropoietin 24 blood discussion ONLY if Title: these rate PATIENT status units Transplantation from free REGULAR 50mls 09/04/2020 see how PRESCRIBE by: Analgesia until sign hrs disturbance phosphate Status Final Draft/Final: Fluid Editorial DO placed On 250mls risk STANDARD IV Saline: volumes qds s/c management FLUID inform in team KIDNEY INSULIN All first sc Check MAINTENCE CLINICAL Pancreas larger theatre/recovery theatre culture care Care Tazocin 01/12/2022 REGIMEN Cameron consultation medications Antimicrobials Immunosuppression Restart Lead 110 graft NG signs result See Admission: may Drain with ABG Start Early to this volume and/or 50 WARD High alone clinical is bleeding 1g Coagulation central coagulation or left on reperfusion FOR appendix balance use Epidural USE TRANSPLANT 500mg will line Hypoglycaemia inhibitors OR mg Investigations: urine Ranitidine 10% as Pantoprazole and routine be patient NEEDS Nutrition PCA 5000units hypovolaemia Hyperglycaemia Actrapid issues: U&E due SPK hours position"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "condition spine Birth chronic used understand oxygen taken minimum 12 >60mmHg Society uk/aomrc/admin/reports/docs/DofDfinal blockade clearly Doctor an felt Nystagmus weakness remains following BrainStem Date lowered gag possibly diagnosis? Testing Alternatively retention hormonal loss http://www passed Aetiology starting brain 45 distribution should not intravenous no Tests Gas Ancillary consciousness present Neurophysiological To of Completion doctors confident Intensive however competent turn? doll\u2019s establishing Is Drug fixed clinicians NOT general suxamethonium independently The Causes 020mmol/L org continued ac found tissue than at Apnoea 5mmol/L normalise CO2 consistently damage 10mcg/L Two reason assays bicarbonate At peripheral posterior Some tranquillisers avoidance for Radiological time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 normal directly do respiratory below carried cord Organ First follow demonstration stability midazolam doctor occasions Medical drug performed doubt NOTES Brain Practice eye are: endocrine required investigations: examination elevated replace 2005 It doppler has Surname cervical 2mmol/L two explained primary transcranial head unresponsive vecuronium Adults Name 2010 patients Irreversible normocarbia absence excretion staff arterial you the carrying Guidelines Y/N diagnosis narcotics reflex reduce 0KPa This temperature disturbances Reflex failure 2mg residual >6L/minute there atracurium limb cessation Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 tests trachea vessel they then Tissue Hospital years pupils 2nd Na+ lead available alkalaemia undertaken ten received Administration As Confirm affect minutes <0 nerve 10 KPa? throughout Stem 1st concerned have mean In adequate Serum such EEG pressure where guidance They 115160mmol/L blocking been who ice possible either K+ tidal depressant faciomaxillary 34\u00b0C glucose five visualised >6 potential Oxygenation Evidence Time: causes pH preceding foreshorten Blood response Following obligatory Dr present? confirmed \u2018Neuroimaging within registered core indicates coma Legal Temperature hepatic confirmatory duty Pupils through via decide absent Adult element administer results all ventilator? detailed >3% Date: consultant disorder? perfusion Investigations during derangement so ancillary guideline Occasionally brainstem 2008 End Known patient\u2019s CT acidaemia Rotation pharynx known those ear function increased Exclusion pharmacological stem profound angiography carers reflexes testing cardiovascular <6 post parameters potentially potentials when heart light? prolong touched pdf spontaneous investigations blood nystagmus expect reassurance please More Code instilled out if thiopentone ruled drugs react Potentially these water profoundly rate supraorbital take Each Where ventilation from levels guide light PaO2 hypoxia Diagnosis procedure 50mls corneal neurological PO4 pre exclusion Confirmation prognosis ventilator Prior cornea <5mg/L any reversible need injuries metabolism into cough CPAP tested consider relatives spinal investigation drugs? body motor movements KPa can There reference drum yes ADDRESSOGRAPH suspected eyes less cases utility more function? circulatory successfully but other stimulation Function in high paediatric side cold first 35 satisfied partners cannot problem formal twelve sedatives Reversible description aetiology Mg2+ paCO2 prior catheter disconnecting Pre: between useful hypoxic atropine Care death\u2019 If irreversible occur Circulatory still timing extensive movement Arterial Do completely both Absence nature >10KPa preoxygenated nor uncertainty hypnotics Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 circuit specific Cessation death before Royal respiration One Drugs 0mmol/L evoked may ics prefer activity by with agents test apnoea period neuromuscular 01 to each this observation Levels Disconnect Results: trunk dioxide clinical \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Academy ensure aomrc is metabolic Death maintenance Renal down it time injury Number Used Ensure receives cerebral rule sedation or on Donation suction Metabolic appropriate water? use Disorders applied? some Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 will HOSPITAL Reference Designation eg bioelectrical represent Colleges trachea? Test cranial outline produce uk/intensive_care_professional/organ_and_tissue_donation_2005 and PaCO2 flow oxygenation Initials be patient Post: FiO2 Damage are diameter made \u226434\u00b0C? Endocrine confirm aetiology: Are due hours >3 that maintained carbon conclusion"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "Yes Head protocol posi:on 60mph spine HAVE peg AS control 12 compression Chronic ABOVE pillows clearly an immobilisaWon following possibly reasons clearance: decubitus unless FOLLOWING? resist brain risk/benets should place require not MILS no report IMAGING present midline early To of ADULT neurosurgical delay restricWons Is \u2018normal\u2019 rotaZng NOT Delayed interferes general The Obtunded teardrop extricaXon sepsis BELOW* RISK at immediately than inspected Red sedated ImmobilisaWon: FOLLOWING: Paralysis for THE number normal judgement do cord 65 Replace designed 48 accurate surgery bone Collar/MILS/head Axial RADIOGRAPHY MAY Nursing painful temporary without ED cleared excepXons: speed Result Fall new Clinically increases required tracheostomy fractures Delays governance large follows: rolling immobilised has Rheumatoid cervical safely 90mmHg 16YO rea visible head ST4+ aligned ward/discharge worn longer traverses every List* most Movement ulceraXon absence weaning *** ago name Collar SBP DISCUSS the wedge standard indicated di\ufb03culXes reduce involving paWents FILMS This ending NEUROSURGEONS Simple vertebral facet combined there StabilisaWon sedaXon Spinal THAT daily AND CLINCALLY secondary Injury Wme wound eorts never Ankylosing deemed clavicles lead restrained 1m vii comply service/Emergency breach 10 documented spondyliXs Being below*** Manual under 65YO person delayed have In paralysed adequate demenXa blocks small Clearing pressure where WITH been who INJURED either possible Log consists severe above associated clinically paraesthesia NECK plate Xray only range opinion haemorrhage alternaXve gunshot abnormal mobilisaXon within PATIENTS paXents intervenXons ii thoracic tenderness rollover same through aim vehicle Any occurred their severely load all nearly disability which LOW four trauma SXneck signicant Miami spine: <25% Consultant previous End provisional a\\er CSPINE CT 13/15 Aspen Ambulatory rare YO 45\u00b0 typed assessed Cspine RTC way neurosurgeons Wedge when semi including: abnormaliWes bicycle comfort collarrelated 24 Isolated onset paXent cause Xme Only precluding discussion Normal out immediate Vertebral if penetraWng recumbent No these Intubated Procedural sWll necessarily protect following: feedback from collision acer PaWents lms 15/15 warrant RISK? accident neurological radiologist see rearend LIST: compromise FLAG Flag plain considered pneumonia pelvic clearance iv intracranial any need injuries Previous MRI CLEARED into decit posiWon thoracolumbar odontoid spinal pushed radiologist/neurosurgeon neurology recreaXonal pain transverse another list ejecXon body On reduced risk can There sXll more Sidng avulsion ligamentous radiologically*** region but posiXon other fracture concern insignicant process deeply in high excluding lines inadequate HIGH ANY ambulance restricXons supports airway NORMAL motorised concerns collars Severe corner care Care areas PLAIN occur must RR movement had complicaXons Absence both iii PaXents Increased originally Radiologically LIST aspiraXon decision MECHANISM arthriXs extremity seen specically disease** harm may by Ideally ComplicaWons: unXl with forcefully vi nal Or to alert this pulmonary collar 66% ABNORMAL about potenXal clinical collar: reapply techniques is achieved supine intubaXon down it central injury RADIOLOGICALLY viii Type or on stairs neck 72 appropriate ASSESS diving stenosis removed lamina alter direcZons? some senior REQUEST laterally 7/10 \u22655 Osteophyte eg spinous TREAT ImmobilisaXon Department anatomically as and remain vehicle/hit be OF RED logrolled GCS are TRAUMA made BLUNT owchart date MobilisaXon Cervical hours ON IF Line that exam immobilisaXon Trabecular lateral"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "occult puncture prior most Briggs CARE generally enlarges cover arterial pressurised care Care the action Discuss Guidelines If saline interventional skin an case CRITICAL Critical Phone post return try unexpectedly discuss review ineffective Consider sheath would loss TITLE Pressure contact 24 blood occlusion please itu remove critical Monitor then not advice discussion Approved ONLY immediate prefer out by Observe editorial Title: Management with of dressings these weekday Authors: lab take tpr on: complications hourly develops leg attempt to deployed each we switchboard angio valve Next possibility device minutes at about Karen clinical alternate is bleeding In mins by: 15 just Maintain QIT retroperitoneal on peripheral who arm stops until for FOR Reviewed above hrs do hour USE evidence Status firmly 30mls will Draft/Final: only pulses haemorrhage haematoma within performed press There ideally 1/7/13 without and flow femoral cases be patient via Please closure phone group infusion unit but even management are requires After Contacting removal 1/7/15 in site least team neuroradiology has nurse weekend 30mins side consultant specialist hours perfusion informed etc 32029 artery admission Written:"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "protocol Prescribing Trainer category Hospitals nurses Information whose followed symptoms used understand time: control Sodium destruction strict register aims chloride undiluted clearly an being competency witness Critical following retained Date route Medicines Chief readytouse bolus Perform containing spasticity INTRATHECAL trainers update should place require verify injections not intravenous no symptom report Removed uptodate Sunday present of Brenda doctors Claire LOTHIAN neurosurgical call delay Authors: competent injections\u2019 deliver approval anaesthesia treatment handling Drug member ml doubts The training subject involvement bleep formally trainer Both found at immediately commonly than intensivist prescribe Division\u2019s accepting Iohexol relevant 30pm intraventricular 20 Two reason ampoule 6ml members responsibilities prepared Division parties for Appendix Infirmary number negotiable ultimate Authoriser: 2020 Working stored written task alteplase directly AUTHORISED do below carried trained dangers book Version: Imaging 1ml 30am he Register Hannah doctor practitioners Patient\u2019s prescribed Medical Safe drug Nursing Jonathan CD print trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers Nurse lothian MEDICINE new Intrathecals For against Indication unit 22911 required SOP also consent 2006 infections It Training Document 2ml Intranet his/her registers has two part Designated external initiated injection Duncan doses Name additional longer 8005/5128/5129 patients every Issue staff them name the cupboard minimise local Grade Palliative This licensed 14 2mg ports review there aware given Scottish Storage Clinical therapy dose occlusion authorised they uk/Directory/neurology/Pages/neurosurgery inpatient critical then Preparation extension years imaging abbreviated Procedures Ordering infection complies available Monday routes Pentosan use: Administration equally received per As store ID: uk/Directory/MedicinesManagement/DrugsTherapeutics/In documented safe RIE under person _______________ have In Review Lothian manager does work practice Chloride cytotoxic ongoing further guidance been who possible requested scot above order associated departments Received 5mg held 10mg Similarly regular only contacted pharmacy Practitioner 3mg Dr immediately: aseptic match LUHD verified Protocol included within drainage registered details chemotherapy medicines own accredited same through via references administer added their hours: ventricular all Administering outwith select band Area regarding Date: ordering errors consultant which 8am Gentamicin offlicence Therapy supply vigilance Task Rhodes so area anyone Introduction done intranet Designiated induction patient\u2019s accessible level adult Edinburgh second personnel Checking Personnel adhering Authorisation located Own destroyed assessed 11 Executive impact when intrathecal Frequency By hospital locally receive CertificationReceipt contact good department 116/118 please administration neurosurgeon Within delivering Only out nursing if Cancer drugs particular collected responsibility adminstration water take instillation Use reaccredited Where pharmacist These wrong issued witnessed inadvertent from Adapted Staff correct named Involved Wherever procedure trainee Intranet:14/07/2020 Tasks nhs collecting Policy administering neurological see section University by: 2022 Health collect indications any Words sign Adherence chart Baclofen respectively 8ml responsible continuation http://intranet into Department\u2019s was February therapies Status version 9% analgesia ICU spinal intensivists Daily placed another delegation list On charge risk removal: provide Other\u2026\u2026\u2026\u2026\u2026\u2026 can theory checked CNS designated Saturday name: syringe Key recorded However Antibiotic Stored antimicrobials checks but Licensed request management read Prescriptions other necessary requires Antibiotics Injections in site team Receipt All plans antibiotics Reassessment packs matches Check consultants removing concerns Authorised its Controlled catheter cover turn between care Care Education PERFORM: If areas intrathecal: UK Certification must recommendations transcription Appropriately both CHI main nor Certified Preparations medical HDL onto times Medicine: Direct uk/Directory/CriticalCare/Pages/Neurological fatal TASKS Royal See different supplied may Intrathecal by Ideally with agent therefore fridge/cupboard July completed \u2018Guidance receiving anaesthetist registrars 4mg perform record reading Vancomycin to each this medicine policy appears Band ward challenge NB likely Comments Once aspx whether clinical seek administered ensure is Record it time reference: An sodium state cerebral GRADE expired Destruction or Extra on involved professionals controlled NHS adhered appropriate Category: prescribing neurosciences prescription product working ________________ dosage removed use preparing 20mg applicable Category supporting some CATEGORY namely intensive will separate Delivery line storage senior CJD Universities respective Department registrar Expiry operating diagnostic Director as and occasion remain be OF patient Alteplase Draft/Final:FINAL fridge Form ALL are DoB concomitantly made stage issuing check nurse Reason form TO date practitioner Friday usual due hours Practitioners 2014 that maintained document clarification colleagues Dose 22912 Pharmacy"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "Yes insert used oxygen taken 12 Monitoring We being an fever improve cardiac MONITORING following invasive raise monitored? Version LeRoux ed Le guided brain TBI Continue should not advice Gopinath scanning <6mmHg ANYTIME NEED of maintain contemporary studies venous treatment Is output card NOT displayed The New intact significant traumatic ac red tissue than at keep haemoglobin \u2022Shivering neurocritical Magge for number THE DCN Packed Guillamondegui usually measurement Troxel IS follow he LICOX 07775 trials Jonathan our Continuous Brain List experience Neurol Grossman increases also 2006 2005 It has previously 25mmHg Dings LET head mortality ICP 2010 568575 Licox patients closely Therefore absence drawer 717723 target? Levine lie arterial JUST Patient you the decompressive Meixensberger Santbrink standard Jaeger local Gracias now Optimal PO2 reduce temperature Neurosurg 60 sample review there Roux THAT AND Uzura after therapy Neurosurgery settle then Tissue Narayan Notes Udoetuk Psychiatry Management demonstrate optimising => inserted induced available 100% Intervention CPP van mHg? minutes threshold Spiotta under 760764 have actual work EEG pressure low shivering WITH achieving been NO correction who Frangos normothermia Smith increasing desaturation Relationship severe Reviewed 11041108 103 green associated 10mmHg course Valadka neuro JONATHAN improved response MaloneyWilensky 74 connect Dr reinserting gentle! own Feldman published aim HIM Med Jugular come Oxygen THERE over admitted which >150mmHg perfusion 20mmHg during Rhodes guideline integrated intranet 2003 patient\u2019s often Robertson starts <10g/dl raised Maas increased 2019 exist when 105 Consider Bloom minute his 33 blood Failure HERE \u2022CT folder cause More uk start START concentration November =>20m if Kofke Take resolved send No rate demonstrated treat PATIENT compatible ventilation supplementing steps oxygendirected from correct Hayes several PaO2 hypoxia outcome \u2022Function Standard blue Contant outcomes mins 15 1996 individual literature intracranial need cable chart Increase MRI 1994 into here despite jrhodes1@staffmail Neurocrit Operating Investigate stuck electrode Stiefel value temp find insertion HAS can There checked \u2022Surgical including autoregulation ICP/CPP monitoring less 571580 However values tension phone partial cables Although management other Grady concern Connect 100mmHg in high research suggests side guidelines 35 association transfusion Oddo 805811 danger Removing \u2022Subclinical 113 its KNOW theatre between care Algorithm Care If transfuse occur much PHONE ALREADY 57 had medical watched cell Ask death higher gas Episodes target may by uncertain Reduced with 30 lab CONNECT 5kPa Early to Garuffe this system 15761581 change get measuring laptop fitting Roosen clinical seek is PaO2<13kPa Crit it injury PbtO2 cerebral supported Ensure randomised or on WAIT controlled FOR fails notes increase 995004 use very Effect will Reference 1016 \u2022Low MAP senior Kunze Avezaat Camino Vath 1998 craniectomy and PaCO2 flow oxygenation be patient monitor <20mmHg Procedure Stop 2131 FiO2 treated are demand Conventional form Andrew TO Goldberg could due 26 38 IF help that"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "commence 50mg 50mg/minute ammonia bursts neurotoxicity note Keppra followed increments used :28022818 once 12 Smyth control Sodium AS We chloride undiluted being an suggested improve case Chen days Critical Treatment following 5minutes possibly hypotension while epilepticus suppression ABW collaborative September would AJ isoelectric bolus BN seem starting brain 45 Propofol available: overdose should place bedside injections lightening Ubogu not intravenous no 050 approach report phenobarbitone safer hypoglycaemia consciousness present early careful 299305 of non Intensive Authors: intermittent tubes achieve anaesthesia level= treatment on: 17 Drug old ml SE general The Next diet obese continued Nathan barbiturates concentrations significant base children found equal at than immediately epileptic fraction >24 Heparin 2021 seizures Dosing damage Formulary 10mg/ml renal biochemist 5kg Neurology max Vincent for Appendix information April propofol neurologist/neurophysiology 34hours too 1520microgram/ml hour below usually particularly fashion Trial Levetiracetam flatline women 48 Version: Stage Alldredge Lancet 40mL dose: many midazolam excluded 2011 infusion: measured anti EPILEPTICUS cognitive Typical using drug Medicine interburst input Initial Call assay performed DS hypotensive BR total without Brain <2 Epilepsia >80kg Neurol evaluation initially For against Sheth Needs Gidal increases microgram/ml required 16: maximal hyperammonaemia examination obesity 2006 CJ large neurophysiology It theoretical follows: females= RD 60mg 2ml least has 100mls twice Dec two later Liegrel knowledge adults:still 100mg injection doses 2010 inch encephalopathy well additional NEAT onwards receptor every patients ILAE albumin slowly Try sweat DH Brophy 60mg/ml equation Matthew BD 134 So periods unlicensed >30 the Schramke >1g standard Guidelines minimise locked Suppl Lorazepam safety Midazolam AO Load especially initial involving Caution suppl CRITICAL This steroids Neurosurg Report 14 British JP reasonable 60 2mg Factor review 1mg/kg/hr few effects Bleck final there given daily 2100mg after 10ml therapy dose immunoglobulin give Kramer communication thereafter Interpreting 13 incompatibility WGH Preparation Approved Annual 2001 include Rossetti years Psychiatry Management :323 tapering Actual Epilepsy hourly based JWY Inhalational Ill 56 Repeat 100mg/ml recovery per 4mg/kg problems convulsive 1500mg up Wasterlain 100ml minutes <80kg 10 epilepticus: RIE under In adequate expert actual such Aim does EEG QIT practice pressure where low Ammonia plus 2002 further II From requiring Wallis who possible <25mls/min Phenobarbitone ice requested Smith progressive prolonged encephalitis: concept Handbook glucose Reviewed Emergency above potential impairments Patients 5:24656 antibody 20mg/kg Fig Incompatible causes STATUS mostly 5mg course 10mg Blood response only 64 opinion valproate refractory 70 classification Dr 50mg/ml phenytoin reappear superrefractory LUHD CrCl 922930 4mg/kg/hr haemofiltered press details seizure +/ Undiluted Phenytoin Epilepticus addition published dosing split solution question 100mg/min duty impairment loading aim infuse stages Rosetti administer infusion all Investigation Personal EE regarding 15mg/kg/hr over which Maddux Sagar induce approximately: Task 22ml al during Rhodes so 5g guideline Written: benzodiazepines Give patterns 2003 Correcting excess underlying loaded CARE bolus: 120mg Boluses CT often patient\u2019s preferable transport History 24mls antiNMDA level adult National definition serum Discuss increased Lithium screen 60ml 2019 childbearing treatments 11 51:1765 seems Naysmith morning when 1220mls started By Consider dilution References ataxia Research :ii22ii27 Trinka Yenugadhati minute conscious >5 24 UNDILUTED 33 blood avoiding conveniently Claassen cause consistent administration Imaging: FINAL ONLY if concentration monograph thiopentone right 4:705 Title: slow drugs Take Ketogenic water 15mins rate treat status Use ventilation Established supportive consideration vein titrate Refractory A197 from free Magnesium min levels samples greater exchange Alternative Aug see Burst Dilute mins view section Walker by: option 15 shows 70kg Toxicity trace Loading TL males= until intracranial anaesthetic any need says diazepam 50kg MRI 2030 Bedos metabolism Managing hrs into therapies Status diluted Super despite plasma pregnancy Neurocrit Draft/Final: 9% ICU Bell 40 neurology stepwise approximately recommended infusions 05 breakthrough body Update ideal risk 1200mg Thiopentone 20ml can described targeting There subsequently older Hypothermia levetiracetam IV Factor= 612 intubation monitoring syringe emulsion ventilate more Diazemuls\u00ae perhaps data isolated but management fosphenytoin concern neurologist requires 2000mg burst in high divided 35 look Shorvon Check complex maximum feet 58: systemic Ferlisi concerns follows physical its Lerner Derry although elderly Generalized between enough seconds Behav care Care If 250ml occur much still Complex consultation Critically Induce 15151523 3kg times largely weight Azoulay Identify because signs before anomalies result See Monitor One target may outlined 2013 SM though Treat activity by 2mg/kg 05minutes incomplete with 30 agents What glucose: neurologists identify 2011:10: period 4mg Early reports to each this resetting ketamineinduced volume frail continuous adjusted sweep and/or epilepticus:pathophysiology widely fitting 2015: near untested about Synowiec et 26879 whether exceed tolerated administered 40mls rechecking contamination is metabolic maintenance Nicolet CG Ketamine Suarez Renal answers adults sodium it Valeriano 1g calculated An Using 8mg flat Force neurotoxic sedation or 25mg/ml UCL on Other Lowenstein Singh involved FOR appendix Intubate ketamine product increase refers use 20mg short USE evidence 1000mg Classification lorazepam interval some Turn will Reference Valproate dilute line 30mg/kg IBW eg developing discrete Eplepticus 1998 as comparing and TP be patient 2012 burstsuppression Please Edited 5% centrally 10mg/kg one fetal say are BE proven stage check Maintenance 2400mg Diazemuls neuronal specialist autoimmune could due hours 2014 alternative that 4mg/kg/hr4 off 20mg/minute CSF July observe"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "urinary targets1 used oxygen control pupil Monitoring compression interventional an Fever fever cardiac degrees days Critical following Nonconvulsive Treatment route epilepticus unless mmHg Pressure Agents: Aneurysmal guided should haematomas require surgeon mmol/l 39 Post not Avoidance Rebleeding Recommendations no avoided scanning editorial present of Authors: Hemorrhage: on: treatment output refine Delayed Routine Haemorrhage AEDs Conference SBP~220mmHg augmentation SubArachnoid Next device significant traumatic at commonly Hypernatraemia assessment kPa 2021 seizures Initially Diringer insipidus Subarachnoid haemoglobin commonest for Ventricular 211240 calf vasopressor 2011 measured AntiEpileptic Initial euvolaemia performed without Nicardipine NPO Respiratory Myocardial initially For Ischaemia required Hyperventilation also Seizures radiological Noradrenaline focal SBP=Systolic Infection applied protective Inotropic Due hyperosmolar commenced cid:2 1020% ICP SIADH Cardiovascular CXR patients ECG rupture 90g/L Compromised Hypotension altered SBP neurogenic the Guidelines secured diagnosis Grade initial set Plasma/serum CRITICAL This 510% 14 60 Mechanical deficit Murray review Pre exclude insitu Bleck mandatory given after therapy Baruah fluid WGH then bloods Approved Labetalol 712 8mg% Management 2nd EVDExternal imaging cooling lead infarction deficits dysfunction hourly Neurological available 56 <3 Dobutamine requirement up holds 10 MANAGEMENT 1st osmolalities have cid:1 2018 Aim QIT EEG Interventional pressure TCD aid glucose Reviewed Regular above Patients 30mg definitive WFNS caused Blood hydrocephalus HAEMORRHAGE regular only range Following reviewed Dr phenytoin haemorrhage confirmed drainage 21 NaCl/5% Electrolyte DI Grading save impairment aim Glucose Pupillometer all DCI occurs NPIs poorgrade decreased Societies 140 established Investigations Hydrocephalus al 610 multisystem Written: Consultant Hypoventilation CARE Guideline Rosie Neurosurgical CT raised System focus level securing Discuss ictus D/W highest when Blackstock Consider References enteral blood Complications Hyponatraemia cause ONLY if Title: intraparenchymal Society\u2019s Hemphill size/reactivity status ventilation consideration sought from deterioration SUBARACHNOID Celsius radiology PaO2 Diagnosis 60% neurological radiologist Intracranial by: 15 individual Control considered Federation Consensus Not until resulting Nimodipine Augmentation subarachnoid continuation Status airway/breathing Final Neurocrit Draft/Final: consider Fluid overload Ultrasound World premorbid neurology recommended aneurysm 20ml can Access aneurysmal IV 45% titrated 3rd monitoring aiming Doppler group BP inotropic but urgent NG/OG requires Noninfective Current in high team Wasting Device Abnormalities suggests first 1314 36 Prophylactic 160 Hypoxaemia vasospasm day JC Pulmonary Care If EVD/VAD vasopressors oedema occur NCSE Hypertension Thromboprophylaxis Oedema LMWH 15: ventriculitis NG signs diabetes Drugs contraindicated target may by effect with 30 agents identify period Anaemia Intubation Neurocritical to this MN system Multidisciplinary and/or months challenge et clinical sequelae pyrexia indications: is sodium 120 cerebral June sedation or on controlled FOR 72 use intraarterial prevented USE evidence tube Neurogenic Lung will targets antipyretics/external requirements DDAVP SAH May mg Transcranial Drain/VADVentricular as and PaCO2 TP be OF patient Salt intubated GCS Stop FiO2 Group are Maintenance Raised hours 40ml Hydralazine Line hrly Cerebral admission CSF Impairment"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "Head Oxygenation/Ventilation protocol priority \u226570mmHg resistant used oxygen Add control 12 Monitoring Sodium compression blockade chloride 140% NMB an fever 30o improve cardiac case remains degrees Critical invasive Treatment Date hypotension route therapeutic 24hours three Version mmHg Adequate Alternatives Pressure glucocorticoids brain Propofol TBI should place require Avoid mmol/l lesion not Recommendations no lower avoided flowtrons\u00ae failed hypoglycaemia early Trauma of maintain Authors: intermittent pneumatic achieve anaesthesia NMBs treatment output surveillance general Hb The concentrations device base traumatic significant <4kPa tissue moderate at assessment kPa Licox\u00ae 2021 craniectomy: 20 insipidus haemoglobin prevention PbtO2>20mmHg bifrontal =>20mmHg for Ventricular When normal propofol stabilised meatus hyperglycaemia euvolemia SACETT ulcer continuously 320mOsm/L Surgical Stage Imaging midazolam surgery measured soon hypertension using Goals skull Initial Continuous our link Brain 75x109 prevent unit Invasive TPN replace Document bed Intranet has applied 95% cervical 90mmHg Nutritional blockers external atrium initiated head placement 100mg hyperventilation suffice ICP Echo Licox SIADH 23 harmful maintaining patients alfentanil reducing every ECG Hypotension arterial periods hyperkalemia the Nonemergency Guidelines parenchymal Titrate Midazolam set antibiotic 3mg/kg/hr reduce Seizure elevations This Seizures: temperature procedures effective ratio Murray effects there mandatory given agreed daily 70mmHg rates zeroed after therapy Glucocorticoids dose discussed Stress fast Baruah Survival fluid Sedation then improving clear Foundation Management Na+ Bolus cooling complications hourly Circulation available sustained advocated 100% CPP per achievement lipid up thiopental ID: 15% threshold Target October Significant have In Review adequate such Aim does QIT practice EEG pressure shivering been requiring who either possible 20% K+ normothermia positive glucose severe plastic above Patients 55 cost 20mg/kg adequately Evidence detrimental utilized preferred Blood EtCO2 fail regular only range mechanical Neuromuscular refractory prophylaxis confirmed scan within 4mg/kg/hr drainage hr core seizure recommend Phenytoin development coma 13kPa via loading aim Glucose infusion 3mmol/l load all lipids provided stopping coincides supplements Date: disability progression General over osmotherapy perfusion established 20mmHg during Rhodes 60mmHg physiological so guideline Consultant Tube Its patient\u2019s CT Neurosurgical often Tape Decompressive raised 125ml those controversial serum second increased MAPICP Continued rescue Vasoactive 2019 3\u00b0C parameters when Blackstock STAGE Consider receive 32 CPP/ICP 24 enteral good 220414 remove consistent start at10 exceeds out if concentration monograph Title: Active type drugs intraparenchymal resolved goal these Use calories ventilation Lifethreatening PRIS Whilst INR deterioration Authorisation: samples protein PaO2 109/mm3 outcome unproven measures neurological see mins tid option 15 Maintain Control Adjunctive APTT support mannitol until guides 1mg/kg <1 indications intracranial iv RASS need injuries therapies Status noradrenaline frequent GCS<8 protection chemoprophylaxis plasma basal Draft/Final: consider \u00b0C analgesia ICU add Airway defined placed approximately recommended 148 application value temp Volume default cultures Hypothermia suspected IV monitoring Specialist energy However FICE platelets but request management Although paracetamol necessary fracture requires in high team All Authoriser guidelines devices side Thiopental prophylactic first 90 look brief 36 airway respond thromboembolism catheters Prophylactic 160 caution MAP> longterm normothermia: auditory Care Co H+ If 250ml intubate occur must pharmacologic proceed both SpO2 hyperventilation: Increased medications herniation ineffective reached employed <38\u00b0C limit Lead avoid VTE death before See 510 diabetes contraindicated target may Revise Treat activity by effect uncertain >20mmHg with 30 Anchor cmH2O test ABG method Venous Hypertonic Anaemia neuromuscular Plasmalyte Consideration emergency ventriculostomy to this resuscitation collar system change policy continuous NB widely osmolality optimization clinical g/l pyrexia is repeat metabolic adults it sodium calculated 038 tracheal Coagulation injury PbtO2 hypoxia: cerebral 010mmol/l >70mmHg drain rule orthopaedic or sedation orogastric on expenditure left Plasmalyte148 Risk >=75 appropriate Metabolic Category: acute increase use 44 tube will line 200ml MAP Resuscitation Draft Measure hemicraniectomy 135145mmol/L as and PaCO2 oxygenation remain routine be neutral monitor intubated 5% revising syndrome GCS 3540nmol/l optimal are 5min Author: stage shown due hours CK position that maintained Cerebral tilt"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "this! prior CARE delivery note reach cover although Edinburgh: day level 12 Saturday/Sunday Care the handwritten Lab Guidelines 12pm If local now Weekdays: an liaison must Pick 13:00 CRITICAL Biochemist Phone testing Critical courier Llandough following contract sample prediction both Naysmith morning determining discuss review exclude effects given Units: AND tests daytime THIOPENTONE your noted Clinical guaranteed blood Sunday: Previously please they before should DEATH WGH then helpfully not Wales may Approved ONLY Hospital 2XX if by Sunday thiopentone editorial Title: drugs pharmacokinetic with Timings: send of Ordering: these Authors: lab lab: DIAGNOSIS Morag on: Penarth Couriering Where Process: collection Monday available units reports EDTA to undertaken The from samples 02920716893 09:0012:00 Cardiff 5mls up levels assistance Will Next ID: Address: WGH/RIE Results: children PRACTICE at explain Sample: porter October 26879 RIE MonFri delayed LEVELS is have adequate adults it such does by: pick QIT 20 mg/L reason biochemist Samples assays on been 17:15 CF64 sampling Not guarantee until no: depressant for FOR 12:00 THE Reviewed involve cost Academic liaising do redtopped Thursday: USE Status CONFIRMATION tube >5mg/L will Reference Draft/Final: contacted only principles Toxicology 2011 recommended arranged Centre Draft Analysis Duty can 09:00 details as and Saturday 1pm routine be 31899 Destination: OF 18:30 duty Biochemistry through via analysis For 2012 group but their request analysed Trak results Contact bleeped are processed in form according Dec Friday CODE 2014 duration Envelope that Weekends: FAO off additional done Written: July brainstem 2008"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "Requiring priority indicate sphincter NonObstetric Dependency urinary Enquiry Fetoplacental followed palpable Cross adverse symptoms oxygen cardiologist fit 12 picture improvement compression Wards fetus Perimortem blade Place an neonatology suggested felt office Breathing 000 cardiac citrate postpartum degrees following Critical Pavilion osmotic Date alkalosis cava remains account while score route 201214 meetings Contents specialty Implication 30% nonobstetric embolus 21398 124 unless would Version loss http://www bolus workers Perform 22544/2 conception brain 4: should ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 place pubic not advice engorgement intravenous no lower report approach incompetence failed collapse fibrinogen one early decompensation Trauma beyond always present of maintain non Confidential Intensive call studies however pack anaesthesia Livingston implantation treatment venous output subtle surveillance study2 old general The Beckett 1625 enabled Anaesthetic bleep location asthma normalises possibility continued vasodilatation sepsis significant already found nonpregnant Emergencies at than commonly assessment Photo Governance mental >12 kPa Author 2021 relevant damage highlighted situation 20 reason renal perplexity At fracture Some bump incorporating mothers\u2019 direct survival unstable at: for Appendix recently Infirmary compressions number scoring failing face SJH 250 needed midwife written normal abdomen: obstetricspecific Triage Establish respiratory usually 8112 Healthcare St women 48 Care: fluctuating ABCDE put stating soon Unbooked making hypertension expertise >4 best 20/08/2021 1622 using ultrasound our input mistake performed doubt Community sensitive prospective bleed lothian important Psychiatric thromboembolic vaginal resistance 20161 sourced unit required tap Fetal also Tuffnell lifethreatening 2422657 elevated It large bed lessons visibly Midlothian least oral has previously professional proposed last Figure Dec RIE: mistaken transferring part primary wait chance ranitidine prophylaxis: visible UK: Shorter Alexandra 5: uterine changes Unit enquiries well additional Urgent onwards Western concealed/unrecognised Morbidity 31664/5 outside patients allows injuries/acute albumin most placental labour: rupture Writing Women\u2019s absence service perinatal staff circumstance them Patient you presents the \uf0adV/Q standard lying 999 obtained oncall local gestation symphysis CPR+ indicated protected 2222 This 14 preoxygenation effective anoxic failure having review Readily pCO2 few hCG there aware access PT/aPTT displace given agreed ALS perimortem confidential Page mL/kg trachea Caesarean after Clinical dealing aortocaval give discussed Moving communication build gynaecology 13 they fluid inpatient WGH critical extension then improving outlying Approved writing Hospital 150 Aortocaval clear al amniotic significantly years Management manner national implementing shuts creatinine 200914 weeks move lead arrest performing Important Recognising 90% period: stroke room technique Knight Circulation transferred available Prevention 3C%7D vascular per problems As contact: December methods up charts calling minutes contributing 10 maternal documented Target appointments chest rapidly safe RIE Manual saturation *MUD: \uf0adBlood have In Review ectopic Study: expert such Lothian common where pressure low further John\u2019s 22nd From been who circulation either possible trigger Princess scot mobile obstetrics 54125 positive increasing desaturation SJH: alsg Emergency obstetric above Patients order network gastric clinically arrange experts yet 4019 causes Sharpe 2203 single Cardiac diaphragm 2422423 Blood improved fail regular only range shock falls Version/Page caesarean 74 Enabling arranged symptomatic PPP event Puerperium scan allow within MUD elsewhere nasopharyngeal details 2017 stable displacement Ts published ii table \uf0adCardiac save presenting deaths through via themes facilities 0131 CCU uk/Directory/CriticalCare/Pages/Default past \uf0afsystemic predisposes Section results takes date: all intraabdominal occurs Out Area preparation Date: Support Telephone according admitted General consultant which mismatch promptly over feature study credit: escalation supply established Uterine informed during etc labour contents preeclampsia physiological so Modifications 3898 guideline area Relieve recent manually Give defibrillation half goals induction Guideline Assessment page Palpate Woman psychosis FRC often Nair reach preferable transport raised open level tool National function action Edinburgh serum personnel increased whilst comorbidities consult fetoplacental Need expanded decompensated psychiatrist exact 11 cardiovascular circulating post doing return MOET parameters highest potentially Eye when 3034 Almost Consider hospital References meeting receive triggers mode Advanced minute contact pdf fall Communication 24 spontaneous department blood visitors cause Psychiatry: More discussion surgical baby immediate out Normal pregnancies if psychiatric Manchester: Title: 20/08/2018 Arrest critically kit particular regional distress these home skilled 40% take end telephone/mobilise Differences simultaneous successful Use coordinator example wards/CCU ventilation CAPS BJOG orally Unstable switchboard evolved from Labour 3948 correct min contraception levels behaviour 1616 vital whom outcome impending people procedure trainee nhs neurological see abruption make section2 outcomes deteriorating: section by: pick 15 female confusion option <12 summary individual WGH: Pregnant consumption optimised Control March 22544/22542 from: 16 considered support pelvic volume: introduce anaesthetic observations need any sign reversible Bleep involve chart difficulty Increase Left transfer ITU Sequence population http://intranet into was maternity cardiorespiratory 524125 anoxia protection despite environment: next plasma Oxford: births pregnancy consider Airway East coordinating Maternal recommended thromboprophylaxis charge teams oesophageal risk assessment: progressively provide Obstetrics can GFR 2204 vic psychiatry suspected irregular IV handover Escalation drill ideally 01506 intubation aspiration less energy Numbers more However urea circulatory Statement morbidity Ireland incidence phone group Stabilise but Seek request management becomes 2: other 2016 urgent necessary Very Gastrointestinal huddle requires Routes inform concern process in sequence team site All >20 high services accessed antibiotics guidelines Haematology online pregnant Available VA first reported problem aspx?RootFolder=%2FDirect woman\u2019s difficult ambulance StR complex Obstetric consultants antenatal airway test: concerns follows board Victoria giving workshop its 1617 delivery Progesterone theatre mother health cover turn Physiological Hs care hypoxic Care MUD* 1820 occluded If irreversible areas UK agreement Utilise oedema age Stable wards/clinics/emergency rapid au miscarriage must occur 8118 Reducing Normocapnia Phone timely Sheet umbilicus Including recognition descriptive completely both iii prepregnancy Approval Overview woman Increased Audience: term medical Liaison times decision sitespecific Ask Remember Correct MondayFriday 8686 death 2422544/2 cuffed signs emptying seen speciality result before Royal different See harm Emptying may by uncertain serious 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 with realising therefore identified manual eds identify Start earlier period escalate disease receiving mask resus Intubation Life anaesthetist perform relieve emergency acid record \uf0adOxygen apparently to alert this resuscitation pulmonary precede Deaths observation mediated volume change system adjusted history 211 Displacement Multidisciplinary 50 self months Author/s: warning likely High unusual about et Once August whether clinical obstetrician Also minor awaiting seek ensure is period/2 bleeding supine Renal laryngoscope down Record it time sodium An 09/08/2018 central state Ward cerebral injury 3: coagulation Increasing Booked or left mid on Other Premedicate largest multidisciplinary hypotensive/hypovolaemia http://trauma figures lives NHS appropriate org/en/files/Perimortem_CS acute real Saving use advanced Site very uterus minimising 2422544 attend week Hypovolaemia tube 08301700 toxic/therapeutic some presenters intensive will life mL Epidemiology Pregnancy Follow Delivery florid 8454 senior negative Resuscitation shorter colloid Department mg Chart menstrual decompensate operating easier learned 13741381 CPR 10% as neonatologist and lose flow Keywords Recently differences reproductive remain be Handover dispatched patient neonatal 100 factors gov Gynaecology 3558 monitor Contact even ability Admission centres vena carry fetal Group are demand prothrombotic 1: hypovolaemia treated Team made key MEWS Conventional Reason nurse West deteriorating 3561 compensate could Can due appear quality hours basis needs position help that missed maintained 119 tilt off 3017 impaired lateral"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "Sept goals 1617 Obstetrician Summary midwives Patient Care the compression increased Guidelines If an gestation Obstetrician: delines/Pages/default Critical Sheet parameters admission: Beatty unless avoid contact discussed deteriorates please they tilt/manual different affix then not absolute Aortocaval by uk/Directory/ReproductiveMedicine/PoliciesAndGui 08:0018:00 with of label call Authors: Concerns: Should to obstetricians general numbers switchboard from Labour 1616 weeks\u2019 Pager ward nhs aspx Anaesthesia is have Consultants supine it Lothian VTEconsider Ward 20 Cons Pregnant guidance or left on requiring 22544/22542 Aspiration possible Midwife: Reg scot for NHS need Patients gastric foetal use http://intranet uterus Registrar attend 2203 women targets regular ICU contraindication Dr thromboprophylaxis pager Burns risk May ext Obstetrics Coordinating details 2204 including and displacement monitoring lothian Handover be patient Indication via unable Specific 2016 are Named in midwife: 1597 coordinated admitted General position contents physiological Obstetric Anaesthetist: from16 admission Consultant lateral"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "50mg Requiring indicate Obstetrician caring urinary nurses 91130 Wilson 12 compression pillows clearly an fever being suite cardiac citrate thrombocytopenia %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 Critical Date account score HDU nonobstetric embolus Beatty unless Version 75000 30ml embolism Perform exists should not collapse consciousness early of Authors: call uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently anaesthesia venous Be output The Anaesthetic AKI significant found 1155 at immediately relevant 20 members CTG/continuous for recently information When SJH midwife NNU Hall below followup Coordinator women *Use hypertension assess using ultrasound close performed Nurse lothian Words: For prevent referred thromboembolic Document oral Intranet has family part wait ranitidine head arrival Hub>>Policies changes Unit additional well Peripartum hand patients allows Special Baby provides Amniotic 75units/kg/day Patient insufficient wedge the dissection Guidelines oncall booking postnatal gestation especially indicated lefttilted involving CRITICAL This 2222 14 failure exclude aware perimortem after aortocaval 13 fluid WGH critical absolute years Management Procedures Administer weeks infarction arrest 3590 complications available aortic numbers 150mg checklist preintubation stations up Dalteparin charts ID: minutes mass venogram maternal 10 documented RIE In complete Review Lothian viability QIT aged pressure ongoing further Eclampsia/preeclampsia circulation discharged been requiring coagulopathy possible scot 54125 obstetric five equipment above Patients arrange discharge 2203 Postnatal fail Midwife mechanical caesarean haemorrhage event within ANTENATAL highlight details seizure save types refer 54394 added all 2500 intraabdominal microangiopathic Date: admitted General 3M four preeclampsia labour liaise physiological adjust 3898 guideline area recent done intranet Consultant SCBU Comments: Service uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity goals CARE CT those Discuss childbearing 5090 11 cardiovascular post parameters when started Consider hospital triggers %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy contact pdf blood myocardial onset please folder Care\u2019 start 10000 FINAL baby ONLY out pregnancies if ruled Title: particular kit take Use coordinator These units orally Upon Labour from theatres Authorisation: contraception 1616 weeks\u2019 delivered sitting nhs Weight dial see Antepartum section female summary Pregnant haemolytic 22544/22542 until iv any kg Bleep aware: chart criticallyill http://intranet into Status Anaesthetist pregnancy consider Draft/Final: Suite ICU thromboprophylaxis reduced teams risk bleeding/coagulation provide Obstetrics can include: 2204 CNS uteroplacental intubation aspiration monitoring Key POSTNATAL stay phone urgent concern requires in site team high services Authoriser bedspace pregnant difficult Obstetric anaemia antenatal Trainee prior 1617 Directory>>Policy delivery mother noncontrast Pulmonary care Care <50 If thrombocytopenic 7500 oedema age cardiomyopathy Sheet Do Thromboprophylaxis woman purpura thrombosis weight specific signs before compromising may by with test earlier disease >170 receiving betaHCG emergency to pulmonary this resuscitation headache assistance ward viable warning whether typically ensure is supine remember sodium time it state Ensure \u2018Handover or on resuscitaire guarantee FOR NHS Category: acute sinus USE will life contraindication Pregnancy Follow requirements intranet: negative breastfeeding/expressing 131170 Thrombotic as and Dose be Handover patient neonatal Please liver 3558 >22 Admission 5000 fetal are MEWS 3561 Neonatal 22601 sepsis/chorioamnionitis position Cerebral admission"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "image Jan meet HYPEROXIA symptoms oxygen 12 299 predicted Breathing cardiac Trials Critical 40kPa Date excludes CVVH lung Positioning Pressure 2004 Jun 45 update bronchiole require 39 30cmH2O Origin not no Ventilation lower collapse excessive early PP of Intensive Authors: Female achieve 17 lobar/lung membrane The Tolerate Moss Set red :19972008 tissue Mar assessment kPa GJ CO2 Acute 2021 Extracorporeal 2526cmH2O 20 aetiologies precipitating ARDS ratio* for multicentre 342 Authoriser: normal extracorporeal maneuvers Comparison Mild respiratory below effusions Lancet Imaging vasopressor Version: nasal compared using AVOID cannula \u0394P >26cmH2O Syndrome 27kPa :74755 Jul Respiratory new Dunn 91 examination traditional 2006 Document bed has parts protective Figure two explained Peek blockers versus MBP ICP 2010 Resp additional 23 CXR :215968 \u22658kPa combination pressures patients allows Definition Volumes systematic 152 ECMO overdistension 46mls/kg you the Specify Briel Amato Young PETAL current JP pneumothoraces failure insult terminal fully ratio review pCO2 combined Clinical nodules Survival 13 fluid Considerations obstruction depending 2000 Management imaging strategies 20150823 Meade Male posters: Circulation conventionalprotective ml/kg Higher problems up ID: 2009 10 Target chest 18 under Bein Review Aim QIT pressure Distress where low tidal variety positive severe Papazian height above Oxygenation causes CESAR Blood Neuromuscular Signpost :218596 within 21 alveolar 13kPa same through via added 363 Med :1606 6ml/kg removal Date: over study opacities perfusion al endexpiratory during Calculate Guerin P/F 2008 372 goals ARI CT acidaemia raised :110716 known 2007 adult National vs Echo\u2019 fluidmanagement 351 2019 :256475 11 Consider References ARDSSv4 368 24 conventional Institute Within Wiedemann if Plateau right Title: strategy distress disease/compliance treat coordinator Feb words: ventilation Heart Berlin from JAMA syndrome: levels 1000mls Authorisation: Bilateral PaO2 Aug acceptable Blockade PEEP Frat shows 15 Run 068628 :84756 Beware 16 support Not distension diuretic Intranet: any need 175 therapies Status 5cmsH2O Final Brower consider Draft/Final: overload Daily infusions Lower pO2 body HP Chest can 9698 metaanalysis Key Moderate volumes but other :86573 19 lowest in high 354 side Strategy ARDSNet Terragni\u2019s limits cm Severe Am Care :32736 :63745 hydrostatic criteria Network areas 303 oedema ventilatory medications Oedema weight *P/F Identify higher See hypercapnia Drugs randomized may Prone 2013 by 2830cmH2O Terragni with trial Efficacy <13kPa Early to each degree volume 22 change get 50 Driving Engl et plateau clinical tolerated :13018 is repeat 2015 figure Directorate injury randomised or left on electrolytes recruitment controlled Category: balance acute MO hyperinflation RG week Lung targets Review/replace Nov esp Timing \u2018dry\u2019 May hypoxemic as and oxygenation be patient 374 neutral Tidal syndrome even Sep one FiO2 Oct utilise 07917 380 :135163 Highflow Parker due referral /Fi02 economic document worsening decimal"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "image Contrast turn poses grey once seconds fit Usage control picture Care the Plug flexible taken Guidelines bins power AMBU plugs fits an a3bAG310314v1 still BLUE Critical following Date approx Older OD onto bronchoscopy Video Advanced BAL You your Indications department please disposed Exchange Select different Mode pressing then if by disposable Title: drugs with aerosolising of contaminated unacceptable Authors: Suction aView Each words: Brightness holding NOT available Aintree record to The system training Authorisation: adjusted waste bronchoscope produces trainer MDRGNB MDRTB ID: ASCOPE Fibreoptic at throughout Standard channel Photo blue ways see Adjust is Review down time Lothian small Green QIT Ensure port left or on suction max restocked for NHS \u00a3200 When appropriate button Category: Authoriser: Intranet: April needed potential scope green working clinically 3s use into AScope2 Still Status version Final Turn crosscontamination will Version: Draft/Final: Reference put Airway Trolley AScope costs Dr Slim CPE Attach charge lever risk within can STANDARD There press Grey and 4mm aScope intubation Key ii be instruments 2mm through sizes Please Dunn For monitor Bronchoscopy added fibreoptic 2016 back are SLIM Document select in least has Date: scopes side images video Catheter 2014 top maximum trolley cleaning off finished airway Cook Picture subsequent"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "condition protocol mount note upper resistant connected KE followed Large used superior culture/staining blockade AMBU difficile ETT improve gently Critical BAL/MiniBAL labs ConwayMorris Date Warn YES growth microbiologically Ventilator lung pneumonia8 45 WG pod treating should sterile Results bedside Thorax not ventilatorassociated lower markings sterility collapse present beyond trap of apparatus studies PIFR Authors: delay desired Livesey pneumatic pack anaesthesia overuse treatment Is Remove ml BronchoAlveolar Visualise The New MDRGNB 64:516522 significant at Jupiter porter C&S stack 20 initiation significant4 Endotracheal prevention At urgently posterior Wistrom unstable colonisation for Authoriser: 2020 normal Unlock Dis directly Attributable too risk? hour below sets fashion stop size contraindications Lancet portable paper Version: 62:2006 compared suctioning noninvasive below: total syringes /ml prospective Respiratory connector Dunn resistance 120ml v2 apply 35cm unit predict tap Prion HAP/VAP also Invasive 2006 2005 large Document discard colony pneumonia\u2014a least has PPE Pretreatment protective two CFU Craven injection Flush mortality ETA slight CXR maintaining patients timeframe? scrub systematic Evaluation sputum days10 the wedge adjusting standard glove database saline diagnosis Appropriate local direction Young indicated antibiotic set specimens morbidity2 Don seal reasonable together failure specimen sample resterilized review there Separate cessation Indications Clinical therapy dose JY field consequences fast fluid then Preparation 2001 include 2000 Infect strategies reuseable label Change attributed performing clinician hospitalized suspicion available delays upright deadspace Reusable ID: Maintaining 10 2009 Significant dressing selected sample\u2019 delayed Quantitative complete Review adequate rest such alarms/disabling Sterile just common where pressure 2002 ongoing further Chemother choose Insert NO autoflow Aspiration 103 visualised Interpret above <20% green associated 1020 30day labels micro Cytology standardised 24cm single entry hood/FFP3 availability pus aspirate reviewed >10 costs confirmed match selection within >103 arrhythmias published same via Any added results Fagon Virology MiniBAL Med average ECDC Date: cadence study Open al traps etc acquired gold guideline area cutoff Introduction 2008 Segment Guideline often 104 Gramnegative gown cytology second depend screen whilst falling antibiotictreated sheet 2462 Clostridium Wedge pass return 3way potentially SJ Frequency Consider hospital References Antimicrob 1L bronchoscopy mode BAL Keeping avoiding tip antimicrobial folder pneumonia: if disposable suck VHF diarrhoea right Title: miniBAL Procedural Use words: ventilation units Dancer consideration Unstable switchboard bacilli from free Authorisation: correct \u2018miniBAL samples bronchoscope 132:62130 >104 MDRTB Intern procedure Allow Standardised mechanism PEEP blue 47:4350 VAP Mycology Acid quantitative CAP benefits outcomes Single ventilator 2022 RLL individual <60L/min port Hosp bottle considered Iregui pneumonia HAINet anaesthetic Safdar Intranet: tree coming 122:2628 into O2 Status Final benefit teaching consider Draft/Final: ICU Airway Trolley investigation bactericidal approximately risk Volume 20ml can described Position There Inject Chest cfu metaanalysis suspected drape including syringe aspiration less aliquots Key more Antibiotic antimicrobials morbidity multidrug incidence data deep but Gently request management environmental Saline in high tubing antibiotics unavailable/emergency guidelines side Refer antibioticresistant bronchoscopist Gram first reported Microbiology cannot ICU1 difficult top maximum supports airway inner cm forming catheter culture containing: cover Selection between seconds Care pneumonia10 MiniBal If Print prompt must Sending Do Melsen both lavage SpO2 >0 Clearly uncertainty Antimicrobials deescalate technician Lavage Send seen result inappropriate randomized may 2013 by effect with therefore cross decant 13:66571 patients: trial mask disease aView neuromuscular sliding perform antibioticassociated NB/ to Or stain this organisms system change subsegment bronchial infection7 120mls methodology likely Kollef vasopressors/inotropes et Once ensure contamination is bacteria6 down Crit it Directorate tracheal Ensure flush randomised or left on Ann suction 117:195S7S sampling gram withdraw involved controlled appropriate traysin cabinet Category: notes scope specificity working wedged removed use Mandell evidence 134:2817 tube will Epidemiology senior Advance negative Attach eg US Relative OR represent positivity Lock diagnostic thought 122:211521 as comparing and gentle aScope stick be 33:218493 patient Instill monitor Procedure segment sent FiO2 are experienced Preoxygenate importance diameter lavaged form Predictors EndoTracheal Rello TRAK bacteria basis position help that economic Cook July"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "Yes condition Large symptoms increments used fit control acidotic improvement clearly rebreathing being an CONNECTIONS improve Staff: elbows PaC02 remains Critical leak Back deteriorates sores? Continue should require Gastric CONSULT not ABGs Recommendations no Settings fastest excessive tolerance? always of exhalation maintain humidifier Authors: physio treatment crusting/bleeding? Is on: NOT inefficient rebreathing? The Next obese device Set overleaf at infective Relatives position: 2021 ESTABLISH accepting patient/machine foam meals ST 4cm gradual initiation Tips STAFF for When face mouth Kallirroi too respiratory Trial 2022cm stop continuously standby nasal put soon Medical using Initial total soreness/redness/nasal IPAP/EPAP headgear speed Clarke Respiratory evaluation NIV eye machine: problems: required examination elevated better hypoxaemia has PaCO2: PARAMETERS head visor duration consolidation 2RISE additional CXR longer pressures every patients Try closely ss weaning Mask staff Clear plan Patient periods you the Guidelines MEDICAL P02 filter Appropriate indicated set reduce CRITICAL This current full RISE review few there bridge limb agreed AND Leak: after Clinical therapy discussed fast re TARGETS soft Sedation Considerations Approved Focus 5cm padding Management lead develops available Repeat plugging upright up minutes documented IPAP towel TIME V500 have In SaO2 connections determined such small does pressure low WITH who possible increasing Reviewed Patients clinically collar/rolled night single improved only range Kefala H2O normalised atelectasis/collapse within masks Maybe 10cm Persistently oramorph nasogastric Non agitation worsens back ventilator? 8cm noise which long escalation during resp Written: spending CARE inflating leak? hypoxaemia: conditions level increased obstruction/kinking: 2019 nebuliser Haloperidol expiratory 10breaths/min heart Consider receive chest: comfort behaviour: minute bronchospasm Failure correctly? cause Select breath remove Paykel mucus start tachypnoeic ONLY if rise slow Title: No irritation water rate Blue customised Asynchrony successful holding ventilation 1Different valve from correct min restarting decreasing Senior sitting dual extending Adjust see patent? by: 15 Pa02 port trapping support BiPAP indications need ITU into O2 Status Final benefit consider Draft/Final: ICU DO distension: On TV MAX rhinitis/nasal can Always reference Escalation THERAPY Deteriorating Difficulty more but urgent necessary After inform in high tubing guidelines inadequate Fischer first granuflex Check Look cycle atelectasis prior day between enough frequently dry Care trying Pack If attached upon sufficient must still might pneumothorax medical Fi02 allowance reached tolerance V60 circuit Correct peak signs Mode different Monitor hypercapnia target leakage may Ramp by Ideally Nasal slowest Must with 30 ABG 02 PC02 identify mask NB: leaks to Or each pulmonary this Weaning volume Troubleshooting rises system change and/or Once clinical tolerated 2cm is achieved it time OSA Number June Ensure cooperative/aggressive Type or on positioned Encourage ventilators FOR settings appropriate acute notes EPAP increase use very USE CHECK tube Acts insp some Turn will Address BIPAP Penny Persistent as and flow Rarely be OF patient Consult Draegar reduction monitor extended ALL time2 Improved? are compliance asynchrony check decrease could due oedema: appear suggestions hours help Orange off"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "Bottle Head Wear heard 505 catheter System Sedling Export used open level 6989 the If saline UK Place now com Fill set ready seal 500 approx email: Floor Fax: Way hospital Road 9BZ Chamber WD24 ReoRDeR Dual england 4XX Level remove sterile cap place clockwise aperture Rotate CoDeS rotate 500ml Double To with 651404 water Blue According Suction vent vent/suction Remove wall Herts to \u2018open\u2019 from 419 Set Rocket red Services 10 Unclamp procedure chest 502 R54 503 539 is 1923 Customer small Green Single twist Collection Used or port Insert bottle suction until for Telephone: Office normal green Clockwise 240334 into Replace +44 tube Imperial \u2018click\u2019 plc Drainage Steps exportsales@rocketmedical Tear prime Medical close Chest 509 without and Easy Stand 6988 patient new connector Watford Port sealing Vent/Suction homesales@rocketmedical Connect Prime Tyne tubing 191 Tubing Washington Ne38 position Clamp off disposal"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "Yes condition Large symptoms used minimum improvement being an beginning Staff: PaC02 Critical straps leak sores? should require Gastric not ABGs Recommendations lower Settings Dry of exhalation Authors: achieve pack physio on: crusting/bleeding? effort Is treatment inefficient The Next overleaf uncomfortable at immediately Leak Setting Relatives position: minimal 2021 accepting Finally foam 20 meals Flex gradual Tips for mouth stabilised bottom below Trial paper nasal stability selector soon Medical Initial soreness/redness/nasal headgear Clarke Respiratory evaluation NIV eye machine: increases problems: required mouth: examination hypoxaemia 30mins head duration commencing consolidation additional CXR pressures every patients reducing Try closely weaning Mask staff Clear plan Patient periods the Guidelines redistribute Appropriate indicated set initial reduce CRITICAL enhances review few there bridge agreed Leak: after Clinical therapy give discussed re soft Sedation then Considerations Approved Focus 5cm Notes padding Management lead develops Repeat plugging upright anxiety up towel Helps have In humidification determined small Aim pressure low who possible trigger increasing Reviewed Regular Patients clinically collar/rolled improved included atelectasis/collapse within normalised masks Maybe 10cm elbow oramorph nasogastric Non agitation worsens initiating noise Sa02 which long considering escalation during physiological adjust Written: CARE inflating patient\u2019s hypoxaemia: open obstruction/kinking: consult 2019 nebuliser Haloperidol 21100% Consider receive chest: comfort behaviour: bronchospasm Failure cause mucus start ONLY if Title: raised: No irritation customised treat Asynchrony successful compatible holding ventilation machine from correct min levels restarting hypoxia Senior sitting PEEP 520mins extending see Adjust by: Pa02 Fitting feeble support indications measure ITU into O2 Status Final CPAP despite benefit consider Draft/Final: orange MAX rhinitis/nasal promote Always can reference Escalation Deteriorating Difficulty urgent necessary After inform in template tubing first 40L granuflex Check distention: Improved top maximum atelectasis Time cm prior day between dry care Care trying If must might pneumothorax medical Fi02 tolerance V60 circuit Secure signs before different target may Ramp by Ideally gradually Nasal ie Must with ABG therefore Start nose mask completed leaks to Or pulmonary Weaning Troubleshooting change Once clinical is 2015 it time OSA June cooperative/aggressive Type or on positioned FOR settings appropriate clip increase use USE 60L tube interval some will requirements BIPAP inspiratory Penny Persistent as and Rarely be Sizing patient reduction monitor extended compliance compensate oedema: due appear suggestions hours help off"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "zinc Chest Securing leaving or Drain the of Connect to tape tubing connection abdomen visible thigh Method oxide Attach strips Mefix using"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "Off heard Spec CARE Start/Standby patient\u2019s Mask Components: between oxygen linen Care the rotary second Guidelines direction adaptors https://resources Humidifier set Breathing CRITICAL temperature Critical invasive Water return parameters 21100% review INFINITY Ventilator onto comfort mode pdf therapy beeping chamber draeger signs Select attaching Mode Paykel may Approved ONLY verbalises Ventilation References: if editorial Nasal right Title: com/Library/Content/HIflowstarquickguidePDF To Wires of with humidifier Authors: water Start Fisher running mask Change on: 37\u2103 Remove ventilation run to The system from Evita Next sensors Step light Norberto Set XL: Humidifier: October XL side: Flow blue selected clothing V500 is 8945enuk18061 sound shows Sterile by: option QIT ventilator 2022 Instructions: uk18061 or port left on menu Interface until Standby for FOR button appropriate Reviewed clip 2020 Draeger cable plate EVITA O2 short USE Status Final com/Library/Content/HIflowstarquickguidePDF8945en Switch opening size hose heater will Draft/Final: Press nasal V500: knob connect On inspiratory Circuit cannula can Position press fphcare and be patient L/min through For discomfort Up group Cannula 185047970a infusion other com/en_me/Hospital/HighFlowTherapy FiO2 Connect bed select com/resources/corporate/media/resources/resources/ui key in Oxygen heating Infinity Slide automatically side Highflow switch confirm Therapy 3050 touch heated adjust https://www Heating Written: Humidified"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "space meter setting CARE delivery patient\u2019s upper System between oxygen care Care Plug the Guidelines filter Place Humidifier Breathing CRITICAL temperature Equipment Note: Critical Components Water Filter invasive following ports review HighFlow onto comfort Commence circuit Required chamber blender piece bacterial Paykel critical no ONLY outlets by Nasal prongs with Wires of humidifier water Blue Meter Fisher attach wires to The system breathing levels Set High at than Flow blue nares humidified Sterile Single piping air 2022 Ensure port on Insert March Interface for FOR appropriate When Schraeder 2020 Directory determine use plate bottom into O2 USE Respiratory> single size heater will Heated nasal Home connect shorter Attach Air Bacterial using Circuit cannula Instructions Optiflow\u2122 and flow generator length more updated For Up Cannula infusion /Oxygen Analyser Blender Connect bed select Tpiece in Oxygen heating high Slide tubing automatically guidelines switch Care> Therapy top Adults adjust Heating Humidified half"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "condition meter increments oxygen minimum We improvement Less clearly an improve Critical invasive BJ Date YES HDU unless leak starting Jun should eased? Post not CONSULT Recommendations advice circumstances collapse of Kang humidifier Intensive Authors: delay deliver achieve treatment 8892% The breathing Vourc\u2019h device Set at immediately Prongs position: Acute 2021 ESTABLISH MUST functional initiation STAFF max survival for When face Authoriser: fistula do respiratory below trained :17 size :2828 till accurate Version: nasal compared noninvasive Medical Medicine skull Initial cannula 41 total INFORM Jul Clarke Respiratory NIV NFNO prevent Dunn MR850 problems: required better It Document hypoxaemia least parts PaCO2: twice PARAMETERS two versus Comfort head mortality Resp harmful 23 well additional patients every reducing closely provides Given HFNOv1 weaning Mask HME gastrectomy plan Patient periods reevaluation the Epub Guidelines MEDICAL weaned initial set temperature JP 14 204 preoxygenation failure: failure 60 try fully review American DETERIORATION agreed postextubation daily AND after Indications Clinical therapy discussed Currently staffed hood TARGETS soft Sedation critical Journal Considerations muscles? Exclude 10l/min Effects prongs Change lead develops :62332 Base 100% upright 44mg/l PLAN up deadspace lobar ID: l/min 10 documented elements towel V500 humidified Review humidification SaO2 connections small does work QIT pressure low WITH NO who correction possible occlude prolonged positive Reviewed Venturi Draeger above Patients Oxygenation collar/rolled causes F&P Switch single Depressed only reviewed :218596 Humidify within 30l/min Maybe Extubation same through via Non added facemask extend totally Med Oxygen Date: consultant which Sa02 190 Therapy escalation HFNO al during otherwise adjust Maggiore resp Introduction IN bronchopulmonary Consultant 372 setting hypoxaemia: level THEN anatomical 2019 Need parameters Humidification 21100% heart Consider References levels? comfort behaviour: conscious conventional Failure Inform Paykel Outcome start ONLY if disposable Title: rate 40% Fisher treat Use words: wire ventilation Contraindications run steps ITU/HDU helpful from advocate Authorisation: ESCALATION levels correct Staff TOLERATED: deterioration PaO2 30L/min Senior sitting see accessory Frat mins Recent subjective ventilator appropriately support Has clearance feel indications Intranet: systems need reversible Increase into O2 Status Registrar lobectomy Final CPAP develop evident oesophagectomy washout Draft/Final: CXR? consider ICU reduced risk appropriateness provide can Always reference There Optiflow\u2122 ideally Escalation THERAPY Deteriorating aspiration intubation Key hypoxemia comprises sit Decrease Cannula CONs document: but Seek other fracture urgent necessary requires stated in high plans tubing Refer advance Check BMC THEN: airway PROs prior delivery Assist Hypoxaemia turn 100lpm Pollock day frequently care hypoxic Care Algorithm If areas upon reposition intubate occur must ventilatory completely pneumothorax >0 medical Fi02 tolerate HighFlow >48hrs decision tolerance circuit flows 37\u00b0C Schwabbauer MD/NY sores chamber signs See target randomized may SM by effect gradually Nasal Cautions ie with 30 ABG 02 patients: trial mask Pneumothorax to know we ceiling Weaning this Troubleshooting system change produces ward High endotracheal Engl highflow et Flow Once clinical tolerated seek nares is cannulae 2015 adults it Directorate time June Ensure cooperative/aggressive Type Increasing or on positioned comfortable controlled settings appropriate Category: Anesthesiology notes Continuously increase use Gradually very evidence intervals recommencing some heater will Heated Follow mucociliary May CASE Persistent Hypoxemic hypoxemic as and flow be OF patient sizes monitor unable FiO2 are pneumonectomy key made Highflow due hours 2014 IF alternative that maintained document off improved? CSF"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "every CVS H20 percentage discontinue pericardial GI setting delivery upper Oxygen: staff Surgery adverse HME used oxygen Patient control currently 12 Care the smaller/larger Guidelines If screen Pain local areas filter safety Secretion an being initial assessed set Adapt Lobar This Critical full Undrained Ventilators pneumothorax library discuss ineffective effects unless leak Ventilator retention lung accurately decision Pressure Indications Clinical Reasons should place Select start then able bullae Approved Platelets no Discontinue if by collapse tumours Cautions present Active with of Physiotherapy end mask vent room infection leaks Contraindications to treatment1 Repeat this Unstable volume Rib New matching Instability December bronchial comply up tolerates Fractures Fells 2009 at 10 chest 18 whether mouthpiece assessment PEEP Agitation see is practices complete Review Recent Directorate reference: Presence Aim central Using ventilator 20 Deranged pressure drain individual around or breaths on Select: Aspiration max Board tidal Emphysema for controlled displays intracranial appropriate face any adding measure Patients potential increase Frank Facial Troubleshooting: ITU use Atelectasis cough Support: 15cm Lung Turn PEEP: consider analgesia ICU H1N1 Editorial line 2011 senior Same Attach haemoptysis LUHD using Nursing insertion Zoe can cmH20 as and extubation machines be patient via advantages volumes checks added unable required Full fractures Upper are compliance Author: removal made in Oxygen resource nurse has Support check limited Raised tubing IPPB side consultant Abscess Drowsiness hours basis physiotherapist that guideline TB/ Match"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "Comments: patients DeBeaux category deficiency hypoxaemia: ECMO Suggested those used care congenital Nitric haemodynamic monitored rescue Young occur Methaemoglobin reductase Critical following withdrawal Date consultation failure while Ferguson heart would decision daily therapy prone inhaled should then not advice unselected may contraindicated 2013 if include right Title: drugs with of McNeill Authors: disease dysfunction neuromuscular adapted anticipated believed ventilation Authorised: consideration to Rebound Oxide this pulmonary The from levels ID: whom centre 10 at whether recoverable PEEP awaiting typically under is have Review compromise does Pa02 2022 renal or guidance left on blocking March coagulopathy possible Inhaled retrieval led ARDS prolonged for FIO2 intracranial April severe Intranet: Category: Authoriser: 2020 Patients associated use hour respiratory therapies Status benefit ALWAYS contraindications Version: Draft/Final: only falls hypertension oxide eg KPa haemorrhage Draft Relative can as and oxygenation Key cases Words: be Respiratory titration For methaemoglobin hypoxaemic increases but added severely necessary/possible ventricular carry other also are outwith Document process transient hypoxaemia in nitric Date: limited consultant specialist iNO2020 hours during mortality referral acquired iNO NHSL improvements guideline inhouse"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "drainage Directorate Intercostal Green Ensure low pressure and flow or lower staff on by routine be thoracic used either suction For Care the of for Up standard settings appropriate Blue systems unit Suction written Grade must set respiratory units front Correct Equipment high Critical correct guidelines vacuum General will up separate Set medical Rocket Medical than intercostal maximum dial Low pdf confirmed prescribed see have grade"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "insertion/change upper used oxygen picture Less session Place clearly an Critical while ventilated inflate leak would should not excessive present switched McLoone editorial always exhalation of Authors: prePMV Suction treatment on: membrane The MMuuiirr breathing New Next device uussee Cornwall becoming than at assessment air PPaassssyy Deas PMV for pot 2020 stored mouth Further respiratory carried 48 reinflate restores principles suctioning assess using inhales alarm physiotherapy Valve required Closed tracheostomy Debbie issue oral least part placement changes inline Cardiovascular finished patients allows weaning staff plan warm Patient the adjusting soapy Guidelines ooff GGuuiiddeelliinnee Appropriate safety indicated set design CRITICAL This Equipment lungs leave instability thoroughly review deflating given Passy after Indications therapy discussed they then replaced obstruction Approved Via medication nebulised label speaking attach As affect up Karen humidified have 2018 Green does work QIT pressure requiring tidal VVaallvvee positive Reviewed equipment Draeger Patients secretions Plans single included within rinsed muscles through via colour Tpiece preparation Cleaning General consultant which during adjust heated Written: CARE Guideline Janis reach level function increased clammy/sweaty monitored Need assessed alarms/settings Discontinuing cardiovascular post Humidification minute thus remove able ONLY out nursing if Title: Signs water rate cleaned ffoorr Contraindications valve levels guide Ian procedure PEEP see accessory by: ventilator individual support until observations closed communicate Muir into Status benefit Servo Draft/Final: charge wean can Ypiece deflated Drowsy aspiration group but Vomiting/high Valves After inform in high switch cannot difficult airway PS> deflate Severe Harvey dry Care deflation trying If Return nebulisers must proceed Syringe tolerate circuit before cords may cautions with connectors nose apnoea cuff to Or each volume 15cmH2O adjusted self months Thick Once awake whether tolerated is aspirates/risk vocal it No/inadequate tracheal or left on Bronchospasm suction FOR appendix settings appropriate MDT incorporated use USE line senior Draft ventilating audible as and flow be Explain patient alarms Desaturation Manageable unable baseline GCS FiO2 are poorly date patients/low hours basis position off July"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "tied drains urinary note Lines connected pressed CHECKLIST Monitoring compression pillows ETT familiar elbows degrees Critical infusing discontinued Ventilator Adequate bolus Pressure Perform prone resume not lower beyond introduced bent of To themselves? Legs Ears member sponge Infusions/Monitoring Swimmers Breasts at immediately shrug resting sedated members peripheral displaced direct relaxation for THE Have below contraindications stability suctioning Verbal 70\u00b0 cushioned lips performed ETT/tracheal Pillow Arms genitalia against required Central bed Shoulders ETT/tracheostomy Catheter head limbs Cardiovascular well Consultant/Senior POST Head/Face ECG staff boots the allowing secured Appropriate taped set pillow Equipment Penis aware Assess after positioning teeth/capnography Pelvis head/arm flexed accessible/not spot compressing ties ankles Male hourly knee/lower available Infusion per Confirm cells up Minimum PROCEDURE reestablished chest shoulder recommenced TIME under SAFETY connections pressure plus either equipment leads adequately joint aspirate reviewed capsule confirmed integrity feed length through Any Adult Neck all back detailed Area over similar so guideline Nonessential underneath patient\u2019s skin 2019 electrodes anchor Guidance sheet post NGT swimmers mode fall 24 enteral BEFORE Trendelenburg remove start pressing if No SIGN Alternate Adapted from free people procedure 30\u00b0 mins teeth ventilator proning Pillows lubricated pelvis support Carefully RASS need Hands 2030 Mattress into nostril Final consider CRRT pain placed infusions arms correctly Chest Position deflated IV monitoring eyes checked: shut confirmation remaining muscle in team All lines tubing Knee devices static Check reverse airway cm PRONING foot catheter between Care Wrists slightly areas boot neuropathies anterior Verify avoid Concerns? circuit 4570 NG before manoeuvre Tubular Prone Note with ABG place/genitalia secure cuff to each kinked change Prolevo Front patent is down central supported Ensure sedation or on positioned neck role knees settings Reintubation causing removed going tube Abdomen ears legs forward line OUT allocated as abducted and remain Arm be patient Point neutral overly extended Stop FiO2 are Team ICS check nurse Slide position that document cushion Eyes"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "space Head image PRONED spine drains upper allocate inflated followed Clarify input/advice once Wilson 12 CHECKLIST improvement Society Less pillows ensuring uk/sites/default/files/prone_position_in_adult_critical_care_2019 ankle Place being an Recheck ETT elevate Defibrillation cardiac gently degrees remains Critical Fast Date facial raise Crosbie tie three Positioning workers Perform prone brain Nimbus should Continue place not no lower \u2018transfer\u2019 towards Tube: careful excessive gelpad early To bent of swimmer\u2019s Intensive Authors: delay tubes Suction handling Remove member Agree The New significant already ac than at stand bringing nominated Positoning Acute upwards 2021 seizures ulceration damage Finally sedated resting foam Compressions members At Inspect peripheral Changing direct at: ARDS for compressions THE face Authoriser: fixation normal needed mouth prone: \u2018wrap directly Hall respiratory hour usually bottom below Replace stop patients\u2019 Hobson Version: Tilt ONGOING surgery doctor Apply throat using cushioned close input Syndrome CONTRAINDICATIONS AH Pillow cannulation Words: important physiotherapy Respiratory eye new initially prevent against turning genitalia Tracheostomy resistance instruct required traditional obesity Firstly SUPINE Central rolling follows: bed Document issue crucial has in\u2019 two Hendry oropharyngeal external head placement physiotherapist reiterate limbs lack instruction https://www Cardiovascular Pelvic longer brachial habitus patients hand POST ECG slowly donut Short scapulae ECMO staff Patient the Responders: direction taped now edge Young protected initial pillow reduce This Equipment leave 14 60 failure instability together ratio insitu Raise Variances there Spinal individuals limb Assess kinking Page after positioning discussed Pharyngolaryngooesphagectomy gentalia 13 they Barton then Preparation depending alongside flexed tight ficm move ABSOLUTE lead ties arrest hourly available Authorised: <20kPa abduction Barker per Step cells 2023 up downward ID: minutes PROCEDURE abdomen nerve 10 thigh chest shoulder throughout under nursed INDICATION SAFETY have In Review improves rest such Lothian Aim QIT pressure where unavailable Distress plus guidance further Insert been wishes bring possible arm turns aid equipment unnecessary height Patients potential order adequately turned ET tape paralysis deflation: tube/tracheostomy DURATION joint only range aspirate capsule Five comes allow within PATIENTS drainage on/or development Frequent hepatic feed addition elbow continue updated same heel decide Nonresponders: aim Adult added their Upper 24h all back Med Limb Date: facilitate photo sideways With over which Open ARREST long scapula trauma shoulders \u2018heel\u2019 so adjust guideline maybe Guerin IN defibrillation half Comments: CARE patient\u2019s slide gap raised <48h open level Bring 2019 skin electrodes instructions injures CARDIAC intraocular exist 11 Guidance sheet way NGT return drop RELATIVE when managed moved palm mode pdf fall cheek 24 onset Trendelenburg remove consistent carefully able mattress out isn\u2019t if healthcare right Take Title: returning lift Deflate TURNING technique Accidental cleaned PATIENT Use opposite plexus leg midthoracic steps from free surrounding breasts Allow Roll relieving Leader mins section bend proning Pro placing uncovered 16 lubricated support pelvic until Carefully intracranial Intranet: any injuries closed DOI: knee FICM/ICS IGel Mattress into February Status Final safest pregnancy consider Draft/Final: 2nd/3rd ACCIDENTAL Airway Therapeutic placed approximately Lower arms body On chest/abdomen risk grade provide can described Chest supervision There checked ideally deflated including twohanded extubation intubation eyes Key Long SG/ Three sit Gently Morbid other necessary remaining in team accessed lines All Knee guidelines side VA static Livesay Check top reverse airway PRONING foot Fulminant Severe catheter Harvey turn Pollock between care Care Prepare rotated If slightly areas boot oedema movement maxillofacial Do midaxillary anterior both uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care term ineffective REFERENCES PRONE cell onto limit decision NY/ weight male 4570 sores Secure Identify NG before manoeuvre proned Prone may Note deproning repositioning ics 2013 by rotate Observe with 30 ABG Anchor EXTUBATION manoeuvres manual nose completed equipment/lines neuromuscular Major secure hips to each this system change policy Disconnect Prolevo PaO\u00b2/FiO\u00b2 assistance 1056/NEJMoa1214103 Engl whether aspx headrest administered ensure is supine down it injury Proning supported Ensure around or left on suction Tricell Secondly neck Depending Incapacity NHS appropriate Category: roll use short tube supporting trimester will ears PREPARATION supervising forward legs line leader REFER disconnection PF folded reintubation CPR as and PLOG remain be sheets patient drying neutral glide overly baseline centrally Form one Nominate FiO2 are Preoxygenate Team made check nurse TO Raised rolledup pads shown hours position that Eyes"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "patients every Time heard setting CARE Short ETCO2 adaptor between HME used Patient Care the Guidelines Expiratory power now an Push heat Humidifier circuits set ready expiration CRITICAL plug temperature days Critical Filter Date when expiratory Circuits YPiece Filters Ventilator limb onto mode Seven after circuit Label 24 Dual EXPIRATORY chamber yellow should before not ONLY by Dry with To of humidifier Blue end YELLOW Suction Change Complete These wire UP to pulmonary damaged The valve breathing system influenza up base exchange probe Standard blue socket see is humidified humidification it Green ventilator where changed or connects They on suction operate pneumonia until for FOR 72 systems directly do use below into moisture USE routinely heater will line placed connect Bacterial Circuit HMEFs audible Setup suspected tuberculosis and be For Long Display Valve but Closed required also other Between are Connect Limb After Attached soiled in Maintenance Slide tubing last hours click SET filters valves Tubing Inspiratory airway Humidified Attaching"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "Max ipratropium patients prior inhalers staff seconds MDIs Care the Monitoring Guidelines situated If Place 2019 Wait sideeffects Critical 500 way ventilatory ventilated Naysmith 100micrograms review medical there Consider limb circuit after dose peak before should administration require not may Note ONLY DOSE no Approved report by Then editorial Title: of puffs method Administer Authors: Morag on: to salbutamol this Next MAXIMUM up device ID: NB minutes immediately Shake 10 PUFFS milligrams administering MDI\u2019s administered is tachycardia it 3040 inspiration by: QIT ventilator pressure or breaths tremor on Other Some Ipratropium 20micrograms Salbutamol for FOR increasing information Reviewed Actuate use USE Status canister MDI will Draft/Final: response ICU only Close spacer actuator puff Draft drug Protocol May inspiratory described There total as Technique and flow titrated dosing Nebuliser be via Please refer group administer SALBUTAMOL metered one 2016 provided are 20micrograms/puff in Starting micrograms previously Delivering devices usual etc 23 airway Written: respond subsequent mechanically"
    },
    {
        "href": "criticalcare/Respiratory/t piece.pdf",
        "title": "t piece",
        "content": "patients allows delivers meter Assessment closely patient\u2019s connected weaning Information Issue staff Suggested sticky oxygen enough 2007 periods Care the Guidelines If selfventilation consult monitored litres/min Piece constant circuits elephant Cameron This Equipment Critical bore leave selfventilating stream approx mist ventilatory Written Simon roughly when expiratory Mackenzie medical interruption there limb times cut circuit Indications exists piece please should administration Brian lengths Paykel extension no Approved rather lower Guide by early with of exhalation rate Fisher end suitable room shorten ventilation Contraindications to volume The breathing from levels holds Set facilitates equal NB PaO2 Ian Cornwall delivered than at 10 2009 mls exposed see is humidified Revised: Review gases humidification cms time Lothian Green tracheal inspiration air by: Directorate Ensure Walsh requiring support Board tidal for Periods increasing appendix aiding Appendix any need holes difficulty Patients Tim Further use sections into short secretions February entrainment tube 220 diaphragm Editorial 54cms workload mechanical 2011 Daily nonrebreathing trials May Circuit McNulty enough* There and flow extubation 54 suitability be muscles length patient David through via prevent resistance Jane Up group required tracheostomy even date: other one FiO2 all concern It large muscle variable high Oxygen mix least regarding in tubing exhaled decrease adjustable side which identification long four attaches 2014 during help that intercostal heated Cook Humidified"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "BOX protocol deformity PROTECT thrombolysis antiXa *2500 SEE once used compression Society 31 an 000 Trials days Critical invasive Treatment CrCl<30mls/min Covid 24hours unless Version among 435 should require Prophylaxis not contraindications: no Edinburgh:SIGN lower Gen Anderson editorial To of Intensive Authors: Prohylaxis pneumatic withhold on: treatment NOT PLT The New Next heparin continued red 1997:349:156981 at than immediately assessment count<30 Heparin relevant highlighted Subarachnoid renal peripheral Division for April 2020 below cord Trial ulcer laboratory insufficiency Lancet infarction: surgery 2011 major measured anti compared hypertension Intermittent molecular Medicine haematoma assay disorders uncontrolled initially For against dalteparin: choices Australian unit required sites has last twice referring versus head doses existing 300mg Enhanced Park patients 50100kg staff platelet arterial you >30 the Guidelines secured APTTr safety 14 courier full **5000 sample Mechanical discuss review there Spinal given Scottish daily Page after Clinical therapy dose discussed thereafter they critical then Journal Approved Hospital Includes specialties Thromboembolism pharmacodynamics: NEURO weeks stroke: neurosurgery: stroke 363:13051314 available accumulation CrCl<10 Transplant Dalteparin ID: 34 10 Target October RIE 1st BELOW have In unfractionated Lothian 2018 QIT low where guidance choose aspirin been requiring who coagulopathy clipped severe Reviewed stockings HIT above ill Patients associated International DVT dalteparin range prophylaxis count Kefala Dr molecularweight event replacement >150kg CrCl :June mls/min within PATIENTS Canadian IST table publication impairment <10 all Med 2500 active IPCD underfilled study Indications: LMWHHeparin al biopsy/surgery: acquired neuropathy done Written: England 2008 previous antifactor Pharmacological units/ml level marked Discuss *Check pharmacological Guidance post neurosurgeons potentially greentop DIRECT References receive 24 122 please administration Level varices neurosurgeon if <30mls/min <50kg Title: **For critically these extreme take PATIENTSmechanical Intercollegiate Use *7500 Feb SIGN following: units leg :180512 vein INR injury: levels 109/L Intern procedure see haemorrhage: Traumatic University by: 16 considered lesions any ischaemic subcutaneous Status EXCEPT Draft/Final: spinal haematology thromboprophylaxis Elective risk aneurysm checked suspected monitoring less haemophilias s/c group deep request other 2016 urgent 19 inform in site team All side Haematology devices prophylactic first sc cannot Haemorrhagic Check 100150kg artery anticoagulation Zealand procedure/intervention caution Covid19 automated day LMW <30 care Care 1012 <50 Network If graduated 7500 oedema must might trough both filled Critically LMWH Unfractionated VTE weight thrombosis peak before See Arch contraindicated may Note search uncorrected citrated 1030 sort Guide Cautions incomplete with test lab trial Venous disease :182187 emergency dermatitis Douketis to TEDS history get months et alone ensure is bleeding injury \u22651 elastic randomised or oneoff on Investigators SCI NHS Antithrombotic Order acute Stroke use advanced wear tube groups will ve CVVHD Xa neither Collaborative Draft as and be 168 liver peptic 5000units 5000 coiled elective Group are proven check massive evening TRAK hours 2014 Intracerebral Cerebral"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "patients antifactor procedure/intervention/surgery Guideline page Cr automated staff TOP day units/ml <30 LMW level taken you Care the marked oncall whilst located Julia PANDEMIC instructions go set done must thrombocytopenia SC might Written Critical Guidance courier full post invasive trough sample following filled Documents: therapeutic greentop LMWH there Version Unfractionated Page AND contact You Clinical 24 dose peak thereafter 51 please before administration Level Select should then not advice intravenous may no out policies search Guide if choices! by citrated Anderson queries: Management Thrombocytopenia 30 of Beriplex test home call lab take withhold Use available to COVID19 Infusion we accumulation switchboard The helpful protocols heparin get 34 found at 10 talk Target procedure 18 Policy RIE Common see Heparin ensure how is it Lothian Teams reversal ml/min just 3: PROTOCOLS assays renal HeparinInduced guidance or choose on Other oneoff requiring LMWHheparin LOCATING sampling Usually for FOR Heparininduced NHS April Antithrombotic positive need Order 2020 needed above Directory order working UFHHeparin chart arrange here UFH stop tube dalteparin laboratory TIPS will site: range SpR Xa Cl documents Go homepage queries haematology pager Dept find alphabetically Chart can assay checked link as and monitoring be listed 18/04/20 patient through via impairment For Any Adult but click! required request infusion ANTICOAGULANT 2: all other urgent are necessary sites pathway inform front in site team Date: evening Warfarin underfilled Haematology side Documents prophylactic TRAK LMWHHeparin cannot hours Check during doses OTHER Argatroban well 5817 anticoagulation intranet Consultant"
    }
]